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Abstract 
In recent years increasing evidence has established microRNAs as critical regulators of 
neuronal development and plasticity that can act locally, in an activity-dependent manner. 
The hypoxia-regulated microRNA-210 (miR-210) is a highly conserved miRNA, widely 
studied for its role in regulating cellular response to low oxygen conditions. Previously, our 
lab identified miR-210 to be involved in honeybee learning and memory using olfactory 
conditioning indicating it may have a role in neuronal function as well. Within the nervous 
system, miR-210 dysregulation has also been associated with epilepsy, being significantly 
upregulated in rodent temporal lobe epilepsy models and with Alzheimer’s disease (AD), 
being significantly downregulated in brain tissue and cerebrospinal fluid of AD patients. 
This project aimed to further investigate the role of miR-210 in mammalian neuronal 
plasticity both in vitro and in vivo using various molecular, cellular and behavioural 
techniques to identify neuronal regulatory targets of miR-210, determine neuronal 
expression and induction of miR-210 and functionally characterise the effects of miR-210 
dysregulation.  
 Using a biotin pull-down approach in the human-derived SH-SY5Y neuroblastoma 
cell line, 620 unique target genes of miR-210 were experimentally identified by RNAseq. 
Among these targets there was a significant enrichment of neurodegenerative KEGG 
pathways including Huntington’s, Alzheimer’s and Parkinson’s disease as well as a 
number of specific genes known to be regulated by neuronal activity and with neural-
plasticity function. Using dual-luciferase assay validation, miR-210 was shown to directly 
interact with and down-regulate a number of oxidative phosphorylation genes associated 
with neurodegeneration (ATP5G2, ATP5D, COX8A, COX6A1, NDUFS7, NDUFS8, 
NDUFA4L2, CYC1), as well as MAPK/VEGF signalling genes (EIF4EBP1, MAP2K2, 
VEGFB) and genes with a known role in synaptic function or plasticity (GRINA, AP2S1, 
TMUB1, ATP6V0C, ACTB). Differentiated SH-SY5Y cells were also used as a human 
neuronal-like model to examine effects of miR-210 dysregulation and measures related to 
cellular metabolism, including generation of reactive oxygen species and mitochondrial 
membrane potential, were found to be altered. To further elucidate the regulation and role 
of miR-210 in endogenous neuronal systems, an in vitro neuronal model was established 
from primary mouse hippocampal cultures and a conditional neuronal knockout mouse line 
(miR-210-/-;Nestin-Cre) was generated. In wild-type hippocampal cultures quantification of 
miR-210 following (K+)-induced activity found that miR-210 expression was induced in 
response to neuronal activation. Quantification in vivo also found miR-210 displayed 
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expression relevant to learning and memory, being significantly increased within the 
mouse hippocampus compared to other brain regions. Analysis of hippocampal neurons 
cultured from miR-210-/-;Nestin-Cre mice and littermate controls (miR-210loxP/loxP) found 
miR-210 knockout also disrupted neuronal metabolism and altered dendritic morphology in 
vitro. To assess cognitive performance of mice, visual discrimination and reversal learning 
tasks were conducted using touchscreen operant conditioning and miR-210-/-;Nestin-Cre 
mice found to display reduced perseverative behaviour and increased motivation during 
reversal learning.  
 This data provides the first characterisation of mammalian miR-210 neuronal 
function both in vitro and in vivo and has highlighted novel targeting pathways of miR-210 
as well as potential functional roles of miR-210 in neuronal plasticity. Identifying the 
molecular links between neuronal activation, altered metabolism and plasticity is critical to 
understanding how dysregulated metabolism may lead to cognitive deficits in 
neurodegenerative conditions and characterising genes such as miR-210, and other 
sensors of metabolism, provides insight into mechanisms translating environmental signal 
into neural response. 
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INTRODUCTION 
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1.1 General Introduction 
One of the fundamental questions of neuroscience research aims to understand the 
biological basis of cognitive function and the biochemical and structural changes that allow 
for continual memory acquisition, retention and behavioural adaptation. Neuronal plasticity 
defines all aspects of neural adaption required for learning and memory from network 
reorganisation to alteration of synaptic strength (Bi & Poo 1998; Engert & Bonhoeffer 
1999; Markram et al. 1997). All forms of long-lasting plasticity within the brain have a 
requirement for new protein synthesis, which can occur in a targeted and localised manner 
in response to neuronal stimuli or sensory input (Frey et al. 1996; Frey et al. 1989; 
Steward & Schuman 2003). Changes in protein expression, induced in defined spatial and 
temporal patterns, are dependent on highly coordinated and complex translational 
regulation (Costa-Mattioli et al. 2005; Costa-Mattioli et al. 2007; Dyer & Sossin 2000; 
Pinkstaff et al. 2001). Elucidating the regulatory mechanisms involved in neuronal plasticity 
and how they may be disrupted is crucial to understanding learning and memory as well as 
neurological disorders affecting cognition where regulatory pathways may be disrupted 
(Ben-Sasson et al. 2009; Mclean et al. 1999; Ozonoff et al. 1991; Terry et al. 1991). While 
a number of these mechanisms have been identified and are well characterised our 
knowledge of neuroplasticity transcriptional regulation is not complete and it’s likely that 
numerous, novel pathways and mechanisms remain to be identified. MicroRNAs (miRNAs) 
represent an important class of small regulatory RNA, enriched within the nervous system, 
that are capable of repressing translation of a large number of target, messenger RNAs 
(mRNAs; Krichevsky et al. 2003; Lewis et al. 2005). In recent years, increasing evidence 
has established miRNAs as critical regulators of neuronal development and synaptic 
plasticity, with new roles for neuronal miRNAs continually emerging (Guven-Ozkan et al. 
2016; Li et al. 2014a; Sarkar et al. 2016; Zampa et al. 2018). 
 A recent transcriptome study from our lab involving olfactory learning in the 
honeybee identified a number of miRNAs upregulated following olfactory conditioning 
(Cristino et al. 2014b).  Of interest among these miRNAs is the highly conserved, hypoxia-
regulated miR-210, which showed the highest fold-change in expression and was localised 
within relevant higher brain regions of the honeybee. miR-210 has been widely studied in 
non-neuronal cell types and is known to be regulated by the hypoxia inducible factor 1 
(HIF-1), a transcription factor induced by reduced oxygen levels (Bruick & Mcknight 2001). 
As oxygen metabolism changes are strongly coupled to neuronal activity, examining the 
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role of miR-210 may expand our knowledge of how metabolic changes in turn regulate 
neuronal function and contribute to plasticity.  
 
1.2 Translational Control of Learning and Memory 
1.2.1 Localized Translation 
The original assumption of protein synthesis occurring exclusively in the cell soma was 
challenged by the discovery of polyribosomes located selectively within neuronal post-
synaptic regions (Steward & Fass 1983; Steward & Levy 1982). Research has since 
established that dendrites not only facilitate protein synthesis but also contain elaborate 
translational machinery including functional endoplasmic reticulum (ER), post-ER carriers, 
components of the Golgi and post-Golgi trafficking machinery (Kang & Schuman 1996; 
Merianda et al. 2009; Weclewicz et al. 1998).  Additionally, isolated dendrites have been 
shown to be capable of functional mRNA splicing, protein glycosylation and incorporating 
glutamate receptors into membranes (Glanzer et al. 2005; Ju et al. 2004; Torre & Steward 
1996). 
 
1.2.2 Non-coding RNA 
There is increasing interest into the role of non-coding RNA as essential regulators of 
learning and memory. Non-coding intergenic, intronic and untranslated regions comprise 
the majority of the human genome. Although once considered to be ‘junk’ DNA, it’s now 
known that almost the entire genome is transcribed under different conditions and 
increasing expansion of untranslated genomic regions correlates with increased organism 
complexity (Bertone et al. 2004; Britten & Kohne 1968; Kapranov et al. 2002; Lander et al. 
2001; Mercer et al. 2012; Venter et al. 2001). An extensive non-coding regulatory genome 
is therefore thought to have evolved to allow for diversification of complex organisms. 
While many non-coding RNA classes have well-characterised, functional roles in protein 
synthesis, such as transfer RNA (tRNA) and ribosomal RNA (rRNA), other non-coding 
RNA classes have diverse roles in gene expression, including regulation of gene 
transcription and translation.  
 Non-coding transcripts over 200 bp in length are classified as long non-coding 
RNAs (lncRNAs), encompassing a large number of heterogeneous transcripts from 
various genomic origins (Guttman et al. 2009; Hangauer et al. 2013). While the majority of 
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lncRNAs have unknown function, a number of characterised lncRNAs have roles in gene 
regulation both directly, through association with RNA binding proteins, and indirectly, 
through miRNA modulation (Gong & Maquat 2011; Kretz et al. 2013). It’s estimated that 
around 50% of mature human miRNAs are produced from non-coding RNA transcripts, 
many of which are embedded within lncRNA introns (Rodriguez et al. 2004). There is also 
evidence some lncRNAs act as a miRNA sponge, depleting specific miRNAs and therefore 
modulating expression of miRNA target genes (Wang et al. 2013).  
 
1.2.3 Short Non-coding Regulatory RNAs 
MicroRNAs are short, 19-23 nucleotide RNA transcripts, capable of repressing RNA 
translation of complementary mRNA targets, typically through their 3’UTR. A number of 
enzymatic steps are involved with the processing of RNA into a mature miRNA. Primary 
miRNA (pri-miRNA) transcripts arise either from direct transcription or cleavage of an 
existing transcript, a 70-100 nucleotide hairpin structure is then cleaved from the pri-
miRNA by the RNaseIII enzyme, Drosha, leaving a 2 nucleotide overhang (Lee et al. 2003; 
Zeng et al. 2005). This hairpin structure, termed precursor miRNA (pre-miRNA), is 
translocated out of the nucleus by directly binding nuclear export protein, exportin 5 (Lund 
et al. 2004; Yi et al. 2003). Pre-miRNA is further processed in the cytoplasm by the 
RNaseII, Dicer, into a double stranded RNA duplex which is then unwound and complexed 
with an Argonaute (AGO) protein to form an RNA induced silencing complex (RISC; 
Forstemann et al. 2005; Saito et al. 2005). RISC complexing favours what is termed the 
‘guide strand’, typically the strand with the weakest base pairing at its 5’ end, with the 
passenger strand subsequently degraded (Martinez et al. 2002). When associated with 
RISC the single stranded mature miRNA transcript is able to downregulate expression of 
target mRNAs primarily by suppression of translational machinery or, dependent on the 
degree of complementarity, degradation through RISC mediated cleavage (Fig. 1.1; Bagga 
et al. 2005; Jing et al. 2005; Lim et al. 2005).  
 Similarly to miRNAs, small interfering RNAs (siRNAs) also mediate gene silencing 
through the RISC pathway. Endogenous siRNAs differ from miRNAs in their source 
transcripts, primarily originating from repetitive and transposable elements that form 
double stranded RNAs and can be processed directly by Dicer without requiring Drosha 
cleavage (Fire et al. 1998; Hammond et al. 2000). Following complexing into RISC, 
siRNAs mediate mRNA decay through exact complementarity with mRNA targets, 
triggering mRNA cleavage (Elbashir et al. 2001; Haley & Zamore 2004). In lower order 
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organisms such as plants and C.elegans, siRNAs have a self-amplifying mechanism and 
are involved in both post-transcriptional and transcriptional gene silencing (Grishok et al. 
2005; Pak & Fire 2007). The role of endogenous siRNA in flies and vertebrates has been 
widely debated due to their lack of siRNA amplification, however, emerging evidence of 
gene regulation by endogenous siRNAs in mice and human cells indicates they have 
important functional roles in mammals (Tam et al. 2008; Yang & Kazazian 2006).  
 
 
 
 
 
 A third class of small non-coding RNA, Piwi-interacting RNAs (piRNAs), also form 
RISC complexes with members of the PIWI subfamily of Argonaut proteins and act 
exclusively in germline cells to protect genome integrity by silencing activity of 
transposable elements. This occurs through cleavage of transcribed transposable 
elements as well as transcriptional silencing by targeting repressive histone modifications 
and DNA methylation to copies of transposable elements (Le Thomas et al. 2013; Sienski 
et al. 2012). These small RNAs all share related functionality while having distinct roles in 
Figure 1.1:  MicroRNA-processing pathway. Dicer cleaves hairpin pre-miRNA molecules into a 
double-stranded miRNA. Double stranded miRNA is unwound and loaded into the RISC 
complex and can regulate target mRNAs through translation repression or mRNA cleavage, 
dependent on sequence complementarity. 
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regulating the transcriptome with miRNAs the primary regulators of post-transcriptional 
gene repression.  
 Since their discovery the prevalence of miRNAs has become increasingly evident 
with more than 2600 mature miRNA sequences identified to date within the human 
genome (miRBase v22). Being present among all metazoa, miRNAs are widespread 
throughout evolution with a large proportion of miRNAs conserved among closely related 
species (Lagos-Quintana et al. 2001; Lau et al. 2001; Lee & Ambros 2001). A number of 
miRNAs are also broadly conserved with over a third of miRNAs found in C. Elegans 
having human homologs, while many other miRNAs are lineage and tissue specific 
(Friedman et al. 2009; Lagos-Quintana et al. 2002). There is also significant evidence that 
the majority, if not all protein-coding genes in human may be miRNA regulated. A single 
miRNA can target hundreds of mRNAs and individual mRNAs can contain multiple miRNA 
target sites (Lewis et al. 2005). They are also critical regulators in various complex 
pathways and miRNA regulation is integrated throughout numerous developmental 
processes including stem cell regulation, tissue vascularisation, haematopoiesis and 
neuronal differentiation (Dill et al. 2012; Visvanathan et al. 2007; Wang et al. 2008a; Zhu 
et al. 2013). Consequently, miRNA dysregulation or dysfunction is implicated in various 
different diseases ranging from malignancies, cardiac disease and viral infections to 
neurodegenerative and psychiatric disorders (Beveridge et al. 2010; Care et al. 2007; 
Costinean et al. 2006; Cristino et al. 2014a; Jeng et al. 2009; Klase et al. 2007). 
 
1.2.4 Mechanisms of MicroRNA Targeting and Repression 
Translational repression by miRNAs principally occurs through imperfect sequence 
complementarity in target mRNAs, with binding sites containing mismatched nucleotides 
and/or bulges (Brennecke et al. 2005). While this allows for broad specificity of miRNAs, 
the rules predicting an effective binding site are hard to determine. Previously it was 
established that nucleotides in positions 2-8 within the 5’ region of mature miRNA 
sequences, termed the seed region, are important for targeting. Binding sites that have 6-7 
nucleotides with perfect Watson-Crick base pairing in this region are considered canonical 
miRNA target sites (Lewis et al. 2005). A number of non-canonical site types, however, 
have since been identified and found to be functional, such as offset 6-mer and centred-
site binding types (Friedman et al. 2009; Shin et al. 2010). Additional non-canonical site 
types are continually being described and in some data sets are estimated to contribute to 
>60% of mRNA binding sites (Helwak et al. 2013; Kim et al. 2016). Other factors also 
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contribute to the downregluation of a target, such as mRNA secondary structure and the 
presence of multiple target sites within the 3’UTR, either for the same or an alternate 
miRNA, which can function synergistically (Grimson et al. 2007; Kertesz et al. 2007). 
 While the primary mode of miRNA gene regulation is through translational 
repression there is currently no consensus on the mechanism/s concerning how 
repression is achieved. Inhibition of the initiation stage of mRNA translation has been the 
most frequently proposed mechanism of action given evidence that mRNAs lacking a cap 
sequence were resistant to miRNA repression and the discovery of a cap binding motif in 
AGO, thought to prevent cap-binding of initiation factor eIF4E (Humphreys et al. 2005; 
Kiriakidou et al. 2007). Initiation inhibition, however, was later contradicted with miRNA 
repression identified in cap-independent mRNAs and findings that AGO folding and 
association of AGO with it’s binding partner, GW182, prevent its interaction with mRNA 
cap sequences (Eulalio et al. 2008; Kinch & Grishin 2009; Petersen et al. 2006). In a 
mutually exclusive mechanism, recruitment of eIF6, a factor that inhibits translation 
initiation through preventing 60S ribosome assembly, was shown to be necessary for 
miRNA translational repression (Chendrimada et al. 2007).  
 Concurrently, alternate evidence has accumulated suggesting miRNA translational 
repression occurs post-initiation, during the elongation stage. This is based on 
experimental observations that miRNAs bound to target mRNAs co-sediment with actively 
translating polyribosomes, with the growing polypeptide chain thought to be 
simultaneously degraded (Maroney et al. 2006; Nottrott et al. 2006; Petersen et al. 2006). 
Also linked to miRNA mediated gene silencing are cytoplasmic processing bodies (p-
bodies) that are involved in mRNA turnover (Sheth & Parker 2003). miRNA-bound AGO 
proteins accumulate within p-bodies and mRNAs containing target sites for a given miRNA 
also co-accumulate with miRNA within p-bodies (Liu et al. 2005). AGO:miRNA complexes 
were also found to associate with GW182, a protein localised within p-bodies that 
functions in miRNA based translational repression (Jakymiw et al. 2005).  
 Aside from canonical miRNA function in regulation of translation, alternate functions 
of miRNAs have also been reported. This includes both repression and activation of gene 
expression at the transcriptional level by miRNAs in association with argonaute. A number 
of miRNAs have been found to promote transcriptional activation of specific target genes, 
which involves recruitment of RNApolII to the promoter and local chromatin modification 
through the deposition of activating histone marks (Huang et al. 2012; Place et al. 2008). 
Conversely, transcriptional gene silencing can also be induced by certain miRNAs and 
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involves an increase of repressive chromatin marks at promoter regions (Kim et al. 2008). 
Although occur at seemingly low frequencies, these nuclear, epigenetic functions of 
miRNA-directed Argonaute highlight the diversity of miRNA gene regulatory mechanisms. 
 
1.2.5 Regulation of MicroRNA Function 
Activity of miRNAs themselves is subject to regulation with numerous potential regulatory 
checkpoints during biogenesis as well as mature miRNA degradation and RISC protein 
modulation. Turnover of miRNAs can be regulated through 3’ modification of both pre-
miRNAs and mature miRNAs. Selective terminal uridylation of pre-miRNAs targets them 
for degradation, inhibiting further processing into mature miRNAs (Hagan et al. 2009; Heo 
et al. 2009). Selective uridylation of mature miRNAs followed by mature miRNA 
degradation can also occur, while 3’ terminal adenylation blocks uridylation modifications 
and can stabilise mature miRNAs (Katoh et al. 2009; Thornton et al. 2014). Once 
processed, mature miRNAs can also associate reversibly with RISC in a regulated manner 
(Pai et al. 2014). Further adding to the complexity of miRNA function is a high proportion of 
miRNA isomers (IsomiRs) within the human transcriptome. IsomiRs are miRNAs that arise 
from the same RNA sequence but contain slight variations from the annotated mature 
miRNA in the form of, 3’ non-templated nucleotide addition, 5’ or 3’ trimming occurring 
from variable cleavage or single nucleotide substitutions (Zhang et al. 2010). miRNAs and 
their IsomiRs are associated equally with translational repression and appear to function 
cooperatively with substantial overlap in their targeting (Cloonan et al. 2011).	
 Within the nervous system, miRNAs have been shown to be important regulators of 
neuronal plasticity during learning and memory. This was first demonstrated in Drosophila 
where the RISC protein, Armitage, was found to be degraded following memory 
acquisition, and knockout of Armitage in drosophila models resulted in improved olfactory 
learning (Ashraf et al. 2006).  Throughout the brain, miRNA-processing enzyme, Dicer is 
expressed primarily in large projection neurons and is enriched within dendritic spines, 
principally within the post-synaptic density (Lugli et al. 2005; Lugli et al. 2008). Synaptic 
activity induces calpain-mediated cleavage of Dicer, promoting release of Dicer from the 
post-synaptic density and increasing Dicer catalytic RNaseIII activity (Smalheiser & Lugli 
2009). Rapid turnover of miRNAs has also been identified to occur following neuronal 
stimulation, including both activity-dependent decreases of specific miRNAs as well as 
translational upregulation of various miRNAs (Eacker et al. 2011; Joilin et al. 2014; Krol et 
al. 2010; Kye et al. 2011; Park & Tang 2009; Wibrand et al. 2010). In addition, functional 
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studies have characterised specific roles for a number of miRNAs in learning and memory 
using various models (Guven-Ozkan et al. 2016; Hansen et al. 2016; Rajasethupathy et al. 
2009; Tognini et al. 2011; Vetere et al. 2014; Wang et al. 2017b; Wu et al. 2017).  
 
1.3 Regulation and Function of MicroRNA 210  
1.3.1 Identification of miR-210 in Honeybee Olfactory Learning 
In a previous study from our lab, gene expression changes were examined following long-
term memory formation in the honeybee brain, using an olfactory conditioning paradigm 
(Cristino, et al., 2014b). In this model, bees learn to associate a specific odour to a sugar 
reward with recall assessed 24 h after training by assessment of proboscis extension 
response (PER) upon re-exposure to the odour. Total RNA was extracted from honeybee 
brains and used for microarray analyses 24 h after conditioning. Among the differentially 
expressed genes, a general down-regulation of protein coding genes (45/56, 80%) and a 
corresponding up-regulation of non-coding regulatory genes (20/21, 95%) was identified. 
To determine if non-coding miRNAs were involved in the downregulation of protein coding 
genes during conditioning, a predicted miRNA targeting network was constructed based 
on target sites found in the 3’UTRs of downregulated genes. From this network, seven 
miRNAs highly connected within this network were evaluated for differential expression 
following conditioning using quantitative PCR (qPCR; Fig. 1.2a,b). This highlighted miR-
210-3p and miR-932-5p as potentially important regulators, being most highly upregulated 
following conditioning (Fig. 1.2b). 
 In Situ hybridisation determined expression of miR-210 and miR-932 in relevant 
regions of the honeybee brain including neuronal Kenyon cells within the mushroom 
bodies, involved with learning and memory, as well as regions around the antennal lobes, 
which process olfactory sensory information (Cristino, et al., 2014b; Deisig et al. 2006). 
Functional effects of miRNA knockdown were also assessed using an antagomir silencing 
approach, involving a synthetic anti-sense nucleic acid probe. These antagomirs were 
conjugated to cholesterol to enhance neuronal uptake as an essential nutrient, enriched in 
neuronal membranes that cannot be synthesised by bees (Bjorkhem & Meaney 2004; 
Clark & Block 1959). Honeybees were treated with synthetic miR-210 and miR-932 
antagomir probes and trained using olfactory conditioning 24 h later before long-term 
memory was assessed by PER at 48 h. Impairments in recall were observed in bees 
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treated with both miR-932 and miR-210 antagomir, providing the first evidence of a role for 
miR-210 in learning and memory (Fig. 1.2d).  
 
 
 
 
Figure 1.2:  miR-210 in honeybee olfactory conditioning. a. Constructed putative miRNA target 
network of differentially expressed genes following olfactory learning. Down regulated protein-
coding genes are shown in red with increasing node size proportional to fold-change, 
upregulated miRNAs are shown in green. Thick edges depict interactions between proteins and 
arrows depict predicted miRNA targeting b. Fold change in miRNA expression following 
conditioning with two different odours (floral mix and linalool), detected by qPCR. c. miR-210 in-
situ hybridisation in honeybee brain, mb = mushroom body, al = antennal lobe. d. Percentage 
of honeybee proboscis extension response (PER) to conditioned odour 48 h after treatment with 
cholesterol-conjugated miRNA antagomirs. Memory recall was reduced by antagomir treatment 
compared to control groups (sugar/scrambled). Different letters above bars indicate significant 
difference at p <0.05, general linear model (GLM). Figure adapted from “Neuroligin-associated 
microRNA-932 targets actin and regulates memory in the honeybee”, by Cristino, A.S, et al., 
2014, Nature communications, vol 5, pg 5529.  
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1.3.2 Known Function of MicroRNA-210 
Found across vertebrates and invertebrates, miR-210 is a highly conserved, hypoxia-
regulated miRNA. Within the miR-210 host transcript not only is the stem-loop sequence 
highly conserved but also a core hypoxia response element (HRE) in it’s promoter, and, in 
all tissue and cell types examined so far, miR-210 has been upregulated under hypoxic 
conditions (Crosby et al. 2009; Huang et al. 2009; Kulshreshtha et al. 2007; Lou et al. 
2012). While miR-210 is often described as intergenic, within the human genome, the miR-
210 transcript originates from an intronic region of the predicted lncRNA transcript 
AK123483 (Ota et al. 2004). This transcript is one of largely unknown function, but has 
recently been suggested to be involved in myocardial ischaemic-reperfusion injury and 
miR-210 and AK123483 also appear to be co-expressed in response to hypoxia (Camps et 
al. 2008; Zheng et al. 2018). The active strand of miR-210 is the 3p arm, miR-210-3p, and 
subsequent mentions of mature miR-210 within the text refer to the active miR-210-3p 
strand.  
 miR-210 appears to have a role in a broad range of functions, already identified to 
be involved in cell cycle regulation, differentiation, DNA repair and mitochondrial 
metabolism and has been well-studied in disease, particularly cancer and cardiac disease  
(Chan et al. 2009; Crosby et al. 2009; Mizuno et al. 2009; Zhang et al. 2009). Across 
numerous different cancer types miR-210 has been found consistently overexpressed and, 
although predominantly has been of interest as a circulating biomarker for cancer, it has 
also been shown to have an oncogenic effect on bladder cancer cell-lines (Camps et al. 
2008; Juan et al. 2010; Liu et al. 2012b; Malzkorn et al. 2010; Miko et al. 2009; Satzger et 
al. 2010). Hypoxia is a common feature of tumours that enhances tumour survival through 
stimulating angiogenesis, primarily through vascular endothelial growth factor (VEGF). 
Correspondingly, miR-210 has been shown to promote VEGF-directed endothelial cell 
migration and capillary-like formation through ephrin-A3 in vitro and increase epithelial cell 
proliferation and angiogenesis in vivo (Fasanaro et al. 2008; Pulkkinen et al. 2008). In 
mice models, miR-210 has also been found to rescue cardiac function following 
myocardial infarction by inhibiting apoptosis and increasing focal angiogenesis (Hu et al. 
2010). Consistent with its role in hypoxia and correlation with cancer, miR-210 is involved 
in the metabolic shift to glycolysis during hypoxia by downregulating iron-sulphur cluster 
scaffolding proteins required for conversion of citrate to isocitrate (Chan et al. 2009). 
Additionally it has been demonstrated that miR-210 released into extracellular space can 
be transported into recipient cells and actively repress iron-sulphur cluster scaffolding 
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genes in recipient cells (Hale et al. 2014). In this study, released extracellular miR-210 was 
found to be associated with the RISC complex protein, AGO2, and detected both within 
and outside of microvesicles, although the majority of extracellular miR-210 was present in 
microvesicle-depleted conditioned media.  
 A number of studies have also identified roles for miR-210 within the nervous 
system. Analogous to its functions in non-neuronal cell types, miR-210 overexpression in 
the adult mouse brain sub-ventricular zone stimulates angiogenesis and proliferation of 
neural progenitor cells (Zeng et al. 2014). Similarly within the developing mouse brain, 
miR-210 was found to be expressed within embryonic neocortex and regulate neural 
progenitor proliferation through cell-cycle gene, CDK7 (Abdullah et al. 2016). In vitro a 
study utilising primary neuronal cultures found soluble amyloid-beta, the pathogenic 
component of Alzheimer’s disease, significantly increased miR-210 levels in an NMDA-
receptor (NMDA-R) dependent manner (Li et al. 2014b). In a separate honeybee study it 
was also shown that miR-210 upregulation is associated with age-related behavioural 
changes in honeybees, being upregulated in aged bees following their transition from 
nursing to foraging behaviours (Behura & Whitfield 2010).  
 Significant dysregulation of miR-210 in neurological conditions has also been 
detected in various studies examining differential miRNA expression. Research 
investigating temporal-lobe epilepsy in rodent models has identified differential miR-210 
expression in both chronic and acute epilepsy stages induced via administration of 
convulsant drugs, kainic acid and pilocarpine, or electrical stimulation (Chen et al. 2016; 
Gorter et al. 2014; Hu et al. 2012; Kretschmann et al. 2015; Schouten et al. 2015). 
Dysregulation of miR-210 was detected in dentate gyrus, hippocampal and 
parahippocampal brain regions at numerous time points ranging from 3 hours to 4 months 
following seizure induction. While downregulation of miR-210 was apparent under certain 
conditions, miR-210 primarily appears to be significantly overexpressed in rodent epilepsy 
models. In humans, miR-210 expression was found to be decreased in hippocampal tissue 
from temporal-lobe epilepsy patients who have also developed hippocampal sclerosis 
(HS), charactered by severe neuronal loss and gliosis in the hippocampus (Mckiernan et 
al. 2012). In this study decreased miR-210 correlated with decreased Dicer activity and 
unchanged levels of pre-miRNA.  
 Multiple human studies on Alzheimer’s disease (AD) patients have found miR-210 
significantly downregulated in patient samples from various brain regions, including cortex, 
medial frontal gyrus and hippocampus at both early and late stages of disease as well as 
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in cerebrospinal fluid and serum of patients with AD or those with mild cognitive 
impairment who are at risk of developing AD (Cogswell et al. 2008; Hebert et al. 2008; Zhu 
et al. 2015). Details of studies that have found miR-210 to be significantly dysregulated in 
association with neuronal activation or neurodegeneration are summarised in Table 1.1. 
These observations, in epilepsy models and AD, along with those from our lab, strongly 
support modulation of miR-210 occurs in response to neural activation within the brain and 
implicates a potential role for miR-210 in neurological function. 
 
 
 
Condition Model Species Timepoint/s Brain Region Reference 
Long-term 
Consolidation OC Honeybee 24 hr Whole brain Cristino et. al., 2014 
Epilepsy 
(acute seizure) ES Mouse 3 hr Hp Kretschmann et. al., 2015 
Epilepsy PILO Mouse 28 d Hp Kretschmann et. al., 2015 
Epilepsy KA Mouse 3 d DG Schouten et. al., 2015 
Epilepsy ES Rat 1 d/1 w PHC Gorter et. al., 2014 
Epilepsy ES Rat 3-4 m DG Gorter et. al., 2014 
Epilepsy PILO Rat 1/3/7/14/30 d Hp Chen et. al., 2016 
Epilepsy PILO Rat 2 m Hp Hu et. al., 2012 
Epilepsy w/ HS - Human - Hp McKiernan et. al., 2012 
Alzheimer’s 
Disease - Human Early stage Hp Cogswell et al., 2008 
Alzheimer’s 
Disease - Human Late stage Hp, MFG Cogswell et al., 2008 
Alzheimer’s 
Disease - Human - Cortex Hebert et al., 2008 
Alzheimer’s 
Disease - Human - CSF, Serum Zhu et al., 2015 
Mild Cognitive 
Impairment - Human - CSF, Serum Zhu et al., 2015 
Table 1.1:  Dysregulation of miR-210 associated with neuronal activity and neurological 
disorders. Conditions where miR-210 was found significantly upregulated or downregulated are 
highlighted in green or red, respectively. OC = olfactory conditioning, PILO = pilocarpine, ES = 
electrical stimulation, KA = kainic acid, Hp = hippocampus, DG = dentate gyrus, PHC = 
parahippocampal cortex, MFG = medial frontal gyrus, CSF = cerebrospinal fluid, h = hours, d = 
days, m = months, w = weeks. 
   14 
1.4 Project Synopsis 
1.4.1 Summary 
While there is evidence miR-210 is expressed and regulated in the adult brain under 
various conditions little is known about how it functions within the nervous system and 
what neuronal genes or pathways it may target. As miR-210 is hypoxia-regulated and 
involved in regulating metabolic function in non-neuronal cells types, it seems likely that it 
may have a significant role in neuronal function given the brain has highly dynamic 
metabolic requirements and oxygen tension under physiological conditions. Although it is 
well established that metabolic demands are driven by neuronal activity within the brain 
through neurovascular and neurometabolic coupling mechanisms, there remains a gap in 
understanding of how altered metabolism and potential secondary changes in oxygen 
concentration may effect gene expression and plasticity. Characterising genes such as 
miR-210, regulated by oxygen and other sensors of metabolism may provide significant 
biological insight into the mechanisms involved in translating environmental signal into 
neural response and consequently cognitive function and behaviour. To follow on from 
findings of miR-210 involved in honeybee learning and memory, this project aimed to 
further characterise miR-210 and identify if it may have a potential role in neuronal function 
and plasticity in mammalian systems. In this project a wide range of approaches, including 
RNAseq, bio-informatics, molecular biology, cell-culture and behavioural experiments were 
utilised to identify neuronal targets of miR-210, functionally assess effects of miR-210 in 
neuronal cell lines and primary neurons, directly examine miR-210 regulation in neurons 
as well as characterise miR-210 expression and function in vivo. 
 
1.4.2 Statement of Hypothesis 
Involvement of miR-210 in honeybee olfactory conditioning and modulation of miR-210 by 
neural activity in rodents and humans supports the hypothesis of a conserved role for miR-
210 in mammalian learning and memory. Given the nature of miR-210 induction, miR-210 
may act as sensor of neural activity through associated changes in neuronal metabolism of 
oxygen. Hypoxia induction of miR-210 may subsequently influence neural plasticity and 
contribute to cognitive processing through the regulation of relevant target genes within the 
mammalian transcriptome. 
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1.4.3 Thesis Outline 
Chapter Two: Neuronal Oxygen Metabolism in Physiological and Pathological Conditions. 
 In Chapter Two relevant literature regarding neuronal oxidative metabolism is reviewed 
and discussed. This includes a summary of known mechanisms of neurovascular and 
neurometabolic coupling and the potential role of hypoxia in normal neuronal function. 
Evidence of disrupted oxidative metabolism in neurodegenerative disorders is also 
summarised as well as research supporting oxygen as a driver of neuronal plasticity. 
Chapter Three: Identification of miR-210 Targeting by mRNA Pull-down. 
Chapter Three presents results regarding experimental target identification of miR-210 in a 
human neuronal system along with gene ontology analyses of identified target genes and 
target validation. 
Chapter Four: Regulation and Function of miR-210 in In Vitro Neuronal systems. 
In this chapter functional effects of miR-210 dysregulation in a human neuronal cell line 
are analysed. A primary neuronal system was also utilised for further functional analyses 
and to identify neuronal regulation of miR-210 in vitro. 
Chapter Five: Effects of miR-210 Neuronal Knockout In Vivo. 
Data from a conditional miR-210 neuronal knockout mouse line is incorporated in this 
chapter including expression analyses and behavioural and cognitive experiments. 
Chapter Six: General Discussion. 
This final chapter provides a general discussion of the work presented in this thesis and 
the wider implications of this research in the context of the current literature. 
 
 
 
 
  
 
 
 
 
 
 
 
 
CHAPTER TWO 
 
NEURONAL OXYGEN METABOLISM IN 
PHYSIOLOGICAL AND PATHOLOGICAL CONDITIONS 
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2. 1 Introduction 
Regulation of tissue metabolite supply and cellular energy metabolism is essential to 
maintain healthy cellular and systemic function. This regulation is especially critical to the 
central nervous system (CNS) where energy consumption is highly dynamic. Within the 
brain, increased neuronal activity drives increased energy consumption and compensatory 
metabolic and vasculature changes in turn enhance neuronal function (Roy & Sherrington 
1890). Proper brain function therefore requires metabolism to be tightly regulated both 
temporally and spatially from a regional level down to the level of a single synapse. 
Currently, our knowledge of the relationship between neuronal activity and oxygen 
metabolism is not complete and it is likely that numerous mechanisms and complex 
regulatory pathways are yet to be uncovered.  
 While making up only a small fraction of our total body mass, the brain represents 
the largest source of energy consumption, accounting for over 20% of total oxygen 
metabolism. Of this, it is estimated neurons consume 75-80% of energy produced in the 
brain (Hyder et al. 2013). This energy is primarily utilised at the synapse with a large 
proportion spent in restoration of neuronal membrane potentials following depolarisation 
(Harris et al. 2012). Vesicle recycling, neurotransmitter synthesis and axoplasmic transport 
also contribute to synaptic energy depletion and the requirement for an elevated metabolic 
rate in neurons (Attwell & Laughlin 2001; Rangaraju et al. 2014). Energy requirements, 
therefore, are not uniform throughout the brain but are instead increased in localised 
regions dependent on neuronal activity. While mechanisms have been identified to modify 
oxygen supply to brain regions in response to activity there appears to be a role for 
hypoxia in modulating neuronal function and behaviour. Disruption of oxygen metabolism 
and mitochondrial function are also consistent pathological features of various age-related 
neurodegenerative diseases associated with cognitive decline (Silverman et al. 2001; 
Zhou et al. 2008). Despite this, the underlying molecular mechanisms preceding 
neurodegeneration remain relatively unknown. In recent years a number of studies have 
identified links between metabolically regulated genes and behaviour, which may provide 
insight into the role of neuronal oxidative metabolism in both health and disease. 
 
2.2 Neurovascular and Neurometabolic Coupling 
To compensate for varying energy demands throughout the brain and to increase 
efficiency of metabolite supply, neurovascular and neurometabolic coupling mechanisms 
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have evolved to enhance blood flow and utilisation of metabolites in areas of neural 
activity. 
 
2.2.1 Neurovascular Coupling 
Cerebral blood flow (CBF), blood volume, glucose consumption and oxygen metabolism 
are all increased following neuronal stimulation within localised regions of activity. This 
relationship between neuronal activity and CBF defines the concept of neurovascular 
coupling. First postulated by Roy & Sherrington in 1890, neurovascular coupling forms the 
basis of many functional neuroimaging technologies, where areas of neuronal activity are 
detected by activity-coupled increases in local CBF. While there has been substantial 
research on neurovascular coupling since this finding, details of the molecular 
mechanisms are still being uncovered.  
 Significant evidence suggests neurovascular coupling is mediated through the free 
radical, nitric oxide (NO) produced in neurons. Vasodilation is strongly stimulated by NO 
through activation of the enzymatic NO receptor, soluble guanylate cyclase (sGC), 
producing cGMP and leading to vasodilation by cGMP-dependent kinase signalling 
(Archer et al. 1994; Miki et al. 1977). Production of NO by neuronal nitric oxide synthase 
(nNOS) is tightly coupled to glutamatergic excitation with activation of nNOS being linked 
to stimulation of ionotropic glutamate receptors, principally through NMDA receptors due to 
strong binding between the NMDA-R clustering protein, post-synaptic density protein 95 
(PSD-95), and nNOS (Brenman et al. 1996; Garthwaite et al. 1988). Evidence also 
suggests that NO is able to spread rapidly beyond the area of directly activated neurons 
and is likely to be self-regulating as enhanced blood flow inactivates NO signalling 
through increased erythrocyte-mediated scavenging of NO (Santos et al. 2011; Steinert et 
al. 2008). Astrocytes also play a role in mediating CBF regulation during neuronal 
activation by triggering Ca2+ release within astrocytic end feet and inducing various 
downstream Ca2+ signalling pathways known to control vasodilation (Mulligan & Macvicar 
2004; Takano et al. 2006). It recently became clear that astrocytic Ca2+ signalling acts on 
contractile perictyes surrounding capillaries and not on arterioles. The current view on 
neurovascular coupling, therefore, is that increased CBF is triggered by astrocytic Ca2+ 
signalling in the capillary bed and by neuronal NO, generated through NMDA-R activation, 
acting at the arteriolar level (Fig. 2.1a,b; Mishra et al. 2016; Peppiatt et al. 2006). 
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2.2.2 Neurometabolic Coupling 
This synergistic function of astrocytes and neurons in CBF regulation is mirrored in their 
differing metabolic profiles with astrocytes predominantly metabolising glucose via 
glycolysis while neurons rely on oxidative metabolism (Kasischke et al. 2004). Astrocytes 
closely appose both capillary walls and synaptic clefts and are crucial regulators of 
Figure 2.1: Neurovascular and neurometabolic coupling mechanisms. Schematic illustrating 
neuronal and astrocytic mechanisms responsible for activity-related blood flow and metabolic 
changes. a. NMDA receptors (NMDA-R) are linked to neuronal nitric oxide synthase (nNOS) 
through post-synaptic density protein 95 (PSD-95) and neurovascular coupling during activity is 
thought to be triggered through the neuronally-produced vasodilator NO, which can diffuse 
rapidly and freely through membranes to act on arterioles. b. Vasodilation is also thought to be 
controlled at the capillary level through astrocytic Ca+ signalling acting on contractile perictyes. 
c. In the glutamine-glutamate cycle, glutamate (Glu) released into the synaptic cleft is cleared 
by Na+-dependent astrocytic uptake, primarily through GLT-1. Glutamate is converted to 
glutamine (Gln) and returned to neurons to replenish neurotransmitter stores. d,e. The 
astrocyte-neuron lactate shuttle (ANLS) hypothesis suggests associated increases in astrocytic 
Na+ concentration triggers activation of Na+/K+ ATPase pumps, promoting glucose uptake and 
glycolysis. Glycolytically-generated lactate is released and utilised as a substrate for oxidative 
phosphorylation in neurons during periods of activity. LDH = lactate dehydrogenase, MCT = 
monocarboxylate transporter. Solid lines indicate enzymatic activity, dashed lines indicate 
solute movement. 
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neurometabolic coupling during neuronal activity. One of the best-characterised roles of 
astrocytes in neuronal activation is maintaining neurotransmitter stores through the 
glutamine-glutamate cycle. Glutamate released into the synaptic cleft during excitation is 
rapidly cleared by astrocytic uptake, primarily through the Na+-dependent glutamate 
transporter GLT-1 (EAAT2), causing attenuation of postsynaptic activation (Bergles & Jahr 
1997; Danbolt et al. 1992). Cleared glutamate is primarily converted by astrocytes into 
glutamine, which is then released back into extracellular space for neuronal re-uptake and 
conversion back to glutamate (Fig. 2.1c; Hertz et al. 1978; Kvamme 1998). In the 
astrocyte-neuron lactate shuttle (ANLS) hypothesis, proposed by Pellerin and Magistretti 
(Pellerin & Magistretti 1994), a secondary effect of astrocytic glutamate uptake prompts a 
switch from oxidative metabolism to aerobic glycolysis in astrocytes causing glucose 
metabolism to be diverted from the tricaboxcylic acid (TCA) cycle to the glycolytic pathway 
and lactate production. This switch is thought to be triggered by the associated intracellular 
increase in Na+ concentration, which activates Na+/K+-ATPase pumps stimulating glucose 
uptake and glycolysis (Fig. 2.1d; Pellerin & Magistretti 1997). This adaptation seems to 
support an increased neuronal metabolic load with lactate generated from astrocytic 
glycolysis being utilised as a substrate for oxidative metabolism in neurons. This 
hypothesis is supported by numerous studies detecting increased lactate in regions of 
brain activity as well as evidence that lactate is crucial for synaptic transmission in rat 
hippocampal slices and sufficient to support synaptic activity in the absence of glucose 
(Fig. 2.1e; Frahm et al. 1996; Machler et al. 2016; Maddock et al. 2009; Schaller et al. 
2014; Schurr et al. 1999; Schurr et al. 1988; Suzuki et al. 2011).  
 This segregated metabolism is supported by distinct gene expression patterns 
observed in neurons and astrocytes. Differential expression of lactate transporter proteins, 
monocarboxylate transporters (MCTs), supports shuttling of lactate from astrocytes to 
neurons. The lactate efflux transporter MCT4 is expressed primarily in astrocytes and 
neurons primarily express MCT2, an isoform which allows for rapid substrate uptake of 
lactate (Debernardi et al. 2003; Rafiki et al. 2003). Additionally, the lactate dehydrogenase 
(LDH) isoenzyme, LDH-5, which promotes conversion of pyruvate to lactate is highly 
expressed in astrocytes but not in neurons while LDH-1, which promotes pyruvate 
production is found in both neurons and astrocytes (Bittar et al. 1996; Broer et al. 1997). In 
support of glycolysis induction in astrocytes, the pyruvate dehydrogenase kinase-4 (PDK4) 
is expressed at high levels in astrocytes causing its target, pyruvate dehydrogenase 
(PDH), to remain in an inactive, phosphorylated state, thereby decreasing pyruvate entry 
into the TCA cycle (Halim et al. 2010; Zhang et al. 2014). Correspondingly, astrocytes 
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express higher levels of the glyoxalase enzymes Glo-1 and Glo-2 that detoxify 
methyglycoxal, a metabolic by-product of glycolysis (Belanger et al. 2011). An enzymatic 
promoter of glycolysis, 6-phosphofructo-2-kinase/fructose-2,6-bisphosphate 3 (Pfkfb3), is 
also found to be functional in astrocytes but subject to constant degradation in neurons 
contributing to diversion of neuronal glucose from glycolysis to the pentose-phosphate 
pathway (PPP; Belanger et al. 2011; Herrero-Mendez et al. 2009; Zhang et al. 2014). 
While there is substantial evidence in support for the ANLS acting as a mechanism for 
coupling of neuronal activity to neuronal metabolism, contradictory evidence continues the 
debate of this hypothesis. Glucose uptake and phosphorylation has been shown to 
preferentially occur in neurons, not astrocytes. Further, neurons metabolise substantial 
amounts of glucose and increase glucose metabolism in response to activity (Lundgaard 
et al. 2015; Patel et al. 2014). Contradictory evidence may be due to metabolism being 
differentially regulated in different neural networks or brain regions. These observations all 
contribute, however, to mounting evidence suggesting that neurons can sustain and 
enhance oxidative metabolism to meet energetic requirements during periods of activity.  
 
2.3 Oxidative Metabolism and Hypoxia 
2.3.1 Oxygen Concentration in the Brain 
While there is significant evidence to support enhanced neuronal oxidative metabolism 
during activity, what remains unclear is what happens to cellular oxygen concentration 
following activation. This is partly due to difficulties in recording oxygen concentration as 
well as from confounds in interpreting oxygen consumption imaging signals. Blood-
oxygen-level dependent (BOLD) fMRI which relies on neurovascular coupling to measure 
regions of brain activity based on measurements of oxyhaemoglobin and 
deoxyhaemoglobin consistently generates signals with a post-stimulus undershoot (Van 
Zijl et al. 2012). The physiological basis of the BOLD undershoot is heavily debated and is 
likely stimulus-dependent, one theory however, suggests this reflects an uncoupling of 
CBF and energy metabolism. This is supported by evidence that oxidative metabolism 
remains elevated post activation after both blood flow and blood volume have returned to 
baseline (Lu et al. 2004). Consistent with this, numerous studies have reported similar 
increases in oxidative metabolism indicating that sustained focal activation raises the rate 
of oxidative metabolism to a new steady state level (Donahue et al. 2009; Frahm et al. 
2008; Hoge et al. 2005; Lin et al. 2010; Mangia et al. 2007). With dynamic changes in 
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oxygen metabolism occurring during neuronal activity, dynamic changes are likely to be 
reflected in levels of oxygen concentration, potentially having secondary effects on protein 
function and gene expression. 
 Neurons and neuronal functions are generally viewed as highly sensitive to hypoxia 
with disruption of oxygen supply to the brain causing detrimental damage within minutes.  
Although there is not a clearly defined ‘critical’ oxygen tension (PtO2) at which hypoxic 
damage will occur in neurons, in rat cortex a PtO2 value between 6.8-8.8 mm Hg has been 
estimated as a PtO2 where oxidative metabolism will be disrupted (Rolett et al. 2000). 
Under physiological conditions, PtO2 measurements in rat range from 6-40 mm Hg within 
the cortex (6-16 mm Hg in white matter and 19-40 mm Hg in grey matter) and from 1-60 
mm Hg across all brain regions with proximal structures displaying large variations in 
oxygen tension (Erecinska & Silver 2001). During embryonic development, oxygen tension 
is low in the foetal brain (0.076 – 7.6 mm Hg) and hypoxia is essential for proper embryo 
morphological development. Within the developing brain, oxygen tension acts as a 
regulator of neurogenesis with low oxygen promoting progenitor expansion in cortical 
neurogenic regions and decreasing dopaminergic neurogenesis in the midbrain 
(Wagenfuhr et al. 2015; Wagenfuhr et al. 2016). Additionally, in the adult brain, hypoxic 
injury caused by ischemic stroke triggers increased neuronal stem cell proliferation and 
neurogenesis (Arvidsson et al. 2002; Macas et al. 2006; Marti-Fabregas et al. 2010). This 
evidence supports a role for hypoxia as a regulatory mechanism in neuronal function and 
indicates that physiological hypoxia, induced by normal processes occurring in the adult 
brain, may play a functional role.  
 
2.3.2 Hypoxia Inducible Transcription Factors 
Long-term changes in cellular response to hypoxia are mediated through changes in gene 
expression with hypoxia predicted to regulate around 1-1.5% of the genome, primarily 
through hypoxia-inducible transcription factors (HIFs; Denko et al. 2003; Koong et al. 
2000). HIF is a heterodimeric complex consisting of a constitutively expressed β subunit 
shared by a family of three oxygen-sensitive α subunits. Most widely studied among these 
is the HIF-1α subunit. HIFα protein is constitutively expressed but is immediately targeted 
for degradation by HIF prolyl hydroxylases (PHDs) that associate with and hydroxylate two 
conserved HIFα proline residues in an oxygen dependent manner (Bruick & Mcknight 
2001) The Von Hippel-Lindau tumour suppresser ubiquitin ligase complex (pVHL), 
subsequently recognises HIFα causing HIFα ubiquitination and protein degradation (Ivan 
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et al. 2001; Jaakkola et al. 2001). During hypoxia, though oxygen-limited inactivation of 
HIF prolyl hydroxylase activity, HIFα is no longer targeted by pVHL and is able to 
accumulate in the cytoplasm before translocating to the nucleus and acting to promote 
transcription (Fig. 2.2). Within the nervous system HIF-1α and HIF-1 target genes are 
widely expressed under hypoxia, but regulation of HIF-1α can differ among neuronal 
subtypes (Bergeron et al. 1999; Stroka et al. 2001). Following hypoxia, HIF-1α has been 
shown both in vitro and in vivo to be significantly upregulated in interneurons but not in 
pyramidal neurons and in neuronal and non-neuronal cells it has been established that the 
redox state of a cell contributes to HIF-1α regulation (Ramamoorthy & Shi 2014; Welsh et 
al. 2002). Additionally, during in C. elegans development, hypoxia has been shown to 
cause defects in axonal migration that occur in a neuronal cell-type specific manner and 
are dependant on stabilisation of Hif-1 by either hypoxia or increased ROS (Pocock & 
Hobert 2008). Being a primary source of reducing agents, glucose is a major contributor to 
the redox state of a cell and HIF-1α expression in neurons has been shown to increase in 
a glucose-dependent manner during hypoxia (Guo et al. 2008; Shi & Liu 2006). There is 
also a negative relationship between HIF-1α and ROS levels indicating ROS promotes 
HIF-1α degradation while a reducing environment stabilises HIF-1α (Niecknig et al. 2012; 
Schafer & Buettner 2001).  
 ROS are highly reactive free radial molecules that can cause cellular damage 
through oxidation of lipids, proteins and DNA. ROS production primarily occurs through 
electron leakage at electron transport chain (ETC) complexes I or III during normal 
oxidative respiration. This causes conversion of 1-2% of oxygen into the superoxide anion, 
a precursor to hydrogen peroxide and hydroxyl free radicals. Within the brain, a high 
neuronal oxidative rate heightens the potential for ROS production and neurons are 
especially vulnerable to oxidate damage due to low levels of antioxidant enzymes such as 
glutathione (GSH; Dringen et al. 1999). Neuronal diversion of glucose catabolism from 
glycolysis to the PPP through Pfkfb3 degradation therefore not only supports oxidative 
metabolism of lactate but also enhances neuronal antioxidant capacity through production 
of the reducing agent, NADH. HIF-1α is also involved in this process and acts as a 
glycolytic enhancer through transcriptional activation of metabolic genes including Pfkfb3 
and PDK1, both positive regulators of glycolysis and MCT4, the lactate efflux transporter 
(Fig. 2.2; Kim et al. 2006; Minchenko et al. 2002; Ullah et al. 2006).  
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 As an oxygen-sensitive molecule, which is highly integrated into metabolic 
processes, HIF-1α is likely to have an important role in brain plasticity and dysregulation of 
HIF-1α expression has already been implicated in neuronal activation and learning and 
memory. In a rat microarray study, seizures induced by injection of Kainate, a potent 
glutamate receptor agonist that causes overstimulation of neurons, resulted in a 2.2-fold 
increase in HIF-1α 24 hours (Hunsberger et al. 2005). In another microarray study HIF-1α 
was found to be increased 7-fold in mice following environmental enrichment, where mice 
are exposed to heightened sensory stimulation known to promote neurogenesis and 
improve performance in memory tasks (Rampon et al. 2000). Elevated HIF-1α levels have 
also been observed in rats following learning in the Morris water maze and analysis of 
genes upregulated at early-time points following Morris water maze tests has found an 
over-representation of hypoxia response elements (HREs), binding sites for HIF, in their 
Figure 2.2: Hypoxia Inducible Transcription Factor Regulation. Under normal oxygen conditions 
HIF-1α is hydroxylated by prolyl hydroxylase (PHD) enzymes and targeted for ubiquitination by 
the Von Hippel-Lindau tumour suppresser ubiquitin ligase complex (pVHL). During hypoxia or 
low oxygen conditions, HIF-1α is stabilised, translocates to the nucleus and associates with 
HIF-β to promote gene expression, targeting genes containing a hypoxia response element 
(HRE). HIF-1α acts as a glycolytic enhancer through transcriptional activation of metabolic 
genes including 6-phosphofructo-2-kinase/fructose-2,6-bisphosphate 3 (PFKFB3) and pyruvate 
dehydrogenase kinase-1 (PDK1), both positive regulators of glycolysis and monocarboxylate 
transporter 4 (MCT4), the lactate efflux transporter. Ub = ubiquitin, OH = hydroxyl group. 
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promoters (O'sullivan et al. 2007). These data support a significant role for hypoxia in 
neuronal activity, potentially, though neurovascular uncoupling and enhanced neuronal 
oxidative metabolism depleting oxygen levels. 
 
2.4 Disrupted Metabolism in Neurodegenerative Disorders 
2.4.1 Alzheimer’s Disease  
Neurodegenerative disorders encompass a range of conditions characterised by 
progressive neuronal damage and degeneration as well as neuronal cell death. Although 
neurodegenerative disorders vary in the neuronal populations and cognitive or motor 
functions affected, metabolic dysfunction is a unifying pathology underlying many of these 
disorders (Silverman et al. 2001; Tabrizi et al. 2000; Zhou et al. 2008). The most prevalent 
and most extensively studied of these is Alzheimer’s disease (AD) occurring in around 
1:10 people aged over 65, with memory loss one of first apparent symptoms (Brown et al. 
2017; Jahn 2013). AD is classified by the presence of two hallmark neuropathologies; 
extracellular amyloid plaques, formed from aggregation of amyloid (Aβ) peptide, and 
intraneuronal neurofibrillary tangles formed from aggregation of hyperphosphorylated tau 
(Glenner & Wong 1984; Goedert et al. 1989). In AD patients, regional hypometabolism in 
the brain is a predictor for progressive cognitive decline and reduced cerebral metabolism 
is associated with carriers of the AD risk allele of the ApoE epsilon 4 gene (Silverman et al. 
2001; Small et al. 1995). At the cellular level, mitochondria isolated from AD patients 
display reduced enzymatic activity of the ETC complex IV (cytochrome C oxidase; Parker 
et al. 1990; Parker & Parks 1995) Similarly, in mouse models of AD, oxidative respiration 
is diminished and Aβ is found to localise and progressively accumulate in neuronal 
mitochondria (Manczak et al. 2006; Mucke et al. 2000; Rhein et al. 2009; Yao et al. 2009). 
This progressive accumulation of Aβ in mitochondria is associated with reduced oxidative 
respiration and reduced activity of the rate-limiting TCA cycle enzyme, α-ketoglutarate 
dehydrogenase complex (KGDHC), and the pyruvate dehydrogenase complex (PDHC), 
which generates acetyl-CoA for entry into the TCA cycle (Casley et al. 2002). Both 
metabolic dysfunction and mitochondrial Aβ accumulation appear to occur early in disease 
progression, preceding the onset of extracellular plaque formation (Du et al. 2010; Wirths 
et al. 2001). This indicates that early metabolic dysfunction is a key process in AD 
progression and a potential target for therapeutic intervention.   
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 Also preceding extracellular plaque formation in the AD brain is significantly 
increased ROS production and oxidative stress. Substantially increased ROS activity and 
oxidative damage is consistently detected in AD patients by various measures (Calingasan 
et al. 1999; Gabbita et al. 1998; Greilberger et al. 2008; Hensley et al. 1995; Pratico et al. 
1998). Increased oxidative stress occurs early in disease progression being observed in 
patients with mild AD as well as in cases of mild cognitive impairment, a high-risk factor for 
development of AD (Baldeiras et al. 2008). The Aβ peptide is also known to be a source of 
ROS production and a cause of neuronal oxidative damage in AD (Fig. 2.3; Behl et al. 
1994; Bianca et al. 1999; Harris et al. 1995).  
 
 
 
 
 
Figure 2.3: Disrupted metabolic pathways in neurodegenerative diseases. Hypoxia associated 
with AD leads to increases in the HIF-1α target, β-site β-amyloid precursor protein cleavage 
enzyme 1 (BACE1), which cleaves amyloid precursor protein (APP) to produce Aβ. Aβ 
accumulates in neuronal mitochondria (MC) early in disease progression and disrupts oxidative 
metabolism. Acetyl-CoA production and TCA cycle entry is decreased in AD through reduced 
activity of the pyruvate dehydrogenase complex (PDHC). In all three diseases, activity of α-
ketoglutarate dehydrogenase complex (KGDHC) is reduced, ROS is increased and 
transglutaminase (TG) activity is increased. TG increases α-synuclein aggregation and reduces 
oxidative respiration.  
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 Related to oxidative stress, and also implicated in AD pathology, is dysregulated 
homeostasis of redox transition metal ions including zinc, copper, and iron (Ayton et al. 
2015; Schrag et al. 2011; Ventriglia et al. 2012). Both elevation and deficiency of zinc is 
associated with AD and evidence suggests that altered compartmentalisation of zinc rather 
than altered zinc levels may be the cause of zinc pathology in AD (Schrag et al. 2011; Suh 
et al. 2000). This is supported by dysregulation of numerous zinc transporters in AD 
patient brains (Beyer et al. 2009; Lovell et al. 2006; Lovell et al. 2005). Zinc has important 
roles in normal neuronal function and is co-released along with glutamate at the synapse 
(Vogt et al. 2000). A major role of zinc is its significant antioxidant capacity, such that zinc 
deficiency is linked to neuronal oxidative stress (Aimo et al. 2010). Like zinc, copper 
elevation and copper deficiency have both been associated with AD as well as co-
localisation of copper with Aβ plaques (Miller et al. 2006; Schrag et al. 2011; Ventriglia et 
al. 2012). Copper is also modulated by synaptic activation in neurons and both zinc and 
copper are able to bind Aβ (Schlief et al. 2005; Tougu et al. 2008). In AD pathology, 
copper enhances Aβ toxicity and copper:Aβ complexes are a source of ROS production 
and oxidative damage in neurons (Dikalov et al. 2004; Ellis et al. 2010; Liu et al. 2008a). 
The redox active iron, although vital for cellular function, is also a pro-oxidant and 
promotes generation of highly reactive hydroxyl radicals from hydrogen peroxide. Elevated 
levels of brain iron in the AD brain as well as iron association with Aβ plaques and 
neurofibrillary tangles has been detected in various studies (Bartzokis et al. 2000; Raven 
et al. 2013; Smith et al. 1997). Recently elevated iron has been shown to predict AD 
progression and elevated iron was linked to the APOE-4 AD risk allele suggesting it may 
have a pathological role in AD (Ayton et al. 2015).  
 Another common feature of AD that contributes to AD pathology is vascular 
dysfunction. Cerebrovascular disease, characterised by disrupted blood flow to the brain, 
significantly increases AD risk and occurs before Aβ accumulation and cognitive decline 
(Arvanitakis et al. 2016).  In animal models, hypoperfusion also leads to symptoms similar 
to AD and exacerbates existing AD pathology (Walsh et al. 2002; Wang et al. 2010b). 
Vascular dysfunction contributes to the pathology of AD due to lower capillary density, 
meaning narrowed blood vessels and decreased cerebral blood flow (Hamel et al. 2008). 
Diminished blood flow reduces metabolite and oxygen supply to the brain and potentially 
contributes to build-up of Aβ through impaired clearance of neurotoxic molecules (Kumar-
Singh et al. 2005; Shibata et al. 2000). Aβ itself is also thought to amplify deficits in 
cerebral blood flow and glucose utilisation in AD through impairing vasodilation and 
cerebrovascular autoregulatory mechanisms (Niwa et al. 2002). Cerebrovascular 
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dysfunction can lead to disrupted oxygen metabolism through hypoperfusion-hypoxia and 
hypoxia in-turn can enhance AD pathology by promoting tau phosphorylation as well as 
transcriptionally upregulating the HIF-1 target, β-site β-amyloid precursor protein cleavage 
enzyme 1 (BACE1) that cleaves amyloid precursor protein (APP) to produce Aβ (Fig. 2.3; 
Sun et al. 2006).  
 
2.4.2 Parkinson’s and Huntington’s Disease 
Aside from rare cases of genetic mutations in familial AD, the major risk factor for 
developing AD is aging (Lindsay et al. 2002). Correspondingly, AD, shares a number of 
similarities with other late-onset neurodegenerative disorders including Parkinson’s 
disease and Huntington’s disease. Parkinson’s Disease (PD) is thought to be caused by 
both genetic and environmental factors and primarily impacts patient motor function 
(Priyadarshi et al. 2001; Simon-Sanchez et al. 2009). PD involves the formation of protein 
aggregates consisting mainly of α-synuclein and affects the dopaminergic neurons of the 
midbrain substantia nigra (Damier et al. 1999; Greenfield & Bosanquet 1953). Huntington’s 
disease (HD) is an inherited neurodegenerative disorder caused by expanded CAG 
repeats in the Huntingtin (HTT) gene causing progressive neuronal degeneration and cell 
death throughout the brain, affecting mood, cognition and motor skills (Macdonald et al. 
1993; Tabrizi et al. 2009). Inclusions are also found in HD brain from aggregation of 
mutant HTT (mHTT) protein (Difiglia et al. 1997). Like AD, both PD and HD are associated 
with increased oxidative stress as well as decreased activity of the KGDHC enzyme 
(Gibson et al. 2003; Klivenyi et al. 2004; Tabrizi et al. 2000; Zhou et al. 2008). Also, 
common to all three disorders is increased activity of transglutaminase (TG; Jeitner et al. 
2008; Johnson et al. 1997; Junn et al. 2003). TG catalyses polyamination post-
translational modification of proteins and is known to be increased by ROS and also 
attenuates HIF-1 signalling (Campisi et al. 2004; Filiano et al. 2008). TG can decrease 
oxidative metabolism through modification of glycolytic enzymes and is known to cause 
oxidative stress in HD and aggregation of α-synuclein in PD (Fig. 2.3; Cooper et al. 1997; 
Junn et al. 2003; Kim et al. 2005).  
 Mutations in mitochondrial genes have also been identified in cases of familial PD 
and exposure to the neurotoxin MPP+, which inhibits ETC Complex I and therefore 
oxidative respiration, causes permanent Parkinsonism (Langston et al. 1983; Parker & 
Parks 2005; Plun-Favreau et al. 2007). Altered metal ion homeostasis may have a role in 
PD pathology as well with disrupted levels of both zinc and copper observed in PD 
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patients (Brewer et al. 2010; Davies et al. 2014). Similar to Aβ, copper also contributes to 
α-synuclein aggregation and can contribute to oxidative stress through the formation of 
reactive copper:α-synuclein complexes (Dell'acqua et al. 2015; Wang et al. 2010a). α-
synuclein is also know to exacerbate mitochondrial dysfunction in the presence of toxic 
oxidising agents, with loss of α-synuclein in animal models conferring resistance to 
mitochondrial toxins (Klivenyi et al. 2006; Norris et al. 2007). Additionally, levels of α-
synuclein are increased when oxidative metabolism is inhibited and animal models 
expressing mutant forms of α-synuclein exhibit neuronal mitochondrial degeneration and 
cell death (Lee et al. 2002a; Martin et al. 2006). In Huntington’s disease, increased 
oxidative damage to mitochondrial DNA is observed as well as higher frequencies of 
deletions in the mitochondrial genome and deficits in ETC function with decreased 
expression of complex II in the striatum and decreased activity of complex IV in striatal and 
cortical regions (Horton et al. 1995; Polidori et al. 1999). Neuronal mitochondrial 
permeability is also disrupted by the mHTT protein through increasing sensitivity of the 
permeability transition pore to Ca2+ concentration, leading to mitochondrial dysfunction and 
decreased ATP production (Brustovetsky et al. 2003; Milakovic et al. 2006). Vascular 
deficits and disrupted blood flow is a major pathology of HD as well with altered blood 
vessel density and size found in cortical grey matter, putamen and striatal regions. In HD 
patients, inclusions of mHTT are also detected in the basal membrane and epithelium of 
cortical blood vessels and in mouse models of the disease pericytic coverage of cortical 
and striatal blood vessels is decreased (Drouin-Ouellet et al. 2015; Hsiao et al. 2015).  
 
2.4.3 Ageing 
A number of the metabolic pathologies observed in neurodegenerative disorders are 
associated with normal aging and may explain the age-related manifestation of 
neurodegenerative disease phenotypes. While no longer thought to be directly causative 
of aging, free radicals and oxidative stress accumulate in the aging brain as in 
neurodegeneration (Smith et al. 1992). Mitochondrial function is also linked to aging due to 
the association of mitochondrial DNA (mtDNA) haplotypes with longevity and the 
generation of mtDNA mutator mice that have a premature aging phenotype (Alexe et al. 
2007; Bilal et al. 2008; Trifunovic et al. 2004). It has also been shown there is an increased 
rate of damaging mutations in mtDNA of post-mitotic aging cells as opposed to aging 
mitotic cells (Greaves et al. 2012). While it has been suggested that the somatic rate of 
mtDNA mutation is unlikely to have a pathological affect due to redundancy in cell 
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mitochondrial numbers, in post-mitotic neurons mtDNA mutation rates are significantly 
higher than average and, within the cortex, mitochondria with large mtDNA deletions 
possess a replicative advantage during mitochondrial expansion (Bender et al. 2006; Fukui 
& Moraes 2009; Kraytsberg et al. 2006; Song et al. 2005). Aside from AD and PD, 
deficiency of zinc is also associated with aging, being decreased in the general elderly 
population (Pepersack et al. 2001). Diminished cerebral blood flow occurs in normal aging 
as well with cortical perfusion found to decrease with age in healthy adults (Chen et al. 
2011). An age-dependent reduction in perictyes also occurs in mice and is associated with 
microvascular changes and neurodegeneration (Bell et al. 2010). Substantial evidence 
therefore exists supporting disrupted neuronal oxygen supply and oxidative metabolism as 
a major pathological component of age-related neurodegeneration.  
 
2.5 Oxygen Metabolism as a Driver of Neuronal Plasticity 
Although it has been well established that metabolic regulation is critical to neuronal 
function and that metabolic dysfunction is a major pathology in diseases affecting 
behaviour and cognition, there is little known regarding how regulators of metabolism may 
be involved in neuronal plasticity. A number of studies, however, support a direct role for 
metabolic regulation and metabolically linked genes in influencing learning and memory. 
One of the best examples of this is exposure of hypoxia as a modulator of cognitive 
performance. In C. elegans, hypoxia acts as an enhancer of gustatory sensory perception 
through Hif-1 dependent induction of the neurotransmitter serotonin within specific sensory 
neurons (Pocock & Hobert 2010). In rodent models, exposure to hypobaric hypoxia in 
adult rats for periods of 7-21 days causes decline in spatial learning similar to aging and is 
associated with aging-related lipofuscin deposition and ultrastructure changes in 
mitochondria. Increasing duration of hypobaric hypoxic exposure also positively correlates 
with increasing expression of ageing markers (Biswal et al. 2016). Brief hypoxic exposure 
(100 sec) in rats also causes synaptic arrest of pyramidal CA1 hippocampal neurons and 
deficits in spatial memory that are both reversed by blockade of receptors for Adenosine, 
an inhibitory neurotransmitter (Sun et al. 2002). Intermittent hypoxia (90-120 sec intervals 
of 6-10% O2 for 10 h/day) also produces deficits in acquisition of spatial memory in adult 
rats that could be prevented by administration of antioxidant (Row et al. 2003; Ward et al. 
2009). In contrast, long-term facilitation of motor output in adult rats is enhanced by 
intermittent hypoxia (3 x 3 min intervals, separated by 5 min hyperoxia) increasing both 
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phrenic amplitude and burst frequency, which was not observed with continuous hypoxia 
of the same cumulative duration (Baker & Mitchell 2000). Differing effects of hypoxia in 
brain plasticity are likely related to differing exposures as well as measurement of different 
outputs. Interestingly, mild hypoxia preconditioning confers protection of cognitive abilities 
during subsequent exposure to severe hypoxia implicating a role for HIFs and 
transcriptional changes induced by mild hypoxia (Rybnikova et al. 2005). Indeed, neuronal 
knockout of HIF-1α in mice impairs spatial memory and stabilisation of HIF improves 
hippocampal memory in fear conditioning (Adamcio et al. 2010; Tomita et al. 2003). 
Similar learning deficits and age-related changes are also observed in a D-galactose 
induced model of aging where oxidative injury was the major stimulus for aging (Li et al. 
2016). 
 In learning and memory studies using an inhibitory avoidance paradigm, changes in 
metabolic gene expression were observed at 24 h, with increased expression of Na+/K+ 
ATPase, Glut1, Glut3 and, most prominently, lactate transporters MCT1 and MCT4  
detected, suggesting transcriptional modulation of neurometabolic coupling occurs 
following learning (Tadi et al. 2015; Yao et al. 2009). Altered expression of lactate 
metabolic enzymes and transporters is also related to stress induced improvements in 
cognitive function. Psychological stress, while harmful under chronic conditions, has 
evolved to enhance cognitive function and improve reactions to stressful situations through 
hypothalamic activation of adrenergic receptors and hypothalamic-pituitary-adrenal axis 
glucocorticoid production (Dong et al. 2017). In a mouse model of stress, induced by 
activation of the β2adrenergic receptor (β2AR), cognitive function was improved with 
short-term (3-5 days) activation while longer activation (>6 days) was harmful. Improved 
cognitive function following short-term stress induction corresponds with β2AR-dependant 
increases in lactate dehydrogenase A, MCT1 and MCT4 expression, the expression of 
which was modulated by b-arrestin-1 activation of HIF-1α downstream of β2AR (Dong et 
al. 2017).  
 Altered expression of ETC oxidative phosphorylation genes is also associated with 
altered behaviour in the honeybee. In a study exploring molecular profiles in aggressive 
honeybee behaviour, oxidative phosphorylation was most significantly enriched in 
association with increased aggression. This was found to be true for aged bees that 
display increased aggressive behaviour as well as following environmentally enhanced 
aggression by alarm pheromone exposure and genetic-related aggression occurring in the 
Africanised honeybee population (Alaux et al. 2009). Consistent with this, inhibition of 
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oxidative phosphorylation by treatment with drugs targeting the TCA cycle increased 
aggression of honeybees measured using and intruder assay (Li-Byarlay et al. 2014). In 
the same study, cell-type-specific knockdown of ETC complex genes using GAL4 drivers 
in Drosophila found that neuron-specific, but not glia-specific, knockdown of the complex I 
gene ND20-like, significantly increased aggressive lunging behaviour in flies (Li-Byarlay et 
al. 2014).  
 Also involved in learning and memory are non-coding miRNA genes which are 
regulated during neuronal activity by various mechanisms and able to regulate translation 
of various downstream target genes. A number of miRNAs have been associated with 
plasticity including the hypoxia-regulated miR-210 that is known to be involved in 
metabolic regulation. miR-210 is significantly upregulated 24hrs after long-term memory 
formation in the honeybee using an olfactory conditioning paradigm. Upregulation of miR-
210 also correlated with downregulation of a number of metabolically linked protein-coding 
genes including Gapdh2, Glucose dehydrogenase, Laccase2 and Aldose reductase-like. 
Inhibition of miR-210 by treatment of honeybees with miR-210 antogmiR also resulted in 
reduced memory retention in the olfactory conditioning assay indicating a functional role in 
learning and memory (Cristino et al. 2014b). Another hypoxia-regulated miRNA, miR-181c, 
is also associated with modulating cognitive function in rats. In a model of chronic cerebral 
hypoperfusion miR-181c was continuously inhibited, correlating with upregulation of its 
plasticity-related target gene, TRIM2. Hypoperfusion in this model was associated with 
deficits in spatial learning that were ameliorated by hippocampal overexpression of miR-
181c (Fang et al. 2016). These studies all provide support to the hypothesis that 
metabolically regulated genes are directly involved in regulation of neuronal plasticity.  
 
2.6 Conclusions 
While neurovascular coupling mechanisms appear to maintain steady-state oxygen levels 
in the brain, it is becoming evident that neurovascular uncoupling may in fact have a 
physiological role in regulating plasticity through oxygen depletion and induction of 
downstream hypoxia response pathways. Disruptions to hypoxia and oxidative metabolism 
have also been extensively attributed to neurodegeneration pathology although there 
remains a lack of understanding as to how these disruptions are triggered and how they 
may be therapeutically targeted to halt disease progression and improve cognitive and 
motor functions. Altered behaviour and learning and memory associated with 
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dysregulation of metabolic genes highlights the importance of understanding the role of 
oxygen metabolism in neuronal plasticity. Further elucidation of how the hypoxia response 
pathway and other metabolic genes are involved in neuronal function will be critical in 
determining the molecular links between cognitive function and oxidative metabolism as 
well as disrupted metabolism and cognitive deficits in neurodegeneration.  
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
CHAPTER THREE 
 
IDENTIFICATION OF MIR-210 TARGETING BY MRNA 
PULL-DOWN 
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3.1 Introduction 
Previous identification of the highly conserved, hypoxia-regulated miR-210 in honeybee 
olfactory conditioning raises the question of how miR-210 may regulate plasticity in more 
complex mammalian systems and through which mRNA targets miR-210 may mediate 
functional effects in neuronal cells. Given the diversity in miRNA targeting and 
heterogeneous nature of miRNA:mRNA binding, accurately identifying miRNA targets 
presents a number of challenges (Brennecke et al. 2005). Based on sequence 
complementarity a number of miRNA binding site prediction programs have been 
developed to computationally detect target genes. A variety of parameters are used for the 
prediction of miRNA targets such as 5’ seed region binding, compensatory 3’ binding and 
free energy required for binding interactions. Available prediction tools all differ in how they 
weight various parameters and their allowance of G:U wobble base pairing or 
mismatches/bulges in targets sites and subsequently, in their restrictions for classification 
of high-confidence targets (Krek et al. 2005; Lewis et al. 2003; Vlachos et al. 2012). In 
addition, some programs take into consideration the degree of sequence conservation 
across species or unique criteria such as mRNA secondary structure and accessibility of 
the site (John et al. 2004; Kertesz et al. 2007; Xu et al. 2014). Due to these differences 
there can be a large disparity in targets predicted for a single miRNA dependent on the 
program used and a high false discovery rate in detecting functional targets (Krek et al. 
2005; Lewis et al. 2003). Endogenous miRNA regulation will also be dependent on a 
number of external factors such as co-expression and colocalisation of miRNA and mRNA, 
or the presence of other regulatory factors or miRNAs that may compete for target binding.  
 In recent years a number of experimental approaches have been developed to 
overcome shortcomings in miRNA target prediction, which also provide feedback for 
improved target prediction (Wang 2016). First described by Ørom et al., (2008) biotin-
linked chromatography has been used to directly capture miRNA-bound mRNA which can 
be analysed by downstream RNA quantification methods (Tan et al. 2014; Wani & 
Cloonan 2014). Alternative methods for experimental identification of miRNA targets have 
also been developed such as cross-linked immunoprecipitation followed by high-
throughput sequencing (HITS-CLIP). This involves UV cross-linking of mRNAs and 
miRNA:RISC before RNase degradation of exposed RNA, not bound to protein, before 
isolation using an AGO2 antibody and sequencing of miRNA and mRNA fragments 
(Licatalosi et al. 2008). miRNA targets can also be isolated by overexpression of a miRNA 
together with an epitope tagged Argonaute protein before co-immunoprecipitation of 
   36 
AGO2 and bound miRNA:mRNA (Hendrickson et al. 2008). Unlike biotin-linked miRNA 
pull-down, these approaches restrict pull-down of only RISC-associated miRNAs, however 
AGO2-immunoprecipitation may also bias isolated targets as other mammalian AGO 
isoforms are also involved in miRNA gene regulation and analysis of HITS-CLIP data also 
relies on computationally inferred miRNA:mRNA interactions. Here, RNAseq analysis of 
biotin-tagged miR-210 pull-down has been utilised to identify global targeting and function 
of miR-210 within the human SH-SY5Y transcriptome.   
 
3.2 Methods 
3.2.1 SH-SY5Y Cell Culture and Transfection 
SH-SY5Y cells were maintained in 5% CO2 at 37°C in Dulbecco’s Modified Eagle’s 
Medium (DMEM)/F-12 nutrient mix/15 mM HEPES (Gibco) supplemented with 10% fetal 
bovine serum (FBS; SAFC Biosciences) and 100 U/mL;100 µg/mL penicillin-streptomycin 
(pen-strep; Gibco). At ~80% confluency, cells were passaged by collection of media 
containing cells in suspension before washing attached cells with warm phosphate 
buffered saline (PBS) and detaching cells with one volume of 0.05% trypsin/EDTA (Gibco) 
at 37°C. Trypsin dissociation was stopped by addition of three volumes of complete media. 
Collected media and detached cells were spun down together at 150 x g and seeded at a 
density of 4-6 x 104 cells/cm2. For transfection, cells were plated in 6-well, cell culture 
plates at a density of 1x106 cells/well in complete media and allowed to attach overnight. 
600 pmoles/well of biotin-tagged miRNA oligo and 5 µL/well of Lipofectamine 2000 
reagent (Thermo-Fischer) were diluted in Opti-MEM I reduced serum medium (Gibco) and 
incubated at room temp for 5 min before oligo and lipid solutions were combined, briefly 
vortexed and incubated at room temp for 30 min. Media was replaced with fresh media 
and transfection mix was added to a total volume of 2 mL and final concentration of 50 nM 
biotin-tagged miRNA mimic. To assess transfection efficiency cells were fixed 24 h after 
transfection with 4% paraformaldehyde (PFA) in PBS for 10 min and washed 3 x 5 min in 
PBS. Non-specific binding in cells was blocked with 2% (w/v) bovine serum albumin 
(BSA)/0.3% Triton X-100 (TX) in PBS for 30 min at room temp before incubating with 
1:400 Streptavidin-Alexa Flour 594 (Thermo-Fischer) in 2% BSA/0.3% TX/PBS for 1 h at 
room temp. Cells were washed 3 x 5 min in 0.3% TX/PBS, stained with 1 μg/mL DAPI in 
PBS for 10 min and washed again 3 x 5 min in 0.3% TX/PBS. Images were collected on a 
Nikon Eclipse Ti microscope fitted with a Nikon digital-sight DS-U3 camera using the NIS 
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elements AR software. Images were collected from 5 regions/well from 4 replicate wells, 
transfection efficiency was calculated as percentage of total cells that were positive for 
fluorescence. 
 
3.2.2 Biotin Pull-down Assay 
For each condition, 6 x 106 SH-SY5Y cells were plated in triplicate and transfected as 
described with 600 pmoles of single-stranded biotinylated-miR-210-3p mimic (bi-miR-210; 
Genepharma; 5’CUGUGCGUGUGACAGCGGCUGA-biotin) or bi-miR-239b-5p mimic 
(Genepharma; 5’UUUGUACUACACAAAAGUACUG-biotin). Biotin-tagged miRNA mimics 
were synthesised using 2’O-methyl modified RNA bases that are less sensitive to 
degradation for all nucleotides in the miRNA mimic sequence. An additional 3 wells were 
plated for control, un-transfected cell lysate sample collection. For each replicate, 150 µL 
of resuspended Dynabeads M-280 Streptavidin (Thermo-Fischer) were prepared for RNA 
manipulation according to manufacturer directions. Briefly, resuspended beads were 
placed on a DynaMag magnet (Thermo-Fischer) for 2 min before removing supernatant 
and washing 3X with Bead Wash Buffer (5 mM Tris-HCL, 0.5 mM EDTA, 1 M NaCl, pH 
7.5). Beads were then washed 2 X 2 min in 150 µL of Solution A (0.1 M NaOH, 0.05 M 
NaCl) and 1 X 2 min in 150 µL of Solution B (0.1 M NaCl). Prepared beads were blocked 
overnight while on rotation at 4°C in 300 µL of Bead Blocking Solution (1 mg/mL yeast 
tRNA, 1 mg/mL BSA). 24 h after transfection, cells were trypsinised, spun down and 
washed twice in ice-cold PBS before lysing on ice for 30 min in 360 µL of Cell Lysis Buffer 
(10 mM Tris-HCl, 10 mM KCl, 1.5 mM MgCl2, 5mM DTT, 0.5% IGEPAL CA-630 [Sigma], 
50 U/mL RNaseOUT [Thermo-Fischer], 1X complete mini-protease inhibitor cocktail 
[Roche], pH 7.5), pipetting every 10 min to aid cell lysis. Cell lysates were transferred to 
1.6 mL MAXYmum recovery microtubes and cleared by centrifugation at 4°C/5,000 x g for 
5 min. Supernatant was collected and lysate adjusted to 1M NaCl concentration/450 µL 
with 90 µL of 5 M NaCl. Blocked beads were washed once with 150 µL and resuspended 
in 450 µL of Wash Buffer (Cell Lysis buffer with NaCl concentration adjusted to 1 M). For 
immobilisation, cell lysate was mixed with beads and incubated on rotation for 30 min at 
room temp. Beads and bound complexes were then washed 3X in 150 µL of Wash Buffer 
before resuspension in 250 µL of RNase/DNase free water. For control lysate samples, 
250 µL of cleared cell lysate was used directly for RNA extraction as described for 
immobilised RNA samples.  
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3.2.3 RNA Extraction, cDNA Synthesis and Quantitative Real-Time-PCR 
To isolate RNA, 750 µL of TRIzol reagent (Thermo-Fischer) was added to resuspended 
bead complexes and samples incubated on ice for 5 min. 200 µL of chilled chloroform was 
added to samples before shaking vigorously for 30 secs and incubating for 3 min on ice. 
Samples were then centrifuged at 15,000 x g for 20 min at 4°C. The upper aqueous phase 
was aspirated and transferred to a clean tube and 20 µg of glycogen (Thermo-Fischer) 
and 500 µL of cold isopropanol added. Samples were mixed well by inversion and RNA 
precipitated overnight at -20°C.  RNA was pelleted by centrifugation at 14,000 x g for 30 
min at 4°C. Pellets were washed with cold 75% ethanol and spun again at 10,000 x g, 4°C 
for 10 min. Pellets were then dried, resuspended in 15 µL of RNase/DNase free water and 
incubated at 45°C for 15 min. RNA was quantified using a NanoDrop Lite 
spectrophotometer based on absorbance at 260 nM to determine concentration and 260 
nM/280 nM measurements as an indication of RNA purity, followed by quantification with a 
Qubit fluorometer using the Qubit high-sensitivity RNA assay (Thermo-Fischer) before 
storing at -80°C. Synthesis of cDNA was performed using SuperScript III reverse 
transcriptase (RT; Thermo-Fischer) according to manufacturer directions using 100 ng of 
random primers and 45 ng of RNA/reaction. Quantitative real-time PCR (qRT-PCR) was 
performed in 10 µL reactions on the Roche LightCycler480 system using the 
LightCycler480 SYBR Green I Master Mix (Roche) and gene-specific primers (Table 3.1). 
Control reactions with no reverse transcriptase were including for each sample as well as 
a blank control.  
 
3.2.4 RNAseq 
RNA samples were run on an Agilent 2100 Bioanalyser using the RNA 6000 Pico chip to 
determine RNA quality. To improve RNA quality, samples were enriched for intact mRNA 
using poly(A) beads to minimise contamination with rRNA, typically the major contaminant 
in small RNA samples (Matts et al. 2014). 10 ng of mRNA was used for cDNA synthesis 
using the TruSeq stranded mRNA Library Prep Kit (illumina) and paired-end sequencing 
reads were generated on an illumina HiSeq 2000. Read quality was analysed using the 
FastQC app. Trimmomatic v0.33 was used to trim low quality bases from read ends, 
remove adapter sequences and discard reads <36 base pairs long (Bolger et al. 2014). 
Sequences were aligned to the genome with TopHat v2.1.0 and Bowtie2 v2.2.6 index tools 
using the UCSC hg19 reference (Kim et al. 2013; Langmead & Salzberg 2012). TopHat 
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output annotation and alignment files were sorted using SAMtools v1.2 and read count 
files were generated using HTSeq v0.6.1 (Anders et al. 2015; Li et al. 2009) Analysis of 
data was performed in R using the DESeq2 package v1.10.11 (Love et al. 2014). 
Differential expression was compared using a threshold-based Wald test of significance at 
log fold change (lfc) >1 in DESeq2. A list of miR-210 target genes was generated from the 
differential expression output using an adjusted (Benjamin & Hochberg corrected) p-value 
of <0.05 and a log2 fold change  >1.5 as cut-offs for significant enrichment. 
 
 
 
Gene Sequence 5’>3’ Tm (°C) 
OST4 F: TCGCCATCTTCGCCAACAT 62.0 
 R: GACGGCCACGTAGTGATAGAG 61.7 
RPL28 F: CTTCCGCTACAACGGACTGAT 61.9 
 R: ATGACCACCACGACACCTTTG 62.6 
PGLS F: CATCCCGGTTTTCGACCTG 60.5 
 R: TCGGGGAGTCACTGATGGG 62.7 
NDUFS7 F: CTTCGCAAGGTCTACGACCAG 62.4 
 R: GGAATAGTGGTAGTAGCCTCCTC 60.7 
MLST8 F: GGGACTTGAAAACAGACCACA 60.1 
 R: CCGTCAGATTCCAGACATAGCA 61.5 
GRINA F: ATGATCGCCAGCTTCTACAAC 60.2 
 R: GTGAAGTCGTAGCGGGTCTG 62.3 
SH3BGRL3 F: CTCCCGCGAAATCAAGTCCC 62.9 
 R: CCCGTTGACAATCTGGGGTG 62.8 
EIF4EBP1 F: CTATGACCGGAAATTCCTGATGG 60.5 
 R: CCCGCTTATCTTCTGGGCTA 60.8 
 
3.2.5 Network Construction and Ontology analysis  
An Interactome network was generated from significantly enriched pull-down miR-210 
targets using Cytoscpape v3.3.0. Protein and gene interactions were obtained from the 
BioGRID homo sapiens interaction database v3.4.132. For developing a list of genes 
differentially regulated during long-term consolidation in vivo, relevant studies were found 
through PubMed searches and included on the basis of transcriptome/proteome 
expression analysis (Microarray/RNA-Seq/2-Dimensional Gel Electrophoresis) following 
Table 3.1: Gene-specific human primers used in qRT-PCR.  
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various forms of long-term consolidation (spatial discrimination, fear conditioning, electrical 
stimulation, etc.) and availability of data. Gene/Array ID’s were converted to homologous 
human ID’s using Ensembl BioMart (Kersey et al. 2017). Enrichment for biological 
processes gene ontology (GO) terms and KEGG pathways was calculated using the 
DAVID functional annotation tool v6.7 using default settings and significance cut-offs (p-
value <0.1; Huang Da et al. 2009). Transcription factor binding site (TFBS) enrichment 
was determined using the oPOSSUM single-site analysis online tool v3.0, parameters 
were set to detect TFBSs within 5000 bp of upstream sequence and 2000 bp of 
downstream sequence and all other options were set to default values, cut-offs used for 
significant enrichment were Z-score >2.58 (99% confidence interval) and target TFBS 
nucleotide rate/background TFBS nucleotide rate >1.5 (Kwon et al. 2012). 
 
3.2.6 Cloning of 3’UTRs and miRNA Recognition Elements 
Primers flanking the 3’UTRs of selected target genes were designed with 5’ Xho I and 3’ 
Not I restriction sites flanking forward and reverse primers, respectively (Table 3.2). For 
miRNA recognition elements (MREs) and short 3’UTRs the entire sequence with 5’ Xho I 
and 3’ Not I complimentary overhangs was designed as single-stranded synthetic DNA 
oligos (Table 3.3). In a thermocycler, 100 pmoles of oligos were phosphorylated and 
annealed with 10 units of T4 Polynucleotide Kinase (NEB) in T4 ligase buffer (37°C/30 
min, 95°C/5 min, ramp to 25°C/1°C min-1). Q5 high-fidelity DNA polymerase (NEB) was 
used to amplify 3’UTRs from SH-SY5Y cDNA, according to manufacturer directions after 
optimisation of conditions and annealing temp for each primer set using gradient PCR. 
PCR products were run on a 1% agarose gel with 1X SYBR safe, extracted on a blue light 
transilluminator, and purified using the QIAquick Gel Extraction Kit (QIAGEN) as per kit 
directions. Purified PCR products and ΨCheck2 vector (Promega) were double-digested 
with 20 units of Xho I, 20 units of Not I-high fidelity (Not I-HF) restriction enzymes and 0.1 
mg/mL BSA in 1X Cut-Smart buffer (NEB). Digest reactions were incubated at 37°C/1 h 
followed by 80°C/20 min to inactivate enzymes. Following digestion, ΨCheck2 vector was 
dephosphorylated using 6 units of rAPid alkaline phosphatase (Roche) in 1X alkaline 
phosphatase buffer, incubated for 37°C/2 h followed by 75°C/15 min for enzyme 
inactivation. Digested PCR products and ΨCheck2 vector were again purified by gel 
extraction as described.  
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Target Primer: Sequence 5’ > 3’ Tm (°C) 
 Sequencing:  
ΨCheck2 
 
F: GGACGCTCCAGATGAAATG 
R: CAAACCCTAACCACCGCTTA 
51.1 
51.8 
 PCR Amplification: 
 
AP2S1   
3’UTR 
F: CAGTCAAGCTCGAGCAGGCTGATGCTACAGTCCCTG 
R: TCAACTGCGGCCGCGTCGCAGGACCACAGGTTTATTG 
53.2 
51.8 
TMUB1   
3’UTR 
F: CAGTATTGCTCGAGCAGATGTACCGCCCGTAGTGC 
R: ATCATTTAGCGGCCGCATCACTTCACAGTTACTTTAATCTGCACGG 
52.6 
56.7 
GRINA  
3’UTR 
F: CAGTATCACTCGAGCAGAGGAGTAGCCGAGCTCCAG 
R: ATAGTTTAGCGGCCGCGTCTGCAGAGAGCAAATCCCATTTATTGGA 
55.4 
56.7 
ATP6V0C   
3’UTR 
F: CAGTGACTCTCGAGCAGAAGTAGACCCTCTCCGAGC 
R: TCACTGGCGGCCGCGTAGCCCGTCACATCCAAGAAC 
53.2 
53.2 
ACTB 
3’UTR 
F: CAGTATCACTCGAGCAGGGCGGACTATGACTTAGTTG 
R: ATCATTTAGCGGCCGCGTCGGTGTGCACTTTTATTCAACTG 
51.8 
51.1 
MLST8   
3’UTR 
F: GAATGACTCTCGAGCAGCTGCCTGGCCTTCAATGAC 
R: TCAACTGCGGCCGCGTCCCGAGCAACATCTGCGTG 
53.2 
52.6 
VEGFB   
3’UTR 
F: CAGTCATACTCGAGCAGGAGCTCAACCCAGACACC 
R: ATCATTAGCGGCCGCGTCCCAGAGAAGTTTGAGACTATCTTTACG 
52.6 
56.7 
EIF4EBP1   
3’UTR 
F: CAGTGACTCTCGAGCAGAGCACCAGCCATCGTGTG 
R: TCACTGGCGGCCGCGTCCTTGGCCCTAGGGCGAAG 
52.6 
54.9 
MAP2K2   
3’UTR 
F: CAGTGACTCTCGAGCAGGTGACAGTGGCCGGGCTC 
R: TCACTGGCGGCCGCGTAGCCTCTGAGACCACACACAGCA 
57.2 
58.6 
ATP5G2   
3’UTR 
F: CAGTGACTCTCGAGCAGATGTGAAGGAGCCGTCTC 
R: TCACTGGCGGCCGCGTATCTCTGTCAAACCCTGAGC 
50.3 
51.1 
ATP5D   
3’UTR 
F: CAGTGACTCTCGAGCAGGAGTAGGCGGTGCGTACC 
R: TCACTGGCGGCCGCGTACAGGCTTCCGGGTCTTTAATGG 
54.9 
56.7 
COX8A   
3’UTR 
F: CAGTGACTCTCGAGCAGACAGGAGGCCAGAGTGAAG 
R: TCACTGGCGGCCGCGTACCACCAAGCAGGGTCAGT 
53.2 
52.6 
COX6A1   
3’UTR 
F: GAATGATCTCGAGCAGAGAGAATCTGGACCACTACC 
R: TCACACGCGGCCGCGTCTATTTAAGCCATCTCCTGCCA 
51.8 
50.5 
NDUFS7   
3’UTR 
F: CAGTCAAGCTCGAGCAGGATCTGGTACCGCAGGTAG 
R: TCAACTGCGGCCGCGTCGAGGGCAGGTTTATTGACAAC 
53.2 
52.4 
NDUFA4L2   
3’UTR 
F: CAGTGACTCTCGAGCAGCAGACTTCTAAGCCAGGCTGG 
R: TCACTGGCGGCCGCGTCGTATTTTGCCCACGGCTGC 
56.3 
53.2 
CYC1   
3’UTR 
F: CAGTGACTCTCGAGCAGCCTGTCCAGTGTCTGCTTGC 
R: TCACTGGCGGCCGCGTACCATGATGGGGGCTGAAGG 
55.9 
55.4 
UQCRC1   
3’UTR 
F: CAGTGACTCTCGAGCAGGGGAAGCCTATGTAAGCAAG 
R: TCACTGGCGGCCGCGTATCACTTCTCAGCAGAGGATT 
51.8 
49.7 
APOE   
3’UTR 
F: GAATGACTCTCGAGCAGAATCACTGAACGCCGAAGC 
R: CATGCAGCGGCCGCGTATGATGCGTGAAACTTGGTGAATC 
51.1 
53.5 
Table 3.2: Primer sequences for cloning 3’UTRs. Red text indicates restriction enzyme sites, 
grey text indicates restriction site flanking regions and sequences in black are gene specific 
regions.  
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Target Oligo: Sequence 5’ > 3’ 
NDUFS8  
3’UTR -A 
Top: TCGAGCAGCGCCCCACCGGCCCGCAGCCCCTG 
Bottom: TTGGGCAGCAGGGGCTGCGGGCCGGTGGGGCGCTGC 
NDUFS8  
3’UTR -B 
Top: CTGCCCAATAAAACCACTCCGACCCCACGGAGACGC 
Bottom: GGCCGCGTCTCCGTGGGGTCGGAGTGGTTTTA 
(+) CTRL 
MRE 
Top: TCGAGCAGTCAGCCGCTGTCACACGCACAGGACGC 
Bottom: GGCCGCGTCCTGTGCGTGTGACAGCGGCTGACTGC 
GRINA 
MRE 
Top: TCGAGCAGCCAGCTCGCTGTGCCCGCTCAGGACGC 
Bottom: GGCCGCGTCCTGAGCGGGCACAGCGAGCTGGCTGC 
VEGFB  
MRE 
Top: TCGAGCAGGCAGCAGTTTCCACATGTGCACGACGC 
Bottom: GGCCGCGTCGTGCACATGTGGAAACTGCTGCCTGC 
ATP6V0C  
MRE 
Top: TCGAGCAGACAGCCTGACACATACGCACGGGGACGC 
Bottom: GGCCGCGTCCCCGTGCGTATGTGTCAGGCTGTCTGC 
TMUB1  
MRE 
Top: TCGAGCAGGCATCTGCTGTCGCTGCCTCGGCGACGC 
Bottom: GGCCGCGTCGCCGAGGCAGCGACAGCAGATGCCTGC 
GRINA  
Mutant 
Top: TCGAGCAGCCAACTCACTATGCCCGCTCAGGACGC 
Bottom: GGCCGCGTCCTGAGCGGGCATAGTGAGTTGGCTGC 
VEGFB  
Mutant 
Top: TCGAGCAGGCAACAGTTTCCAAATGTGAACGACGC 
Bottom: GGCCGCGTCGTTCACATTTGGAAACTGTTGCCTGC 
ATP6V0C  
Mutant 
Top: TCGAGCAGACAACCTGACACATACACAAGGGGACGC 
Bottom: GGCCGCGTCCCCTTGTGTATGTGTCAGGTTGTCTGC 
TMUB1  
Mutant 
Top: TCGAGCAGGCATCTACTATAGCTGCCTCGGCGACGC 
Bottom: GGCCGCGTCGCCGAGGCAGCTATAGTAGATGCCTGC 
 
 For ligation, 50 ng digested/dephosphorylated ΨCheck2 vector was mixed with 
either digested PCR products at a molar ratio of 1:3 – 1:5, dependent on sequence length, 
or 1 µL of oligo kinase reaction and incubated at 70°C/5 min. DNA mix was cooled on ice 
and adjusted to 20 µL with 1X T4 ligase buffer and 400 units of T4 DNA ligase (NEB). 
Reactions were incubated at room temp for 3 min before overnight incubation at 4°C. 1 µL 
of ligation reaction was incubated with 50 µL of DH5α chemically competent E. Coli (NEB) 
for 30 min on ice and transformed by heat-shock at 42°C/30 secs. Transformed cells were 
recovered on ice for 5 min followed by 1 h in shaker at 37°C/225 rpm in 250 µL of SOC 
media. Cells were plated on LB-agar plates with 100 µg/mL ampicillin and incubated 
overnight at 37°C. Individual colonies were selected and inoculated overnight in LB 
Table 3.3: Oligo sequences for cloning short MREs and 3’UTRs. Red text indicates restriction 
enzyme sites overhangs, grey text indicates restriction site flanking regions and sequences in 
black are annealing regions.  
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broth/100 µg/mL ampicillin. Plasmid DNA was extracted from cultures using the QIAprep 
spin miniprep kit (QIAGEN) as per manufacturer directions. Insert sequences were verified 
using Sanger sequencing using primers flanking the ΨCheck2 vector multiple cloning site 
(micromon; Table 3.2). 
 
3.2.7 Cos-7 Cell Culture and Transfection 
Cos-7 cells were maintained in 5% CO2 at 37°C in DMEM/high glucose (Gibco) 
supplemented with 10% FBS and 100 U/mL;100 µg/mL pen-strep. To passage, media was 
aspirated and cells washed with PBS before detaching with 0.05% trypsin/EDTA at 37°C. 
Trypsin reaction was stopped with FBS supplemented media and cells spun down at 150 x 
g before seeding at 1 x 104 cells/cm2. For luciferase assays, cells were plated at a density 
of 1 x 104 cells/well in 48 well plates and attached overnight. Media was replaced the 
following day before transfection with fresh media without antibiotics. Cells were 
transfected with 1 µL/well Lipofectamine LTX  (Thermo-Fischer) with either 100 ng of 
plasmid alone or co-transfected with 30 pmoles of hsa-miR-210-3p mimic or cel-miR-239b-
5p mimic (Dharmacon), before incubation for 24 h.  
 
3.2.8 Dual Luciferase Assay 
The Dual luciferase Reporter Assay System (Promega) was used as described by the 
manufacturer. 24 h after plasmid/mimic transfection, Cos-7 Cells were washed with warm 
PBS before lysis in 1X passive lysis buffer on a shaker at room temp for 20 min/200 rpm. 
20 µL of cell lysate samples was added to 96 well flat bottom LUMITRAC™ plates with 1-2 
additional tests wells loaded for gain adjustment. Luciferase activity was measured using a 
CLARIOstar microplate reader (BMG LABTECH), primed with Luciferase Assay Reagent II 
(LARII) and Stop & Glo reagent (S&G). The plate reader was programmed to inject 100 µL 
of reagent and collect measurements every 0.5 secs for 60 secs/reagent. LARII, which 
activates firefly luciferase was measured for each well before injection of S&G, which 
quenches firefly luciferase and activates renilla luciferase.  From collected measurements, 
a 20 sec time frame of stable luminesce was selected for analysis. Luminescence, 
measured in arbitrary light units, was calculated to units/sec for each luciferase protein and 
renilla data normalised to firefly data before calculated luciferase ratios for vector 
constructs were normalised to native ΨCheck2 values. Transfected samples for each 
construct were normalised to plasmid only transfected samples for graphing. 
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3.2.9 Statistics 
Statistical analyses of qPCR and luciferase data were carried out in R v3.2.4. Significance 
was calculated at a 95% confidence interval (α = 0.05). Homogeneity of variance and data 
normality distribution was determined using Levene and Shapiro-Wilk tests, respectively. 
Specific means tests and appropriate post-hoc analyses were used as indicated in the 
text. 
 
3.3 Results 
3.3.1 Biotin Pull-Down of miR-210 Targets 
While a selection of miR-210 targets have already been identified in different cell types, 
not much is know about specific genes miR-210 may target in the nervous system. To 
form a complete picture of miR-210 targeting the human-derived neuroblastoma cell-line, 
SH-SY5Y was chosen as a model system, commonly used in neuronal studies. 
Undifferentiated SH-SY5Y cells are non-polarised, proliferative cells that do not closely 
reflect mature neurons, however they possess a number of practical advantages for in 
vitro miRNA pull-down (Kovalevich & Langford 2013). They are able to be cultured on a 
large scale without the need for long differentiation protocols or specialised medium 
supplements and are able to be easily transfected. SH-SY5Y cells also seemed to be an 
appropriate model for detecting functional targets of miR-210 as a cell line where miR-210 
is expressed and known to be modulated in response to BDNF differentiation and MPTP 
exposure (Goldie et al. 2014; Zhang et al. 2017).  
 For pull-down of mRNA, miRNA mimics were designed and synthesised as sense-
strand miRNA oligo sequences with a biotin molecule conjugated to the 3’end of the oligos 
to minimise potential binding interference with the 5’ miRNA seed region (Fig. 3.1a). In 
addition to human miR-210 mimic (hsa-miR-210-3p) a C. elegans miRNA, miR-239b mimic 
(cel-miR-239b-5p), that is reported to have no homology in the human genome, was also 
included as a negative control. Successful transfection of biotin-conjugated mimics into 
cells was initially confirmed by staining of biotin-miR-210 transfected SH-SY5Y cells with 
streptavidin-594. Transfection was found to be highly efficient with >85.9% of cells staining 
positive for streptavidin.  
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 For pull-down of targets, cells transfected with either hsa-miR-210 or cel-miR-239b 
biotin-conjugated mimics were lysed and target RNA was isolated by biotin-streptavidin 
affinity pull-down (Fig. 3.1a). Captured RNA samples were sequenced using RNAseq and 
targets were identified as genes displaying significantly greater enrichment in miR-210 
pull-down samples compared to control miR-239b pull-down. From this, a total of 676 
genes were identified as potential miR-210 targets, of which 620 were targets not 
previously associated with miR-210 (significance cut-off: adjusted p-value [padj] <0.05, 
Log2[Fold Change] > 1.5; Appendix 3.1; Fig. 3.1b,c). The top 20 genes that displayed the 
most significant enrichment by miR-210 are listed in Table 3.4. 
 Among these top 20 targets alone are multiple genes with an already established 
role in neuronal and/or synaptic plasticity (highlighted rows, Table 3.4) Particular genes of 
interest include GRINA (padj = 1.02E-25, FC = 4.16) a subunit of the NMDA-receptor 
complex and the translation initiation binding protein, EIF4EBP1 (4E-BP1; padj = 5.55E-
23, FC = 4.04), known to be phosphorylated by neuronal activation signalling pathways 
and thought to be involved in regulating local gene expression in an activity-dependent 
manner (Gelinas et al. 2007; Kumar et al. 1991). Transmembrane protein, TMUB1 (padj = 
3.78E-23, FC = 4.25) is also involved in synaptic transmission through regulating surface 
expression of AMPA receptors containing GluR2 subunits, and, the adaptin AP2 complex 
subunit, AP2S1 (padj = 1.46E-25, FC = 4.50) also modulates endocytosis of AMPA and 
GABAA receptors (Lee et al. 2002b; Yang et al. 2008). As an additional validation of the 
RNAseq data the significant enrichment of a selection of target genes in miR-210 samples 
was confirmed by quantitative real-time PCR (qRT-PCR) using control lysate sample 
expression to normalise the data for relative quantification (Fig. 3.2; validated genes 
indicated in Table 3.4 with ▲). 
Figure 3.1: RNAseq identification of genes enriched by miR-210 pull-down. a. Schematic of the 
biotin-streptavidin pull-down approach used to isolate miR-210 target RNA. b. Scatter plot of 
pull-down RNAseq data, 676 genes, highlighted in red, were found to be significantly enriched 
by hsa-miR-210 compared to cel-miR-239b using thresholds; Log2(fold change) > 1.5, adjusted 
p-value <0.05, n = 3 biological replicates, DEseq2: Wald ‘greater’ test of significance, lfc 
threshold = 1. c. Interactome network of genes significantly enriched by miR-210. Edges 
indicate validated protein or gene interactions, increasing node and font size correlates to 
increasing fold change.  
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Gene ID Gene Name padj FC 
OST4 Oligosaccharyltransferase Complex Subunit 4 (Non-Catalytic) ▲ 1.96E-91 7.31 
RPL28 Ribosomal Protein L28  ▲ 1.08E-54 6.02 
PGLS 6-Phosphogluconolactonase ▲ 1.74E-42 6.27 
NME4 NME/NM23 Nucleoside Diphosphate Kinase 4  3.36E-30 4.97 
NDUFS7 NADH:Ubiquinone Oxidoreductase Core Subunit S7 ▲ 9.47E-29 5.07 
MLST8 mTOR Associated Protein, LST8 Homolog ▲ 3.47E-27 4.41 
PPDPF Pancreatic Progenitor Cell Differentiation And Proliferation Factor 2.53E-26 4.29 
SLC39A4 Solute Carrier Family 39 (Zinc Transporter), Member 4  7.50E-26 5.42 
GRINA Glutamate Receptor, Ionotropic, N-Methyl D-Aspartate-Associated Protein 1 (Glutamate Binding) ▲ 1.02E-25 4.16 
AP2S1 Adaptor Related Protein Complex 2 Sigma 1 Subunit 1.46E-25 4.50 
PEMT Phosphatidylethanolamine N-Methyltransferase 1.46E-25 4.80 
PPP1CA Protein Phosphatase 1, Catalytic Subunit, Alpha Isozyme 9.00E-25 4.81 
VEGFB Vascular Endothelial Growth Factor B 1.27E-24 4.40 
SH3BGRL3 SH3 Domain Binding Glutamate-Rich Protein Like 3 ▲ 6.90E-24 3.98 
TMUB1 Transmembrane And Ubiquitin-Like Domain Containing 1 3.78E-23 4.25 
GNG5 Guanine Nucleotide Binding Protein (G Protein), Gamma 5 4.70E-23 5.21 
CD320 CD320 Molecule 4.72E-23 4.72 
EIF4EBP1 Eukaryotic Translation Initiation Factor 4E Binding Protein 1 ▲ 5.55E-23 4.04 
GDAP1L1 Ganglioside Induced Differentiation Associated Protein 1-Like 1 3.49E-22 4.21 
LY6E Lymphocyte Antigen 6 Complex, Locus E 9.13E-22 4.54 
 
 To further determine genes from this target list which might be significant to the role 
of miR-210 in learning and memory a list of homologous human genes was generated 
from genes previously identified in our lab as differentially regulated in honeybee olfactory 
Table 3.4: Top miR-210 targets identified from pull-down RNAseq analysis. Top 20 genes most 
significantly enriched from biotin-miR-210 pull-down. FC = Fold Change, padj = adjusted p-
value. Rows highlighted in grey indicate genes with a known role in plasticity. Genes in bold 
indicate genes previously identified as differentially regulated by long-term consolidation, ▲ 
indicates genes validated by qRT-PCR. 
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conditioning (Cristino et al. 2014b). Additionally data was compiled from 11 other in vivo 
studies profiling gene expression during long-term consolidation with published gene 
expression data (Appendix 3.2). This included rodent studies of both chemically induced 
LTP as well as behavioural long-term consolidation paradigms (Donahue et al. 2002; 
Haberman et al. 2008; Katz & Lamprecht 2015; Levenson et al. 2004; Maag et al. 2015; 
Mcnair et al. 2007; Park et al. 2006; Ploski et al. 2010; Robles et al. 2003; Ryan et al. 
2011; Sirri et al. 2010). From this list of long-term consolidation associated genes, 14.94% 
of miR-210 enriched genes were identified as differentially regulated in at least one study 
of long-term consolidation. This included a number of pull-down target gene homologs 
inversely correlated with miR-210 upregulation during honeybee olfactory conditioning 
(ACTB, GAPDH, HSPB1, REEP6 and TECR) as well as targets differentially regulated 
across multiple long-term consolidation studies (ACTB, ARID5A, C11orf96, C1QTNF1, 
CAPNS1, CRABP1, GAPDH, HSPB1, TIMP1 and VGF). 
 
 
 
 
 
Figure 3.2: qPCR validation of genes identified by RNAseq. Pull-down samples were 
normalised to un-transfected control lysate samples and fold change calculated as enrichment 
of genes in hsa-miR-210 pull-down samples compared to cel-miR-239b samples. Errors 
represent standard deviation, *** = p <0.001, n = 3 biological replicates, Welsh two sample t-
test, u indicates corresponding fold change from RNAseq data. 
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3.3.2 Global Ontology Analysis of miR-210 Targeting 
To gain further insight into the functionality of miR-210 the publically available DAVID 
functional annotation tool was used to examine gene ontology (GO) enrichment of miR-
210 targets identified by pull-down RNAseq (Huang Da et al. 2009). The most significantly 
enriched biological processes and KEGG pathways among miR-210 targets are 
summarised in Table 3.5 (p<0.1). The full list of significantly enriched biological processes 
(Appendix 3.3) included 138 GO terms. These terms were primarily associated with the 
broader functionalities of small molecule synthesis (26.8%), energy metabolism (20.3%), 
macromolecule synthesis (10.1%), transcription/RNA synthesis and processing (7.2%) and 
translation/protein synthesis (5.8%). In addition a number of GO processes previously 
associated with miR-210 were significantly enriched including GO terms related to cell 
proliferation (GO:0008284, GO:0001938, GO:000936), cellular response to stress 
(GO:0006976, GO:0033554), anti-apoptosis (GO:0006916) and DNA repair 
(GO:0006307). 
 KEGG pathway analysis of the target gene set was also consistent with known 
regulatory functions of miR-210 including oxidative phosphorylation (OXPHOS; p=0.0089) 
and the VEGF signalling pathway (p=0.0212; Table 3.5 and Appendix 3.4; Liu et al. 2012a; 
Zeng et al. 2014). Also among enriched KEGG pathways were multiple cancers previously 
associated with miR-210 either by an identified oncogenic role of miR-210 (Bladder cancer 
[p=0.070]) or by elevated expression of miR-210 (Renal Cell Carcinoma [p=0.045] and 
Acute Myeloid Leukaemia [p=0.064] (Liu et al. 2012b; Zhao et al. 2013). Multiple 
neurodegenerative diseases were also represented among miR-210 target genes 
including Huntington’s disease (p=0.002) Alzheimer’s Disease (p=0.018), and Parkinson’s 
disease (p=0.049). Also significantly enriched and relevant to neurodegeneration was the 
mTOR signalling pathway (p=0.044). In AD patients there is a significant upregulation of 
phosphorylated mTOR at serine 2481, [p-mTOR(Ser2481)] and a significant correlation 
between p-mTOR(ser2481) and tau phosphorylation. Total levels of mTOR target 4E-BP1 
are also increased in AD patients and p-4E-BP1 is correlated with increased levels of total 
tau (Li et al. 2005). Dysregulation of miR-210 itself has also been correlated with AD, 
being downregulated in AD patient brain samples within the anterior temporal cortex, 
frontal cortex and hippocampal regions as well as in cerebrospinal fluid and serum of AD 
patients (Hebert et al. 2008; Zhu et al. 2015). This data indicates miR-210 may have a role 
in neurodegenerative disorders and supports a potentially significant neuronal function of 
miR-210. 
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Biological Process GO Number Count p-value 
Translational Elongation GO:0006414 16 1.03E-06 
Translation GO:0006412 26 1.03E-04 
Macromolecular Complex Assembly GO:0065003 38 1.31E-03 
RNA Elongation GO:0006354 8 1.33E-03 
Protein Complex Assembly GO:0006461 31 1.37E-03 
Protein Complex Biogenesis GO:0070271 31 1.37E-03 
Generation of Precursor Metabolites And Energy GO:0006091 22 1.68E-03 
Phospholipid Biosynthetic Process GO:0008654 11 1.95E-03 
Mitochondrion Organization GO:0007005 13 2.03E-03 
Macromolecular Complex Subunit Organization GO:0043933 39 2.23E-03 
 
KEGG Pathway KEGG Number Count p-value 
Ribosome hsa03010 15 3.14E-06 
Huntington's Disease hsa05016 16 2.76E-03 
Purine Metabolism hsa00230 14 4.44E-03 
Pyrimidine Metabolism hsa00240 10 8.61E-03 
Oxidative Phosphorylation hsa00190 12 8.90E-03 
Glutathione Metabolism hsa00480 7 1.02E-02 
Alzheimer's Disease hsa05010 13 1.82E-02 
VEGF Signalling Pathway hsa04370 8 2.12E-02 
mTOR Signalling Pathway hsa04150 6 4.35E-02 
Renal Cell Carcinoma hsa05211 7 4.56E-02 
 
 Additionally within this gene set overrepresented transcription factor binding sites 
(TFBSs) were looked at using the oPOSSUM single site online analysis tool (significance 
cut-off: Z-score >2.58, target rate to background ratio >1.5; Appendix 3.5; Kwon et al. 
2012). miR-210 already has a well-established role in regulation of hypoxia, being induced 
under hypoxic conditions through a hypoxia-inducible factor (HIF) TFBS in its promoter. 
Moreover, a number of other genes transcriptionally regulated through HIF have 
previously been identified as miR-210 regulatory targets. Among the pull-down miR-210 
target set the heterodimeric HIF-1A::Arnt transcription factor complex was one of 32 
Table 3.5: Gene ontology terms enriched among miR-210 target genes. Most significantly 
enriched biological processes and KEGG pathways from miR-210 pull-down targets. Generated 
using the DAVID functional annotation tool, count indicates number of miR-210 target genes 
associated with each annotation, significance cut-off = p-value < 0.1. 
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overrepresented transcription factors, with a total of 410 target gene hits (60.65% of total 
targets; Z-score: 65.1, target/background ratio: 1.75). This could indicate the miR-210 may 
act, at least in part, as a downstream modulator of HIF through target genes containing 
HIF binding sites that are potentially co-regulated with miR-210. However miR-210 has 
also been found to be a positive regulator of HIF-1α and the relationship between miR-210 
and HIF function is likely to be complex (Kelly et al. 2011). We also looked at KEGG 
pathway annotations for all enriched transcription factors, which highlighted functionalities 
similar to miR-210 (Fig. 3.3). Overall, the enriched functionalities identified from gene 
ontology analysis are consistent with already known roles of miR-210 and indicate that 
identified biotin-miR-210 pull-down targets may be functionally significant regulatory 
targets of miR-210.  
 
 
 
 
 
3.3.3 Validation of miR-210 Target Regulation 
While identification of mRNAs pulled down by biotin-miR-210 highlighted genes potentially 
binding miR-210 this may not necessarily indicate a functional interaction. To further 
confirm weather genes are direct regulatory targets of miR-210, various genes of interest 
Figure 3.3: Enriched transcription factor binding site KEGG pathway terms. Graphical 
representation of KEGG pathways terms annotated to multiple transcription factors with 
enriched binding sites among miR-210 target genes. Node size correlates to number of 
associated transcription factors. 
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were chosen for dual-luciferase assay validation as previously described (Cristino et al. 
2014b; Joilin et al. 2014). Selection of genes of interest was based on associated gene 
ontology and/or known neuronal function using enriched KEGG pathway annotations to 
identify genes potentially significant to miR-210 functionality (Table 3.6). This highlighted a 
substantial overlap of metabolic genes between OXPHOS and Huntington’s, Alzheimer’s 
and Parkinson’s disease pathways. This included genes encoding multiple subunits of the 
electron transport chain (ETC) complexes I, III, IV and V (Fig. 3.4). There was also 
significant overlap of annotated genes across VEGF/MAPK signalling pathways and miR-
210 associated cancers. A number of these OXPHOS/neurodegeneration genes and 
cancer-related genes were selected for validation along with a number of genes with a 
known role in synaptic/neuronal plasticity including those discussed earlier among the 
most significantly enriched target genes (Table 3.4).  
 
 
 
 
Figure 3.4: Targets in the oxidative phosphorylation pathway. A number of identified miR-210 
pull-down targets are subunits of large protein complexes that make up the OXPHOS electron 
transport chain. Multiple subunits of complexes I, III, IV and V were significantly enriched by 
miR-210, all are nuclear encoded OXPHOS genes. 
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Huntington's 
disease 
Oxidative 
phos. 
Alzheimer's 
disease 
VEGF 
signalling 
pathway 
mTOR 
signalling 
pathway 
Renal cell 
carcinoma 
Parkinson's 
disease 
Acute 
myeloid 
leukaemia 
Bladder 
cancer 
         
AP2S1 ATP5D APOE BAD EIF4EBP1 HRAS ATP5D BAD HRAS 
ATP5D ATP5G2 ATP5D HRAS MAPK3 MAP2K2 ATP5G2 EIF4EBP1 MAP2K2 
ATP5G2 ATP6V0C ATP5G2 HSPB1 MLST8 MAPK3 COX6A1 HRAS MAPK3 
CLTB ATP6V0E2 BAD MAP2K2 PGF PGF COX8A MAP2K2 PGF 
COX6A1 ATP6V1F COX6A1 MAPK3 RPS6KB2 TCEB2 CYC1 MAPK3 VEGFB 
COX8A COX6A1 COX8A MAPKAPK3 VEGFB TGFB1 NDUFA4L2 RPS6KB2  
CYC1 COX8A CYC1 RAC3  VEGFB NDUFS7   
GPX1 CYC1 GAPDH SPHK2   NDUFS8   
NDUFA4L2 NDUFA4L2 MAPK3    UBE2L6   
NDUFS7 NDUFS7 NDUFA4L2    UQCRC1   
NDUFS8 NDUFS8 NDUFS7       
POLR2E UQCRC1 NDUFS8       
POLR2I  UQCRC1       
POLR2J         
POLR2L         
UQCRC1         
	         
Table 3.6: Target genes annotated to enriched functional KEGG pathways. Potential key target genes were selected based on multiple 
annotations among KEGG pathways. Metabolic genes overlapping across oxidative phosphorylation and neurodegenerative pathways are 
highlighted in dark blue, cancer-associated genes overlapping with mTOR and VEGFB signalling pathways are highlighted in dark green. 
Vacuolar ATPase Genes highlighted in dark red are associated with synaptic vesicle recycling in neurons. 
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 As miRNAs primarily target genes through their 3’UTRs, whole 3’UTRs for 19 
selected genes of interest were amplified and cloned into the ΨCheck2 dual-luciferase 
vector backbone. The ΨCheck2 vector contains a firefly luciferase gene that acts an 
internal control as well as a renilla luciferase gene upstream of the multiple cloning site, 
meaning its activity can be modulated by inserted regulatory regions (Fig. 3.5a). For 
assaying luciferase activity the Cos-7 cell line, derived from African green monkey kidney, 
was chosen as a readily transfected cell system that possesses mammalian RISC 
components required for assessing miRNA functionality. The primate miRNA genome also 
displays significant diversification from human so utilising a primate cell line may 
potentially reduce background noise from endogenous regulatory factors (Berezikov et al. 
2006). To assay gene regulation, constructs were transfected into the mammalian Cos-7 
cell line either alone or co-transfected with hsa-miR-210 mimic or cel-miR-239b negative 
control mimic. Luciferase expression was measured after 24 h and all data normalised to 
native ΨCheck2 vector samples to account for effects of mimic transfection and potential 
interactions with foreign sequences in the ΨCheck2 vector.  
 Efficiency of the dual-luciferase assay was assessed by measuring activity with a 
positive control plasmid, containing an anti-sense miR-210 sequence with exact 
complementarity to miR-210-3p, that was found to significantly reduce protein expression 
in the presence of miR-210 mimic (Fig. 3.5b). Transcriptional miR-210 regulation was 
subsequently measured for 3’UTR constructs of selected genes of interest. From this, it 
was found that the majority of genes tested (17/19, >89%) were significantly down 
regulated by miR-210 through their respective 3’UTRs (Fig. 3.6). Significantly regulated 
genes associated with neuronal/synaptic plasticity included those mentioned previously 
among the top enriched target genes from pull-down data (GRINA, AP2S1 and TMUB1) as 
well as the OXPHOS-related, ATP6V0C, a subunit of Vacuolar ATPase (v-ATPase), 
involved in synaptic vesicle function, and the actin subunit ACTB whose homolog was also 
identified in our lab as a potential target of miR-210 in the honeybee (Table 3.4, Fig. 3.6a; 
Cristino et al. 2014b; El Far & Seagar 2011). MAPK/VEGF signalling related genes, 
EIF4EBP1, VEGFB and MAP2K2 as well as numerous neurodegenerative related genes 
were also validated as significantly regulated by miR-210, including OXPHOS genes 
(ATP5G2, ATP5D, COX8A, COX6A1, NDUFS7, NDUFS8, NDUFA4L2 and CYC1) and the 
apolipoprotein E gene, APOE, the major genetic risk factor for AD (Fig. 3.6b,c; Corder et 
al. 1993).   
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 To confirm the specificity of luciferase assays, miRNA recognition elements 
(MREs), which correspond to predicted miR-210 binding sites within the target mRNA 
sequence, were looked for in 3’UTRs of significantly down regulated genes of interest.  
Four MREs were identified using the hybridisation-based algorithm RNAHybrid in the 
3’UTRs of GRINA, VEGFB, ATP6V0C and TMUB1 (Fig. 3.7). MRE constructs were 
assayed alongside mutant MREs with G/C>A point mutations introduced into binding 
regions which confirmed that down regulation by miR-210 through these MREs was 
disrupted by mutation of these sites (Fig. 3.6d). This data suggests that the majority of 
gene targets identified through our biotin pull-down approach are genuine regulatory 
targets of miR-210 and that miR-210 may regulate a number of key genes involved with 
neuronal function and neurodegeneration. 
 
 
Figure 3.5: ΨCheck2 vector construct and dual-luciferase assay efficiency validation. a. The 
ΨCheck2 contains a Firefly luciferase internal control gene and a Renilla luciferase gene with a 
modifiable 3’ regulatory region, ori = origin of replication, Ampr = ampicillin resistance gene. b. 
Efficiency of the dual luciferase assay system and miR-210 mimic was confirmed using a 
positive control plasmid containing a sequence with exact complementarity to miR-210-3p (+) 
CTLR. Error bars represent standard error, *** = p <0.001, n = 4 biological replicates, two 
sample t-test. 
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3.4 Discussion 
From the results presented here, an overall regulatory network of miR-210 targeting has 
been generated in a human neuroblastoma system and overall functionalities and disease 
pathways potentially regulated by miR-210 through this targeting network have been 
identified. Among the already known roles of miR-210 and diseases associated with miR-
210 overexpression a number of novel miR-210 regulatory pathways have been identified 
including multiple neurodegenerative disorders. It was also validated that miR-210 is able 
to directly regulate various genes associated with metabolic function and MAPK/VEGF 
signalling as well as a number of key synaptic genes.  
 From gene ontology analysis of pull-down miR-210 target genes, one of the major 
functionalities identified was oxidative phosphorylation, which is consistent with some of 
the known roles of miR-210 in other cell types (Chen et al. 2010b). Target genes 
annotated to enriched neurodegenerative KEGG pathways also overlapped significantly 
through OXPHOS annotated genes. Metabolic decline and oxidative stress are hallmarks 
of neurodegeneration and neurodegenerative diseases are strongly associated with 
degeneration or dysfunction of the brain microvasculature which diminishes cerebral blood 
flow and oxygen supply. While hypoxia regulated genes such as miR-210 may have a role 
in regulating metabolism in response to hypoxic stress across various tissues, this 
regulation may be especially critical within the brain not just during oxidative stress but 
during normal brain function, given the complex and dynamic nature of metabolic 
regulation in the CNS.  
 In neurons, like oxidative metabolism, translation also occurs locally within 
synapses and dendrites and in an activity dependent manner. Regulation of translation is 
also linked to metabolism and hypoxic stress, being an energy expensive process that is 
Figure 3.6: Dual-luciferase assay validation of miR-210 target regulation. a-d. Measured 
Renilla/Firefly luciferase ratios, of target region/ΨCheck2 vector constructs transfected into Cos-
7 cells alone or in combination with hsa-miR-210 mimic of cel-miR-239b negative control mimic, 
normalised to native ΨCheck2 and plasmid only values. a. 3’UTRs of neuronal/synaptic 
plasticity genes. b. 3’UTRs of cancer-related, mTOR/VEGF signalling pathway genes. c. 
3’UTRs of metabolic/neurodegenerative pathway genes. d. Short MREs in predicted target 
gene 3’UTRs (Wt) and mutated MRE sites (Mut).  Error bars represent standard error, * = p < 
0.05, ** = p < 0.01, *** = p <0.001, n = 4 biological replicates, two sample t-test. 
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downregulated during hypoxia (Kraggerud et al. 1995). From ontology analysis, mRNA 
translation was another significant pathway identified, which is a function not previously 
associated with miR-210 but one that is critical to plasticity. Already numerous 
mechanisms of translational control are known to be involved in activity-dependent 
neuronal plasticity and miRNAs are important regulators of translational proteins, as their 
synthesis does not require translational machinery One important mechanism regulating 
translation of gene expression during learning and memory is the inhibition of cap-
dependent translation initiation by eIF4E, regulated by a family of binding proteins (4E-
BPs). Best characterised of these is EIF4EBP1 (4E-BP1), which was found to be targeted 
by miR-210. 4E-BP1 binds with high affinity to inhibit eIF4E in its hypophosphorylated form 
and with low affinity following activity-induced hyperphosphorylation, promoting an 
increase in translation (Gelinas et al. 2007).  
 
 
 
 
 
 It was found that miR-210 directly interacts with and downregulates a number of 
genes involved synaptic function including GRINA, TMUB1 and AP2S1. GRINA is a 
Figure 3.7: Predicted miR-210 miRNA recognition elements (MREs) in selected targets. MRE 
predictions generated using the RNAhybrid algorithm. Specified bp’s indicates position 
downstream from stop codon, ‘|’ indicates complimentary base-pairing, ‘:’ indicates G:U wobble 
base-pairing, mfe = minimum free energy, ‘’ indicates position of introduced point mutations; 
G/C>A. 
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subunit of the NMDA-receptor complex, which is a critical target of regulation during 
synaptic plasticity, and has been associated with epilepsy and dysregulation during fear 
conditioning (Bonaglia et al. 2005; Levenson et al. 2004; Yashiro & Philpot 2008). Both 
TMUB1 and AP2S1 are synaptosomal, transmembrane receptor-binding proteins involved 
with regulating trafficking and surface expression of AMPA and GABAA receptors (Kittler et 
al. 2000; Lee et al. 2002b; Yang et al. 2008). Also validated as a target gene of miR-210 
was ATP6V0C, one of three subunits of the v-ATPase identified from pull-down data. In 
neurons v-ATPase is involved in synaptic function being required for loading of 
neurotransmitter into synaptic vesicles and potentially involved with vesicle fusion (El Far 
& Seagar 2011).  
 Another gene of interest validated as a miR-210 target here is ACTB encoding the 
non-muscle cytoskeletal protein isoform Actinβ. ACTB regulation is a critical aspect of 
plasticity and is consistently shown to be regulated during learning and memory and 
various forms of plasticity (Fischer et al. 1998; Levenson et al. 2004; Park & Tang 2009). 
We also previously identified actin as a potential regulatory target of miR-210 in the 
honeybee in the homologous Act5C gene and observed inversely correlated expression of 
miR-210 and Act5C following olfactory conditioning, indicating a potentially conserved 
miRNA:mRNA target relationship (Cristino et al. 2014b). Additionally, among validated 
miR-210 targets was the neurodegeneration-associated APOE, a major genetic predictor 
of AD. APOE has both protective and risk factor allelic variants effecting Amyloidβ plaque 
clearance as well as glutamate receptor function in neurons (Chen et al. 2010a). 
  Identification of a number of novel miR-210 targets involved with plasticity and/or 
synaptic function suggests potential novel functional effects of miR-210 in neuronal 
systems. Enrichment of oxidative metabolism and neurodegenerative pathways is 
consistent with known disruptions to brain oxygen and metabolism in neurodegenerative 
disease. This also highlights functions that may be relevant to miR-210 downregulation in 
AD and also potentially of interest to Huntington’s and Parkinson’s disease oxidative stress 
pathology. Functional insights gained from this targeting analysis were used as a guide for 
downstream characterisation of miR-210 at the cellular level. 
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4.1 Introduction 
Pull-down analysis highlighted potential regulatory pathways of miR-210 including several 
functions previously found to be modulated by miR-210 as well as a number of diseases 
associated with miR-210 dysregulation. While this adds confidence to the functional 
validity of identified targets, functional analyses of miR-210 in other studies has focused on 
non-neuronal cell-types and further characterisation is therefore critical to understanding 
the potential role of miR-210 in neuronal plasticity (Cogswell et al. 2008; Hale et al. 2014; 
Kretschmann et al. 2015).  
  Metabolic regulation appears to be a common feature associated with both 
expression and function of miR-210 target genes and miR-210 has previously been shown 
to promote glycolysis through downregulating essential components of oxidative 
respiration in vitro (Chan et al. 2009; Hale et al. 2014). Given the role of miR-210 in 
regulating metabolism in non-neuronal cell-types and significant evidence that neurons 
also undergo aerobic glycolysis following activation, it seems likely that miR-210 may play 
an important role in regulating neural metabolism as well (Pellerin & Magistretti 1997). 
Given the observed functional effect of miR-210 knockdown in honeybee olfactory 
conditioning, neuronal plasticity in mammals may also be affected by miR-210 
dysregulation, either directly through identified neuronal targets or indirectly as a 
secondary effect of metabolic regulation. 
  As miR-210 induction has been associated with brain activity, quantification of miR-
210 expression in neurons may provide further insight into how it may be regulated during 
normal neuronal function as well as during disease (Cristino et al. 2014b; Kretschmann et 
al. 2015; Schouten et al. 2015). To examine neuronal miR-210 induction and explore 
effects of miR-210 on target-associated cellular functions, neuronal dysregulation of miR-
210 was modelled in vitro using differentiated SH-SY5Y cells and primary mouse 
hippocampal neurons. 
 
4.2 Methods 
4.2.1 SH-SY5Y Differentiation and Transfection 
For differentiation, SH-SY5Y cells were passaged as described previously (3.2.1) and 
plated at a density of 1 x 104 cells/cm2 in complete media. Cells were incubated overnight 
before replacing media with DMEM/F-12/HEPES supplemented with 10% FBS and 10µM 
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all-trans retinoic acid (Sigma-Aldrich) without antibiotics. After 3 days, media was changed 
to DMEM/F-12/HEPES, 10 µM retinoic acid with 3% FBS before incubating again for 3 
days. Media was then changed to DMEM/F-12/HEPES supplemented with 10 ng/mL brain-
derived neurotrophic factor (BDNF; EMD Millipore) and cells were incubated for 1-3 days. 
For probe transfection, cells were transfected after treatment with retinoic acid for 6 days, 
media was changed to DMEM/F-12/HEPES without supplements and cells were 
transfected with either hsa-miR-210-3p miRIDIAN microRNA mimic (Dharmacon; 
CUGUGCGUGUGACAGCGGCUGA), cel-miR-239b miRIDIAN microRNA mimic (negative 
control mimic 2; Dharmacon; UUGUACUACACAAAAGUACUG) or hsa-miR-210 miRIDIAN 
microRNA hairpin inhibitor (Dharmacon; CUGUGCGUGUGACAGCGGCUGA) to a final 
concentration of 50 nM using 0.5 µL of Lipofectamine 2000 (Invitrogen)/mL of media. 
Following transfection, media was replaced with BDNF supplemented media. For imaging, 
cells were plated in 24 well plates on glass coverslips previously sterilised in 75% ethanol 
and coated with 1X Histogrip (Thermo-Fischer) in acetone, according to the manufacturer 
instructions. 
 
4.2.2 Mitochondrial Membrane Potential and ROS Detection 
For ROS detection in SH-SY5Y cells, cells were stained with 25 µM DCFDA (2’,7’-
Dichlorofluorescin diacetate; Sigma-Aldrich) in DMEM/F-12/HEPES for 30 min in 5% CO2 
at 37°C. Cells were washed with PBS, trypsinised and resuspended as a single-cell 
suspension in PBS/0.2%BSA. DCFDA fluorescence was detected by flow cytometry on a 
BD FACS Calibur instrument. Data was analysed using the Flowing software. For 
detection of mitochondrial membrane potential in SHSY-5Y cells and membrane potential 
or ROS in primary hippocampal neurons, cells were stained with TMRE (tetramethyl 
rhodamine ethyl ester; Sigma-Aldrich) or DCFDA, respectively. Cells were washed three 
times in Tyrode’s buffer (145 mM NaCl, 5 mM KCl, 10 mM glucose, 1.5 mM CaCl2, 1 mM 
MgCl2, 10 mM HEPES, pH 7.4) before staining in 150 nM TMRE or 10 µM DCFDA diluted 
in Tyrode’s buffer for 30 min at 5% CO2/37°C. Stain was removed and cells washed three 
times in Tyrode’s buffer before imaging of live cells.  
 
4.2.3 RNA Extraction 
For RNA extraction, cells were washed once with warm PBS before adding 1 mL/well of 
TRIzol reagent directly to plates. Samples were incubated on ice for 5 min before 
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transferring samples to 1.6 mL eppendorf tubes, 500 µL of chilled chloroform was added to 
samples before mixing vigorously for 30 secs. Samples were incubated on ice for 2-3 min 
and spun at 12,000 x g for 20 min at 4°C, the upper aqueous phase was isolated and 20 
µg of glycogen (Thermo-Fischer) added with 500 µL of chilled isopropanol. Samples were 
mixed by inverting for 40 secs and RNA precipitated overnight at -20°C before spinning 
again at 12,000 x g for 30 min at 4°C. Supernatant was decanted and pellet washed with 1 
mL of chilled 75% ethanol before spinning at 10,000 x g for 10 min at 4°C. Ethanol was 
removed and pellets were resuspended in 10-20 µL of RNase-free water and incubated at 
45°C for 15-20 min to dissolve. Samples were quantified on a NanoDrop Lite 
spectrophotometer. 
 
4.2.4 cDNA Synthesis and Quantitative Real-Time PCR 
Synthesis of cDNA for protein-coding gene expression was performed using SuperScript 
III RT according to manufacturer directions using oligo-dT. qRT-PCR reactions were 
performed in triplicate on the Roche LightCycler480 system using the QuantiNova SYBR 
Green PCR Kit (QIAGEN) using gene-specific primers with a melting temp (Tm) of ~60°C. 
For protein-coding genes, Tbp and Hprt1 were used for normalisation as housekeeping 
genes commonly used in neuronal studies (Ryan et al. 2011; Vetere et al. 2014). For miR-
210 in both human and mouse RNA samples, 5S ribosomal RNA was chosen for 
normalisation as a non-coding housekeeping gene that isn’t subject to miRNA regulation 
commonly used for normalisation of miRNA expression (Lardizabal et al. 2012; Lin & Lai 
2013). Primer sequences were either designed using NCBI primer blast or sourced from 
PrimerBank (Table 4.1). For miRNA detection, a stem-loop reverse transcription primer 
was designed using a previously described template for stem-loop formation and the last 6 
bp’s modified to be complimentary to the 3’ end of the mature miRNA sequence (Chen et 
al. 2005). Stem-loop primer was annealed in a thermo-cycler (95°C/5 min, ramp to 
25°C/1°C min-1) and kept below room temperature when in use. cDNA was synthesised 
using 0.1 µM primer, 0.25 µL of RT and 0.1 µL of RNaseOUT/reaction and reverse 
transcription performed using a low-temp cycling program (16°C/30 min, 42°C/30 min, 
85°C/5 min, 4°C/hold) as described previously (Kramer 2011; Varkonyi-Gasic et al. 2007). 
Reverse primer used for qRT-PCR was also used as gene-specific primer for cDNA 
synthesis of housekeeping genes. For qRT-PCR, forward miRNA-specific primer was 
designed to be complimentary to the first 16 bp of the mature miR-210 sequence with an 
additional 4 bp’s added to the primer 5’ end to a final Tm of ~60°C. Reverse primer was a 
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universal primer specific for the stem-loop region of the RT primer (Table 4.1; Chen et al. 
2005). Forward primer was used at a final concentration of 1.5 µM and universal stem-loop 
reverse primer at 0.7 µM.   
 
 
 
Target Primer: Sequence 5’>3’ Tm (°C) 
RNA5S1 
(hsa) 
F: CGCCCGATCTCGTCTGAT 59.0 
R: GGTCTCCCATCCAAGTACTAACCA 61.4 
miR-210 
(hsa/mmu) 
RT: GTCGTATCCAGTGCAGGGTCCGAGG 
       TATTCGCACTGGATACGACTCAGCC 
68.5 
F: GCCACTGTGCGTGTGACAGC  57.9 
R: CCAGTGCAGGGTCCGAGGTA 57.9 
App 
 
F: TCCGAGAGGTGTGCTCTGAA 62.4 
R: CCACATCCGCCGTAAAAGAATG 61.8 
Arc 
 
F: AAGTGCCGAGCTGAGATGC 62.4 
R: CGACCTGTGCAACCCTTTC 61.0 
Egr2 F: GCCAAGGCCGTAGACAAAATC 61.6 
R: CCACTCCGTTCATCTGGTCA 61.2 
Fos F: CGGGTTTCAACGCCGACTA 62.3 
R: TTGGCACTAGAGACGGACAGA 62.3 
Hdac1 F: AGTCTGTTACTACTACGACGGG 60.4 
R: TGAGCAGCAAATTGTGAGTCAT 60.5 
Hif-1α F: ACCTTCATCGGAAACTCCAAAG 58.6 
R: CTGTTAGGCTGGGAAAAGTTAGG 60.0 
Hif-2 α F: CTGAGGAAGGAGAAATCCCGT 59.0 
R: TGTGTCCGAAGGAAGCTGATG 60.0 
Hprt1 F: GAGGAGTCCTGTTGATGTTGCCAG 63.4 
R: GGCTGGCCTATAGGCTCATAGTGC 64.8 
Tbp F: AGAACAATCCAGACTAGCAGCA 59.4 
R: GGGAACTTCACATCACAGCTC 59.0 
Timp1 F: GCAACTCGGACCTGGTCATAA 60.1 
R: CGGCCCGTGATGAGAAACT 60.1 
 
 
Table 4.1:  Primer sequences for qRT-PCR and cDNA synthesis. Sequences in black text are 
gene specific regions, blue text indicates stem-loop primer sequences, red text indicates 
additional non-specific bp’s added to miR-210 forward qRT-PCR primer. 
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4.2.5 Animals  
Wild-type, C57BL/6 mice were bred and housed by Monash Animal Research Platform 
(MARP, Monash University, Clayton, Australia). A conditional mouse line containing a 
floxed miR-210 exon (Mir210tmMtm), generated in the McManus laboratory and deposited in 
MMRRC was imported from the Jackson Laboratory (JAX, Bar Harbour, US) for 
generation of miR-210 neuronal knockout mice (Park et al. 2012). This line was produced 
from a vector construct containing a reporter lacZ gene upstream of the miR-210 stem-
loop sequence flanked by FRT recombinase sites and a neomycin resistance gene flanked 
by both FRT and loxP recombinase sites with a third loxP site directly downstream of the 
stem-loop (FRT – lacZ – loxP – Neo – FRT – loxP – Stem-Loop – loxP). This construct 
was electroporated into 129P2/OlaHsd-derived E14 embryonic stem cells, which were 
used to generate chimeric mice. Chimeric mice were crossed with mice of mixed genetic 
background before backcrossing with C57BL/6J mice for 2-3 generations. Heterozygous 
Mir210tmMtm mice were inbred to produce mice homozygous for the floxed allele (miR-
210loxP/loxP). To generate a neuronal miR-210 knockout line, miR-210loxP/loxP mice were 
crossed with Nestin-Cre mice (B6.Cg-Tg(Nes-cre)1Kln/J), a kind gift from Dr Jason Cain, 
to produce mice homozygous for the floxed allele and heterozygous for Nestin-Cre (miR-
210-/-;Nestin-Cre; Fig. 4.1). Mice of both miR-210loxP/loxP and miR-210-/-;Nestin-Cre  
genotypes were maintained for continual breeding and all offspring from colony genotyped 
for Nestin-Cre. All animal breeding and animal procedures were performed with approval 
by MARP animal ethics committee and in accordance with Australian National Health and 
Medical Research Guidelines on Ethics in Animal Experiments (Appendix 2). 
 
4.2.6 Genotyping  
For genotyping mice from the breeding colony tail-tip clippings were collected from mouse 
pups at 1-2 weeks old by MARP and samples delivered on dry ice before storage at -20°C. 
For genotyping time-mated embryos tail tips were collected from decapitated embryos into 
1.6 mL eppendorf tubes. For DNA extraction, tails were thawed at room temperature and 
50 µL of QuickExtract DNA Extraction Solution (epicentre) added per sample. Tails were 
vortexed in QuickExtract solution for 15 seconds before incubating at 65°C for 8 min. 
Samples were vortexed again for 15 secs, then incubated at 98°C for 5 min and cooled on 
ice. Samples were PCR amplified in 10 µL reactions using 1 µL of DNA extract with Q5 
Hot-Start DNA polymerase (NEB) as per the manufacturer directions and analysed by gel 
electrophoresis. For genotyping of the miR-210 targeted allele the primers and thermo-
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cycler program specified by JAX were utilised (Table 4.2). A single primer pair amplified 
either a single 250 bp product (wild-type), a single 342 bp product (homozygous mutant) or 
both (heterozygous mutant). For detecting the Cre genotyping, JAX specified primers for 
Cre and internal control genes were used (Table 4.2). For embryo genotyping of Cre a 
modified, shortened thermo-cycling protocol was developed (98°C/3 min, [98°C/10 sec, 
51.7°C/15 sec, 72°C/10 sec] x 35 cycles, 72°C/2 min). 
 
 
 
 
 
4.2.7 Primary Hippocampal Neuronal Culture 
Mice at embryonic day 18.5 (E18.5) were chosen as the ideal developmental stage for 
isolation of hippocampal neurons. Generation of pyramidal neurons is practically complete 
at this stage while generation of dentate granule neurons hasn’t yet started. The 
Figure 4.1:  Generation of a miR-210 conditional knockout mouse line. Simplified breeding 
schematic for miR-210 knockout generation. Heterozygous mice carrying a targeted miR-210 
mutation with loxP sites flanking the miRNA stem-loop region were inbred to generate mice 
homozygous for the floxed allele (miR-210loxP/loxP). Mice carrying the targeted mutation were 
also intercrossed with Nestin-Cre mice to generate mice homozygous for the floxed allele and 
heterozygous for Nestin-Cre (miR-210-/-;Nestin-Cre) where miR-210 will be deleted in cells of 
neural-lineage. Mice carrying these genotypes were bred for generation of knockouts (miR-210-
/-;Nestin-Cre) and littermate controls (miR-210loxP/loxP). 
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hippocampus is also easier to dissociate during late-embryonic development and contains 
fewer glial cells (Banker & Cowan 1977). To culture primary neurons, timed-mating’s were 
set-up and mating pairs housed overnight before checking for appearance of vaginal plugs 
the following morning, with the day of plug designated as E0.5. Hippocampal neurons 
were cultured as previously described, without the use of a glial feeder layer (Kaech & 
Banker 2006; Widagdo et al. 2015). At E18.5 pregnant females were sacrificed by 
asphyxiation in CO2. The abdomen was cut open to expose embryos, which were quickly 
removed from the embryonic sac and decapitated. Heads were collected in ice-cold 
dissection media containing 1X Hank’s Balanced Salt Solution (HBSS) -Ca2+/-Mg2+ 
(Gibco), 100 U/mL Pen-Strep, 1m M Sodium-pyruvate (Gibco), 20 mM HEPES (Gibco) 
and 25 mM Glucose (Sigma-Aldrich). Skin was removed and developing skull cut mid-
sagittaly and peeled away using fine forceps, whole brains were removed and placed in 
fresh dissection media to minimise exposure of brain tissue to blood. Hippocampi were 
dissected out using curved forceps under a dissection microscope and collected on ice 
into dissection media (Fig. 4.2).  
 
 
 
 
Figure 4.2:  Hippocampal dissection for neuronal culture. Light microscope images detailing the 
micro dissection of hippocampus from E18.5 mouse brain. a. Cerebellar and midbrain tissue 
were removed by cutting beneath cortices. b. Hemispheres were separated and turned medial 
side up. c. Olfactory bulb was removed. d. Using fine forceps, the meninges were peeled away 
as a single sheet. e, f. Hippocampus was carefully cut away from cortex and removed.  
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 Hippocampi were digested for 20 min at 37°C in dissection media with 20 U Papain 
(Sigma-Aldrich) and 1% DNase-I (Sigma-Aldrich), with gentle perturbation every 5 min. 
Dissociation solution was removed from tissue and hippocampi washed 2-3X in warm 
neuronal medium (Neurobasal Medium (Gibco), 1X GlutaMAX supplement (Gibco), 100 
U/mL Pen-Strep, 5% FBS (Gibco) and 1X B-27 supplement (Gibco). Neurons were then 
dissociated in 1 mL of neuronal medium using 3 consecutively smaller fire-polished 
pipettes. Cells were spun at 200 g for 5 min before filtering through a 70 µm cell strainer 
and plating in neuronal medium. For imaging, neurons were plated at 5 x104 cells/well in 
12 well plates on glass coverslips coated with 0.5 mg/mL poly-D-lysine (PDL; mol wt 
30,000-70,000: Sigma-Aldrich) diluted in 0.1 M borate buffer pH 8.5. For RNA extraction, 
neurons were plated in 6 well plates coated with 0.1 mg/mL PDL at 5 x 104/well. 
Coverslips were prepared by washing in 70% nitric acid for 2 days before rinsing 
thoroughly in water and storing in Ethanol. Coverslips were flamed before adding to plates 
and coverslips/plates were coated with PDL overnight at 37°C before rinsing 3-4X in sterile 
milliQ water and incubating in neuronal media without B-27 for at least 2 hrs. For 
electrophysiology, cells were plated at a density of 1 x 105/ well in 24 well plates on glass 
coverslips coated with PDL followed by 10 µg/mL laminin. When neurons were attached 
(~4-6 h after plating), media was removed and replaced with fresh neuronal medium. The 
following day medium was removed again and replaced with neuronal medium without 
FBS. Neurons were maintained in serum-free medium at 37°C/5% CO2, exchanging 50% 
of medium every 3 days, removing antibiotics from medium after 2-3 media changes. 
Under standard conditions, neurons were kept at ambient O2 concentration, N2 
displacement was used for culturing of neurons under low oxygen conditions. 
 
 
 
Target Primer: Sequence 5’>3’ Tm (°C) 
miR-210 mutation 
(floxed allele) 
F: AGACAGGCCTGCTTGTAGGA	 60.5 
 R: TCAGGAGGTGGGTCCTGTAG	 62.5 
Cre Transgene 
 
F: GCGGTCTGGCAGTAAAAACTATC	 63.0 
 R: GTGAAACAGCATTGCTGTCACTT	 60.9 
Internal Control F: CTAGGCCACAGAATTGAAAGATCT 62.0 
 R: GTAGGTGGAAATTCTAGCATCATCC 64.1 
 
Table 4.2:  Primer sequences for mouse genotyping.  
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4.2.8 Immunocytochemistry 
Neurons were washed once with warm PBS before fixing in 4% PFA in PBS for 10 min at 
room temp followed by washing 3 x 5 min with PBS. Cells were blocked for 30 min in 3% 
BSA, 0.3% TX in PBS at room temperate before adding chicken anti-MAP2 primary 
antibody (1:5000; Abcam, ab5392) diluted in 3% BSA/0.3% TX/PBS and incubating 
overnight at 4°C in a humidified chamber. Primary antibody was removed and cells were 
washed 3 times with 0.3% TX/PBS for 5 min. Cells were then incubated with secondary 
antibody, goat anti-Chicken IgY AlexaFluor® 647 (1:400; Abcam; ab150171), in a dark, 
humidified chamber on shaker at low speed for 2 hrs. Secondary antibody was washed off 
with 3 x 5 min washes in PBS/TX and coverslips were mounted onto glass slides using 
fluorescent mounting media with DAPI (DAKO). 
 
4.2.9 Imaging and Analysis 
All staining was visualised on an upright Zeiss Axio Imager M2 fitted with a Zeiss Axio 
Cam 506 mono camera and images were collected using the Zen 2 pro software (Zeiss, 
2017). For fluorescent intensity analysis, fluorescent channel and differential interference 
contrast (DIC) images for each experiment were collected using the same gain and 
exposure settings. Fluorescent intensity was analysed using the ImageJ software, using 
freehand draw and measure tools. The synchronise windows tool was used to delineate 
cell somas using DIC images while measuring fluorescence intensity of single channel 
fluorescence images. For analysis of primary neuron dendritic morphology the Fiji 
distribution of ImageJ and Sholl plugin was used. Single channel fluorescent images of 
MAP2 staining were used for analysis and images were ’cleaned’ to remove neuronal 
processes of neighbouring cells to generate images of isolated neurons as required for 
Sholl tracing. Images were converted to 8-bit grey scale images and analysed as 
described in the plugin manual with starting radius set to 10 µM and radius step size set at 
5 µM. Image contrast was enhanced uniformly for figure preparation. 
 
4.2.10 Electrophysiology   
Patch clamping was performed on cultured hippocampal neurons in whole cell mode at 
25°C. Coverslips were placed in a recording chamber bath (Warner Instruments, Hamden 
CT, USA) and cells were continuously perfused with extracellular physiological salt 
solution (137 mM NaCl, 4 mM NaHCO3, 0.3 mM NaH2PO4, 0.44 mM KH2PO4, 0.5 mM 
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MgCl2, 0.4 mM MgSO4, 5.6 mM glucose, 10 mM HEPES, 1.5 mM CaCl2, pH 7.4). Glass 
micropipette electrodes were set to obtain resistances of 2-5 MΩ, and backfilled with 
intracellular pipette solution (130 mM KCl, 0.4 mM CaCl2, 1 mM Mg2ATP, 1 mM EGTA, 10 
mM HEPES, pH 7.4). Electrical activity was recorded using an Axopatch 200A series 
amplifier controlled by pCLAMP v10 software and data digitised at 5-20 kHz using Clampfit 
10 (Axon Instruments, Inc, CA, USA). Voltage-gated currents were recorded in voltage-
clamp mode using 10 mV depolarising steps of 500 ms duration from a holding potential of 
-140 mV to +60 mV. Tetraethyl ammonium chloride (TEA; Sigma-Aldrich) was infused 
extracellularly to block potassium channels. For current-clamp recordings, spontaneous 
firing activity was recorded for 10 seconds without any current injection, to determine 
resting membrane potential, input capacitance and resistance. The membrane current was 
set to zero and action potentials were evoked using depolarising 35 pA current injections 
of 1 sec duration.  
 
4.2.11 In Situ-Hybridisation in Cultured Neurons 
Fixed cells on glass-coverslips were deproteinated in 20µg/mL Proteinase K in PBS for 10 
min, before washing 2X in PBS for 5 min. To remove residual PBS coverslips were 
incubated 2X 10 min in fresh imidazole buffer (0.13 M 1-methylimidazole, 300nM NaCl, pH 
8.0). Cells were fixed in l-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC;Thermo-
Fischer) in imidazole buffer for 1-2 h in a humidified chamber. Cells were washed once 
with 0.2% (w/v) glycine in PBS and twice in PBS for 5 min each before incubation in fresh 
acetylation solution (0.1M triethanolamine, 0.5% (v/v) acetic anhydride) for 10 min washing 
2X in PBS for 3 min on shaker. Cells were then incubated in hybridisation buffer (50% 
formamide, 5X SSC, 250 µg/mL yeast tRNA [Thermo-Fischer], 500 µg/mL salmon sperm 
DNA [Sigma-Adlrich], 5X Denhardt’s solution, 2% Blocking reagent [Roche], 0.5 % Tween, 
9.2 mM citric acid) for 1 h at hybridisation temperature (58°C). DIG-conjugated LNA 
probes for miR-210-3p or Scramble-miR (Exiqon) were denatured at 75°C for 4 min, 
cooled on ice and diluted in hybridisation buffer to 10 nM. Diluted LNA probes were added 
to coverslips for 16 h at hybridisation temp in a humidified chamber. Following 
hybridisation, cells were washed 3X 10 min in 0.1X SSC at 4-8°C above hybridisation 
temp with agitation. Coverslips were then washed in 2X SSC for 5 min on shaker before 
incubating in 3% hydrogen peroxide/PBS for 20 min. Cells were then washed 3 x 3 min in 
Buffer I (100 mM Tris-HCl, 150 mM NaCl, pH 7.5) on shaker before a 30 min incubation in 
blocking buffer (100 mM Tris-HCl, 150 mM NaCl, 0.5% Blocking reagent, 0.5% BSA, 0.1% 
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Tween). DIG was detected by incubation with mouse αDIG primary antibody (1:500; Perkin 
Elmer) and neurons also immunostained with αMAP2 (1:5000) diluted in blocking buffer for 
1-2 hrs. Cells were washed 3 x 5 min in Buffer II (100 mM Tris-HCl, 150 mM NaCl, 0.1% 
Tween) and MAP2 primary antibody detected as described previously in blocking buffer. 
Cells were washed again 3 x 5 min in Buffer II. Tyramide Signal Amplification (TSA®) with 
Fluorescein (Perkin Elmer) was diluted 1:50 in provided amplification diluent and added to 
coverslips for 10 min in the dark. Sections were then washed 3 x 5 min in Buffer II and 
mounted in fluorescent mounting medium with DAPI.  
 
4.2.12 Neuronal Activation 
For neuronal activation using high concentration potassium (K+), HEPES Buffered Saline 
(HBS; 90 mM KCl, 25 mM HEPES, 33 mM D-Glucose, 2 mM CaCl2, 2 mM MgCl2, 100 µM 
picrotoxin) was applied to neurons at 21 days in vitro for 3 x 1 sec intervals. High K+ HBS 
application was followed by 10 sec recovery in control HBS (NaCl and KCl adjusted to 119 
mM and 5 mM, respectively) before replacement with neuronal media. As a control 
condition neurons were incubated in control HBS for 30 sec. For glycine-induced Chem-
LTP, DIV-18 hippocampal cultures were incubated at room temp for 5 min in extracellular 
solution (ECS; 150 nM NaCl, 2 mM CaCl2, 5 mM KCl2, 10 mM HEPES, 30 mM Glucose, 1 
µM strychinine [Sigma-Aldrich], 20 µM bicuculline methiodide [Sigma-Aldrich]). Neurons 
were then incubated in ECS with 200 µM glycine for 3 min at room temp before replacing 
neuronal medium. As a control condition neurons were incubated 3 min in ECS without 
glycine. For repeated activation, neurons were recovered for 1 h at 37°C in 5% CO2 
between activation regimes. 
 
4.2.13 Statistics 
Statistical analyses were carried out in either R v3.2.4 or in GraphPad Prism v7.0c. 
Significance was calculated at a 95% confidence interval (α = 0.05). Homogeneity of 
variance and data normality distribution was determined using Levene and Shapiro-Wilk 
tests, respectively. Specific means tests and appropriate post-hoc analyses were used as 
indicated in the text. 
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4.3 Results 
4.3.1 Functional Effects of miR-210 Overexpression in Differentiated SH-SY5Y Cells 
To further identify the potential role of miR-210 in enriched pathways, functional effects of 
overexpression were examined in differentiated SH-SY5Y cells. SH-SY5Y cells can be 
terminally differentiated into neuron-like cells, commonly used as a model for 
neurodegenerative diseases (Lopes et al. 2010). This model was an appropriate choice to 
initially address functional effects as targets were identified in this cell line and a number of 
neurodegenerative gene were also established as targets. With increasing interest in 
miRNA research, a number of commercial research tools have been developed to study 
miRNA function both in vitro and in vivo. Most commonly these involve probes synthesised 
using modified ribonucleic-acid bases designed to mimic the effect of endogenous mature 
miRNAs or probes designed to bind and degrade mature miRNA, that can be used as 
models of miRNA overexpression or knockdown, respectively. Transient transfection of 
both miRIDIAN miRNA mimics (double-stranded oligonucleotide probes designed to mimic 
endogenous mature miRNA) and miRIDIAN miRNA hairpin inhibitors (single-stranded 
oligonucleotide probes designed to sequester the active mature miRNA strand) were used 
in this study. In previously published studies, miRNA probes have been transfected at 
varying concentrations, although typically mimics are transfected into cells at ~25 nM -100 
nM concentrations and concentration of inhibitor probes is commonly doubled to see 
effects of miRNA knockdown (Baek et al. 2008; Grimson et al. 2007; Guo et al. 2010; 
Selbach et al. 2008). It has been shown however that transfection of miRNA mimic probes 
at these concentrations leads to supra-physiological levels of miRNA over expression as 
well as the accumulation of high-molecular weight RNA species within cells (Jin et al. 
2015).  
 To determine an optimal transfection concentration in differentiated SH-SY5Y cells, 
miR-210 mimic probe was transfected at concentrations varying from 0.5 nM – 50 nM and 
miR-210 hairpin inhibitor probe at 1 nM – 100 nM and mature miR-210 levels quantified by 
qRT-PCR at 24 h post-transfection (Fig. 4.3). Transfection of miR-210 mimic at 
concentrations above 1 nM (5 nM, 25 nM and 50 nM) led to fold changes in miR-210 
expression >1000 (Fig. 4.3a). At the lowest concentration tested, 0.5 nM, miR-210 
overexpression was not observed in all samples (mean fold change [FC] = 75.93, standard 
error [SE] = 31.05, FC range = 0.11 – 118.97), miR-210 mimic transfected at 1 nM was 
therefore chosen for further validation as a concentration inducing consistent miR-210 
overexpression at a reasonable level while minimising potential for accumulation of high-
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molecular weight RNA species (mean FC = 282.19, SE = 48.19, FC range = 182.37 – 
387.43; Jin et al. 2015). Transfection of miR-210 hairpin inhibitor probe at varying 
concentrations of 1 nM – 100 nM did not result in successful downregulation of mature 
miR-210 at any concentration tested (Fig. 4.3b) This is potentially due to low levels of 
endogenous miR-210 in SH-SY5Y cells or unsuccessful degradation of endogenous 
mature miR-210 by the synthetic inhibitor probe. Use of the inhibitor probe as a model of 
miR-210 knockdown was therefore excluded from further functional analyses. 
 
 
 
 
 
 While miR-210 has been associated with regulation of metabolism previously in 
other cell types, metabolic effects in neuronal systems have not been explored. From pull-
down of miR-210 target genes in SH-SY5Y cells, oxidative phosphorylation and related 
pathways were major functionalities identified and it is likely, therefore, that miR-210 also 
plays a role in neuronal metabolism. For functional experiments, SH-SY5Y cells were 
differentiated by treatment with retinoic acid for 6 days before transfection with 1 nM of 
hsa-miR-210 mimic or 1 nM of cel-miR-239b mimic as a negative control condition. As 
Figure 4.3:  SH-SY5Y miR-210 expression following probe transfection. Expression of miR-210 
measured by qRT-PCR 24 h after transfection of mimic and inhibitor probes at varying 
concentrations, y-axis represents relative fold-change compared to control mock-transfection 
cells. a. miR-210 fold-change following miR-210 miRIDIAN mimic transfection at 0.5 nM – 50 
nM. b. miR-210 fold-change following miR-210 miRIDIAN hairpin inhibitor transfection at 1 nM – 
100 nM. Error bars represent standard error, miR-210 expression was normalised to 5SrRNA, n 
= 3. 
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metabolic function is tightly linked to reactive oxygen species (ROS) production and 
cellular oxidative stress, levels of cellular ROS were detected using the cell-permeant 
compound 2’,7’-Dichlorofluorescin diacetate (DCFDA). DCFDA is a chemically reduced 
non-fluorescent form of fluorescein that produces fluorescence upon oxidation by ROS 
activity in cells (Eruslanov & Kusmartsev 2010). It has been reported that miRNA mimics 
are stable for up to 3 days after transfection with no active decay occurring within 72 h and 
functional effects of miRNA mimics have been frequently reported at 24 and 48 h post-
transfection, various time-points should therefore be examined to determine functional 
effects of miRNA mimics (Baek et al. 2008; Jin et al. 2015; Meister et al. 2004). Following 
transient transfection of differentiated SH-SY5Y cells with mimics, cells were stained with 
DCFDA at 24, 48 and 72 h before detachment of cells from plates and quantification of 
DCFDA by fluorescence activated cell sorting (FACS; Fig. 4.4a). Based on DCFDA 
fluorescence, ROS levels were significantly increased in miR-210 mimic transfected cells 
compared to control at 24 h post transfection although returned to control levels at 48 and 
72 hrs.  
 Mitochondrial membrane potential (ΔΨm) was also examined in miR-210 mimic 
transfected cells using the tetramethylrhodamine, ethyl ester (TMRE). Mitochondrial 
membrane potential reflects the proton gradient of mitochondrial membranes with a net 
internal negative charge essential for the production of ATP by oxidative phosphorylation.  
TMRE is a positively charged red-orange fluorescent compound that is sequestered by 
active mitochondria and can be used as a measure of ΔΨm (Perry et al. 2011). 
Differentiated and transfected SH-SY5Y cells were stained with TMRE at 24, 48 and 72 h 
post transfection and live cells imaged for TMRE before fluorescence quantification of 
captured images (Fig. 4.4b,c). A large reduction in TMRE fluorescence intensity was 
observed 48 h following miR-210 mimic transfection compared to negative control mimic 
transfection (36.48% of control, p = <0.000) and TMRE fluorescence remained reduced, 
but to a lesser extent at 72 h (91.77% of control, p = 0.011). This indicates that miR-210 
overexpression reduced ΔΨm and decreased levels of oxidative phosphorylation in SH-
SY5Y cells, which is consistent with downregulation of identified metabolic targets from 
miR-210 pull-down disrupting the mitochondrial electron transport chain (ETC).  
 
4.3.2 Establishment of a miR-210 Neuronal Knockout Model.   
While differentiated SH-SY5Y cells are a useful neuronal model that possess a number of 
properties of mature neurons, they do not directly mimic the functions of real neurons. 
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Primary neurons grown in culture more accurately represent in vivo neuronal function, 
developing extensive neurite networks and functionally mature synapses. They also 
display spontaneous firing activity and generate action potentials upon depolarisation. 
Given the practical complications associated with culturing human neurons, mice 
represent a suitable model for both genetic manipulation and primary neuronal culture. 
Primary rodent neuronal cultures from late-embryonic hippocampus typically generate 
cultures consisting of >90% excitatory, glutamatergic pyramidal neurons that express both 
glutamate and GABA receptors and form mature synapses by 12 days in vitro (DIV-12) as 
well as a small proportion of GABAergic inhibitory neurons and non-neuronal cell types 
(Benson et al. 1994; Caraiscos et al. 2004; Craig et al. 1993).  
 To further investigate the neuronal function of miR-210 both in vitro and in vivo, a 
miR-210 neuronal knockout mouse line was generated. A conditional knockout mouse 
carrying a floxed miR-210 allele was generated in the McManus lab and mice 
heterozygous for the mutation were obtained through Jackson Laboratories (JAX). 
Heterozygous mice were inbred to generate mice homozygous for the floxed allele (miR-
210loxP/loxP; Park et al. 2012). Mice carrying the mutation were also intercrossed with mice 
carrying a Nestin-Cre allele to generate mice homozygous for the floxed allele and 
heterozygous for Nestin-Cre (miR-210-/-;Nestin-Cre). Nestin is a neural stem and 
progenitor marker expressed during embryonic development from around E10.5 and also 
in neural stem cells of the adult mouse brain (Mignone et al. 2004). Expression of Cre 
recombinase under the Nestin driver therefore promotes recombination of floxed alleles 
and gene deletion throughout the central and peripheral nervous systems (Tronche et al. 
1999). In these mice Cre expression driven by the Nestin promoter should effectively 
delete the miR-210 gene throughout the nervous system. Mice carrying thes miR-210-/-
;Nestin-Cre genotype were subsequently crossed for generation of knockouts (miR-210-/-
;Nestin-Cre) and littermate controls (miR-210loxP/loxP) for use in experiments (Fig. 4.1).  
 To generate primary neuronal cultures, pregnant mice were sacrificed at E18.5 and 
hippocampi isolated from embryos. Tail-tip samples were also collected from embryos and 
used for PCR genotyping of Cre, before dissociating hippocampi and plating Cre positive, 
miR-210-/-;Nestin-Cre mice knockout (KO) and littermate miR-210loxP/loxP mice control 
(CTRL) neurons separately (Fig. 4.5a). Successful knockout of miR-210 in hippocampal 
neurons cultured from nestin-cre positive mice was also confirmed using qRT-PCR. For 
qRT-PCR analysis, RNA was extracted from neurons after DIV-10 and mature miR-210 
levels found to be reduced >10.5 fold (Fig. 4.5b).  
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Figure 4.4:  Effect of miR-210 overexpression on differentiated SH-SY5Y metabolic function. 
Levels of cellular ROS and mitochondrial membrane potential were measured in live SH-Y5Y 
cells using DCFDA and TMRE fluorescent indicators, respectively, at 24, 48 and 72 h following 
transfection with 1 nM hsa-miR-210 mimic. Transfection with 1 nM cel-miR-239b was used as a 
control condition. a. DCFDA fluorescence detected using FACS, represented as median 
fluorescent intensity. b. TMRE fluorescence was detected in cells by fluorescent microscopy 
and mean fluorescent intensity within cell somas was quantified using imageJ, n = 90 – 133 
cells. c. Representative, images of TMRE fluorescence. Error bars represent standard error, * = 
p <0.05, *** = p <0.001, two sample t-test. Scale bar = 30 µm in all images. 
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4.3.3 Functional Analysis of Neuronal miR-210 Knockout In Vitro. 
To analyse the functional effects of miR-210 knockout in hippocampal neurons, metabolic 
parameters were re-examined. As miR-210 is a hypoxia-induced gene and metabolic 
effects of endogenous miR-210 have typically been observed under hypoxic conditions, 
DIV-8 neurons were cultured at 1% O2 for 48 h before analysis of neurons at DIV-10. 
Levels of cellular ROS and mitochondrial membrane potential were quantified in live 
neurons using TMRE and DCFDA staining as described. Images were captured after 
staining and raw images were used to quantify fluorescence intensity within neuronal 
somas with ImageJ (Fig. 4.6). Fluorescent intensity of both TMRE and DCFDA were 
significantly increased in knockout neurons compared to control, indicating that knockout 
of miR-210 increased mitochondrial membrane potential in neurons with a corresponding 
increase in cellular ROS production (Fig. 4.6c,f).  
 
Figure 4.5: Confirmation of miR-210 knockout in cultured hippocampal neurons. Before plating 
neurons, PCR genotyping of embryo tail samples was used for detection of Cre. After 10 days 
in vitro (DIV) RNA was extracted from hippocampal cultures and miR-210 expression quantified. 
a. Representative agarose gel image of Cre genotyping with Cre positive bands (~100bp) 
detected in lanes, 3,6 and 8, internal control ≈ 320 bp. b. Representative relative expression of 
miR-210 in hippocampal cultures, quantified by qRT-PCR, normalised to Rn5s. Expression of 
miR-210 in knockout (KO) neurons was reduced >10.5 fold compared to littermate controls 
(CTRL). 
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Figure 4.6: Effect of miR-210 knockout on neuronal metabolic function. Levels of cellular ROS 
and mitochondrial membrane potential were measured in live hippocampal neurons cultured 
from miR-210 KO and littermate controls (CTRL) using DCFDA and TMRE fluorescent 
indicators, respectively, at DIV-10 following 48 h incubation in 1% O2. a,b Representative 
images of TMRE staining (red) in KO and CTRL cultures as single-channel red fluorescence 
images and merged red/DIC images. c. Quantification of TMRE fluorescence mean intensity 
within the cell soma, n = 41 (CTRL), 54 (KO). d,e Representative images of DCFDA staining 
(green) in KO and CTRL cultures as single-channel green fluorescence images and merged 
green/DIC images. f. Quantification of DCFDA fluorescence mean intensity within the cell soma, 
n = 38 (CTRL), 88 (KO). Error bars represent standard error, *** = p <0.001, two sample t-test. 
Scale bar = 25 µm in all images. 
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 At the cellular level, neuron dendritic morphology can also be examined as an 
output of neuronal development or function. Changes in dendritic branching and density 
may be reflective of a number of physiological neuronal changes including dendritic 
formation, connectivity of neurons and dendritic plasticity. First described by D, Sholl in 
1953, Sholl analysis allows for quantitative comparison of neuronal dendritic morphology 
(Sholl 1953). This analysis involves drawing of concentric circles extending from the 
neuronal perikaryon increasing in size by a discrete radius, with the number of dendrites 
intersecting each radius totalled. This method allows for the measurement of dendritic 
density (number of intersections) as a function of distance (radius) from the cell soma. To 
analyse potential changes in neuronal morphology induced by miR-210 knockout, 
hippocampal neurons from knockout and littermates controls were cultured under normal 
oxygen conditions for 12 days. At DIV-12 neurons were fixed and immunostained for 
microtubule associated protein-2 (MAP2), a neuron-specific protein that stabilises 
microtubules in dendrites of post-mitotic neurons (Kosik & Finch 1987). Stained neurons 
were imaged and single-channel MAP2 fluorescence images were used for Sholl analysis 
of isolated neurons. 
 Analysis of various parameters quantified by the Scholl method found that miR-210 
knockout significantly increased a number of these measures in cultured neurons. This 
included the overall density of dendritic arbours with both the total number of intersections 
as well as the maximum number of intersections at any given radius increased in 
knockouts (Fig. 4.7a,b). Knockout neurons also displayed significantly greater branching, 
measured as ramification index, calculated as the ratio of the maximal number of 
intersections to the number of primary branches extending from the neuronal soma (Fig. 
4.7c). Increases were also observed in the average knockout neuron critical radius, or the 
radius with the highest dendritic density measured by maximal number of intersections. 
Also significantly increased in knockout neurons was the enclosing radius, the largest 
radius at which intersections were detected, indicative of the total size of the dendritic 
arbour (Fig. 4.7d,e). These changes are reflected in the Sholl curves for knockout and 
littermate control neurons with intersections plotted as a function of radius, with miR-210 
knockout Sholl curve having a higher and wider peak (Fig. 4.7f). Increased dendritic 
density and dendritic branching can also be observed in representative images of 
knockout and control neuron MAP2 staining (Fig. 4.7g,h). 
 To further explore potential effects of miR-210 knockout on neuronal function 
preliminary electrophysiology analysis of neurons was performed in vitro. Whole-cell 
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patch-clamp recordings using both voltage-clamp and current-clamp techniques were 
done in cultured neurons from knockout and littermate control mice at DIV-8 (Fig. 4.8). 
Voltage-clamp recordings were used to measured voltage-gated currents from a holding 
potential of -140 mV to +60 mV using 10 mV depolarising steps of 500 ms duration. In 
knockout neurons, a plateau effect of recorded current was observed at higher voltages of 
~30-60 mV under normal perfusion conditions (Fig. 4.8a-c).  
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 Current-voltage recordings were also performed in the presence of 10 mM TEA, a 
non-selective K+ channel blocker, with similar electrical responses observed in both 
knockout and control neurons under these conditions (Fig. 4.8a,d,e). Additionally, 
knockout and control neurons were used for current-clamp recordings to examine neuronal 
firing activity following 35 pA current injections of 1 sec duration. There did appear to be 
differences in firing with knockout neurons less responsive to current injection with smaller 
action potential spiking and prolonged depolarisation observed. Example single-cell 
recordings obtained from current-clamp mode are shown in Fig. 4.8f,g. Due to limited 
sample sizes, statistical analyses were not performed on electrophysiology data. 
 
4.3.4 Neuronal Expression and Induction of miR-210 In Vitro  
As discussed previously, long-term neuronal plasticity requires transcriptional and 
translational changes to occur, and the regulatory mechanisms controlling this need to be 
responsive to neuronal activity. To understand the potential role of miR-210 in plasticity, it 
is therefore important to determine whether miR-210 displays relevant neuronal 
expression and whether it’s expression may be altered in response to activity. To look at 
endogenous miR-210 expression in vitro, wild-type hippocampal neurons were cultured as 
described from E18.5, C57BL/6J mice. To examine miR-210 localisation in hippocampal 
neurons in vitro, cultured neurons were fixed at DVI-21 and miR-210 was detected using a 
Fluorescent In-Situ Hybridisation (FISH) approach (Fig. 4.9). A locked nucleic acid (LNA) 
probe with a 5’ conjugated digoxigenin (DIG) molecule was hybridised overnight before 
detection with a horseradish peroxidase (HRP) conjugated antibody and fluorescein- 
Figure 4.7: Dendritic morphology analysis in miR-210 knockout hippocampal neurons. Scholl 
analysis of dendritic arbours was performed on miR-210 KO and littermate CTRL neurons in 
vitro at DIV-12, using MAP2 as a dendritic marker. a-e. Various output parameters of dendritic 
morphology were quantified and statistically analysed. a. Total number of intersections per 
neuron. b. Maximum number of intersections per neuron. c. Ramification index (maximum 
number of intersections/number of primary branches). d. Average critical radius of neurons, i.e. 
radius with the greatest number of intersections. e. Average enclosing radius of neurons. f. 
Average Scholl curve of neurons, plotted as mean number of intersections per radius. g,h. 
Representative single-channel images of MAP2 staining in KO and CTRL neurons used for 
analysis. Error bars represent standard error, ** = p <0.01, *** = p <0.001, Kolmogorov-Smirnov 
test, n = 184. Scale bar = 50 µm. 
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tyramide, fluorescence signal amplification. To determine background staining levels a 
Scramble-miR LNA probe was used as a negative control condition. Samples hybridised to 
miR-210-3p LNA probe, showed positive staining in neurons throughout neuronal cell 
somas and processes (Fig. 4.9a,b). This included positive detection of miR-210 within 
dendritic spines and synaptic structures. No specific staining was observed following 
Scramble-miR LNA hybridisation in hippocampal neurons in vitro (Fig. 4.9c,d). 
 While there have been a number of studies associating miR-210 upregulation with 
neuronal activity this has primarily been in rodent models of epilepsy using whole brain or 
whole brain regions with a mixed cell population. To determine more directly whether miR-
210 is upregulated in neurons in response to neuronal activity, wild-type primary mouse 
hippocampal neurons were used as an in vitro non-disease model with a more 
homogenous neuronal population. For neuronal activation, neurons were exposed to 
repeated short applications of a high K+ HEPES buffered saline (HBS) to induce transient 
depolarisation, which previously has been used as a method of in vitro long-term 
potentiation (LTP; Appleby et al. 2011; Lu et al. 2001; Pickard et al. 2001). This involved 
incubation of neurons at DIV-21 in 90 mM K+ HBS for 1 sec, followed by a 10 sec recovery 
in control HBS, repeated three times before replacement of neuronal medium. To examine 
repeated neuronal activation, this protocol was repeated on cultured neurons up to three 
times with neurons recovered in between for 1 h under normal culture conditions. As a 
control condition, neurons were incubated for 30 secs in control HBS. Quantification of 
mature miR-210 expression by qRT-PCR found that miR-210 was increased following 1X 
K+ activation compared to control and repeated activation conditions indicating miR-210 
expression is altered by neuronal activity in vitro.  
 As in vitro neuronal models are not truly representative of the complexity of in vivo 
neural networks, long-term expression differences observed in vitro may not be reflective 
of in vivo changes. To determine the potential validity of the model used here, expression 
of genes known to be altered by LTP in vivo at various time points was quantified following 
1X K+ activation in cultured neurons at these same time points (Fig. 4.10b,c; Ryan et al. 
2012). A number of early-response genes found to be induced by LTP as early as 20 min 
in vivo were quantified at 20 min and 5 h after K+ activation in vitro, including Arc, Fos and 
Egr2 (Dragunow & Faull 1989; Lyford et al. 1995; Ryan et al. 2011; Williams et al. 1995). 
At 20 min both Fos and Egr2 were significantly increased, however Arc showed significant 
downregulation at this time point compared to control. After 5 hrs, Arc was significantly 
increased, Fos expression was reduced although still significantly elevated and Egr2 levels 
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had returned to baseline. Expression of other genes altered at later time-points following 
LTP in vivo were also quantified including Timp1, upregulated at 5 h, App, downregulated 
at 24 h and Hdac1, upregulated at 5 h and downregulated at 24 h (Fig. 4.10c; Ryan et al. 
2012). In vitro, Timp1 was also found to be significantly upregulated at 5 h after K+ 
activation and not at 20 min or 24 h time points.  App was reduced although not 
significantly altered from control at 24 h in vitro and no change in Hdac1 expression was 
observed at 5 h or 24 h. While expression of genes quantified after K+ activation in vitro did 
not precisely replicate expression changes following LTP in vivo, similarities in expression 
changes in a similar temporal pattern were observed indicating expression changes 
following K+ activation in vitro do correlate with expression changes following in vivo LTP. 
 To further identify how miR-210 might be regulated by neuronal activity, expression 
of Hif-1α and Hif-2α were also quantified. Although induction of Hif-α under hypoxic 
conditions occurs primarily via protein stabilisation, it has also been shown that Hif-1α can 
also be induced at the transcriptional level (Belaiba et al. 2007; Kang et al. 2008; Rimoldi 
et al. 2012; Tai et al. 2009). Hif-1α and Hif-2α mRNA expression levels were quantified by 
qRT-PCR following 1X K+ activation in vitro at various time-points, 20 min, 5 hrs, 12 h and 
24 h (Fig. 4.10d). No significant induction of Hif-2α was observed at any time-point, 
however Hif-1α mRNA levels were significantly increased 12 h after neuronal activation, 
highlighting Hif-1α as a potential regulator of miR-210 induction under these conditions 
(Fig. 4.10d).  
 As there are a number of different mechanisms for the induction of neuronal activity 
in vitro, a second method was tested to determine whether miR-210 induction may be 
specific to K+ exposure or whether it may be a more general effect of neuronal activation. 
To adress this, a glycine-mediated mechanism of in vitro LTP, commonly termed chem-
LTP, was utilized on DIV-18 neurons as described previously (Jaafari et al. 2013; Louveau 
et al. 2013; Park et al. 2004). Neurons were incubated in an extracellular solution (ECS) 
for 5 min before replacing with ECS supplemented with 200µM glycine for 3 min. Chem-
LTP was repeated 1-3X, with a 1 h recovery period in neuronal medium in between before 
quantification of miR-210 expression after 24 hrs. Similar to K+ activation, miR-210 was 
significantly increased following 1X chem-LTP, compared to control, with no glycine 
added, suggesting miR-210 is induced in cultured neurons via multiple mechanisms of 
neuronal activation (Fig. 4.10e).  
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4.4 Discussion  
Here it has been shown that miR-210 dysregulation has quantifiable effects on a number 
of cellular functions in vitro. In differentiated SH-SY5Y cells, miR-210 overexpression 
decreased mitochondrial membrane potential and increased cellular ROS levels. In 
mouse, primary hippocampal neurons miR-210 knockdown increased mitochondrial 
membrane potential and cellular ROS following hypoxic exposure. Significant changes in 
dendritic morphology were identified in knockout hippocampal neurons and altered 
electrophysiology observed. In primary neurons miR-210 was found to be induced by in 
vitro neuronal activation and a corresponding increase in HIF-1α was also observed.  
 Analysis of mitochondrial membrane potential by TMRE is commonly used as a 
measure of oxidative phosphorylation (Perry et al. 2011). In differentiated SH-SY5Y cells 
miR-210 overexpression did significantly reduce oxidative phosphorylation at 48 h after 
transfection and to a lesser extend at 72 hrs. This result is consistent with the targets 
identified by miR-210 pull-down, with miR-210 overexpression expected to reduce 
oxidative phosphorylation through down-regulation of related target genes such as 
subunits of ETC complexes I, III, IV and V. Typically it would be expected that levels of 
ROS correlate with oxidative phosphorylation being the major source of cellular ROS, 
however no correlating reduction in ROS was observed following miR-210 overexpression 
in SH-SY5Y cells and, conversely, an increase was observed 24 h after transfection. From 
this data alone it is not clear what may be the source of this increase but there are other 
sources of cellular ROS, such as peroxisomes and the endoplasmic reticulum, that may be 
the cause of this increase in ROS following miR-210 mimic transfection (Nyathi & Baker 
2006; Ryu et al. 2002). Given the experimental design, interpretation of results is limited as 
there may be other confounding effects of transfecting synthetic probes in cells and the 
Figure 4.8: Electrophysiology of hippocampal neurons in vitro. Whole-cell current-voltage and 
current-clamp recordings were performed in cultured hippocampal neuron from miR-210 
knockout and control mice at DIV-8 a. Current-voltage curves, plotted as current density/mV 
under normal perfusion conditions and with addition of potassium channel blocker, TEA. n = 9 
(CTRL), 4 (CTRL + TEA), 3 (KO), 4 (KO + TEA). b-e. Sample single-cell recordings from 
knockout and control neurons under normal perfusion conditions and with addition of TEA. f,g. 
Sample current-clamp recordings from knockout and control neurons following depolarising 
current injection of 35 pA for 1 sec duration.  
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nature of exactly how the synthetic probes are working and what potential secondary or 
compensatory effects might be occurring is not completely understood. To overcome these 
issues in a human in vitro system a more ideal model could involve utilising gene-editing 
for targeted knockout of miR-210 and/or lentiviral infection of the miR-210 gene which 
would over-express mature miR-210 through endogenous processing mechanisms.   
 
 
 
 
 
Figure 4.9: Detection of neuronal miR-210 expression in vitro. Fluorescent In-Situ Hybridisation 
(FISH) was used to detect miR-210 in primary hippocampal neurons cultured from wild-type 
C57BL/6 mice. Neurons were fixed at DIV-21 and miR-210 detected using a DIG-conjugated 
LNA, HRP-conjugated αDIG antibody and fluorescein tyramide signal amplification (TSA) 
solution. a. No signal was detected in neurons stained with Scramble-miR LNA probe. b. miR-
210 was detected by FISH in primary hippocampal neurons throughout the cell body and within 
dendritic processes and synaptic formations. Green fluorescence = fluorescein, blue = DAPI, 
red = dendritic marker, MAP2. Scale bar = 50 µm.   
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 Establishment of mouse hippocampal neuronal cultures with miR-210 knocked out 
also represented an improved mammalian system to better study endogenous functional 
effects of miR-210 in primary neurons. Analysis of mitochondrial membrane potential and 
ROS in primary neurons following hypoxia found both oxidative phosphorylation and ROS 
to be co-ordinately increased. This was consistent with anticipated effects that miR-210 
knockout may lead to reduced repression of ETC target genes, enhancing oxidative 
respiration. This also correlated with effects of miR-210 overexpression on mitochondrial 
membrane potential in SH-SY5Y cells. Quantification of dendritic morphology in primary 
neurons also identified increases in dendritic density and dendritic branching in miR-210 
knockout neurons. While axonal formation from miR-210 knockout neurons was not 
examined here, this may provide further insight into the neurodevelopmental role of miR-
210. As mentioned previously, In C. elegans, hypoxic stabilisation of Hif-1 causes axonal 
migration defects, however as miR-210 is not found in C. elegans, this must be mediated 
through other targets (Pocock & Hobert 2008). This does not preclude a role for miR-210 
in mammalian axonal migration though, and miR-210 has already been found to promote 
axon regeneration of peripheral neurons through targeting ephrin-A3 (EFNA3; Hu et al. 
2016). EFNA3 signalling is known to regulate axon guidance as well as dendritic 
Figure 4.10: Induction of miR-210 following neuronal activation. Expression of miR-210 was 
analysed in primary hippocampal neurons cultured from wild-type C57BL/6 mice. a. Relative 
expression of miR-210 24 h after K+ activation, repeated 1-3 times. For activation, neurons were 
exposed to HBS with high K+ solution for 3 x 1 sec intervals with 10 sec recovery intervals in 
HBS, this was repeated up to 3 times with neurons recovered for 1 hr in between, n = 9 
biological replicates from 3 experiments. b,c. A number of genes known to be regulated at 
different time points during LTP in vivo were quantified to determine their expression following in 
vitro K+ activation (1X) at DIV-21, n = 3.  b. Relative expression of early-response genes at 20 
min and 5 h post-activation. c. Relative expression of Timp1 at 20 min, 5 hr and 24 hr, and App 
and Hdac1 at 5 hr and 24 hr. d. Relative expression of Hif-1α and Hif-2α at 20 min, 5 hr, 12 hr 
and 24 h following in vitro K+ activation (1X) at DIV-21, n = 3. e. Relative expression of miR-210 
24 h after glycine-induced Chem-LTP at DIV-18, repeated 1-3 times. For chem-LTP, neurons 
were exposed to extracellular solution with 200 µM glycine solution for 3 min, this was repeated 
up to 3 times with neurons recovered for 1 hr in between, n = 6 biological replicates from 2 
experiments.  Error bars represent standard error, * = p <0.05, ** = p <0.01, *** = p <0.001, one-
way ANOVA, pairwise t-test comparison (a,e), two sample t-test (b-d). Expression data was 
normalised to either Rn5s (miR-210) or Tbp and Hprt1 (protein-coding genes). 
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morphology (Cang et al. 2005; Murai et al. 2003). Further analysis would be needed to 
determine which targets may be involved in the observed alterations in dendritic 
morphology following miR-210 knockdown, however EFNA3 or other pull-down targets 
involved in actin cytoskeletal re-organisation such as ACTB and HSPB1 could be potential 
candidates. Metabolic function may also act as a rate-limiting factor for processes with 
high metabolic demand and altered metabolism could therefore affect various neuronal 
processes such as dendritic outgrowth. 
 Limitations in availability of genetically modified mice as well as restricted time for 
further breeding and experimentation meant that more extensive analysis of primary 
neuronal functions using additional techniques or under varying conditions was not 
possible. This also meant sample sizes for some analysis were somewhat limited, in 
particular for electrophysiology recordings. From preliminary electrophysiology data 
presented here, however, it appears that miR-210 did affect neuronal electrical activity with 
a plateau effect in voltage-gated currents observed in current-voltage recordings. Less 
spiking was also observed following depolarising current injection in current-clamp 
recordings. The observed structural changes of increased dendritic density in miR-210 
knockout neurons might intuitively suggest neurons will display increased excitability. 
Current-voltage recordings however suggest that knockout neurons have altered 
membrane conductance indicating voltage-gated ion channels may be affected (Halliwell & 
Adams 1982; Verdoorn et al. 1991). Reduced spiking following current injection could also 
be indicative of reduced excitability and altered membrane depolarisation and restoration 
of membrane potential (Colino & Halliwell 1987). Given the preliminary nature of this data 
and a large amount of normal variation among neurons, further experimentation would be 
required to confirm these effects and elucidate the potential ion channels affected through 
application of specific channel blockers. Quantification of synaptic markers would also be 
important for characterisation of miR-210 knockout neurons to determine any differences 
in synaptic density or synaptic composition that may affect neuronal membrane 
conductance. 
 While in vivo data already suggests miR-210 is regulated by neuronal activity, data 
presented here found miR-210 was also upregulated by neuronal activation after 24 h in 
vitro in a more homogenous neuronal model. This effect was not observed however with 
repeated activation. This might be indicative of over activation of neurons that can have 
excitotoxic effects, triggering cellular stress and damage processes similar to those 
occurring after ischaemic injury or in neurodegenerative diseases, which can ultimately 
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lead to neuronal cell death (Abramov & Duchen 2008; Xu et al. 2000). Quantification of 
Hif-1α and Hif-2α gene expression also found that Hif-1α was upregulated by K+ activation 
in vitro at 12 hrs. Up-regulation of Hif-1α correlates with the observed upregulation of miR-
210 and suggests miR-210 may be induced following neuronal activation through HIF-1α. 
As this only quantified mRNA levels of Hif-1 and 2α however, protein quantification would 
be necessary to more accurately quantify levels of stabilised HIF-α protein. Inhibition of 
Hif-1α, for example through siRNA knockdown, would also be required to determine a 
direct link between Hif-1α and induction of miR-210 following neural activation. Although 
HIF-1α is the most widely studied HIF-α subunit, it shares a β-nuclear subunit with two 
other α-cytoplasmic subunits, HIF-2α and HIF-3α. HIF-2α can be active for up to 2-3 days 
following physiological hypoxia (<5% O2) in contrast to HIF-1α which is active after 
hypoxia/anoxia exposures of <0.1% O2 for up to 2-24 h (Koh & Powis 2012). As the 
dynamics of oxygen concentration in neurons during and after activity is relatively 
confounded, elucidating the role of both HIF-1α and HIF-2α in neuronal function may be 
important in understanding oxygen changes following activity. Given the timing of HIf-1α 
and miR-210 upregulation in previous studies it appears that HIFs may be important 
regulators during early or mid phase of long term consolidation while HIF target genes 
such as miR-210 active in mid to late phases of consolidation (Cristino et al. 2014b; 
Hunsberger et al. 2005; O'sullivan et al. 2007; Rampon et al. 2000). 
 Overall, functional analysis of miR-210 dysregulation in vitro is consistent with an 
important role for miR-210 in neuronal plasticity. Observed functional effects were also 
consistent with the enriched processes and pathways identified from pull-down of miR-210 
target genes in the human neuronal SH-SY5Y cell line. 
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5.1 Introduction 
Evidence from both molecular and cellular work presented in this thesis support a role for 
miR-210 in neural plasticity and builds on prior evidence of miR-210 dysregulation in 
neurological conditions. To bridge the divide, however, between in vitro research and the 
potential impact of miR-210 in disease, additional in vivo phenotyping is essential.  
 Previous in vivo studies on miR-210 have primarily identified opposing effects on 
angiogenesis and neural progenitor proliferation at differing developmental stages. During 
early neurogenesis stages of mouse embryonic development, miR-210 expression is 
detected in ventricular and sub-ventricular zone neural progenitor cells. Overexpression of 
miR-210 in the embryonic mouse brain also modulates neural progenitor proliferation, 
triggering cell-cycle exit and premature terminal differentiation with corresponding inverse 
effects observed following miR-210 knockdown (Abdullah et al. 2016). In the adult mouse 
brain however, overexpression of miR-210 increases neurogenesis as well as 
angiogenesis within the sub-ventricular zone (Zeng et al. 2014). Similarly, following 
induction of ischaemic stroke in the adult mouse, overexpression improves stroke recovery 
through increased microvesicle density and an increased neural progenitor population 
(Zeng et al. 2016). Consistent with this neuroprotective effect of miR-210, a study 
investigating vagus nerve stimulation, a therapeutic approach used to counter cerebral 
ischemia insult, found that inhibition of miR-210 in adult rats attenuated neuroprotective 
effects of vagus nerve stimulation following ischaemic stroke (Jiang et al. 2015). 
Conversely, reduction of miR-210 levels had neuroprotective effects in a neonatal rat 
model of hypoxic-ischemic injury (Ma et al. 2016). 
 Despite several rodent in vivo studies examining effects of miR-210 within the brain, 
it’s function during normal behaviour and cognition has not yet been explored. While our 
lab found miR-210 to be involved in olfactory conditioning in the honeybee, this model is 
limited in it’s translational potential as well as it’s capacity for examining more complex 
cognitive processes (Cristino et al. 2014b). The conditional miR-210 knockout mouse line 
generated for this project therefore represents an advantageous model for studying the 
effects of miR-210 in normal adult brain function. To determine if the in vitro analysis of 
miR-210 targeting and neuronal function may translate to potential behavioural and 
cognitive phenotypes in miR-210 knockout mice, various locomotor and maze-based 
behavioural experiments were conducted as well as cognitive testing of mice in visual 
discrimination and reversal learning tasks.  
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5.2 Methods 
5.2.1 Animals  
All animals were bred and genotyped as described previously (Section 4.2.5) at Monash 
University with approval by MARP animal ethics committee (Appendix 2). Behavioural 
experiments were conducted at the Florey institute of Neuroscience and Mental Health 
with approval from the Howard Florey Institute Animal Ethics Committee (Melbourne 
University, Parkville, Australia; Appendix 2). All animal experiments were conducted in 
accordance with NHMRC Guidelines on Ethics in Animal Experiments. Except where 
otherwise stated all animals had access to water and food ad libitum and were housed in 
standard light conditions. Two separate cohorts of male mice were used for behavioural 
testing. One cohort was tested only on touchscreen tasks and the second cohort tested in 
the open field task, rotarod, elevated plus maze and Y-mazes tasks. Locomotor and maze 
tasks were conducted in the order listed over three consecutive days. 
 
5.2.2 RNA Extraction and qPCR from Brain Tissue Samples 
For RNA extraction, adult mice of ~11 weeks of age were sacrificed by CO2 asphyxiation. 
Mice were quickly decapitated, and skin removed to expose the skull. Scissors were used 
to cut away skull tissue covering the cerebellum and to make an incision anterior to the 
olfactory bulb before cutting the skull mid-sagittaly and using forceps to peel the skull away 
from cortices. The whole brain was removed and placed into ice-cold PBS before micro-
dissection of brain regions under a dissection microscope. Collected tissue was diced with 
a scalpel blade, transferred into an eppendorf tube and immediately placed on dry ice. 1 
mL of TRIzol was added to tissues and pipetted 5X to break tissue into small pieces. 
Tissue was then passed 5X through a 23 gauge needle with a 1 mL syringe. Samples 
were incubated in TRIzol on rotation at 4°C for 30 min. Samples were spun for 5 min at 
500 x g to pellet undissolved tissues and supernatant was transferred into a fresh tube. 
200 µL of chilled chloroform was added and samples were shaken vigorously for 30 secs 
before incubation on ice for 10-15 min. Samples were centrifuged at 12,000 x g for 15 min 
at 4°C and upper aqueous phase transferred to a new tube. An additional 300 µL of TRIzol 
was added to samples before mixing and incubating on ice for 5 min. Chloroform addition, 
centrifugation and aqueous phase isolation steps were repeated. RNA precipitation and 
resuspension was performed as previously described and RNA was quantified by 
Nanodrop and Qubit RNA high sensitivity assays. Stem-loop primer cDNA synthesis and 
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qRT-PCR reactions were set-up as detailed in section 4.2.4. Primer sequences for Rnu6 
amplification were; Forward - 5’ AACGCTTCACGAATTTGCGTG and Reverse - 5’ 
GCTCGCTTCGGCAGCACA. The reverse amplification primer was also used for gene-
specific reverse transcription of Rnu6 in cDNA synthesis reactions.  
 
5.2.3 Accelerating Rotarod Performance Task 
Motor coordination in mice was tested using an accelerating rotarod apparatus that 
consists of a rotating horizontal cylinder (rod) suspended above a platform. To familiarise 
mice with the apparatus all mice were first placed onto the rotarod at a constant speed of 4 
rpm for 1 min. After this training, mice were tested where the speed gradually accelerated 
from 4 rpm to 40 rpm over a period of 5 min. Mice were placed on the rotarod at 4 rpm 
before starting acceleration and timing. Time spent on the rotarod was recorded as the 
time mice fell from the rod and landed on the platform. Mice were tested on the 
accelerating rotarod for three sessions with mice rested after training and between each 
session. 
 
5.2.4 Locomotor Open Field Test 
An open field arena was used for assessment of locomotor and exploratory activity. The 
arena was a square, open field mouse chamber (Med Associates, St. Albans, VT, USA) of 
dimensions 27.3 (L) x 27.3 (W) x 20.3 (H) cm. The chamber consists of a white plastic 
base with clear walls and ventilated cover. An automated array of infrared (IR) beams 
project across the chamber x and y axes to detect animal location. Chambers were located 
in a dedicated behaviour room under even illumination from overhead lighting. Chambers 
were thoroughly cleaned with 85% ethanol and ethanol was evaporated before testing of 
mice to minimise interference from scents. Mice were transferred to the room and 
habituated for at least 10 min before placing into chambers and recording movements 
using the Activity Monitor software v6.02 (Med Associates). Mice were placed in the centre 
of the field and tracking was initiated when IR beams first detected the animal. The lid was 
replaced and once all mice were loaded into chambers the room was vacated by the 
experimenter to minimise disturbances. Mouse movements were tracked for a period of 1 
h before mice were returned to their home cage.  
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5.2.5 Elevated Plus Maze 
To assess anxiety-like behaviour in mice, the elevated plus maze task was conducted. The 
maze has four arms, of 36 cm (L) x 5 cm (W) dimensions, in a plus shape, elevated 40 cm 
above the floor with an open roof design. Two opposite arms were enclosed by an 18 cm 
high wall and the two perpendicular arms were open (Fig. 5.1a,b). A light-coloured, beige 
maze was used for contrast against the black coat of mice. The maze was placed in a 
dedicated behaviour room with a camera fixed to the ceiling. The maze was positioned to 
be centred under the camera as well as centred under lighting so that open arms were 
evenly illuminated. The camera was connected to the TopScan Lite 2.0 software 
(CleverSys, VA, USA) used for automated recording, tracking and analysis of movements. 
Following positioning of the maze, each arm and the centre region of the maze was 
manually delimited using the TopScan program, zones were delimited so that the entire 
body of the mouse had be within the arm for it to be counted as an entry. Lighting in the 
room was dimmed to 6 lx to enhance mice activity. Mice were transferred into the room 
and habituated for a period of at least one hour before trials were started with noise kept to 
a minimum throughout habituation and testing. The maze-set up was isolated from other 
stimuli within the room by a white curtain and no visual cues surrounding the maze were 
present. Mice were placed into the centre of the maze facing towards an open arm. 
Tracking was initiated by detection of the mouse within the centre zone for a period of 1 
sec. Mice moved freely within the maze and movements were tracked for a period of 5 min 
before retrieving mice. The maze was cleaned with 85% ethanol following each trial.  
 
5.2.6 Y-maze Task 
The Y-maze task was used as a measure of short-term memory performance. The Y-maze 
is composed of three arms set equally at 120° apart. Each arm was 10 cm (W) x 30 cm (L) 
with a surrounding wall 17 cm high (Fig. 5.1c). A light-coloured, beige maze was used for 
contrast against the black coats of test mice. The Y-maze was placed on the floor as 
described for the elevated plus maze, centred under the camera, with lighting evenly 
illuminating all arms. The TopScan Lite system (CleverSys) was used for tracking and 
recording of mice movements within the maze. Each arm was delimited as a separate 
zone with the centre, joint region set as a separate zone. At the end of each arm a distinct 
visual stimuli was fixed above the back arm wall (Fig. 5.1d). The Y-maze task was run as a 
training phase with one arm blocked off followed by a test phase with all arms accessible. 
The arm mice were first placed into was designated as the home arm, and was kept 
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constant for all trials. Arms 2 and 3 were alternated as the novel and familiar using a 
removable wall piece to block the novel arm arms, with the novel arm assignment counter-
balanced across mouse genotype groups. Room lighting was dimmed to 6 lx to enhance 
mice activity and mice were transferred into the room and habituated for a period of at 
least one hour before trials were started with noise kept to a minimum throughout 
habituation and testing. The maze-set up was isolated from other stimuli within the room 
by a white curtain and no visual cues surrounding the maze were present. Mice were 
placed into the end of the home arm facing the back wall and tracking initiated by detection 
of mice within the home arm for a period of 1 sec. During the training phase, mice moved 
freely between the home and familiar arms for a 10 min period before returning mice to 
their home cage. Following a 50 min rest period mice were replaced into the Y-maze with 
all arms accessible and free movement was recorded and tracked for a 5 min period. The 
maze was cleaned with 85% ethanol following each training and trial session. Raw 
tracking data was exported for analysis and percentages of time spent in each arm 
calculated as percentage of time in arm / (total time – time spent in centre). Data for mice 
that made less than 11 total entries into all arms was excluded from analyses.    
 
5.2.7 Touchscreen Behavioural Task Preparation and Equipment Set-up 
Before touchscreen testing, mice were relocated from Monash University to the Howard 
Florey Laboratories (Melbourne University) and housed in a mouse touchscreen behaviour 
room with a reversed 12 h lighting cycle (lights on at 7:00 pm, lights off at 7:00 am), so 
mice could be tested during the active period of their circadian cycle. Mice were 
acclimatised to the reverse lighting cycle for a two-week period. As the touchscreen tasks 
rely on food-based reward, mild food restriction is required for appropriate mouse 
motivation. To establish a baseline weight for all mice, mice were weighed for 3 
consecutive days with access to food and water ad libitum. After establishing a baseline 
weight, food restriction was started to slowly reduce animal weight to a goal weight 
between 85-90% of their baseline weight. Mice were weighed at approximately the same 
time each day and fed ~2-3 g of food per 25-35 g of mouse. Once all mice reached their 
goal weight after 4-5 days, touchscreen training was started with food restriction continued 
throughout the testing period, maintaining mouse weights within the 85-90% weight range. 
The food reward used throughout touchscreen testing was a liquid reward of strawberry-
flavoured milk. To familiarise mice with the reward, strawberry milk was added to mouse 
home cages in a shallow dish for 1 day before beginning stage I of pre-training. 
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 The touchscreen chamber used for testing was a commercially available mouse 
touchscreen operant chamber (Campden Instruments, UK). This chamber is housed in a 
light and sound attenuating fibreboard box equipped with a fan for ventilation. The 
chamber is a trapezoid shape with three black, plastic walls opening onto a 12.1” 
touchscreen (IR photocell, 600 x 800 resolution). The chamber is also equipped with a 
house light, a tone and click generator and a magazine unit. The magazine unit, attached 
Figure 5.1:  Behavioural set-up for elevated plus maze and Y-maze tasks. a. The elevated plus 
maze consists of 4 equal perpendicular arms, raised above the floor with two arms that are 
enclosed by high sides and two open arms. b. 3D schematic of elevated plus maze design. A 
camera fitted to the ceiling captures the movement of the dark animal on light (maze) 
background. Mice are placed in the centre of the maze facing an open arm. Movements of mice 
were recorded and traced for a 5 min period. c. Schematic depiction of the Y-maze task. The Y-
maze task consists of three arms each distinguished by a stimuli at the end of the arm, H = 
home arm. During a 10 min training phase, a removable wall closes off either arm 2 or 3 (novel 
arm) and mice are free to explore the home arm and the second open arm (familiar arm). After 
a 1 h rest period, mice are replaced into the maze with all arms open. Movements were 
recorded and tracked for 5 min. d. Stimuli that were used in the Y-maze task. Arms 2 and 3 
were alternated as the novel and familiar arms, counter-balanced across genotype.  
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to the back of the chamber, is fitted with a light and an IR beam for detecting entries, and 
connects to a pump for milk reward delivery. Two additional IR beams detect mice 
movement in the front and rear of the chamber. The chamber floor is made of perforated 
stainless steel and is raised above a removable tray for collection of faeces/urine. The 
chamber is accessed through a transparent lid and an IR camera was installed above the 
chamber to monitor mice. For all touchscreen pre-training and training tasks described 
here, a black plastic mask with two response windows was fitted in front of the 
touchscreen. Touchscreen chambers were run using the Whisker software and ABET II 
Touch software (Lafayette Instrument, IN, USA). IR camera monitors and computer 
monitors were set-up outside the touchscreen room to minimise external interference 
during testing. For each session, 14 mice were tested in 8 chambers across two runs. 
Each mouse was tested in the same chamber, during the same run for each session with 
mouse genotypes counterbalanced across each run. Touchscreen testing was performed 
5-7 days per week starting at approximately the same time each morning for all sessions. 
After each run, chamber walls and floor were cleaned with 50% ethanol, following the 
second run, screens were also cleaned and trays emptied/cleaned. Before the start of 
each run, all equipment was turned on and the appropriate task schedule loaded in ABET, 
mice were then loaded into the chambers before the room was vacated and session 
started. After all mice had completed the session, mice were removed from the chambers, 
before being weighed and fed.       
  
5.2.8 Pre-training  
Before mice began touchscreen tasks a number of pre-training steps were completed to 
gradually develop appropriate screen-touching behaviour in mice as described previously 
(Fig. 5.2a,b; Horner et al. 2013). Pre-training for visual discrimination and reversal learning 
consisted of five stages, detailed below: 
Stage I – Habituation 
For two sessions of 30 min, mice are habituated to the chamber and the food reward. All 
electronic components were switched on for this period so mice could habituate to any 
associated noises. At the beginning of the session a single large reward was delivered by 
activation of the reward pump for 8000 ms equivalent to ~200 µL (10X the standard 
reward), no visual stimuli is presented on the screen throughout habituation. Criterion for 
advancing past stage one was consumption of all food reward within the 30 min session 
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for two consecutive sessions, with all animals advanced to the next stage during the next 
session after reaching criterion.     
Stage II – Initial Touch Training 
In stage II, Initial Touch training, mice learn the association between stimulus offset and 
reward delivery. In this stage and in the following pre-training tasks, a library of 40 varied 
black and white images are used that have no substantial similarity to the stimuli used in 
discrimination tasks. A single stimulus is presented in one of the response windows, with 
the stimuli location determined pseudo-randomly with the same location not used for more 
than 3 consecutive trials. If not touched, the stimulus was automatically turned off after 30 
secs, and the magazine light was turned on, a conditional reinforcer tone sounded (1 sec, 
3 kHz) and a single 800 ms reward was delivered. If the screen was touched before the 30 
sec offset, mice were immediately rewarded, the magazine was illuminated, tone sounded 
and a triple-reward delivered to encourage screen-touches. Following reward delivery, the 
magazine light was switched off upon mouse entry into the magazine and an inter-trial 
interval (ITI) timer of 20 secs started following magazine exit, after which the next trial 
began automatically. Criterion for advancing past stage II was completion of 30 trials within 
a 60 min session.     
Stage III – Must Touch Training 
In this stage, the session conditions were similar to stage II however no automatic offset or 
reward delivery occurred. Following touches to the screen, magazine illumination, tone 
and single reward delivery occurred. Completion of stage III required reaching a criterion 
of finishing 30 trials in one 60 min session.  
Stage IV – Must Initiate Training  
In this stage mice must trigger the presentation of stimuli onto the screen by entry and exit 
from the magazine, termed trial initiation. The session began with a single free reward 
delivery with the magazine illuminated. The magazine light switched off upon mouse entry 
into the magazine and upon mouse exit the stimulus was presented on the screen. After a 
trial is completed and the ITI timer finished, the magazine is illuminated to indicate a new 
trial can be initiated. When the animal head enters the magazine the light switches off and 
a click sound occurs (0.2 sec) upon exit. Stage IV criterion was reached once mice 
completed 30 trials in one 60 min session.  
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Figure 5.2:  Mouse operant conditioning using touchscreen technology. a-d. Schematics 
depicting pre-training, visual discrimination and reversal learning training. a. During stage I of 
pre-training, mice are habituated to the chamber with all equipment switched on. A single 
reward is delivered which must be consumed within the 30 min session, no stimuli is presented. 
b. During pre-training stages II-V, various random stimuli are presented with no significant 
similarity to stimuli used for operant conditioning. Each session begins with the magazine light 
turning on and a single reward delivery, sessions end when mice complete 30 trials or after 60 
min. For all trials, a single stimulus is presented at a time in a pseudo-randomised location, with 
the condition that the same location is not used more than three times in a row. Trials are 
completed by entry into the magazine upon reward delivery and an inter-trial interval of 20 secs 
was used for each stage. During stage II, touch is encouraged by triple reward delivery, if not 
touched a single reward is delivered after 30 secs. In stage III, stimuli must be touched for 
reward delivery. In stage IV mice must initiate trials by magazine entry. In stage V, incorrect 
response to the blank screen are punished by the house light switching on and a 5 sec time-out 
period. Mice must do correction trials until the correct response is given, before the trial is 
completed. Criterion for completing stage V is 85% accuracy for two consecutive sessions. c-f. 
Visual discrimination and reversal learning schematic and stimuli. e. For visual discrimination 
two stimuli, a plane and a spider are presented at the same time in pseudo-random locations for 
each trial, one stimuli is rewarded (CS+) and one is unrewarded (CS-). Mice must learn to 
discriminate between stimuli and reach a criterion of at least 80% accuracy for two consecutive 
sessions. f. After reaching criterion CS+ and CS- stimuli are switched for reversal learning. 
Assignment of CS+ and CS- stimuli was counterbalanced across genotypes.  
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Stage V – Punish Incorrect Training  
In the final stage of pre-training mice are discouraged from making incorrect responses 
and introduced to incorrect response cues. As in stage IV, sessions began with a free 
reward delivery and mice had to initiate all trials. Touches to the blank screen during 
stimulus presentation were registered as incorrect responses. Incorrect responses 
triggered a 5 sec time-out period, during which the house light is turned on. After the time-
out period a 20 sec ITI occurs before a correction trial (CT) begins, CTs were initiated in 
the same way as non-correction trials and the same stimulus was presented in the same 
location. CT responses did not count towards the overall accuracy score of a session or 
towards the trial limit of a session. If a mouse continues to respond incorrectly there is no 
limit to the number of CTs that can be completed in a session or on a single trial and CTs 
will continue until a correct response is given. CT responses are rewarded or punished in 
the same manner as non-correction trials. Criterion for advancing from stage V of pre-
training was completion of 30 trials in 60 min with an accuracy of ≥85% (≥ 26 correct 
responses) in two consecutive sessions.  
 
5.2.9 Visual Discrimination 
Following completion of pre-training all mice were moved onto the visual discrimination 
task at the same time in the following session. Visual discrimination sessions began with a 
free initial reward delivery to indicate that a trial may be initiated. For each trial, two stimuli 
where presented in the two response windows in a pseudo randomised manner, with the 
stimuli not presented in the same locations for more than 3 trials in a row. For this study 
the two stimuli used where a plane and a spider with one stimulus designated as CS+ 
(correct) and one as CS- (incorrect; Fig. 5.2). Designation of CS+ as the plane or as the 
spider was counterbalanced across mice genotype group to minimise effects of potential 
bias for a particular stimulus. Responses to CS+ were rewarded as described in pre-
training with a tone, magazine illumination and a single 800 ms food reward delivery. 
Responses to CS- were punished as described for blank touches in stage V of pre-
training, with the house light switched on for a 5 sec time-out period. The ITI timer was set 
to 20 secs as in pre-training and all trials had to be initiated by magazine entry/exit. 
Incorrect responses triggered the following trial to be a CT with the same stimuli presented 
in the same location, as in pre-training, CTs did not count toward accuracy or session trial 
limit. All visual discrimination sessions finished after completion of 30 non-correction trials 
or after a 60 min timeout. Once mice reached a criterion of completing 30 trials in 60 min 
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and achieving ≥80% accuracy (≥ 24 correct responses) for two consecutive sessions, mice 
were immediately moved on to the first reversal learning session the following day. Data 
from one mouse in the knockout group was excluded from all touchscreen analyses as 
they had not reached criterion for visual discrimination after 12 sessions and were a 
statistically significant outlier in the majority of visual discrimination parameters. 
 
5.2.10 Reversal Learning 
For the reversal learning task sessions were run as described for visual discrimination with 
the only change being the CS+ and CS- stimuli for each mice were switched. The first 
reversal learning session was split across two 60 min runs on two days with each session 
consisting of 15 trials to total 30 trials for session. If mice did not complete 15 trials within 
the first run, the total trial limit of run two was altered to achieve 30 trials total (i.e. 10 trials, 
run one, 20 trials run two). For mice that did not complete 30 trials in two runs, the first 
session of 30 trials was spread over three runs on three consecutive days. For subsequent 
sessions the trial limit was set to 30 although for some mice, who did not come close to 
completing 30 trials in 60 min in session two, session two was split over two runs on 
consecutive days. All mice were trained on the reversal learning task for 10 sessions.     
 
5.2.11 Statistics 
Statistical analyses were carried out in either R v3.2.4 or in GraphPad Prism v7.0c. 
Significance was calculated at a 95% confidence interval (α = 0.05). Homogeneity of 
variance and data normality distribution was determined using Levene and Shapiro-Wilk 
tests, respectively. Outliers were detected using the ROUT method with Q = 1%. Specific 
means tests and appropriate post-hoc analyses were used as indicated in the text. 
 
5.3 Results 
5.3.1 Expression of miR-210 In Vivo 
Despite some studies that have looked at miR-210 expression in the mouse brain during 
disease states and embryonic development there has been limited quantitative analysis of 
miR-210 expression within the normal adult mouse brain. To further characterise miR-210 
expression within the brain and identify potential brain regions where it may be expressed, 
miR-210 expression was quantified using qRT-PCR. Various different brain regions were 
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micro-dissected from control mice (miR-210loxP/loxP) at 10-12 weeks of age and used for 
RNA extraction and analysis (Fig. 5.3a). This included hippocampal and cortical regions 
associated with memory processes and higher cognitive functions as well as the 
cerebellum, a region involved with sensorimotor processing and various other cognitive 
processes related to emotion and intellect (Stoodley 2012). Expression in the Sub-
Ventricular Zone (SVZ) of the adult brain was examined as a region where neurogenesis 
occurs and also where miR-210 expression was detected at certain embryonic stages 
during murine development (Abdullah et al. 2016). The olfactory bulb was also included in 
expression analysis as miR-210 was previously found to be expressed in olfactory 
processing regions within the honeybee brain (Cristino et al. 2014b). 
 
 
 
 
Figure 5.3:  Expression of mature miR-210 across brain regions. a. miR-210 was quantified 
within various brain regions in control mice (miR-210loxP/loxP) by qRT-PCR. Expression is relative 
to average expression across all brain regions analysed. OB = olfactory bulb, SVZ = sub-
ventricular zone, HPC = hippocampus, CRTX = cortex, CERR = cerebellum, n = 4, one-way 
ANOVA, Tukey HSD. b. To confirm knockout of miR-210 in knockout mice, expression of miR-
210 in the hippocampus of knockout mice was quantified relative to control mice hippocampal 
expression, n = 4 (CTRL), 3 (KO), Two-sample t-test. miR-210 was normalised to Rnu6, error 
bars represent standard error *** = p <0.001.      
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 To determine relative expression of miR-210 across these brain regions normalised 
expression data for each region was compared to average expression levels across all 
brain regions. From this it was found that miR-210 expression was significantly higher 
within the hippocampus, with a relative fold increase >17.5 (p = <0.0001, SEM = 2.05). No 
significance fold change was seen across other brain regions compared to average 
expression levels or to other brain regions (Fig. 5.3a).  qRT-PCR analysis was also used 
to determine successful knockdown of miR-210 in neuronal knockout mice (miR-210-/-
;Nestin-Cre). Since levels of miR-210 were low in most brain regions and may potentially 
be undetectable in these regions in knockout mice (KO), expression of miR-210 in the 
hippocampus of adult knockout mice was compared to littermate control (CTRL) 
hippocampal expression (Fig. 5.3b). This confirmed that nestin-driven cre-recombinase did 
sufficiently knockout miR-210 and reduce mature miR-210 expression within the 
hippocampus (>122.78 fold reduction, p = <0.0001).  
 
5.3.2 Motor Function and Locomotor Behaviour in miR-210 Knockout Mice 
As this genetic strain of mice have not been previously characterised, we assessed miR-
210 knockout mice in a battery of behavioural and cognitive tests. We first measured basic 
motor functions using two different assays. It is worth noting that knockout mice were 
smaller than their littermate controls in body size and body weight (Fig. 5.4a). This is most 
likely a consequence of the nestin-cre allele as this phenotype has been previously 
observed in this mouse line (Declercq et al. 2015). Aside from this, no other gross 
abnormalities or defects were observed in miR-210loxP/loxP or miR-210-/-;Nestin-Cre mice. 
As a measure of basic motor skills, knockout and littermate control mice were tested on 
the accelerating rotarod performance task which measures various motor functions 
including balance and coordination (Deacon 2013). The task consists of a motor-driven, 
rotating horizontal rod, which the mice must walk forwards on to avoid falling. The latency 
to fall or time spent on the rotarod is used as a measure of motor co-ordination. No 
differences in rotarod performance were observed between knockout and littermate 
controls with both groups spending the same average time on the rotarod as well as the 
maximum rotarod trial time for each mouse (Fig. 5.4b,c). This indicates there was no 
significant effect of miR-210 knockout on motor co-ordination in mice.  
 As an additional measure of locomotor and exploratory activity, mice were tested in 
the open field task. In this task mice are placed into an empty arena, large enough to  
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invoke a sense of being in an open space. Mice movement within the open field relies on 
the natural exploratory behaviour of mice and their desire to explore novel places 
(Seibenhener & Wooten 2015). The task can be correlated with various physical and 
cognitive aspects of mice locomotor behaviour such as motor function and exploratory 
drive, respectively. For this study the open field task was primarily utilised and analysed for 
the purpose of detecting potential differences in mice baseline activity levels. Mice were 
placed into the open field chamber and movements tracked for a period of 1 hour. Total 
ambulatory time and total ambulatory distance travelled was analysed as well as 
ambulatory time and distance travelled throughout the session, with data grouped into 5 
min bins (Fig. 5.5).  Although there was greater variability within the knockout group no 
differences were observed in either the total ambulatory distance or the total time that mice 
were active during the 1 h period (Fig. 5.5a,b). There were differences however in analysis 
of activity curves for both ambulatory time (p = 0.041) and ambulatory distance travelled (p 
= 0.021) over 5 min intervals (Fig. 5.5c,d).  Typically, mouse exploration and activity within 
the open field is highest at the start of the trial with activity decreasing over time as the 
novelty of the environment wears off. This typical activity curve is observed in littermate 
control mouse, however in knockout mice this curve was somewhat flattened with mice 
appearing to be less active during earlier time points and with activity levels remaining 
more stable throughout the trial period.   
 
 
 
 
Figure 5.4:  Baseline weights and motor co-ordination in miR-210 neuronal knockout mice. a. 
Baseline weights of adult male mice at 13 weeks of age. n = 13 (CTRL), 15 (KO), Two-sample t-
test. b,c. Assessment of mouse motor skills using the accelerating rotarod task, n = 6 (CTRL), 7 
(KO), Two-sample t-test. b. Average time spent on rotarod over three trials. c. Max time spent 
on rotarod out of three trials. Error bars represent standard error, *** = p <0.001. 
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5.3.3 Elevated Plus Maze and Y-Maze Tasks 
To extend the behavioural characterisation, the elevated plus maze and Y-maze tasks 
were also employed. The elevated plus maze is a well-known behavioural tool frequently 
used for assessment of anxiety-like behaviour in mice. The maze consists of four arms in a 
plus-sign configuration elevated above the floor. Two arms of the maze are enclosed by 
high walls, while two arms remain open (Fig. 5.1a,b). The elevation of the maze means the 
open arms promote a sense of fear in mice and their motivation to explore the novel area 
is conflicted by their aversion to the open arms. The amount of time spent in the open 
arms as well as the number of entries into the open arms are therefore used as a measure 
of anxiety in mice, with reduced anxiety leading to increased exploration of the open arms 
(Komada et al. 2008). In this study, levels of anxiety in both knockout and littermate control 
mice appeared to be high with all mice spending very limited time in the open arms and 
making few or no entries into the open arms. Minimal time spent in the open arms by all 
mice may reflect high levels of anxiety caused by factors that resulted in the testing 
conditions being sub-optimal such as limited handling. Given the limited entries of into the 
open arms, interpretation of these results is limited and any possible strain effects on 
anxiety could potentially be masked by this floor effect. Analysis of this data however 
found no differences in entries to either the open arms, closed arms or the centre zone of 
the maze and no differences in the percentage of time spent in any one zone (Fig. 5.6a,b).  
   The Y-maze task is used for assessment of short-term spatial memory and also 
takes advantage of the exploratory nature of mice in novel environments. The maze has 
three arms set at equal angles in a Y shape with each arm identified by a distinct visual 
cue affixed at the end (Fig. 5.1c,d). Following a training session where the novel arm is 
blocked, spatial memory of mice is tested by their preference for the novel arm when they 
are later returned to the maze with the novel arm open. In this study, the home arm, into 
which mice were initially placed, was kept constant for all mice and all trials. The remaining 
two arms were alternated between mice as either the novel or familiar arm with the novel 
Figure 5.5:  Locomotor behaviour of miR-210 neuronal knockout mice in an open field. Mice 
were placed in an open field and locomotor activity tracked for a 60 min period. a. Total 
ambulatory time. b. Total distance travelled. c. Average ambulatory time throughout session in 
5 min intervals. d. Average ambulatory distance covered throughout session in 5 min intervals. 
Error bars represent standard error, n = 6 (CTRL), 7 (KO), Two-sample t-test (a,b), non-linear 
regression, curve fit comparison (c,d) * = p <0.05.  
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arm counter-balanced across genotype groups to avoid effects from any potential bias for 
a particular arm or for a particular visual cue. From measurements tracked during the test 
phase a number of parameters can be analysed to assess mice preference for the novel 
arm. This includes the arm that the mouse chooses to explore first, i.e. whether the mouse 
enters the novel or familiar arm first when leaving the home arm, the time taken for the 
mouse to enter the novel arm, or novel arm latency and the percentage of time spent in 
the novel arm throughout the test period. As activity levels can affect mouse exploration of 
the Y-maze and interpretation of the data, three mice that made less than 11 total entries 
into all arms were excluded from analyses. Given their preference for novel spaces it is 
expected that mice will chose to enter the novel arm first. This was true for all of the 
control mice (5/5) and knockout mice (5/5) analysed. No significant difference was 
observed between control and knockout mice latency for the novel arm, although knockout 
mice did display less variability in this measure and a trend toward decreased novel arm 
latency (11.1 ± 2.5 [KO], 41.5 ± 20.8 [CTRL], p = 0.0556; Fig. 5.6c). Both groups also 
spent a similar amount of time in the novel arm, with no difference between knockout and 
control mice (Fig. 5.6d). This data indicates that short-term spatial memory was not 
significantly impacted in the miR-210 neuronal knockout line.   
 
5.3.4 Pre-training for Touchscreen Operant Conditioning 
As miR-210 was previously found to be involved in honeybee olfactory conditioning, long-
term learning and memory was further characterised in miR-210 knockout mice using a 
touchscreen operant task for visual discrimination and reversal learning. The rodent 
touchscreen cognitive tests represent a relatively new testing approach for behavioural 
and cognitive functions in rodents with a battery of different cognitive tasks that have been 
developed and optimised (Horner et al. 2013; Mar et al. 2013; Oomen et al. 2013; Talpos 
et al. 2010). The touchscreen set-up and computer-automated tasks allow for standard, 
simultaneous testing of mice in a controlled environment with improved sensitivity of 
various measures. Stress and experimenter interference is also minimised in touchscreen 
testing and demands on animal motility are low. The tasks in the touchscreen battery are 
also highly translatable and directly related to the human touchscreen tests that make up 
the Cambridge Neuropsychological Automated Battery (CANTAB), widely used for 
cognitive assessment in clinical research (Nithianantharajah & Grant 2013). The significant 
capacity and sensitivity of touchscreen testing has already been demonstrated by studies 
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detecting discrete cognitive profiles upon disruption of closely related genes within the 
same family (Nithianantharajah et al. 2013; Ryan et al. 2013).  
 
 
 
 
 
 Before testing mice in cognitive tasks, knockout and control mice first completed a 
series of pre-training tasks to habituate mice to the chamber and to train them to correctly 
interface with the apparatus. The mouse touchscreen operant chamber uses a liquid 
reward of strawberry milk delivered into the magazine for appetitive reinforcement. In pre-
Figure 5.6:  Elevated plus maze and Y-mask task analysis. a,b. Analysis of movements within 
the elevated plus maze tracked over 5 min a. Total number of entries into open arms, closed 
arms and centre zone. b. Percentage of time spent in open arms, closed arms and centre 
zones, n = 6 (CTRL), 7 (KO). c,d. Analysis of mice performance in the Y-maze task. One hour 
after a 10 min training session with the novel arm closed, mice were replaced in the maze with 
the novel arm open and movements were recorded and tracked over a 5 min period. c. Latency 
for the novel arm, i.e. time from entry into the maze until entry into the novel arm. d. Percentage 
of time spent in the novel arm. Error bars represent standard error, n = 5, Two-sample t-test.  
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training stages, mice are habituated to the chamber and reward delivery system and learn 
to associate reward with stimulus touch, typically by nose-poking. In the later stages, mice 
are discouraged from making incorrect responses with the introduction of a mild aversive 
stimuli and correction trials. All mice in both control and knockout groups completed all 
pre-training stages and passed criteria for all pre-training tasks in the minimum possible 
amount of sessions (Fig. 5.7a). Performance of mice in the final stage of pre-training was 
analysed and all mice found to achieve close to 100% accuracy with a similar perservative 
index, or ratio of CTs per incorrect response (Fig. 5.7b,c). Mice in the knockout group 
however did complete these sessions faster than control mice on average (Fig.5.7d).  
  
5.3.5 Visual Discrimination in miR-210 Knockout Mice 
Following pre-training, mice were tested in the visual discrimination touchscreen task 
(Horner et al. 2013). In this task, mice learn to discriminate between a rewarded stimuli 
(CS+) and a non-rewarded stimuli (CS-). Discrimination of environmental cues is an 
important aspect of decision-making and adaptive behaviour that has implications in 
neuropsychiatric disorders. At least two cognitive processes are required for mice to 
complete this task including perceptually discriminating between stimuli and learning to 
associate the correct stimuli with reward. For this study, the two stimuli that used were 
basic silhouette images of a spider and a plane, commonly used in this task (Bussey et al. 
2008). Previously it has been found that rodents display minimal bias for either of these 
stimuli and to further reduce the potential for bias, the CS+ stimuli was alternated among 
mice and counter-balanced across genotype groups. Visual discrimination sessions 
consisted of 30 trials with a time limit of 60 min. As in stages IV and V of pre-training, 
sessions started with a free reward delivery and mice were required to initiate all trials by 
magazine entry/exit. Following initiation, the two stimuli were presented on the screen at 
the same time in a pseudo-randomised location with the same location limited from being 
used for more than three trials consecutively. Touches to the CS+ stimuli were rewarded 
as described for touches to stimuli in pre-training and responses to the CS- resulted in a 
time-out and a correction trial as described for blank touches in stage V. Each trial was 
also followed by a 20 sec ITI. All mice were tested on visual discrimination sessions for 5-7 
days per week until they had reached a criterion of completing all trials with an accuracy of 
80% for two consecutive sessions. One knockout mouse, which was a significant outlier 
and had not reached criterion after 12 sessions, was excluded from all touchscreen 
analyses. For all remaining mice it took between 4 to 9 sessions to achieve this criteria.   
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Figure 5.7:  Pre-training of miR-210 knockout mice for touchscreen operant conditioning. 
Before visual discrimination and reversal learning tasks mice completed a series of five pre-
training tasks where mice are habituated to the chamber, learn associations between touching 
stimuli and reward delivery, trained to initiate trials and associate punishments with incorrect 
responses. In stage I, Habituation, mice are habituated to the chamber for 30 min and must 
consume a reward delivered at the start of the session. In stage II, Initial Touch, random stimuli 
are presented and touches to stimuli are triple-rewarded, if the stimulus is not touched a single 
reward is delivered after 30 secs. In stage III, Must Touch, stimuli must be touched to receive a 
reward and complete a trial. In stage IV, Must Initiate, mice must initiate the start of each trial by 
magazine entry. For stage V of pre-training, Punish Incorrect, incorrect response to the blank 
screen are discouraged by triggering the house light to turn on and a 5 second time out period 
before a correction trial begins. a. Number of sessions to reach criterion for each stage of pre-
training. b-d. Performance in Punish Incorrect training sessions. b. Average accuracy over two 
sessions. c. Average perservative index. d. Average time to complete session. Error bars 
represent standard error, n = 6 (CTRL), 7 (KO), Two-sample t-test, ** = p <0.01. 
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 After reaching criteria for the visual discrimination task various different parameters 
reflecting cognitive performance were analysed. One aspect of this analysis involved 
quantification of parameter totals as a measure for how quickly and efficiently mice 
reached the criteria for this task. This included the total number of sessions to criterion, 
total number of trials to criterion, total number of correct, incorrect and correction trials to 
criterion as well as the total time to criterion (Fig. 5.8a-f). In all of these parameters there 
was no significant difference between knockout and control groups. There did appear to be 
a trend however for miR-210 knockout mice to be reaching criterion faster with all of these 
parameters slightly reduced in the knockout group. Average performance measures from 
all visual discrimination sessions were also calculated for various parameters, including 
average accuracy and perservative index (Fig. 5.8g,h). Average latency times were also 
quantified for reward collection and trial initiation throughout all sessions. These measures 
indicate the average time taken for the mouse to retrieve a reward following a correct 
response and average time taken by the mouse to initiate a new trial, for all trial initiations 
as well as for post-correct and post-incorrect response trial initiations (Fig. 5.8i-l). In all of 
these average measures there was no difference between knockout and control mice and 
overall performance in visual discrimination appears to be largely undisrupted in miR-210 
knockout mice.  
 
5.3.6 Reversal Learning in miR-210 Knockout Mice 
Immediately after reaching the set criterion for visual discrimination learning, mice were 
individually advanced onto reversal learning where the rewarded CS+ and unrewarded 
CS- stimuli were switched. Reversal learning is widely used as a measure of cognitive 
flexibility and requires subjects to learn to inhibit responses to the previously rewarded CS- 
and relearn the association between the new CS+ and reward. Potential dissociations in 
performance may therefore be expected to occur during the early sessions of reversal 
learning when stimuli are switched just following reaching criterion in visual discrimination. 
Deficits in reversal learning are observed in a number of neurological conditions such as 
obsessive-compulsive disorder, schizophrenia and Parkinson’s disease and there is 
evidence suggesting it involves prefrontal cortical regions as well as serotonin and 
dopamine signalling (Bari et al. 2010; Clatworthy et al. 2009; Ghods-Sharifi et al. 2008; 
Rogers et al. 2000). All mice were tested on the reversal learning task for a set period of 
10 sessions of 30 trials per session to establish a learning curve for each group.  
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 Analysis of percentage correct responses during reversal learning found there was 
no difference in accuracy in knockout and control mice (Fig. 5.9a). There was however a 
significant effect on the perservative index of knockout mice, which is a measure of how 
repeatedly mice responded to the previously rewarded CS- stimuli during correction trials. 
Correction trials occurred following incorrect responses, with the same trial repeated until 
the correct input was given. A significant reduction in perservative index was observed in 
knockout mice in the first reversal session and there was also a significant group effect on 
the perservative index curve of knockout mice (Fig. 5.9b). Also of interest was a large 
reduction in the average session time of knockout mice during early reversal (Fig. 5.9c). 
This reduction in session time suggests a potential increase in motivation in knockout 
mice. To look more definitively at measures of motivation, latencies of various parameters 
across reversal learning sessions were analysed. Response latencies, measuring the time 
that mice took to touch screen after stimuli presentation, appeared to be largely unaltered 
in knockout and control groups. No difference was seen in latency times for incorrect touch 
responses, although a small but significant reduction was seen in knockout mice in correct 
response latency, specifically in early sessions of reversal when control mice showed large 
variation in this parameter (Fig. 5.10a). No differences were observed in the time mice 
took to collect the reward after a correct response, termed reward latency, which was 
similar in both groups throughout all sessions (Fig. 5.10 b).  
 
Figure 5.8:  miR-210 knockout mice performance in the touchscreen visual discrimination task. 
Following pre-training completion, mice performance was tested in the visual discrimination 
(VD) task. Mice were trained to discriminate between two stimuli, a plane and a spider, with one 
stimuli rewarded (CS-) and one stimuli punished (CS-). Responses to CS+ were counted as 
correct responses and responses to the unrewarded CS- were counted as incorrect responses. 
Criterion for completion of the VD task was achieving 80% accuracy or higher in two 
consecutive sessions. a. Number of sessions taken to reach criterion. b. Total number of trials 
to reach criterion. c. Total number of correct responses to criterion. d. Total number of incorrect 
responses to criterion. e. Total number of correction trials to criterion. f. Total time taken to 
reach criterion.  g. Overall accuracy, or percentage of correct responses. h. Overall perservative 
index (PI) or ratio of CTs/Incorrect responses. i. Latency for reward collection. j. Trial initiation 
latency following correct responses. k. Trial initiation latency following incorrect responses. l. 
Overall trial initiation latency. Error bars represent standard error, n = 6 (CTRL), 7 (KO), Two-
sample t-test. 
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 The greatest dissociation between knockout and control groups was observed in 
initiation latency, a measure of time taken to initiate a new trial following the inter-trial 
interval. Average initiation latency for all trials was significantly reduced in the early 
reversal sessions and a significant group effect observed in knockout mice initiation 
latency curve (Fig. 5.10c). Initiation latencies were significantly reduced after both correct 
and incorrect responses with similar differences in initiation latency curves observed for 
both post-correct initiation latency (p <0.0001) and post-incorrect initiation latency (p 
<0.0001). Data from the reversal learning task suggests that miR-210 mice have greater 
cognitive flexibility that potentially supports enhanced motivation to keep responding and 
commence new trials when task requirements are more complex. 
 
5.4 Discussion 
In vivo characterisation of the miR-210 knockout mouse has highlighted a number of 
important behavioural and cognitive processes potentially modulated by miR-210. 
Quantification of mature miR-210 levels in vivo identified patterns of miR-210 expression in 
control mice and confirmed successful deletion of miR-210 within the brain of knockout 
animals. Locomotor behavioural analysis found differences in knockout mice activity and 
touchscreen operant conditioning identified enhanced performance in reversal learning 
with knockout mice exhibiting reduced perservative behaviour and increased motivation for 
trial initiation.  
 
Figure 5.9:  miR-210 knockout mice performance in the reversal learning touchscreen task. 
After reaching criterion for VD each mouse was moved onto reversal learning in the following 
session. This task was the same as VD except the CS+ and CS- stimuli for each mouse were 
switched. Each mouse was tested on the reversal learning task for 10 sessions. a. Acquisition 
curve of reversal learning plotted as percentage accuracy/correct responses over session. b. 
Perservative index (CTs/Incorrect responses) across each session. c. Average session time 
across all sessions. Error bars represent standard error, n = 6 (CTRL), 7 (KO), non-linear 
regression (curve fit comparison), Two-sample t-test (single session comparison) * = p <0.05, ** 
= p <0.01,  *** = p <0.001.  
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 In the open field task, miR-210 knockout mice appeared to have a minor locomotor 
phenotype, being initially less active than controls. Although it is unclear what may cause 
the perceived deficits in this task it is evident that any locomotor differences did not play a 
role in touchscreen performance. Conversely, miR-210 knockout mice were more active 
than controls and completed trials faster in touchscreen tasks and observed improvements 
in reversal learning could not be correlated with locomotor assessment. While miR-210 
knockout mice performed significantly better in some parameters of reversal learning, 
including preservation and trial initiation, other parameters such as accuracy were 
unaffected indicating that miR-210 has specific roles in this cognitive task, possibly related 
to network or cell specific functions. 
  The data presented here represents the first behavioural characterisation of a miR-
210 knockout mouse and the first study that has used the touchscreen operant 
conditioning technology for cognitive testing of a microRNA knockout mouse. It is 
important to note that this was a preliminary study and the cohort sizes used here were 
relatively small, in particular for maze-based tasks which are subject to high variation and 
may require larger numbers to draw more definitive conclusions from the data. Due to 
limitations in the availability of touchscreens and the requirement for male and female mice 
to be tested separately in dedicated operant chambers, only male mice were behaviourally 
assessed in this study. While there is no evidence to suggest a gender-specific role of 
miR-210, characterisation of female knockout mice would be required to confirm if these 
same phenotypes are observed in both males and females. As mentioned, decreased 
body weight was also observed in miR-210 knockouts, likely due to the presence of the 
Nestin-cre transgene in these mice. Nestin-cre mice have been found to have mild 
hypopituitarism leading to decreased levels of growth hormone and reduced weight, which 
has been attributed to expression of the human growth hormone minigene, inserted 
Figure 5.10:  Latencies of miR-210 knockout mice during the reversal learning touchscreen 
task. Various latency measured were analysed for the reversal learning task, which indicates 
the time delay for various touchscreen behaviours. a. Touch latency for mouse selection of CS+ 
over each session. b. Latency for reward collection following correct responses. c. Overall 
latency for initiating trials following the inter-trial interval. Error bars represent standard error, n 
= 6 (CTRL), 7 (KO), non-linear regression (curve fit comparison), Two-sample t-test (single 
session comparison) * = p <0.05, ** = p <0.01,  *** = p <0.001.   
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downstream of Cre to enhance expression, in the hypothalamus (Declercq et al. 2015). 
Behavioural analyses of Nestin-cre mice has found the transgene does not effect mice 
locomotor ability, exploratory activity, learning and memory, sociability, startle response or 
sensorimotor gating in mice, however a significant affect of the Nestin-cre transgene was 
identified in contextual and cued fear-conditioning (Giusti et al. 2014). While these 
behaviours were not characterised here, Nestin-cre mice, which do not carry the miR-210 
floxed allele, would be an important control to include in further characterisation of the 
miR-210 knockout line to confirm whether observed effects are due solely to miR-210 
deletion.         
 From quantification of miR-210 within the mouse brain, mature miR-210 expression 
was significantly higher within the hippocampus compared to other brain regions. This 
expression is consistent with previous studies associating miR-210 dysregulation with both 
temporal lobe epilepsy and Alzheimer’s disease which both effect this region. This is also 
consistent with activity-related expression, with the hippocampus being one of the main 
brain regions involved in memory processing. Given evidence that miR-210 is modulated 
by neuronal activity, expression quantification following various cognitive or behavioural 
testing may provide further functional insight as mice used here for expression analyses 
were subject to standard animal housing and limited stimulation. Further expression 
analyses using staining techniques in tissue slices could also identify more specific areas 
of expression or cell-type specific expression.  
  Although only visual discrimination and reversal learning touchscreen tasks were 
utilised in this study, these tasks make up part of a larger battery of tests that can be 
performed using the touchscreen operant chambers (Horner et al. 2013; Mar et al. 2013; 
Oomen et al. 2013; Talpos et al. 2010). This battery includes tasks for assessing various 
different components of learning, long-term memory, working memory and executive 
function such as attention, paired-associate learning and extinction tasks. Visual 
discrimination and reversal learning were used for preliminary behavioural assessment as 
relatively easy tasks that can be completed in 20-30 days. To comprehensively 
characterise mice behaviour however and develop a complete cognitive profile of a genetic 
strain it is recommended to test mice on all tasks in the touchscreen battery, which was 
not completed here due to limitations on time. The spider and plane stimuli that were used 
in these tasks are also relatively easy to discriminate and the difficulty of this task can be 
increased by the use of more visually complex stimuli or two stimuli with greater similarity. 
Increasing the difficulty of this task may help to dissociate more subtle differences in visual 
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discrimination learning that may not be detected with easier stimuli (Horner et al. 2013). 
This may be the case for miR-210 knockout mice, which showed a trend for reaching 
criterion faster than controls in visual discrimination. 
 As this study has looked at cognitive performance in adult mice with a primary focus 
on neuronal plasticity within the developed brain it is important to consider the potential 
developmental effects of miR-210 neuronal knockout, particularly in early neurogenesis 
and stem cell differentiation. As Nestin is expressed during early neurogenesis there is 
potential for miR-210 deletion to effect neuronal progenitor proliferation during 
development. Evidence that miR-210 overexpression regulates neurogenesis in the adult 
mouse brain, suggests the endogenous miR-210 knockout may also effect adult stem cell 
population, which could impact on cognitive function. Although there is evidence that 
nestin-cre recombination is minimal in early stages of neurogenesis and sufficient deletion 
occurs only in early postnatal stages, further research is required to discriminate whether 
behavioural phenotypes are a consequence of disrupted neuronal development, altered 
regulation of adult stem cell proliferation and/or plastic changes in terminally differentiated 
neurons (Liang et al. 2012). This discrimination could be detected through developmental 
analyses of miR-210 knockout mice or through the use of different conditional or inducible 
Cre lines. Given the association of miR-210 downregulation in Alzheimer’s disease and 
also the identification of neurodegenerative diseases enriched among miR-210 pull-down 
targets, testing of young adult mice and re-testing of aged mice may also provide insight 
into the potential role of miR-210 in aging and age-related neurodegenerative disorders. 
 Observed differences in miR-210 knockout mice reversal learning support a 
conserved role for miR-210 in learning and memory of more complex mammalian models 
and identifying discrete cognitive processes affected in miR-210 knockout mice provides 
insight into endogenous miR-210 functionally. Further molecular and behavioural profiling 
of these mice may establish specific disrupted mechanisms that are potentially relevant to 
cognitive dysfunction in neurological disorders where miR-210 expression is altered.  
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6.1 Thesis Summary 
Deciphering the complexities of gene regulation during neuronal plasticity is critical to 
understanding the molecular processes driving cognition and how these processes are 
disrupted in neurological disorders. While miRNA regulation is an important aspect of this, 
elucidating specific roles of miRNAs in neuronal plasticity presents a number of difficulties. 
Mechanisms of miRNA targeting generate diverse potential in genes and pathways that 
can be regulated and the possibility of synergistic or antagonistic co-regulation of targets 
through other miRNAs or regulatory factors confounds predicted miRNA function. In this 
project, a comprehensive experimental approach has been used to explore the neuronal 
function of hypoxia-regulated miR-210, from molecular targeting analyses to cellular and 
behavioural phenotyping (Fig. 6.1).  
 A number of novel neuronal miR-210 target genes and pathways were identified 
using RNAseq analysis of miR-210 pull-down targets. This included a number of genes 
previously found to be dysregulated in vivo during long-term consolidation and/or with an 
established role in neuronal plasticity as well as a significant enrichment of 
neurodegenerative diseases; Huntington’s, Alzheimer’s and Parkinson’s disease (Fig. 
6.1a). The majority of identified were also successfully validated as regulated by miR-210 
using dual-luciferase assays, including targets associated with cancer and MAPK/VEGF 
signalling (MAPK2K2, VEGFB, EIF4EBP1), genes involved in neuronal plasticity (GRINA, 
AP2S1, TMUB1, ATP6V0C, ACTB) and genes associated with neurodegenerative disease 
that converge on oxidative metabolism pathways (ATP5G2, ATP5D, COX8A, COX6A1, 
NDUFS7, NDUFS8, NDUFA4L2, CYC1, APOE).  
 In vitro experiments in both human neuronal-like cells and mouse primary 
hippocampal neuron models found functional effects of miR-210 modulation consistent 
with regulation of identified metabolic targets as well as morphological effects supporting 
involvement in plastic neuronal processes. Overexpression of miR-210 in differentiated 
SH-SY5Y cells resulted in a substantial decrease in oxidative metabolism, while in primary 
mouse neurons both oxidative phosphorylation and ROS production were significantly 
higher following hypoxic exposure in miR-210 knockout cultures compared to littermate 
controls. Quantitative morphological comparison also found increased dendritic density 
and branching of miR-210 knockout neurons (Fig. 6.1b) and preliminary electrophysiology 
of cultured neurons suggested knockout neurons exhibit differences in electrical activity. 
Expression and induction of miR-210 in primary neurons in vitro also indicates activity-
regulated expression of miR-210 that may be relevant in vivo to cognitive processing of 
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sensory input, with mature miR-210 localised throughout neuronal somas, dendrites and 
synaptic structures and induction of miR-210 observed following neuronal activation in 
wild-type primary mouse hippocampal neurons. 
 
 
 
 
 
 Expression analyses and preliminary behavioural and cognitive characterisation 
was also carried out in vivo using the conditional neuronal knockout mouse model. 
Quantification of mature miRNA levels across various brain regions in control mice 
identified miR-210 expression in vivo to be consistent with activity-modulated induction, 
being substantially increased within the hippocampus. For phenotyping of knockouts and 
littermate controls, adult male mice were tested on a series of locomotor and behavioural 
tasks, utilising traditional, motor and maze-based testing methods. These results found 
Figure 6.1:  Summary of hypothesised role of miR-210 in neuronal plasticity. a. Neuronal 
activation induces miR-210 through HIF-1α induction and miR-210 targets a number of 
functional pathways including oxidative metabolism and MAPK/VEGF signalling as well as 
genes involved in synaptic plasticity. b. Knockout of miR-210 leads to increased oxidative 
phosphorylation, ROS and dendritic complexity at the cellular level and increased cognitive 
flexibility in reversal learning in a behavioural model. 
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slightly altered locomotor behaviour in miR-210 knockout mice but no effect on basic motor 
co-ordination. In short-term memory and visual discrimination tests no significant 
differences between knockout and control mice were detected however a trend was 
observed for miR-210 knockout mice to be performing slightly better in these tasks. 
Knockout mice, also displayed significantly enhanced cognitive flexibility in the reversal 
learning task, exhibiting reduced perservative behaviour and increased motivation for trial 
initiation. Improvements in certain aspects of cognition detected reveal miR-210 may have 
an important role in learning and memory. 
 
6.2 Neurodegeneration and Experience Dependent Cognitive Decline 
6.2.1 miR-210 and HIF-1 in Neurodegenerative Disease 
Previously, three separate studies have identified a significant downregulation of miR-210 
in Alzheimer’s disease (AD) patients at both late and early stages of AD as well as in 
sufferers of mild cognitive impairment (Cogswell et al. 2008; Hebert et al. 2008; Zhu et al. 
2015). Identification of an enrichment of neurodegenerative pathways among miR-210 
targets is therefore of interest and potentially significant to AD pathology. Metabolic 
dysfunction is a consistent, common feature among the neurodegenerative diseases 
identified, and this was reflected in pull-down targets annotated to these disorders, the 
majority of which were oxidative metabolism related (Silverman et al. 2001; Tabrizi et al. 
2000; Zhou et al. 2008). As miR-210 has been associated previously with effecting 
metabolism through functional assays and found to target iron-sulphur clustering proteins, 
it may seem implicit that a miRNA targeting metabolism will identify targets associated with 
neurodegeneration (Chan et al. 2009; Hale et al. 2014). While this may be true, here, a 
number of novel miR-210 oxidative metabolism targets were identified that make up 
subunits of multiple electron transport chain complexes. KEGG pathway annotation of 
diseases used for ontology analysis is also based on experimental evidence from 
published literature (Kanehisa et al. 2016). Consequently, identification of targets 
annotated to neurodegenerative disease provides direct molecular links to genes affected 
in disease, mostly oxidative metabolism genes but also other pull-down targets such as 
the AD risk allele APOE. Taken together with evidence from patient miRNA expression, 
identification of miR-210 targets associated with AD suggests that miR-210 
downregulation may not just be ancillary to disease but may also have a functional effect. 
Both deficits in oxidative phosphorylation and increased oxidative stress in the brain are 
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hallmarks of neurodegeneration and metabolic dysfunction is known to occur early in 
disease progression, preceding cognitive decline (Du et al. 2010; Wirths et al. 2001). 
Given that miR-210 was found to target a number of oxidative phosphorylation genes and 
loss of miR-210 increased oxidative metabolism and ROS in cultured neurons, it seems 
feasible that dysregulation of miR-210 may exacerbate oxidative stress and metabolic 
dysfunction in the AD brain.  
 Downregulated expression of the hypoxia-regulated miR-210 in AD may seem 
counter-intuitive given that vascular dysfunction and hypoperfusion of the brain are major 
features of AD as well as significant risk factors for developing dementia (Arvanitakis et al. 
2016; Kumar-Singh et al. 2005; Shibata et al. 2000; Walsh et al. 2002; Wang et al. 2010b). 
Accumulation of HIF-1α, however, has been found to be attenuated in ischemic tissues 
with age. This reduction of HIF-1α occurs through increased protein degradation by 
increased hydroxylation of HIF-1α and is associated with reduced levels of VEGF and 
angiogenesis in aging tissues (Chang et al. 2007; Rivard et al. 2000; Rohrbach et al. 
2005). HIF-1α appears to be further reduced in the AD brain with levels significantly 
decreased in patients compared to age-matched controls (Liu et al. 2008b). The effect of 
hypoxia within the AD brain is also thought to be amplified by Aβ causing impairments to 
cerebral blood flow contributing to a feed-forward loop of disease progression (Niwa et al. 
2002). While this may suggest a neuroprotective effect of HIF-1α, which is diminished in 
AD, the role of HIF-1α is confounded by evidence that it may accelerate AD pathology. 
HIF-1α has been found to increase Aβ production through inducing BACE1, which 
promotes cleavage of APP to Aβ (Sun et al. 2006; Zhang et al. 2007b). The apoptotic 
protien BNIP3 is also induced by HIF-1α and knockdown of HIF-1α leads to reduced 
BNIP3 and reduced neuronal cell death induced by Aβ (Zhang et al. 2007a). Further 
research is evidently needed to elucidate the role of HIF-1α and its regulatory targets in 
AD and whether or not it is neuroprotective. This may likely be dependent on the disease 
stage, progression of neurodegeneration and whether the brain has been exposed to 
prolonged hypoxia. The reduction of HIF-1α and its targets such as VEGF and miR-210 
within the AD brain, despite hypoperfusion, suggests that induction of HIF-1α in response 
to hypoxia is inhibited. The role of increased oxidative stress in the AD brain may be 
significant in this occurrence as ROS also promotes degradation of HIF-1α (Niecknig et al. 
2012; Schafer & Buettner 2001). The involvement of numerous interrelated risk factors and 
pathological components in AD that feedback to each other makes it difficult to determine 
a definitive cause or trigger. However, as metabolic dysfunction occurs early in disease 
progression, targeting of metabolic regulators and metabolically regulated genes, such as 
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HIF-1α and its targets may be an important therapeutic approach for AD and related 
neurodegenerative disorders.  
 
6.2.2 Experience Dependent Neurodegeneration 
Identification and characterisation of genes regulated by neuronal stimulation is also of 
interest to the ‘use it or lose it’ nature of neurodegenerative disorders. For many years, 
environmental enrichment in animal models has been known to enhance cognitive 
performance and neurogenesis in the brain (Kempermann et al. 1998; Wainwright et al. 
1993). Substantial epidemiological data has also identified a number of factors, which 
decrease the risk of cognitive decline in human populations such as higher education, 
maintaining a demanding occupation, and physical activity (Friedland et al. 2001; Mortimer 
1997; Schmand et al. 1997; Stern et al. 1995; Stern et al. 1994). This evidence has lead to 
the theory of cognitive reserve, whereby a lifestyle incorporating increased neuronal 
activity and stimulation creates a neuroprotective cognitive reverse, reducing the risk of 
developing dementia. More recently it was found that environmental enrichment can delay 
the onset of motor deficits and prevent loss of cerebral volume in a mouse model of 
Huntington’s disease (Van Dellen et al. 2000). This highlighted the significant potential of 
environmental enrichment as a therapeutic for neurodegenerative disorders in a disease 
that was once thought to be purely genetic. Since then, environmental enrichment has also 
been found to enhance cognitive performance in mouse models of AD and confer 
resistance to induced Parkinsonism in mice (Arendash et al. 2004; Bezard et al. 2003; 
Faherty et al. 2005; Jankowsky et al. 2005). Aside from neurodegenerative diseases, 
environmental enrichment has positive effects on other brain traumas and neuropsychiatric 
disorders and has been used to prevent motor seizures and reduce apoptosis in epilepsy 
models, increase motor skills following ischemic stroke, and ameliorate behavioural 
impairments in a schizophrenia model (Burrows et al. 2015; Johansson 1996; Johansson 
& Ohlsson 1996; Manno et al. 2011; Young et al. 1999).  
 Comparable to environmental enrichment, similar enhancements of cognitive 
function are observed by increased exercise in animal models (Fordyce & Farrar 1991; 
Fordyce & Wehner 1993; Van Praag et al. 1999). In humans, clinical data from exercise 
studies has generated mixed results with measurable effects on cognition not consistently 
observed, potentially due to variable trial conditions. In some studies trials, however, 
exercise has been found to improve executive function in both healthy adults and adults 
with mild cognitive impairment (Baker et al. 2010; Smith et al. 2010). The observed 
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benefits of exercise on cognitive function and reducing AD risk have been attributed to 
increased cerebral blood flow and reduced risk of cerebrovascular disease (Hiura et al. 
2014; Sato et al. 2011). Various other changes, however, in metabolite supply and 
consumption also occur within the brain during exercise and exercise recovery including 
oxygen, glucose, lactate and glycogen substrates (Ide et al. 2000; Matsui et al. 2012; 
Matsui et al. 2015).  
 As discussed previously, neuronal metabolism is under complex regulation by 
activity-sensitive mechanisms (Pellerin & Magistretti 1994, 1997). HIF-1α is also involved 
in these regulatory pathways, which, at least in some circumstances, is induced following 
activity, possibly through elevated oxidative metabolism depleting neuronal oxygen levels 
(Hunsberger et al. 2005; Rampon et al. 2000). As hypoxia is linked to neural activity as 
well as exercise and neurodegeneration, it is likely that HIF-1α is a critical aspect of 
cognitive reserve. Neuronal activity as well as environmental enrichment and physical 
exercise may act through HIF-1α induction as forms of hypoxic pre-conditioning within the 
brain. In this way, physiological hypoxia, occurring during normal activity, may increase 
brain resistance to future, more severe hypoxic insults such as age-related vascular 
dysfunction, a common risk factor for dementia. Significant effects of miR-210 knockout on 
neuronal and cognitive function observed in this study as well as detected miR-210 
expression and induction are consistent with this rationale and with activity-induced HIF-1α 
and miR-210 upregulation in neurons. Understanding oxygen metabolism and associated 
gene regulatory pathways may therefore be important in understanding the mechanisms of 
cognitive reserve and the benefits of environmental enrichment and physical exercise on 
neurodegenerative risk.  
 
6.3 Hypoxia Resistant Neurocircuitry 
6.3.1 Inhibitory Interneurons  
While hypoxia is well established as both a casual and non-casual feature in various 
neurological conditions and disorders, there is also evidence hypoxia may act as a 
regulatory factor in normal cognitive function. A potential indication of this regulatory 
function may be the contrasting sensitivities of neuronal subtypes to hypoxia. Within the 
brain, pyramidal excitatory projection neurons are most sensitive to hypoxia-induced cell 
death while inhibitory interneurons are most resistant to hypoxic conditions (Frahm et al. 
2004; Fryd Johansen et al. 1983; Katchanov et al. 2003). Consistent with a 
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neuroprotective role, expression of HIF-1α is induced in interneurons but not pyramidal 
neurons following ischemia (Ramamoorthy & Shi 2014). One subset of GABAergic, 
parvalbumin (PV) expressing interneurons provides inhibitory control over excitatory, 
neural circuits through synchronous fast-spiking activity, which generate gamma 
oscillations (Cobb et al. 1995; Gupta et al. 2000; Miles et al. 1996; Sohal et al. 2009). 
Interneurons and gamma oscillations are generally thought to be involved in excitatory 
control of cognitive processing and, in mouse models, have been shown to enhance signal 
transmission in the neocortex and control sensory input into the barrel cortex and spatial 
working memory in the hippocampus (Cardin et al. 2009; Korotkova et al. 2010; Murray et 
al. 2011; Sohal et al. 2009). Loss of dopamine interneuron modulation in the prefrontal 
cortex has also been found to impair cognitive flexibility in reversal learning in rats and, in 
humans, hippocampal GABAergic interneurons are involved in the suppression of 
unwanted thoughts (Gruber et al. 2010; Schmitz et al. 2017).  
 
6.3.2 Interneuronal Function in Neurological Disorders 
Understanding interneuron function is of interest to both neurodegenerative and 
neuropsychiatric disorders, in particular, schizophrenia where PV GABAergic interneurons 
are selectively damaged (Zhang & Reynolds 2002). Although psychosis symptoms may be 
the most perceptible in Schizophrenia, cognitive dysfunction is a core component of the 
disease that appears many years before psychosis and is a predictor of poorer patient 
outcome (Green 2006; Reichenberg et al. 2010). Consistent with a deficiency in 
interneuronal signaling, GABA-mediated inhibition and gamma oscillations are diminished 
in Schizophrenia (Cho et al. 2006; Lodge et al. 2009). In sufferers of schizophrenia, deficits 
are also observed in various cognitive processes requiring inhibitory control including 
extinction, reversal learning, paired-associated learning and attentional control (Barnett et 
al. 2005; Fuller et al. 2006; Holt et al. 2009; Leeson et al. 2009; Maruff et al. 1996; Waltz & 
Gold 2007).   
 Aside from schizophrenia, interneuron circuitry is linked to various other neuronal 
conditions. In a model of Parkinson’s disease, characterized by dopaminergic neuronal 
degeneration in the striatum, feed forward inhibition by GABAergic interneurons 
exacerbated imbalances of striatal projection neuron firing (Mallet et al. 2006). Deficits in 
the interneuron-specific voltage-gated sodium channel, Nav1.1 are also observed in 
mouse models of AD and restoration of Nav1.1 improves gamma synchrony and memory 
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deficits in these mice (Verret et al. 2012). Decreased striatal PV interneurons were also 
observed in a model of obsessive-compulsive disorder associated with deficits in 
behavioral response inhibition and defective down-regulation of striatal projection neuron 
activity (Burguiere et al. 2013). In agreement with disease observations, targeted ablation 
or inhibition of PV interneurons leads to development of compulsive behaviours and 
hyperkinetic motor dysfunction in mice (Gittis et al. 2011; Xu et al. 2015). Both inactivity 
and loss of interneurons associated with reductions in inhibition are also linked to epilepsy 
syndrome (Bekenstein & Lothman 1993; Dinocourt et al. 2003; Sayin et al. 2003). Based 
on the hypoxic-resistance and HIF-1α expression of inhibitory interneurons as well as their 
established cognitive role, the observed improvements in reversal learning following miR-
210 deletion may relate to a functional role of HIF-1α upregulation in inhibitory 
interneurons. These cognitive processes affected in miR-210 knockout mice also align with 
circuitry affected in epilepsy, where miR-210 is overexpressed. Taken together these data 
implicate a role for miR-210 in inhibitory control of reversal learning. Cellular analyses 
indicated that miR-210 knockout results in increased oxidative metabolism and dendritic 
complexity of neurons in vitro. In vivo, this may translate into increased connectivity and/or 
activity of hypoxia-resistant interneuron circuitry where miR-210 is likely active in controls 
and therefore increases inhibition of learned associations and repetitive behaviours. In vivo 
expression analysis of miR-210 within PV interneurons under both normal and hypoxic 
conditions could provide insight into this hypothesis which could be tested through 
behavioural profiling of mice with targeted deletion of miR-210 from PV interneurons, to 
determine if the same effects on cognitive flexibility are observed. 
 
6.4 Translational Potential of miR-210  
6.4.1 microRNA Function as a Therapeutic Target  
Since the discovery of miRNA targeting as a novel RNA interference pathway and the 
development of tools for miRNA inhibition and overexpression, a number of miRNA-
targeting clinical trials have been initiated. The first of this kind was for an anti-sense oligo 
drug targeting miR-122 inhibition as a treatment for hepatitis C viral infection (Janssen et 
al. 2013). miR-122 has a unique function, modulating hepatitis C viral RNA replication 
through a binding site in it’s 5’UTR (Jopling et al. 2005). It also offers a number of 
advantages for clinical translation such as high conservation of miR-122 from zebrafish to 
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humans, making it amenable to pre-clinical trials in a number of different species. 
Additionally, restricted localisation of the liver specific miR-122 makes it an easy target for 
anti-sense oligos as they are found to accumulate in the liver and kidneys following 
subcutaneous injection (Elmen et al. 2008; Geary et al. 2009; Lagos-Quintana et al. 2002). 
A modified anti-sense oligo against miR-122 with a phosphatidylserine backbone and 3’ 
and 5’ LNA modifications was designed and optimised through a series of pre-clinical trials 
and, at present, has completed phase-IIa clinical trials with positive outcomes (Janssen et 
al. 2013).  
 Currently a number of other phase-I trials have been initiated or completed using 
miRNAs as interventions for various diseases including a miR-155 agonist for a sub-type 
of cutaneous T-cell lymphoma and a mimic of miR-29b for fibrosis (Montgomery et al. 
2014; Thai et al. 2007; Zhu et al. 2016). So far, one phase-I trial investigating miR-34 
mimic as a treatment for various cancer forms, was terminated due to immune-related 
serious adverse effects in 5 participants, highlighting the potential dangers of miRNA 
targeting as a therapeutic approach (Beg et al. 2017). Within the nervous system no 
clinical trials using miRNA inhibitors or mimics have started, although preclinical data for 
an anti-sense oligo to miR-10b has produced promising results as a glioblastoma 
treatment (Teplyuk et al. 2016). An early phase-I clinical trial is also currently ongoing for 
the use of the drug Gemfibrozol in AD, which has been found to induce miR-107, a miRNA 
reduced in AD that downregulates BACE1 (Nelson & Wang 2010; Wang et al. 2008b).  
 
6.4.2 miR-210 and Clinical Translation  
The pre-clinical benefits of miR-210 have already been demonstrated in mouse models of 
stroke where lentiviral overexpression of miR-210 improved stroke recovery (Zeng et al. 
2016). Additionally, a small molecule drug named Targapremir-210 has been designed to 
selectively bind to the Dicer site in pre-miR-210 and reduce mature miR-210 levels through 
inhibiting Dicer processing (Velagapudi et al. 2014). Reduction of miR-210 by 
TargapremiR-210 increases the miR-210 target, GPD1L, and decreases HIF-1α, triggering 
apoptosis of hypoxic cells. In a mouse xenograft model of human triple negative breast 
cancer tumours, intraperitoneal injection of TargapremiR-210 substantially reduced the 
growth of hypoxic tumours in mice (Costales et al. 2017). This study provides promise for 
future drug development and pre-clinical trials of TargapremiR-210 or other miR-210 
inhibitors not just for triple negative breast cancer but potentially various tumour forms that 
share a similar hypoxic microenvironment.  
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 In terms of clinical translation, however, miRNA targeting as a therapeutic presents 
a number of challenges including the potential for non-specific and off-targeting effects as 
well as tissue specific targeting and delivery. Targeting to the brain is likely to be especially 
difficult as with and other types of brain-targeted therapeutics in the requirement to cross 
the blood brain barrier. While accumulation of anti-sense oligos in the liver and kidneys 
may be of benefit in some circumstances, this issue needs to be overcome for directing to 
other organs, potentially through the use of conjugated targeting molecules, such as 
cholesterol, used previously for antagomiR delivery in the honeybee brain (Cristino et al. 
2014b). Although not directly translatable to humans studies as the majority of our brain 
cholesterol is locally synthesised, a similar approach could utilise 27-hydroxycholesterol, 
for example, an oxysterol which has a net flux from the circulation into the brain (Heverin 
et al. 2005). The large number of miR-210 targets and diversity of pathways identified here 
also limits the likelihood of targeting specific genes or pathways and suggests a high 
possibility of non-specific effects.   
 Apart from functional targeting of miR-210 in disease, the diagnostic potential of 
miR-210 as a circulating biomarker is being explored in both cancer and preeclampsia 
(Anton et al. 2013; Lai et al. 2015; Yang et al. 2015). Given that miR-210 overexpression is 
detected in various cancers it’s usefulness as a singular biomarker may be limited, the 
development of panel miRNA expression arrays however may have diagnostic potential in 
detecting disease-specific miRNA signatures (Wang et al. 2017a). Currently, elucidating 
the function of miR-210 provides valuable insight into specific mechanisms that may prove 
targeting of miR-210 to be translatable to disease therapeutics or diagnostics in future. 
Within the brain, the greatest therapeutic insight from understanding the function of 
hypoxia and hypoxia-regulated genes may be in understanding how environmental 
manipulation can be exploited for preventative or interventional benefits in disease.     
 
6.5 Conclusions and Future Directions 
This project has made significant contributions towards understanding the role of the 
hypoxia-regulated miR-210 in neuronal function, building on previous evidence of miR-210 
involvement in neuronal plasticity, including dysregulation in AD and epilepsy as well as 
modulation of long-term recall following knockdown in the honeybee. Using a human 
neuronal model, targeting of miR-210 was identified by a global transcriptome approach 
and a number of novel pathways and gene targets of miR-210 were identified. Various 
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genes of interest were also validated as miR-210 targets including key plasticity related 
genes as well as neurodegeneration-associated oxidative metabolism genes. In vitro, 
correlative cellular changes were observed in primary neuronal cultures and activation 
experiments supported activity-dependent induction of miR-210 in neurons. Preliminary 
behavioural characterisation also detected enhanced cognitive flexibility during reversal 
learning, potentially related to altered inhibitory control, in a miR-210 knockout mouse line. 
This data supports a conserved role for miR-210 in learning and memory, and highlights 
important functional processes of miR-210. Characterising the mechanisms controlling 
metabolic changes during neuronal activity is a crucial aspect of understanding the 
translation of sensory input in the brain and how the nervous system may take advantage 
of innately occurring metabolic changes to drive plasticity through hypoxia and oxygen 
sensitive gene regulation.  
 Uncovering mechanisms of plasticity regulation is essential not only for 
understanding normal neuronal function but also for elucidating the molecular basis of 
neurological disorders. Although beyond the scope of this study, given the enrichment of 
age-related neurodegenerative disorders among miR-210 targets, longitudinal studies 
involving cognitive profiling of aged mice may provide insight into the potential functional 
role of miR-210 in these disorders. Further research using inducible or neuronal sub-type 
specific knockout systems may also contribute to distinguishing the role of miR-210 within 
the adult brain, from potential developmental effects as well as functionality in mature 
neurons compared to glial or stem cells. Establishing specific neurocircuitry where miR-
210 may be active could also be relevant to possible roles in disease. As many 
neurological disorders currently have unknown or complex etiology, the development of 
precision diagnostics and personalised medicine is especially critical to advancing 
therapeutics for neurophysiology. The development of biological regulatory molecules as 
therapeutics represents a key aspect of this field and experimental characterisation of 
neuronal miRNA targeting and function provides significant framework for future 
advancements in the diagnosis and treatment of neurological disorders.  
 
  
 
 
 
 
 
 
 
 
REFERENCES 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   134 
Abdullah, AI, Zhang, H, Nie, Y, Tang, W & Sun, T 2016, 'CDK7 and miR-210 Co-regulate 
Cell-Cycle Progression of Neural Progenitors in the Developing Neocortex', Stem Cell 
Reports, vol. 7, pp. 69-79. 
Abramov, AY & Duchen, MR 2008, 'Mechanisms underlying the loss of mitochondrial 
membrane potential in glutamate excitotoxicity', Biochim Biophys Acta, vol. 1777, pp. 953-
964. 
Adamcio, B, Sperling, S, Hagemeyer, N, Walkinshaw, G & Ehrenreich, H 2010, 'Hypoxia 
inducible factor stabilization leads to lasting improvement of hippocampal memory in 
healthy mice', Behav Brain Res, vol. 208, pp. 80-84. 
Aimo, L, Cherr, GN & Oteiza, PI 2010, 'Low extracellular zinc increases neuronal oxidant 
production through nadph oxidase and nitric oxide synthase activation', Free Radic Biol 
Med, vol. 48, pp. 1577-1587. 
Alaux, C, Sinha, S, Hasadsri, L, Hunt, GJ, Guzman-Novoa, E, DeGrandi-Hoffman, G, . . . 
Robinson, GE 2009, 'Honey bee aggression supports a link between gene regulation and 
behavioral evolution', Proc Natl Acad Sci U S A, vol. 106, pp. 15400-15405. 
Alexe, G, Fuku, N, Bilal, E, Ueno, H, Nishigaki, Y, Fujita, Y, . . . Tanaka, M 2007, 
'Enrichment of longevity phenotype in mtDNA haplogroups D4b2b, D4a, and D5 in the 
Japanese population', Hum Genet, vol. 121, pp. 347-356. 
Anders, S, Pyl, PT & Huber, W 2015, 'HTSeq--a Python framework to work with high-
throughput sequencing data', Bioinformatics, vol. 31, pp. 166-169. 
Anton, L, Olarerin-George, AO, Schwartz, N, Srinivas, S, Bastek, J, Hogenesch, JB & 
Elovitz, MA 2013, 'miR-210 inhibits trophoblast invasion and is a serum biomarker for 
preeclampsia', Am J Pathol, vol. 183, pp. 1437-1445. 
Appleby, VJ, Correa, SA, Duckworth, JK, Nash, JE, Noel, J, Fitzjohn, SM, . . . Molnar, E 
2011, 'LTP in hippocampal neurons is associated with a CaMKII-mediated increase in 
GluA1 surface expression', J Neurochem, vol. 116, pp. 530-543. 
Archer, SL, Huang, JM, Hampl, V, Nelson, DP, Shultz, PJ & Weir, EK 1994, 'Nitric oxide 
and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by 
cGMP-dependent protein kinase', Proc Natl Acad Sci U S A, vol. 91, pp. 7583-7587. 
Arendash, GW, Garcia, MF, Costa, DA, Cracchiolo, JR, Wefes, IM & Potter, H 2004, 
'Environmental enrichment improves cognition in aged Alzheimer's transgenic mice 
despite stable beta-amyloid deposition', Neuroreport, vol. 15, pp. 1751-1754. 
Arvanitakis, Z, Capuano, AW, Leurgans, SE, Bennett, DA & Schneider, JA 2016, 'Relation 
of cerebral vessel disease to Alzheimer's disease dementia and cognitive function in 
elderly people: a cross-sectional study', Lancet Neurol, vol. 15, pp. 934-943. 
Arvidsson, A, Collin, T, Kirik, D, Kokaia, Z & Lindvall, O 2002, 'Neuronal replacement from 
endogenous precursors in the adult brain after stroke', Nat Med, vol. 8, pp. 963-970. 
Ashraf, SI, McLoon, AL, Sclarsic, SM & Kunes, S 2006, 'Synaptic protein synthesis 
associated with memory is regulated by the RISC pathway in Drosophila', Cell, vol. 124, 
pp. 191-205. 
Attwell, D & Laughlin, SB 2001, 'An energy budget for signaling in the grey matter of the 
brain', J Cereb Blood Flow Metab, vol. 21, pp. 1133-1145. 
Ayton, S, Faux, NG, Bush, AI & Alzheimer's Disease Neuroimaging, I 2015, 'Ferritin levels 
in the cerebrospinal fluid predict Alzheimer's disease outcomes and are regulated by 
APOE', Nat Commun, vol. 6. 
   135 
Baek, D, Villen, J, Shin, C, Camargo, FD, Gygi, SP & Bartel, DP 2008, 'The impact of 
microRNAs on protein output', Nature, vol. 455, pp. 64-71. 
Bagga, S, Bracht, J, Hunter, S, Massirer, K, Holtz, J, Eachus, R & Pasquinelli, AE 2005, 
'Regulation by let-7 and lin-4 miRNAs results in target mRNA degradation', Cell, vol. 122, 
pp. 553-563. 
Baker, LD, Frank, LL, Foster-Schubert, K, Green, PS, Wilkinson, CW, McTiernan, A, . . . 
Craft, S 2010, 'Effects of aerobic exercise on mild cognitive impairment: a controlled trial', 
Arch Neurol, vol. 67, pp. 71-79. 
Baker, TL & Mitchell, GS 2000, 'Episodic but not continuous hypoxia elicits long-term 
facilitation of phrenic motor output in rats', J Physiol, vol. 529 Pt 1, pp. 215-219. 
Baldeiras, I, Santana, I, Proenca, MT, Garrucho, MH, Pascoal, R, Rodrigues, A, . . . 
Oliveira, CR 2008, 'Peripheral oxidative damage in mild cognitive impairment and mild 
Alzheimer's disease', J Alzheimers Dis, vol. 15, pp. 117-128. 
Banker, GA & Cowan, WM 1977, 'Rat hippocampal neurons in dispersed cell culture', 
Brain Res, vol. 126, pp. 397-342. 
Bari, A, Theobald, DE, Caprioli, D, Mar, AC, Aidoo-Micah, A, Dalley, JW & Robbins, TW 
2010, 'Serotonin modulates sensitivity to reward and negative feedback in a probabilistic 
reversal learning task in rats', Neuropsychopharmacology, vol. 35, pp. 1290-1301. 
Barnett, JH, Sahakian, BJ, Werners, U, Hill, KE, Brazil, R, Gallagher, O, . . . Jones, PB 
2005, 'Visuospatial learning and executive function are independently impaired in first-
episode psychosis', Psychol Med, vol. 35, pp. 1031-1041. 
Bartzokis, G, Sultzer, D, Cummings, J, Holt, LE, Hance, DB, Henderson, VW & Mintz, J 
2000, 'In vivo evaluation of brain iron in Alzheimer disease using magnetic resonance 
imaging', Arch Gen Psychiatry, vol. 57, pp. 47-53. 
Beg, MS, Brenner, AJ, Sachdev, J, Borad, M, Kang, YK, Stoudemire, J, . . . Hong, DS 
2017, 'Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in 
patients with advanced solid tumors', Invest New Drugs, vol. 35, pp. 180-188. 
Behl, C, Davis, JB, Lesley, R & Schubert, D 1994, 'Hydrogen peroxide mediates amyloid 
beta protein toxicity', Cell, vol. 77, pp. 817-827. 
Behura, SK & Whitfield, CW 2010, 'Correlated expression patterns of microRNA genes 
with age-dependent behavioural changes in honeybee', Insect Mol Biol, vol. 19, pp. 431-
439. 
Bekenstein, JW & Lothman, EW 1993, 'Dormancy of inhibitory interneurons in a model of 
temporal lobe epilepsy', Science, vol. 259, pp. 97-100. 
Belaiba, RS, Bonello, S, Zahringer, C, Schmidt, S, Hess, J, Kietzmann, T & Gorlach, A 
2007, 'Hypoxia up-regulates hypoxia-inducible factor-1alpha transcription by involving 
phosphatidylinositol 3-kinase and nuclear factor kappaB in pulmonary artery smooth 
muscle cells', Mol Biol Cell, vol. 18, pp. 4691-4697. 
Belanger, M, Yang, J, Petit, JM, Laroche, T, Magistretti, PJ & Allaman, I 2011, 'Role of the 
glyoxalase system in astrocyte-mediated neuroprotection', J Neurosci, vol. 31, pp. 18338-
18352. 
Bell, RD, Winkler, EA, Sagare, AP, Singh, I, LaRue, B, Deane, R & Zlokovic, BV 2010, 
'Pericytes control key neurovascular functions and neuronal phenotype in the adult brain 
and during brain aging', Neuron, vol. 68, pp. 409-427. 
   136 
Ben-Sasson, A, Hen, L, Fluss, R, Cermak, SA, Engel-Yeger, B & Gal, E 2009, 'A meta-
analysis of sensory modulation symptoms in individuals with autism spectrum disorders', J 
Autism Dev Disord, vol. 39, pp. 1-11. 
Bender, A, Krishnan, KJ, Morris, CM, Taylor, GA, Reeve, AK, Perry, RH, . . . Turnbull, DM 
2006, 'High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and 
Parkinson disease', Nat Genet, vol. 38, pp. 515-517. 
Benson, DL, Watkins, FH, Steward, O & Banker, G 1994, 'Characterization of GABAergic 
neurons in hippocampal cell cultures', J Neurocytol, vol. 23, pp. 279-295. 
Berezikov, E, Thuemmler, F, van Laake, LW, Kondova, I, Bontrop, R, Cuppen, E & 
Plasterk, RH 2006, 'Diversity of microRNAs in human and chimpanzee brain', Nat Genet, 
vol. 38, pp. 1375-1377. 
Bergeron, M, Yu, AY, Solway, KE, Semenza, GL & Sharp, FR 1999, 'Induction of hypoxia-
inducible factor-1 (HIF-1) and its target genes following focal ischaemia in rat brain', Eur J 
Neurosci, vol. 11, pp. 4159-4170. 
Bergles, DE & Jahr, CE 1997, 'Synaptic activation of glutamate transporters in 
hippocampal astrocytes', Neuron, vol. 19, pp. 1297-1308. 
Bertone, P, Stolc, V, Royce, TE, Rozowsky, JS, Urban, AE, Zhu, X, . . . Snyder, M 2004, 
'Global identification of human transcribed sequences with genome tiling arrays', Science, 
vol. 306, pp. 2242-2246. 
Beveridge, NJ, Gardiner, E, Carroll, AP, Tooney, PA & Cairns, MJ 2010, 'Schizophrenia is 
associated with an increase in cortical microRNA biogenesis', Mol Psychiatry, vol. 15, pp. 
1176-1189. 
Beyer, N, Coulson, DT, Heggarty, S, Ravid, R, Irvine, GB, Hellemans, J & Johnston, JA 
2009, 'ZnT3 mRNA levels are reduced in Alzheimer's disease post-mortem brain', Mol 
Neurodegener, vol. 4. 
Bezard, E, Dovero, S, Belin, D, Duconger, S, Jackson-Lewis, V, Przedborski, S, . . . Jaber, 
M 2003, 'Enriched environment confers resistance to 1-methyl-4-phenyl-1,2,3,6-
tetrahydropyridine and cocaine: involvement of dopamine transporter and trophic factors', 
J Neurosci, vol. 23, pp. 10999-11007. 
Bi, GQ & Poo, MM 1998, 'Synaptic modifications in cultured hippocampal neurons: 
dependence on spike timing, synaptic strength, and postsynaptic cell type', J Neurosci, 
vol. 18, pp. 10464-10472. 
Bianca, VD, Dusi, S, Bianchini, E, Dal Pra, I & Rossi, F 1999, 'beta-amyloid activates the 
O-2 forming NADPH oxidase in microglia, monocytes, and neutrophils. A possible 
inflammatory mechanism of neuronal damage in Alzheimer's disease', J Biol Chem, vol. 
274, pp. 15493-15499. 
Bilal, E, Rabadan, R, Alexe, G, Fuku, N, Ueno, H, Nishigaki, Y, . . . Tanaka, M 2008, 
'Mitochondrial DNA haplogroup D4a is a marker for extreme longevity in Japan', PLoS 
One, vol. 3. 
Biswal, S, Sharma, D, Kumar, K, Nag, TC, Barhwal, K, Hota, SK & Kumar, B 2016, 'Global 
hypoxia induced impairment in learning and spatial memory is associated with precocious 
hippocampal aging', Neurobiol Learn Mem, vol. 133, pp. 157-170. 
Bittar, PG, Charnay, Y, Pellerin, L, Bouras, C & Magistretti, PJ 1996, 'Selective distribution 
of lactate dehydrogenase isoenzymes in neurons and astrocytes of human brain', J Cereb 
Blood Flow Metab, vol. 16, pp. 1079-1089. 
   137 
Bjorkhem, I & Meaney, S 2004, 'Brain cholesterol: long secret life behind a barrier', 
Arterioscler Thromb Vasc Biol, vol. 24, pp. 806-815. 
Bolger, AM, Lohse, M & Usadel, B 2014, 'Trimmomatic: a flexible trimmer for Illumina 
sequence data', Bioinformatics, vol. 30, pp. 2114-2120. 
Bonaglia, MC, Giorda, R, Tenconi, R, Pessina, M, Pramparo, T, Borgatti, R & Zuffardi, O 
2005, 'A 2.3 Mb duplication of chromosome 8q24.3 associated with severe mental 
retardation and epilepsy detected by standard karyotype', Eur J Hum Genet, vol. 13, pp. 
586-591. 
Brenman, JE, Chao, DS, Gee, SH, McGee, AW, Craven, SE, Santillano, DR, . . . Bredt, 
DS 1996, 'Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 
and alpha1-syntrophin mediated by PDZ domains', Cell, vol. 84, pp. 757-767. 
Brennecke, J, Stark, A, Russell, RB & Cohen, SM 2005, 'Principles of microRNA-target 
recognition', PLoS Biol, vol. 3. 
Brewer, GJ, Kanzer, SH, Zimmerman, EA, Molho, ES, Celmins, DF, Heckman, SM & Dick, 
R 2010, 'Subclinical zinc deficiency in Alzheimer's disease and Parkinson's disease', Am J 
Alzheimers Dis Other Demen, vol. 25, pp. 572-575. 
Britten, RJ & Kohne, DE 1968, 'Repeated sequences in DNA. Hundreds of thousands of 
copies of DNA sequences have been incorporated into the genomes of higher organisms', 
Science, vol. 161, pp. 529-540. 
Broer, S, Rahman, B, Pellegri, G, Pellerin, L, Martin, JL, Verleysdonk, S, . . . Magistretti, 
PJ 1997, 'Comparison of lactate transport in astroglial cells and monocarboxylate 
transporter 1 (MCT 1) expressing Xenopus laevis oocytes. Expression of two different 
monocarboxylate transporters in astroglial cells and neurons', J Biol Chem, vol. 272, pp. 
30096-30102. 
Brown, L, Hansnata, E & La, H 2017, Economic Cost of Dementia in Australia, University 
of Canberra. 
Bruick, RK & McKnight, SL 2001, 'A conserved family of prolyl-4-hydroxylases that modify 
HIF', Science, vol. 294, pp. 1337-1340. 
Brustovetsky, N, Brustovetsky, T, Purl, KJ, Capano, M, Crompton, M & Dubinsky, JM 
2003, 'Increased susceptibility of striatal mitochondria to calcium-induced permeability 
transition', J Neurosci, vol. 23, pp. 4858-4867. 
Burguiere, E, Monteiro, P, Feng, G & Graybiel, AM 2013, 'Optogenetic stimulation of 
lateral orbitofronto-striatal pathway suppresses compulsive behaviors', Science, vol. 340, 
pp. 1243-1246. 
Burrows, EL, McOmish, CE, Buret, LS, Van den Buuse, M & Hannan, AJ 2015, 
'Environmental Enrichment Ameliorates Behavioral Impairments Modeling Schizophrenia 
in Mice Lacking Metabotropic Glutamate Receptor 5', Neuropsychopharmacology, vol. 40, 
pp. 1947-1956. 
Bussey, TJ, Padain, TL, Skillings, EA, Winters, BD, Morton, AJ & Saksida, LM 2008, 'The 
touchscreen cognitive testing method for rodents: how to get the best out of your rat', 
Learn Mem, vol. 15, pp. 516-523. 
Calingasan, NY, Uchida, K & Gibson, GE 1999, 'Protein-bound acrolein: a novel marker of 
oxidative stress in Alzheimer's disease', J Neurochem, vol. 72, pp. 751-756. 
Campisi, A, Caccamo, D, Li Volti, G, Curro, M, Parisi, G, Avola, R, . . . Ientile, R 2004, 
'Glutamate-evoked redox state alterations are involved in tissue transglutaminase 
upregulation in primary astrocyte cultures', FEBS Lett, vol. 578, pp. 80-84. 
   138 
Camps, C, Buffa, FM, Colella, S, Moore, J, Sotiriou, C, Sheldon, H, . . . Ragoussis, J 2008, 
'hsa-miR-210 Is induced by hypoxia and is an independent prognostic factor in breast 
cancer', Clin Cancer Res, vol. 14, pp. 1340-1348. 
Cang, J, Kaneko, M, Yamada, J, Woods, G, Stryker, MP & Feldheim, DA 2005, 'Ephrin-as 
guide the formation of functional maps in the visual cortex', Neuron, vol. 48, pp. 577-589. 
Caraiscos, VB, Elliott, EM, You-Ten, KE, Cheng, VY, Belelli, D, Newell, JG, . . . Orser, BA 
2004, 'Tonic inhibition in mouse hippocampal CA1 pyramidal neurons is mediated by 
alpha5 subunit-containing gamma-aminobutyric acid type A receptors', Proc Natl Acad Sci 
U S A, vol. 101, pp. 3662-3667. 
Cardin, JA, Carlen, M, Meletis, K, Knoblich, U, Zhang, F, Deisseroth, K, . . . Moore, CI 
2009, 'Driving fast-spiking cells induces gamma rhythm and controls sensory responses', 
Nature, vol. 459, pp. 663-667. 
Care, A, Catalucci, D, Felicetti, F, Bonci, D, Addario, A, Gallo, P, . . . Condorelli, G 2007, 
'MicroRNA-133 controls cardiac hypertrophy', Nat Med, vol. 13, pp. 613-618. 
Casley, CS, Canevari, L, Land, JM, Clark, JB & Sharpe, MA 2002, 'Beta-amyloid inhibits 
integrated mitochondrial respiration and key enzyme activities', J Neurochem, vol. 80, pp. 
91-100. 
Chan, SY, Zhang, YY, Hemann, C, Mahoney, CE, Zweier, JL & Loscalzo, J 2009, 
'MicroRNA-210 controls mitochondrial metabolism during hypoxia by repressing the iron-
sulfur cluster assembly proteins ISCU1/2', Cell Metab, vol. 10, pp. 273-284. 
Chang, EI, Loh, SA, Ceradini, DJ, Chang, EI, Lin, SE, Bastidas, N, . . . Gurtner, GC 2007, 
'Age decreases endothelial progenitor cell recruitment through decreases in hypoxia-
inducible factor 1alpha stabilization during ischemia', Circulation, vol. 116, pp. 2818-2829. 
Chen, C, Ridzon, DA, Broomer, AJ, Zhou, Z, Lee, DH, Nguyen, JT, . . . Guegler, KJ 2005, 
'Real-time quantification of microRNAs by stem-loop RT-PCR', Nucleic Acids Res, vol. 33. 
Chen, JJ, Rosas, HD & Salat, DH 2011, 'Age-associated reductions in cerebral blood flow 
are independent from regional atrophy', Neuroimage, vol. 55, pp. 468-478. 
Chen, L, Zheng, H & Zhang, S 2016, 'Involvement of upregulation of miR-210 in a rat 
epilepsy model', Neuropsychiatr Dis Treat, vol. 12, pp. 1731-1737. 
Chen, Y, Durakoglugil, MS, Xian, X & Herz, J 2010a, 'ApoE4 reduces glutamate receptor 
function and synaptic plasticity by selectively impairing ApoE receptor recycling', Proc Natl 
Acad Sci U S A, vol. 107, pp. 12011-12016. 
Chen, Z, Li, Y, Zhang, H, Huang, P & Luthra, R 2010b, 'Hypoxia-regulated microRNA-210 
modulates mitochondrial function and decreases ISCU and COX10 expression', 
Oncogene, vol. 29, pp. 4362-4368. 
Chendrimada, TP, Finn, KJ, Ji, X, Baillat, D, Gregory, RI, Liebhaber, SA, . . . Shiekhattar, 
R 2007, 'MicroRNA silencing through RISC recruitment of eIF6', Nature, vol. 447, pp. 823-
828. 
Cho, RY, Konecky, RO & Carter, CS 2006, 'Impairments in frontal cortical gamma 
synchrony and cognitive control in schizophrenia', Proc Natl Acad Sci U S A, vol. 103, pp. 
19878-19883. 
Clark, AJ & Block, K 1959, 'The absence of sterol synthesis in insects', J Biol Chem, vol. 
234, pp. 2578-2582. 
Clatworthy, PL, Lewis, SJ, Brichard, L, Hong, YT, Izquierdo, D, Clark, L, . . . Robbins, TW 
2009, 'Dopamine release in dissociable striatal subregions predicts the different effects of 
   139 
oral methylphenidate on reversal learning and spatial working memory', J Neurosci, vol. 
29, pp. 4690-4696. 
Cloonan, N, Wani, S, Xu, Q, Gu, J, Lea, K, Heater, S, . . . Grimmond, SM 2011, 
'MicroRNAs and their isomiRs function cooperatively to target common biological 
pathways', Genome Biol, vol. 12. 
Cobb, SR, Buhl, EH, Halasy, K, Paulsen, O & Somogyi, P 1995, 'Synchronization of 
neuronal activity in hippocampus by individual GABAergic interneurons', Nature, vol. 378, 
pp. 75-78. 
Cogswell, JP, Ward, J, Taylor, IA, Waters, M, Shi, Y, Cannon, B, . . . Richards, CA 2008, 
'Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative 
biomarkers and insights into disease pathways', J Alzheimers Dis, vol. 14, pp. 27-41. 
Colino, A & Halliwell, JV 1987, 'Differential modulation of three separate K-conductances 
in hippocampal CA1 neurons by serotonin', Nature, vol. 328, pp. 73-77. 
Cooper, AJ, Sheu, KR, Burke, JR, Onodera, O, Strittmatter, WJ, Roses, AD & Blass, JP 
1997, 'Transglutaminase-catalyzed inactivation of glyceraldehyde 3-phosphate 
dehydrogenase and alpha-ketoglutarate dehydrogenase complex by polyglutamine 
domains of pathological length', Proc Natl Acad Sci U S A, vol. 94, pp. 12604-12609. 
Corder, EH, Saunders, AM, Strittmatter, WJ, Schmechel, DE, Gaskell, PC, Small, GW, . . . 
Pericak-Vance, MA 1993, 'Gene dose of apolipoprotein E type 4 allele and the risk of 
Alzheimer's disease in late onset families', Science, vol. 261, pp. 921-923. 
Costa-Mattioli, M, Gobert, D, Harding, H, Herdy, B, Azzi, M, Bruno, M, . . . Sonenberg, N 
2005, 'Translational control of hippocampal synaptic plasticity and memory by the 
eIF2alpha kinase GCN2', Nature, vol. 436, pp. 1166-1173. 
Costa-Mattioli, M, Gobert, D, Stern, E, Gamache, K, Colina, R, Cuello, C, . . . Sonenberg, 
N 2007, 'eIF2alpha phosphorylation bidirectionally regulates the switch from short- to long-
term synaptic plasticity and memory', Cell, vol. 129, pp. 195-206. 
Costales, MG, Haga, CL, Velagapudi, SP, Childs-Disney, JL, Phinney, DG & Disney, MD 
2017, 'Small Molecule Inhibition of microRNA-210 Reprograms an Oncogenic Hypoxic 
Circuit', J Am Chem Soc, vol. 139, pp. 3446-3455. 
Costinean, S, Zanesi, N, Pekarsky, Y, Tili, E, Volinia, S, Heerema, N & Croce, CM 2006, 
'Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-
miR155 transgenic mice', Proc Natl Acad Sci U S A, vol. 103, pp. 7024-7029. 
Craig, AM, Blackstone, CD, Huganir, RL & Banker, G 1993, 'The distribution of glutamate 
receptors in cultured rat hippocampal neurons: postsynaptic clustering of AMPA-selective 
subunits', Neuron, vol. 10, pp. 1055-1068. 
Cristino, A, Williams, S, Hawi, Z, An, JY, Bellgrove, MA, Schwartz, CE, . . . Claudianos, C 
2014a, 'Neurodevelopmental and neuropsychiatric disorders represent an interconnected 
molecular system', Mol Psychiatry, vol. 19, pp. 294-301. 
Cristino, AS, Barchuk, AR, Freitas, FC, Narayanan, RK, Biergans, SD, Zhao, Z, . . . 
Claudianos, C 2014b, 'Neuroligin-associated microRNA-932 targets actin and regulates 
memory in the honeybee', Nat Commun, vol. 5. 
Crosby, ME, Kulshreshtha, R, Ivan, M & Glazer, PM 2009, 'MicroRNA regulation of DNA 
repair gene expression in hypoxic stress', Cancer Res, vol. 69, pp. 1221-1229. 
Damier, P, Hirsch, EC, Agid, Y & Graybiel, AM 1999, 'The substantia nigra of the human 
brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease', Brain, 
vol. 122 ( Pt 8), pp. 1437-1448. 
   140 
Danbolt, NC, Storm-Mathisen, J & Kanner, BI 1992, 'An [Na+ + K+]coupled L-glutamate 
transporter purified from rat brain is located in glial cell processes', Neuroscience, vol. 51, 
pp. 295-310. 
Davies, KM, Bohic, S, Carmona, A, Ortega, R, Cottam, V, Hare, DJ, . . . Double, KL 2014, 
'Copper pathology in vulnerable brain regions in Parkinson's disease', Neurobiol Aging, 
vol. 35, pp. 858-866. 
Deacon, RM 2013, 'Measuring motor coordination in mice', J Vis Exp. 
Debernardi, R, Pierre, K, Lengacher, S, Magistretti, PJ & Pellerin, L 2003, 'Cell-specific 
expression pattern of monocarboxylate transporters in astrocytes and neurons observed in 
different mouse brain cortical cell cultures', J Neurosci Res, vol. 73, pp. 141-155. 
Declercq, J, Brouwers, B, Pruniau, VP, Stijnen, P, de Faudeur, G, Tuand, K, . . . 
Creemers, JW 2015, 'Metabolic and Behavioural Phenotypes in Nestin-Cre Mice Are 
Caused by Hypothalamic Expression of Human Growth Hormone', PLoS One, vol. 10. 
Deisig, N, Giurfa, M, Lachnit, H & Sandoz, JC 2006, 'Neural representation of olfactory 
mixtures in the honeybee antennal lobe', Eur J Neurosci, vol. 24, pp. 1161-1174. 
Dell'Acqua, S, Pirota, V, Anzani, C, Rocco, MM, Nicolis, S, Valensin, D, . . . Casella, L 
2015, 'Reactivity of copper-alpha-synuclein peptide complexes relevant to Parkinson's 
disease', Metallomics, vol. 7, pp. 1091-1102. 
Denko, NC, Fontana, LA, Hudson, KM, Sutphin, PD, Raychaudhuri, S, Altman, R & 
Giaccia, AJ 2003, 'Investigating hypoxic tumor physiology through gene expression 
patterns', Oncogene, vol. 22, pp. 5907-5914. 
DiFiglia, M, Sapp, E, Chase, KO, Davies, SW, Bates, GP, Vonsattel, JP & Aronin, N 1997, 
'Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in 
brain', Science, vol. 277, pp. 1990-1993. 
Dikalov, SI, Vitek, MP & Mason, RP 2004, 'Cupric-amyloid beta peptide complex 
stimulates oxidation of ascorbate and generation of hydroxyl radical', Free Radic Biol Med, 
vol. 36, pp. 340-347. 
Dill, H, Linder, B, Fehr, A & Fischer, U 2012, 'Intronic miR-26b controls neuronal 
differentiation by repressing its host transcript, ctdsp2', Genes Dev, vol. 26, pp. 25-30. 
Dinocourt, C, Petanjek, Z, Freund, TF, Ben-Ari, Y & Esclapez, M 2003, 'Loss of 
interneurons innervating pyramidal cell dendrites and axon initial segments in the CA1 
region of the hippocampus following pilocarpine-induced seizures', J Comp Neurol, vol. 
459, pp. 407-425. 
Donahue, CP, Jensen, RV, Ochiishi, T, Eisenstein, I, Zhao, M, Shors, T & Kosik, KS 2002, 
'Transcriptional profiling reveals regulated genes in the hippocampus during memory 
formation', Hippocampus, vol. 12, pp. 821-833. 
Donahue, MJ, Stevens, RD, de Boorder, M, Pekar, JJ, Hendrikse, J & van Zijl, PC 2009, 
'Hemodynamic changes after visual stimulation and breath holding provide evidence for an 
uncoupling of cerebral blood flow and volume from oxygen metabolism', J Cereb Blood 
Flow Metab, vol. 29, pp. 176-185. 
Dong, JH, Wang, YJ, Cui, M, Wang, XJ, Zheng, WS, Ma, ML, . . . Sun, JP 2017, 'Adaptive 
Activation of a Stress Response Pathway Improves Learning and Memory Through Gs 
and beta-Arrestin-1-Regulated Lactate Metabolism', Biol Psychiatry, vol. 81, pp. 654-670. 
Dragunow, M & Faull, R 1989, 'The use of c-fos as a metabolic marker in neuronal 
pathway tracing', J Neurosci Methods, vol. 29, pp. 261-265. 
   141 
Dringen, R, Kussmaul, L, Gutterer, JM, Hirrlinger, J & Hamprecht, B 1999, 'The glutathione 
system of peroxide detoxification is less efficient in neurons than in astroglial cells', J 
Neurochem, vol. 72, pp. 2523-2530. 
Drouin-Ouellet, J, Sawiak, SJ, Cisbani, G, Lagace, M, Kuan, WL, Saint-Pierre, M, . . . 
Cicchetti, F 2015, 'Cerebrovascular and blood-brain barrier impairments in Huntington's 
disease: Potential implications for its pathophysiology', Ann Neurol, vol. 78, pp. 160-177. 
Du, H, Guo, L, Yan, S, Sosunov, AA, McKhann, GM & Yan, SS 2010, 'Early deficits in 
synaptic mitochondria in an Alzheimer's disease mouse model', Proc Natl Acad Sci U S A, 
vol. 107, pp. 18670-18675. 
Dyer, JR & Sossin, WS 2000, 'Regulation of eukaryotic initiation factor 4E phosphorylation 
in the nervous system of Aplysia californica', J Neurochem, vol. 75, pp. 872-881. 
Eacker, SM, Keuss, MJ, Berezikov, E, Dawson, VL & Dawson, TM 2011, 'Neuronal activity 
regulates hippocampal miRNA expression', PLoS One, vol. 6. 
El Far, O & Seagar, M 2011, 'A role for V-ATPase subunits in synaptic vesicle fusion?', J 
Neurochem, vol. 117, pp. 603-612. 
Elbashir, SM, Harborth, J, Lendeckel, W, Yalcin, A, Weber, K & Tuschl, T 2001, 'Duplexes 
of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells', Nature, 
vol. 411, pp. 494-498. 
Ellis, G, Fang, E, Maheshwari, M, Roltsch, E, Holcomb, L, Zimmer, D, . . . Murray, IV 2010, 
'Lipid oxidation and modification of amyloid-beta (Abeta) in vitro and in vivo', J Alzheimers 
Dis, vol. 22, pp. 593-607. 
Elmen, J, Lindow, M, Schutz, S, Lawrence, M, Petri, A, Obad, S, . . . Kauppinen, S 2008, 
'LNA-mediated microRNA silencing in non-human primates', Nature, vol. 452, pp. 896-899. 
Engert, F & Bonhoeffer, T 1999, 'Dendritic spine changes associated with hippocampal 
long-term synaptic plasticity', Nature, vol. 399, pp. 66-70. 
Erecinska, M & Silver, IA 2001, 'Tissue oxygen tension and brain sensitivity to hypoxia', 
Respir Physiol, vol. 128, pp. 263-276. 
Eruslanov, E & Kusmartsev, S 2010, 'Identification of ROS using oxidized DCFDA and 
flow-cytometry', Methods Mol Biol, vol. 594, pp. 57-72. 
Eulalio, A, Huntzinger, E & Izaurralde, E 2008, 'GW182 interaction with Argonaute is 
essential for miRNA-mediated translational repression and mRNA decay', Nat Struct Mol 
Biol, vol. 15, pp. 346-353. 
Faherty, CJ, Raviie Shepherd, K, Herasimtschuk, A & Smeyne, RJ 2005, 'Environmental 
enrichment in adulthood eliminates neuronal death in experimental Parkinsonism', Brain 
Res Mol Brain Res, vol. 134, pp. 170-179. 
Fang, C, Li, Q, Min, G, Liu, M, Cui, J, Sun, J & Li, L 2016, 'MicroRNA-181c Ameliorates 
Cognitive Impairment Induced by Chronic Cerebral Hypoperfusion in Rats', Mol Neurobiol. 
Fasanaro, P, D'Alessandra, Y, Di Stefano, V, Melchionna, R, Romani, S, Pompilio, G, . . . 
Martelli, F 2008, 'MicroRNA-210 modulates endothelial cell response to hypoxia and 
inhibits the receptor tyrosine kinase ligand Ephrin-A3', J Biol Chem, vol. 283, pp. 15878-
15883. 
Filiano, AJ, Bailey, CD, Tucholski, J, Gundemir, S & Johnson, GV 2008, 'Transglutaminase 
2 protects against ischemic insult, interacts with HIF1beta, and attenuates HIF1 signaling', 
FASEB J, vol. 22, pp. 2662-2675. 
   142 
Fire, A, Xu, S, Montgomery, MK, Kostas, SA, Driver, SE & Mello, CC 1998, 'Potent and 
specific genetic interference by double-stranded RNA in Caenorhabditis elegans', Nature, 
vol. 391, pp. 806-811. 
Fischer, M, Kaech, S, Knutti, D & Matus, A 1998, 'Rapid actin-based plasticity in dendritic 
spines', Neuron, vol. 20, pp. 847-854. 
Fordyce, DE & Farrar, RP 1991, 'Enhancement of spatial learning in F344 rats by physical 
activity and related learning-associated alterations in hippocampal and cortical cholinergic 
functioning', Behav Brain Res, vol. 46, pp. 123-133. 
Fordyce, DE & Wehner, JM 1993, 'Physical activity enhances spatial learning performance 
with an associated alteration in hippocampal protein kinase C activity in C57BL/6 and 
DBA/2 mice', Brain Res, vol. 619, pp. 111-119. 
Forstemann, K, Tomari, Y, Du, T, Vagin, VV, Denli, AM, Bratu, DP, . . . Zamore, PD 2005, 
'Normal microRNA maturation and germ-line stem cell maintenance requires Loquacious, 
a double-stranded RNA-binding domain protein', PLoS Biol, vol. 3. 
Frahm, C, Haupt, C & Witte, OW 2004, 'GABA neurons survive focal ischemic injury', 
Neuroscience, vol. 127, pp. 341-346. 
Frahm, J, Baudewig, J, Kallenberg, K, Kastrup, A, Merboldt, KD & Dechent, P 2008, 'The 
post-stimulation undershoot in BOLD fMRI of human brain is not caused by elevated 
cerebral blood volume', Neuroimage, vol. 40, pp. 473-481. 
Frahm, J, Kruger, G, Merboldt, KD & Kleinschmidt, A 1996, 'Dynamic uncoupling and 
recoupling of perfusion and oxidative metabolism during focal brain activation in man', 
Magn Reson Med, vol. 35, pp. 143-148. 
Frey, U, Frey, S, Schollmeier, F & Krug, M 1996, 'Influence of actinomycin D, a RNA 
synthesis inhibitor, on long-term potentiation in rat hippocampal neurons in vivo and in 
vitro', J Physiol, vol. 490 ( Pt 3), pp. 703-711. 
Frey, U, Krug, M, Brodemann, R, Reymann, K & Matthies, H 1989, 'Long-term potentiation 
induced in dendrites separated from rat's CA1 pyramidal somata does not establish a late 
phase', Neurosci Lett, vol. 97, pp. 135-139. 
Friedland, RP, Fritsch, T, Smyth, KA, Koss, E, Lerner, AJ, Chen, CH, . . . Debanne, SM 
2001, 'Patients with Alzheimer's disease have reduced activities in midlife compared with 
healthy control-group members', Proc Natl Acad Sci U S A, vol. 98, pp. 3440-3445. 
Friedman, RC, Farh, KK, Burge, CB & Bartel, DP 2009, 'Most mammalian mRNAs are 
conserved targets of microRNAs', Genome Res, vol. 19, pp. 92-105. 
Fryd Johansen, F, Balslev Jorgensen, M & Diemer, NH 1983, 'Resistance of hippocampal 
CA-1 interneurons to 20 min of transient cerebral ischemia in the rat', Acta Neuropathol, 
vol. 61, pp. 135-140. 
Fukui, H & Moraes, CT 2009, 'Mechanisms of formation and accumulation of mitochondrial 
DNA deletions in aging neurons', Hum Mol Genet, vol. 18, pp. 1028-1036. 
Fuller, RL, Luck, SJ, Braun, EL, Robinson, BM, McMahon, RP & Gold, JM 2006, 'Impaired 
control of visual attention in schizophrenia', J Abnorm Psychol, vol. 115, pp. 266-275. 
Gabbita, SP, Lovell, MA & Markesbery, WR 1998, 'Increased nuclear DNA oxidation in the 
brain in Alzheimer's disease', J Neurochem, vol. 71, pp. 2034-2040. 
Garthwaite, J, Charles, SL & Chess-Williams, R 1988, 'Endothelium-derived relaxing factor 
release on activation of NMDA receptors suggests role as intercellular messenger in the 
brain', Nature, vol. 336, pp. 385-388. 
   143 
Geary, RS, Wancewicz, E, Matson, J, Pearce, M, Siwkowski, A, Swayze, E & Bennett, F 
2009, 'Effect of dose and plasma concentration on liver uptake and pharmacologic activity 
of a 2'-methoxyethyl modified chimeric antisense oligonucleotide targeting PTEN', 
Biochem Pharmacol, vol. 78, pp. 284-291. 
Gelinas, JN, Banko, JL, Hou, L, Sonenberg, N, Weeber, EJ, Klann, E & Nguyen, PV 2007, 
'ERK and mTOR signaling couple beta-adrenergic receptors to translation initiation 
machinery to gate induction of protein synthesis-dependent long-term potentiation', J Biol 
Chem, vol. 282, pp. 27527-27535. 
Ghods-Sharifi, S, Haluk, DM & Floresco, SB 2008, 'Differential effects of inactivation of the 
orbitofrontal cortex on strategy set-shifting and reversal learning', Neurobiol Learn Mem, 
vol. 89, pp. 567-573. 
Gibson, GE, Kingsbury, AE, Xu, H, Lindsay, JG, Daniel, S, Foster, OJ, . . . Blass, JP 2003, 
'Deficits in a tricarboxylic acid cycle enzyme in brains from patients with Parkinson's 
disease', Neurochem Int, vol. 43, pp. 129-135. 
Gittis, AH, Leventhal, DK, Fensterheim, BA, Pettibone, JR, Berke, JD & Kreitzer, AC 2011, 
'Selective inhibition of striatal fast-spiking interneurons causes dyskinesias', J Neurosci, 
vol. 31, pp. 15727-15731. 
Giusti, SA, Vercelli, CA, Vogl, AM, Kolarz, AW, Pino, NS, Deussing, JM & Refojo, D 2014, 
'Behavioral phenotyping of Nestin-Cre mice: implications for genetic mouse models of 
psychiatric disorders', J Psychiatr Res, vol. 55, pp. 87-95. 
Glanzer, J, Miyashiro, KY, Sul, JY, Barrett, L, Belt, B, Haydon, P & Eberwine, J 2005, 
'RNA splicing capability of live neuronal dendrites', Proc Natl Acad Sci U S A, vol. 102, pp. 
16859-16864. 
Glenner, GG & Wong, CW 1984, 'Alzheimer's disease and Down's syndrome: sharing of a 
unique cerebrovascular amyloid fibril protein', Biochem Biophys Res Commun, vol. 122, 
pp. 1131-1135. 
Goedert, M, Spillantini, MG, Jakes, R, Rutherford, D & Crowther, RA 1989, 'Multiple 
isoforms of human microtubule-associated protein tau: sequences and localization in 
neurofibrillary tangles of Alzheimer's disease', Neuron, vol. 3, pp. 519-526. 
Goldie, BJ, Barnett, MM & Cairns, MJ 2014, 'BDNF and the maturation of 
posttranscriptional regulatory networks in human SH-SY5Y neuroblast differentiation', 
Front Cell Neurosci, vol. 8. 
Gong, C & Maquat, LE 2011, 'lncRNAs transactivate STAU1-mediated mRNA decay by 
duplexing with 3' UTRs via Alu elements', Nature, vol. 470, pp. 284-288. 
Gorter, JA, Iyer, A, White, I, Colzi, A, van Vliet, EA, Sisodiya, S & Aronica, E 2014, 
'Hippocampal subregion-specific microRNA expression during epileptogenesis in 
experimental temporal lobe epilepsy', Neurobiol Dis, vol. 62, pp. 508-520. 
Greaves, LC, Elson, JL, Nooteboom, M, Grady, JP, Taylor, GA, Taylor, RW, . . . Turnbull, 
DM 2012, 'Comparison of mitochondrial mutation spectra in ageing human colonic 
epithelium and disease: absence of evidence for purifying selection in somatic 
mitochondrial DNA point mutations', PLoS Genet, vol. 8. 
Green, MF 2006, 'Cognitive impairment and functional outcome in schizophrenia and 
bipolar disorder', J Clin Psychiatry, vol. 67. 
Greenfield, JG & Bosanquet, FD 1953, 'The brain-stem lesions in Parkinsonism', J Neurol 
Neurosurg Psychiatry, vol. 16, pp. 213-226. 
   144 
Greilberger, J, Koidl, C, Greilberger, M, Lamprecht, M, Schroecksnadel, K, Leblhuber, F, . 
. . Oettl, K 2008, 'Malondialdehyde, carbonyl proteins and albumin-disulphide as useful 
oxidative markers in mild cognitive impairment and Alzheimer's disease', Free Radic Res, 
vol. 42, pp. 633-638. 
Grimson, A, Farh, KK, Johnston, WK, Garrett-Engele, P, Lim, LP & Bartel, DP 2007, 
'MicroRNA targeting specificity in mammals: determinants beyond seed pairing', Mol Cell, 
vol. 27, pp. 91-105. 
Grishok, A, Sinskey, JL & Sharp, PA 2005, 'Transcriptional silencing of a transgene by 
RNAi in the soma of C. elegans', Genes Dev, vol. 19, pp. 683-696. 
Gruber, AJ, Calhoon, GG, Shusterman, I, Schoenbaum, G, Roesch, MR & O'Donnell, P 
2010, 'More is less: a disinhibited prefrontal cortex impairs cognitive flexibility', J Neurosci, 
vol. 30, pp. 17102-17110. 
Guo, H, Ingolia, NT, Weissman, JS & Bartel, DP 2010, 'Mammalian microRNAs 
predominantly act to decrease target mRNA levels', Nature, vol. 466, pp. 835-840. 
Guo, S, Bragina, O, Xu, Y, Cao, Z, Chen, H, Zhou, B, . . . Shi, H 2008, 'Glucose up-
regulates HIF-1 alpha expression in primary cortical neurons in response to hypoxia 
through maintaining cellular redox status', J Neurochem, vol. 105, pp. 1849-1860. 
Gupta, A, Wang, Y & Markram, H 2000, 'Organizing principles for a diversity of GABAergic 
interneurons and synapses in the neocortex', Science, vol. 287, pp. 273-278. 
Guttman, M, Amit, I, Garber, M, French, C, Lin, MF, Feldser, D, . . . Lander, ES 2009, 
'Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in 
mammals', Nature, vol. 458, pp. 223-227. 
Guven-Ozkan, T, Busto, GU, Schutte, SS, Cervantes-Sandoval, I, O'Dowd, DK & Davis, 
RL 2016, 'MiR-980 Is a Memory Suppressor MicroRNA that Regulates the Autism-
Susceptibility Gene A2bp1', Cell Rep, vol. 14, pp. 1698-1709. 
Haberman, RP, Lee, HJ, Colantuoni, C, Koh, MT & Gallagher, M 2008, 'Rapid encoding of 
new information alters the profile of plasticity-related mRNA transcripts in the hippocampal 
CA3 region', Proc Natl Acad Sci U S A, vol. 105, pp. 10601-10606. 
Hagan, JP, Piskounova, E & Gregory, RI 2009, 'Lin28 recruits the TUTase Zcchc11 to 
inhibit let-7 maturation in mouse embryonic stem cells', Nat Struct Mol Biol, vol. 16, pp. 
1021-1025. 
Hale, A, Lee, C, Annis, S, Min, PK, Pande, R, Creager, MA, . . . Chan, SY 2014, 'An 
Argonaute 2 Switch Regulates Circulating miR-210 to Coordinate Hypoxic Adaptation 
across Cells', Biochim Biophys Acta. 
Haley, B & Zamore, PD 2004, 'Kinetic analysis of the RNAi enzyme complex', Nat Struct 
Mol Biol, vol. 11, pp. 599-606. 
Halim, ND, McFate, T, Mohyeldin, A, Okagaki, P, Korotchkina, LG, Patel, MS, . . . Verma, 
A 2010, 'Phosphorylation status of pyruvate dehydrogenase distinguishes metabolic 
phenotypes of cultured rat brain astrocytes and neurons', Glia, vol. 58, pp. 1168-1176. 
Halliwell, JV & Adams, PR 1982, 'Voltage-clamp analysis of muscarinic excitation in 
hippocampal neurons', Brain Res, vol. 250, pp. 71-92. 
Hamel, E, Nicolakakis, N, Aboulkassim, T, Ongali, B & Tong, XK 2008, 'Oxidative stress 
and cerebrovascular dysfunction in mouse models of Alzheimer's disease', Exp Physiol, 
vol. 93, pp. 116-120. 
   145 
Hammond, SM, Bernstein, E, Beach, D & Hannon, GJ 2000, 'An RNA-directed nuclease 
mediates post-transcriptional gene silencing in Drosophila cells', Nature, vol. 404, pp. 293-
296. 
Hangauer, MJ, Vaughn, IW & McManus, MT 2013, 'Pervasive transcription of the human 
genome produces thousands of previously unidentified long intergenic noncoding RNAs', 
PLoS Genet, vol. 9. 
Hansen, KF, Sakamoto, K, Aten, S, Snider, KH, Loeser, J, Hesse, AM, . . . Obrietan, K 
2016, 'Targeted deletion of miR-132/-212 impairs memory and alters the hippocampal 
transcriptome', Learn Mem, vol. 23, pp. 61-71. 
Harris, JJ, Jolivet, R & Attwell, D 2012, 'Synaptic energy use and supply', Neuron, vol. 75, 
pp. 762-777. 
Harris, ME, Hensley, K, Butterfield, DA, Leedle, RA & Carney, JM 1995, 'Direct evidence 
of oxidative injury produced by the Alzheimer's beta-amyloid peptide (1-40) in cultured 
hippocampal neurons', Exp Neurol, vol. 131, pp. 193-202. 
Hebert, SS, Horre, K, Nicolai, L, Papadopoulou, AS, Mandemakers, W, Silahtaroglu, AN, . 
. . De Strooper, B 2008, 'Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's 
disease correlates with increased BACE1/beta-secretase expression', Proc Natl Acad Sci 
U S A, vol. 105, pp. 6415-6420. 
Helwak, A, Kudla, G, Dudnakova, T & Tollervey, D 2013, 'Mapping the human miRNA 
interactome by CLASH reveals frequent noncanonical binding', Cell, vol. 153, pp. 654-665. 
Hendrickson, DG, Hogan, DJ, Herschlag, D, Ferrell, JE & Brown, PO 2008, 'Systematic 
identification of mRNAs recruited to argonaute 2 by specific microRNAs and corresponding 
changes in transcript abundance', PLoS One, vol. 3. 
Hensley, K, Hall, N, Subramaniam, R, Cole, P, Harris, M, Aksenov, M, . . . et al. 1995, 
'Brain regional correspondence between Alzheimer's disease histopathology and 
biomarkers of protein oxidation', J Neurochem, vol. 65, pp. 2146-2156. 
Heo, I, Joo, C, Kim, YK, Ha, M, Yoon, MJ, Cho, J, . . . Kim, VN 2009, 'TUT4 in concert with 
Lin28 suppresses microRNA biogenesis through pre-microRNA uridylation', Cell, vol. 138, 
pp. 696-708. 
Herrero-Mendez, A, Almeida, A, Fernandez, E, Maestre, C, Moncada, S & Bolanos, JP 
2009, 'The bioenergetic and antioxidant status of neurons is controlled by continuous 
degradation of a key glycolytic enzyme by APC/C-Cdh1', Nat Cell Biol, vol. 11, pp. 747-
752. 
Hertz, L, Schousboe, A, Boechler, N, Mukerji, S & Fedoroff, S 1978, 'Kinetic characteristics 
of the glutamate uptake into normal astrocytes in cultures', Neurochem Res, vol. 3, pp. 1-
14. 
Heverin, M, Meaney, S, Lutjohann, D, Diczfalusy, U, Wahren, J & Bjorkhem, I 2005, 
'Crossing the barrier: net flux of 27-hydroxycholesterol into the human brain', J Lipid Res, 
vol. 46, pp. 1047-1052. 
Hiura, M, Nariai, T, Ishii, K, Sakata, M, Oda, K, Toyohara, J & Ishiwata, K 2014, 'Changes 
in cerebral blood flow during steady-state cycling exercise: a study using oxygen-15-
labeled water with PET', J Cereb Blood Flow Metab, vol. 34, pp. 389-396. 
Hoge, RD, Franceschini, MA, Covolan, RJ, Huppert, T, Mandeville, JB & Boas, DA 2005, 
'Simultaneous recording of task-induced changes in blood oxygenation, volume, and flow 
using diffuse optical imaging and arterial spin-labeling MRI', Neuroimage, vol. 25, pp. 701-
707. 
   146 
Holt, DJ, Lebron-Milad, K, Milad, MR, Rauch, SL, Pitman, RK, Orr, SP, . . . Goff, DC 2009, 
'Extinction memory is impaired in schizophrenia', Biol Psychiatry, vol. 65, pp. 455-463. 
Horner, AE, Heath, CJ, Hvoslef-Eide, M, Kent, BA, Kim, CH, Nilsson, SR, . . . Bussey, TJ 
2013, 'The touchscreen operant platform for testing learning and memory in rats and mice', 
Nat Protoc, vol. 8, pp. 1961-1984. 
Horton, TM, Graham, BH, Corral-Debrinski, M, Shoffner, JM, Kaufman, AE, Beal, MF & 
Wallace, DC 1995, 'Marked increase in mitochondrial DNA deletion levels in the cerebral 
cortex of Huntington's disease patients', Neurology, vol. 45, pp. 1879-1883. 
Hsiao, HY, Chen, YC, Huang, CH, Chen, CC, Hsu, YH, Chen, HM, . . . Chern, Y 2015, 
'Aberrant astrocytes impair vascular reactivity in Huntington disease', Ann Neurol, vol. 78, 
pp. 178-192. 
Hu, K, Xie, YY, Zhang, C, Ouyang, DS, Long, HY, Sun, DN, . . . Xiao, B 2012, 'MicroRNA 
expression profile of the hippocampus in a rat model of temporal lobe epilepsy and miR-
34a-targeted neuroprotection against hippocampal neurone cell apoptosis post-status 
epilepticus', BMC Neurosci, vol. 13. 
Hu, S, Huang, M, Li, Z, Jia, F, Ghosh, Z, Lijkwan, MA, . . . Wu, JC 2010, 'MicroRNA-210 as 
a novel therapy for treatment of ischemic heart disease', Circulation, vol. 122, pp. S124-
131. 
Hu, YW, Jiang, JJ, Yan, G, Wang, RY & Tu, GJ 2016, 'MicroRNA-210 promotes sensory 
axon regeneration of adult mice in vivo and in vitro', Neurosci Lett, vol. 622, pp. 61-66. 
Huang da, W, Sherman, BT & Lempicki, RA 2009, 'Systematic and integrative analysis of 
large gene lists using DAVID bioinformatics resources', Nat Protoc, vol. 4, pp. 44-57. 
Huang, V, Place, RF, Portnoy, V, Wang, J, Qi, Z, Jia, Z, . . . Li, LC 2012, 'Upregulation of 
Cyclin B1 by miRNA and its implications in cancer', Nucleic Acids Res, vol. 40, pp. 1695-
1707. 
Huang, X, Ding, L, Bennewith, KL, Tong, RT, Welford, SM, Ang, KK, . . . Giaccia, AJ 2009, 
'Hypoxia-inducible mir-210 regulates normoxic gene expression involved in tumor 
initiation', Mol Cell, vol. 35, pp. 856-867. 
Humphreys, DT, Westman, BJ, Martin, DI & Preiss, T 2005, 'MicroRNAs control translation 
initiation by inhibiting eukaryotic initiation factor 4E/cap and poly(A) tail function', Proc Natl 
Acad Sci U S A, vol. 102, pp. 16961-16966. 
Hunsberger, JG, Bennett, AH, Selvanayagam, E, Duman, RS & Newton, SS 2005, 'Gene 
profiling the response to kainic acid induced seizures', Brain Res Mol Brain Res, vol. 141, 
pp. 95-112. 
Hyder, F, Rothman, DL & Bennett, MR 2013, 'Cortical energy demands of signaling and 
nonsignaling components in brain are conserved across mammalian species and activity 
levels', Proc Natl Acad Sci U S A, vol. 110, pp. 3549-3554. 
Ide, K, Schmalbruch, IK, Quistorff, B, Horn, A & Secher, NH 2000, 'Lactate, glucose and 
O2 uptake in human brain during recovery from maximal exercise', J Physiol, vol. 522 Pt 1, 
pp. 159-164. 
Ivan, M, Kondo, K, Yang, H, Kim, W, Valiando, J, Ohh, M, . . . Kaelin, WG, Jr. 2001, 
'HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for 
O2 sensing', Science, vol. 292, pp. 464-468. 
Jaafari, N, Konopacki, FA, Owen, TF, Kantamneni, S, Rubin, P, Craig, TJ, . . . Henley, JM 
2013, 'SUMOylation is required for glycine-induced increases in AMPA receptor surface 
expression (ChemLTP) in hippocampal neurons', PLoS One, vol. 8. 
   147 
Jaakkola, P, Mole, DR, Tian, YM, Wilson, MI, Gielbert, J, Gaskell, SJ, . . . Ratcliffe, PJ 
2001, 'Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-
regulated prolyl hydroxylation', Science, vol. 292, pp. 468-472. 
Jahn, H 2013, 'Memory loss in Alzheimer's disease', Dialogues Clin Neurosci, vol. 15, pp. 
445-454. 
Jakymiw, A, Lian, S, Eystathioy, T, Li, S, Satoh, M, Hamel, JC, . . . Chan, EK 2005, 
'Disruption of GW bodies impairs mammalian RNA interference', Nat Cell Biol, vol. 7, pp. 
1267-1274. 
Jankowsky, JL, Melnikova, T, Fadale, DJ, Xu, GM, Slunt, HH, Gonzales, V, . . . 
Savonenko, AV 2005, 'Environmental enrichment mitigates cognitive deficits in a mouse 
model of Alzheimer's disease', J Neurosci, vol. 25, pp. 5217-5224. 
Janssen, HL, Reesink, HW, Lawitz, EJ, Zeuzem, S, Rodriguez-Torres, M, Patel, K, . . . 
Hodges, MR 2013, 'Treatment of HCV infection by targeting microRNA', N Engl J Med, vol. 
368, pp. 1685-1694. 
Jeitner, TM, Matson, WR, Folk, JE, Blass, JP & Cooper, AJ 2008, 'Increased levels of 
gamma-glutamylamines in Huntington disease CSF', J Neurochem, vol. 106, pp. 37-44. 
Jeng, SF, Rau, CS, Liliang, PC, Wu, CJ, Lu, TH, Chen, YC, . . . Hsieh, CH 2009, 'Profiling 
muscle-specific microRNA expression after peripheral denervation and reinnervation in a 
rat model', J Neurotrauma, vol. 26, pp. 2345-2353. 
Jiang, Y, Li, L, Tan, X, Liu, B, Zhang, Y & Li, C 2015, 'miR-210 mediates vagus nerve 
stimulation-induced antioxidant stress and anti-apoptosis reactions following cerebral 
ischemia/reperfusion injury in rats', J Neurochem, vol. 134, pp. 173-181. 
Jin, HY, Gonzalez-Martin, A, Miletic, AV, Lai, M, Knight, S, Sabouri-Ghomi, M, . . . Xiao, C 
2015, 'Transfection of microRNA Mimics Should Be Used with Caution', Front Genet, vol. 
6. 
Jing, Q, Huang, S, Guth, S, Zarubin, T, Motoyama, A, Chen, J, . . . Han, J 2005, 
'Involvement of microRNA in AU-rich element-mediated mRNA instability', Cell, vol. 120, 
pp. 623-634. 
Johansson, BB 1996, 'Functional outcome in rats transferred to an enriched environment 
15 days after focal brain ischemia', Stroke, vol. 27, pp. 324-326. 
Johansson, BB & Ohlsson, AL 1996, 'Environment, social interaction, and physical activity 
as determinants of functional outcome after cerebral infarction in the rat', Exp Neurol, vol. 
139, pp. 322-327. 
John, B, Enright, AJ, Aravin, A, Tuschl, T, Sander, C & Marks, DS 2004, 'Human 
MicroRNA targets', PLoS Biol, vol. 2. 
Johnson, GV, Cox, TM, Lockhart, JP, Zinnerman, MD, Miller, ML & Powers, RE 1997, 
'Transglutaminase activity is increased in Alzheimer's disease brain', Brain Res, vol. 751, 
pp. 323-329. 
Joilin, G, Guevremont, D, Ryan, B, Claudianos, C, Cristino, AS, Abraham, WC & Williams, 
JM 2014, 'Rapid regulation of microRNA following induction of long-term potentiation in 
vivo', Front Mol Neurosci, vol. 7. 
Jopling, CL, Yi, M, Lancaster, AM, Lemon, SM & Sarnow, P 2005, 'Modulation of hepatitis 
C virus RNA abundance by a liver-specific MicroRNA', Science, vol. 309, pp. 1577-1581. 
   148 
Ju, W, Morishita, W, Tsui, J, Gaietta, G, Deerinck, TJ, Adams, SR, . . . Malenka, RC 2004, 
'Activity-dependent regulation of dendritic synthesis and trafficking of AMPA receptors', 
Nat Neurosci, vol. 7, pp. 244-253. 
Juan, D, Alexe, G, Antes, T, Liu, H, Madabhushi, A, Delisi, C, . . . Liou, LS 2010, 
'Identification of a microRNA panel for clear-cell kidney cancer', Urology, vol. 75, pp. 835-
841. 
Junn, E, Ronchetti, RD, Quezado, MM, Kim, SY & Mouradian, MM 2003, 'Tissue 
transglutaminase-induced aggregation of alpha-synuclein: Implications for Lewy body 
formation in Parkinson's disease and dementia with Lewy bodies', Proc Natl Acad Sci U S 
A, vol. 100, pp. 2047-2052. 
Kaech, S & Banker, G 2006, 'Culturing hippocampal neurons', Nat Protoc, vol. 1, pp. 2406-
2415. 
Kanehisa, M, Sato, Y, Kawashima, M, Furumichi, M & Tanabe, M 2016, 'KEGG as a 
reference resource for gene and protein annotation', Nucleic Acids Res, vol. 44, pp. D457-
462. 
Kang, H & Schuman, EM 1996, 'A requirement for local protein synthesis in neurotrophin-
induced hippocampal synaptic plasticity', Science, vol. 273, pp. 1402-1406. 
Kang, MJ, Jung, SM, Kim, MJ, Bae, JH, Kim, HB, Kim, JY, . . . Kim, SH 2008, 'DNA-
dependent protein kinase is involved in heat shock protein-mediated accumulation of 
hypoxia-inducible factor-1alpha in hypoxic preconditioned HepG2 cells', FEBS J, vol. 275, 
pp. 5969-5981. 
Kapranov, P, Cawley, SE, Drenkow, J, Bekiranov, S, Strausberg, RL, Fodor, SP & 
Gingeras, TR 2002, 'Large-scale transcriptional activity in chromosomes 21 and 22', 
Science, vol. 296, pp. 916-919. 
Kasischke, KA, Vishwasrao, HD, Fisher, PJ, Zipfel, WR & Webb, WW 2004, 'Neural 
activity triggers neuronal oxidative metabolism followed by astrocytic glycolysis', Science, 
vol. 305, pp. 99-103. 
Katchanov, J, Waeber, C, Gertz, K, Gietz, A, Winter, B, Bruck, W, . . . Endres, M 2003, 
'Selective neuronal vulnerability following mild focal brain ischemia in the mouse', Brain 
Pathol, vol. 13, pp. 452-464. 
Katoh, T, Sakaguchi, Y, Miyauchi, K, Suzuki, T, Kashiwabara, S, Baba, T & Suzuki, T 
2009, 'Selective stabilization of mammalian microRNAs by 3' adenylation mediated by the 
cytoplasmic poly(A) polymerase GLD-2', Genes Dev, vol. 23, pp. 433-438. 
Katz, IK & Lamprecht, R 2015, 'Fear conditioning leads to alteration in specific genes 
expression in cortical and thalamic neurons that project to the lateral amygdala', J 
Neurochem, vol. 132, pp. 313-326. 
Kelly, TJ, Souza, AL, Clish, CB & Puigserver, P 2011, 'A hypoxia-induced positive 
feedback loop promotes hypoxia-inducible factor 1alpha stability through miR-210 
suppression of glycerol-3-phosphate dehydrogenase 1-like', Mol Cell Biol, vol. 31, pp. 
2696-2706. 
Kempermann, G, Kuhn, HG & Gage, FH 1998, 'Experience-induced neurogenesis in the 
senescent dentate gyrus', J Neurosci, vol. 18, pp. 3206-3212. 
Kersey, PJ, Allen, JE, Allot, A, Barba, M, Boddu, S, Bolt, BJ, . . . Yates, A 2017, 'Ensembl 
Genomes 2018: an integrated omics infrastructure for non-vertebrate species', Nucleic 
Acids Res. 
   149 
Kertesz, M, Iovino, N, Unnerstall, U, Gaul, U & Segal, E 2007, 'The role of site accessibility 
in microRNA target recognition', Nat Genet, vol. 39, pp. 1278-1284. 
Kim, D, Pertea, G, Trapnell, C, Pimentel, H, Kelley, R & Salzberg, SL 2013, 'TopHat2: 
accurate alignment of transcriptomes in the presence of insertions, deletions and gene 
fusions', Genome Biol, vol. 14. 
Kim, D, Sung, YM, Park, J, Kim, S, Kim, J, Park, J, . . . Baek, D 2016, 'General rules for 
functional microRNA targeting', Nat Genet, vol. 48, pp. 1517-1526. 
Kim, DH, Saetrom, P, Snove, O, Jr. & Rossi, JJ 2008, 'MicroRNA-directed transcriptional 
gene silencing in mammalian cells', Proc Natl Acad Sci U S A, vol. 105, pp. 16230-16235. 
Kim, JW, Tchernyshyov, I, Semenza, GL & Dang, CV 2006, 'HIF-1-mediated expression of 
pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to 
hypoxia', Cell Metab, vol. 3, pp. 177-185. 
Kim, SY, Marekov, L, Bubber, P, Browne, SE, Stavrovskaya, I, Lee, J, . . . Cooper, AJ 
2005, 'Mitochondrial aconitase is a transglutaminase 2 substrate: transglutamination is a 
probable mechanism contributing to high-molecular-weight aggregates of aconitase and 
loss of aconitase activity in Huntington disease brain', Neurochem Res, vol. 30, pp. 1245-
1255. 
Kinch, LN & Grishin, NV 2009, 'The human Ago2 MC region does not contain an eIF4E-
like mRNA cap binding motif', Biol Direct, vol. 4. 
Kiriakidou, M, Tan, GS, Lamprinaki, S, De Planell-Saguer, M, Nelson, PT & Mourelatos, Z 
2007, 'An mRNA m7G cap binding-like motif within human Ago2 represses translation', 
Cell, vol. 129, pp. 1141-1151. 
Kittler, JT, Delmas, P, Jovanovic, JN, Brown, DA, Smart, TG & Moss, SJ 2000, 
'Constitutive endocytosis of GABAA receptors by an association with the adaptin AP2 
complex modulates inhibitory synaptic currents in hippocampal neurons', J Neurosci, vol. 
20, pp. 7972-7977. 
Klase, Z, Kale, P, Winograd, R, Gupta, MV, Heydarian, M, Berro, R, . . . Kashanchi, F 
2007, 'HIV-1 TAR element is processed by Dicer to yield a viral micro-RNA involved in 
chromatin remodeling of the viral LTR', BMC Mol Biol, vol. 8. 
Klivenyi, P, Siwek, D, Gardian, G, Yang, L, Starkov, A, Cleren, C, . . . Beal, MF 2006, 'Mice 
lacking alpha-synuclein are resistant to mitochondrial toxins', Neurobiol Dis, vol. 21, pp. 
541-548. 
Klivenyi, P, Starkov, AA, Calingasan, NY, Gardian, G, Browne, SE, Yang, L, . . . Beal, MF 
2004, 'Mice deficient in dihydrolipoamide dehydrogenase show increased vulnerability to 
MPTP, malonate and 3-nitropropionic acid neurotoxicity', J Neurochem, vol. 88, pp. 1352-
1360. 
Koh, MY & Powis, G 2012, 'Passing the baton: the HIF switch', Trends Biochem Sci, vol. 
37, pp. 364-372. 
Komada, M, Takao, K & Miyakawa, T 2008, 'Elevated plus maze for mice', J Vis Exp. 
Koong, AC, Denko, NC, Hudson, KM, Schindler, C, Swiersz, L, Koch, C, . . . Giaccia, AJ 
2000, 'Candidate genes for the hypoxic tumor phenotype', Cancer Res, vol. 60, pp. 883-
887. 
Korotkova, T, Fuchs, EC, Ponomarenko, A, von Engelhardt, J & Monyer, H 2010, 'NMDA 
receptor ablation on parvalbumin-positive interneurons impairs hippocampal synchrony, 
spatial representations, and working memory', Neuron, vol. 68, pp. 557-569. 
   150 
Kosik, KS & Finch, EA 1987, 'MAP2 and tau segregate into dendritic and axonal domains 
after the elaboration of morphologically distinct neurites: an immunocytochemical study of 
cultured rat cerebrum', J Neurosci, vol. 7, pp. 3142-3153. 
Kovalevich, J & Langford, D 2013, 'Considerations for the use of SH-SY5Y neuroblastoma 
cells in neurobiology', Methods Mol Biol, vol. 1078, pp. 9-21. 
Kraggerud, SM, Sandvik, JA & Pettersen, EO 1995, 'Regulation of protein synthesis in 
human cells exposed to extreme hypoxia', Anticancer Res, vol. 15, pp. 683-686. 
Kramer, MF 2011, 'Stem-loop RT-qPCR for miRNAs', Curr Protoc Mol Biol, vol. Chapter 
15. 
Kraytsberg, Y, Kudryavtseva, E, McKee, AC, Geula, C, Kowall, NW & Khrapko, K 2006, 
'Mitochondrial DNA deletions are abundant and cause functional impairment in aged 
human substantia nigra neurons', Nat Genet, vol. 38, pp. 518-520. 
Krek, A, Grun, D, Poy, MN, Wolf, R, Rosenberg, L, Epstein, EJ, . . . Rajewsky, N 2005, 
'Combinatorial microRNA target predictions', Nat Genet, vol. 37, pp. 495-500. 
Kretschmann, A, Danis, B, Andonovic, L, Abnaof, K, van Rikxoort, M, Siegel, F, . . . Pfeifer, 
A 2015, 'Different microRNA profiles in chronic epilepsy versus acute seizure mouse 
models', J Mol Neurosci, vol. 55, pp. 466-479. 
Kretz, M, Siprashvili, Z, Chu, C, Webster, DE, Zehnder, A, Qu, K, . . . Khavari, PA 2013, 
'Control of somatic tissue differentiation by the long non-coding RNA TINCR', Nature, vol. 
493, pp. 231-235. 
Krichevsky, AM, King, KS, Donahue, CP, Khrapko, K & Kosik, KS 2003, 'A microRNA 
array reveals extensive regulation of microRNAs during brain development', RNA, vol. 9, 
pp. 1274-1281. 
Krol, J, Busskamp, V, Markiewicz, I, Stadler, MB, Ribi, S, Richter, J, . . . Filipowicz, W 
2010, 'Characterizing light-regulated retinal microRNAs reveals rapid turnover as a 
common property of neuronal microRNAs', Cell, vol. 141, pp. 618-631. 
Kulshreshtha, R, Ferracin, M, Wojcik, SE, Garzon, R, Alder, H, Agosto-Perez, FJ, . . . Ivan, 
M 2007, 'A microRNA signature of hypoxia', Mol Cell Biol, vol. 27, pp. 1859-1867. 
Kumar, KN, Tilakaratne, N, Johnson, PS, Allen, AE & Michaelis, EK 1991, 'Cloning of 
cDNA for the glutamate-binding subunit of an NMDA receptor complex', Nature, vol. 354, 
pp. 70-73. 
Kumar-Singh, S, Pirici, D, McGowan, E, Serneels, S, Ceuterick, C, Hardy, J, . . . Van 
Broeckhoven, C 2005, 'Dense-core plaques in Tg2576 and PSAPP mouse models of 
Alzheimer's disease are centered on vessel walls', Am J Pathol, vol. 167, pp. 527-543. 
Kvamme, E 1998, 'Synthesis of glutamate and its regulation', Prog Brain Res, vol. 116, pp. 
73-85. 
Kwon, AT, Arenillas, DJ, Worsley Hunt, R & Wasserman, WW 2012, 'oPOSSUM-3: 
advanced analysis of regulatory motif over-representation across genes or ChIP-Seq 
datasets', G3 (Bethesda), vol. 2, pp. 987-1002. 
Kye, MJ, Neveu, P, Lee, YS, Zhou, M, Steen, JA, Sahin, M, . . . Silva, AJ 2011, 'NMDA 
mediated contextual conditioning changes miRNA expression', PLoS One, vol. 6. 
Lagos-Quintana, M, Rauhut, R, Lendeckel, W & Tuschl, T 2001, 'Identification of novel 
genes coding for small expressed RNAs', Science, vol. 294, pp. 853-858. 
Lagos-Quintana, M, Rauhut, R, Yalcin, A, Meyer, J, Lendeckel, W & Tuschl, T 2002, 
'Identification of tissue-specific microRNAs from mouse', Curr Biol, vol. 12, pp. 735-739. 
   151 
Lai, NS, Wu, DG, Fang, XG, Lin, YC, Chen, SS, Li, ZB & Xu, SS 2015, 'Serum microRNA-
210 as a potential noninvasive biomarker for the diagnosis and prognosis of glioma', Br J 
Cancer, vol. 112, pp. 1241-1246. 
Lander, ES, Linton, LM, Birren, B, Nusbaum, C, Zody, MC, Baldwin, J, . . . International 
Human Genome Sequencing, C 2001, 'Initial sequencing and analysis of the human 
genome', Nature, vol. 409, pp. 860-921. 
Langmead, B & Salzberg, SL 2012, 'Fast gapped-read alignment with Bowtie 2', Nat 
Methods, vol. 9, pp. 357-359. 
Langston, JW, Ballard, P, Tetrud, JW & Irwin, I 1983, 'Chronic Parkinsonism in humans 
due to a product of meperidine-analog synthesis', Science, vol. 219, pp. 979-980. 
Lardizabal, MN, Nocito, AL, Daniele, SM, Ornella, LA, Palatnik, JF & Veggi, LM 2012, 
'Reference genes for real-time PCR quantification of microRNAs and messenger RNAs in 
rat models of hepatotoxicity', PLoS One, vol. 7. 
Lau, NC, Lim, LP, Weinstein, EG & Bartel, DP 2001, 'An abundant class of tiny RNAs with 
probable regulatory roles in Caenorhabditis elegans', Science, vol. 294, pp. 858-862. 
Le Thomas, A, Rogers, AK, Webster, A, Marinov, GK, Liao, SE, Perkins, EM, . . . Toth, KF 
2013, 'Piwi induces piRNA-guided transcriptional silencing and establishment of a 
repressive chromatin state', Genes Dev, vol. 27, pp. 390-399. 
Lee, HJ, Shin, SY, Choi, C, Lee, YH & Lee, SJ 2002a, 'Formation and removal of alpha-
synuclein aggregates in cells exposed to mitochondrial inhibitors', J Biol Chem, vol. 277, 
pp. 5411-5417. 
Lee, RC & Ambros, V 2001, 'An extensive class of small RNAs in Caenorhabditis elegans', 
Science, vol. 294, pp. 862-864. 
Lee, SH, Liu, L, Wang, YT & Sheng, M 2002b, 'Clathrin adaptor AP2 and NSF interact with 
overlapping sites of GluR2 and play distinct roles in AMPA receptor trafficking and 
hippocampal LTD', Neuron, vol. 36, pp. 661-674. 
Lee, Y, Ahn, C, Han, J, Choi, H, Kim, J, Yim, J, . . . Kim, VN 2003, 'The nuclear RNase III 
Drosha initiates microRNA processing', Nature, vol. 425, pp. 415-419. 
Leeson, VC, Robbins, TW, Matheson, E, Hutton, SB, Ron, MA, Barnes, TR & Joyce, EM 
2009, 'Discrimination learning, reversal, and set-shifting in first-episode schizophrenia: 
stability over six years and specific associations with medication type and disorganization 
syndrome', Biol Psychiatry, vol. 66, pp. 586-593. 
Levenson, JM, Choi, S, Lee, SY, Cao, YA, Ahn, HJ, Worley, KC, . . . Sweatt, JD 2004, 'A 
bioinformatics analysis of memory consolidation reveals involvement of the transcription 
factor c-rel', J Neurosci, vol. 24, pp. 3933-3943. 
Lewis, BP, Burge, CB & Bartel, DP 2005, 'Conserved seed pairing, often flanked by 
adenosines, indicates that thousands of human genes are microRNA targets', Cell, vol. 
120, pp. 15-20. 
Lewis, BP, Shih, IH, Jones-Rhoades, MW, Bartel, DP & Burge, CB 2003, 'Prediction of 
mammalian microRNA targets', Cell, vol. 115, pp. 787-798. 
Li, H, Handsaker, B, Wysoker, A, Fennell, T, Ruan, J, Homer, N, . . . Genome Project Data 
Processing, S 2009, 'The Sequence Alignment/Map format and SAMtools', Bioinformatics, 
vol. 25, pp. 2078-2079. 
Li, H, Mao, S, Wang, H, Zen, K, Zhang, C & Li, L 2014a, 'MicroRNA-29a modulates axon 
branching by targeting doublecortin in primary neurons', Protein Cell, vol. 5, pp. 160-169. 
   152 
Li, JJ, Dolios, G, Wang, R & Liao, FF 2014b, 'Soluble beta-amyloid peptides, but not 
insoluble fibrils, have specific effect on neuronal microRNA expression', PLoS One, vol. 9. 
Li, X, Alafuzoff, I, Soininen, H, Winblad, B & Pei, JJ 2005, 'Levels of mTOR and its 
downstream targets 4E-BP1, eEF2, and eEF2 kinase in relationships with tau in 
Alzheimer's disease brain', FEBS J, vol. 272, pp. 4211-4220. 
Li, X, Chen, Y, Shao, S, Tang, Q, Chen, W, Chen, Y & Xu, X 2016, 'Oxidative stress 
induces the decline of brain EPO expression in aging rats', Exp Gerontol, vol. 83, pp. 89-
93. 
Li-Byarlay, H, Rittschof, CC, Massey, JH, Pittendrigh, BR & Robinson, GE 2014, 'Socially 
responsive effects of brain oxidative metabolism on aggression', Proc Natl Acad Sci U S A, 
vol. 111, pp. 12533-12537. 
Liang, H, Hippenmeyer, S & Ghashghaei, HT 2012, 'A Nestin-cre transgenic mouse is 
insufficient for recombination in early embryonic neural progenitors', Biol Open, vol. 1, pp. 
1200-1203. 
Licatalosi, DD, Mele, A, Fak, JJ, Ule, J, Kayikci, M, Chi, SW, . . . Darnell, RB 2008, 'HITS-
CLIP yields genome-wide insights into brain alternative RNA processing', Nature, vol. 456, 
pp. 464-469. 
Lim, LP, Lau, NC, Garrett-Engele, P, Grimson, A, Schelter, JM, Castle, J, . . . Johnson, JM 
2005, 'Microarray analysis shows that some microRNAs downregulate large numbers of 
target mRNAs', Nature, vol. 433, pp. 769-773. 
Lin, AL, Fox, PT, Hardies, J, Duong, TQ & Gao, JH 2010, 'Nonlinear coupling between 
cerebral blood flow, oxygen consumption, and ATP production in human visual cortex', 
Proc Natl Acad Sci U S A, vol. 107, pp. 8446-8451. 
Lin, YL & Lai, ZX 2013, 'Evaluation of suitable reference genes for normalization of 
microRNA expression by real-time reverse transcription PCR analysis during longan 
somatic embryogenesis', Plant Physiol Biochem, vol. 66, pp. 20-25. 
Lindsay, J, Laurin, D, Verreault, R, Hebert, R, Helliwell, B, Hill, GB & McDowell, I 2002, 
'Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of 
Health and Aging', Am J Epidemiol, vol. 156, pp. 445-453. 
Liu, F, Lou, YL, Wu, J, Ruan, QF, Xie, A, Guo, F, . . . Wang, Y 2012a, 'Upregulation of 
microRNA-210 regulates renal angiogenesis mediated by activation of VEGF signaling 
pathway under ischemia/perfusion injury in vivo and in vitro', Kidney Blood Press Res, vol. 
35, pp. 182-191. 
Liu, J, Valencia-Sanchez, MA, Hannon, GJ & Parker, R 2005, 'MicroRNA-dependent 
localization of targeted mRNAs to mammalian P-bodies', Nat Cell Biol, vol. 7, pp. 719-723. 
Liu, L, Komatsu, H, Murray, IV & Axelsen, PH 2008a, 'Promotion of amyloid beta protein 
misfolding and fibrillogenesis by a lipid oxidation product', J Mol Biol, vol. 377, pp. 1236-
1250. 
Liu, Y, Han, Y, Zhang, H, Nie, L, Jiang, Z, Fa, P, . . . Cai, Z 2012b, 'Synthetic miRNA-
mowers targeting miR-183-96-182 cluster or miR-210 inhibit growth and migration and 
induce apoptosis in bladder cancer cells', PLoS One, vol. 7. 
Liu, Y, Liu, F, Iqbal, K, Grundke-Iqbal, I & Gong, CX 2008b, 'Decreased glucose 
transporters correlate to abnormal hyperphosphorylation of tau in Alzheimer disease', 
FEBS Lett, vol. 582, pp. 359-364. 
   153 
Lodge, DJ, Behrens, MM & Grace, AA 2009, 'A loss of parvalbumin-containing 
interneurons is associated with diminished oscillatory activity in an animal model of 
schizophrenia', J Neurosci, vol. 29, pp. 2344-2354. 
Lopes, FM, Schroder, R, da Frota, ML, Jr., Zanotto-Filho, A, Muller, CB, Pires, AS, . . . 
Klamt, F 2010, 'Comparison between proliferative and neuron-like SH-SY5Y cells as an in 
vitro model for Parkinson disease studies', Brain Res, vol. 1337, pp. 85-94. 
Lou, YL, Guo, F, Liu, F, Gao, FL, Zhang, PQ, Niu, X, . . . Deng, ZF 2012, 'miR-210 
activates notch signaling pathway in angiogenesis induced by cerebral ischemia', Mol Cell 
Biochem, vol. 370, pp. 45-51. 
Louveau, A, Angibaud, J, Haspot, F, Opazo, MC, Thinard, R, Thepenier, V, . . . Boudin, H 
2013, 'Impaired spatial memory in mice lacking CD3zeta is associated with altered NMDA 
and AMPA receptors signaling independent of T-cell deficiency', J Neurosci, vol. 33, pp. 
18672-18685. 
Love, MI, Huber, W & Anders, S 2014, 'Moderated estimation of fold change and 
dispersion for RNA-seq data with DESeq2', Genome Biol, vol. 15. 
Lovell, MA, Smith, JL & Markesbery, WR 2006, 'Elevated zinc transporter-6 in mild 
cognitive impairment, Alzheimer disease, and pick disease', J Neuropathol Exp Neurol, 
vol. 65, pp. 489-498. 
Lovell, MA, Smith, JL, Xiong, S & Markesbery, WR 2005, 'Alterations in zinc transporter 
protein-1 (ZnT-1) in the brain of subjects with mild cognitive impairment, early, and late-
stage Alzheimer's disease', Neurotox Res, vol. 7, pp. 265-271. 
Lu, H, Golay, X, Pekar, JJ & Van Zijl, PC 2004, 'Sustained poststimulus elevation in 
cerebral oxygen utilization after vascular recovery', J Cereb Blood Flow Metab, vol. 24, pp. 
764-770. 
Lu, W, Man, H, Ju, W, Trimble, WS, MacDonald, JF & Wang, YT 2001, 'Activation of 
synaptic NMDA receptors induces membrane insertion of new AMPA receptors and LTP in 
cultured hippocampal neurons', Neuron, vol. 29, pp. 243-254. 
Lugli, G, Larson, J, Martone, ME, Jones, Y & Smalheiser, NR 2005, 'Dicer and eIF2c are 
enriched at postsynaptic densities in adult mouse brain and are modified by neuronal 
activity in a calpain-dependent manner', J Neurochem, vol. 94, pp. 896-905. 
Lugli, G, Torvik, VI, Larson, J & Smalheiser, NR 2008, 'Expression of microRNAs and their 
precursors in synaptic fractions of adult mouse forebrain', J Neurochem, vol. 106, pp. 650-
661. 
Lund, E, Guttinger, S, Calado, A, Dahlberg, JE & Kutay, U 2004, 'Nuclear export of 
microRNA precursors', Science, vol. 303, pp. 95-98. 
Lundgaard, I, Li, B, Xie, L, Kang, H, Sanggaard, S, Haswell, JD, . . . Nedergaard, M 2015, 
'Direct neuronal glucose uptake heralds activity-dependent increases in cerebral 
metabolism', Nat Commun, vol. 6. 
Lyford, GL, Yamagata, K, Kaufmann, WE, Barnes, CA, Sanders, LK, Copeland, NG, . . . 
Worley, PF 1995, 'Arc, a growth factor and activity-regulated gene, encodes a novel 
cytoskeleton-associated protein that is enriched in neuronal dendrites', Neuron, vol. 14, 
pp. 433-445. 
Ma, Q, Dasgupta, C, Li, Y, Bajwa, NM, Xiong, F, Harding, B, . . . Zhang, L 2016, 'Inhibition 
of microRNA-210 provides neuroprotection in hypoxic-ischemic brain injury in neonatal 
rats', Neurobiol Dis, vol. 89, pp. 202-212. 
   154 
Maag, JL, Panja, D, Sporild, I, Patil, S, Kaczorowski, DC, Bramham, CR, . . . Wibrand, K 
2015, 'Dynamic expression of long noncoding RNAs and repeat elements in synaptic 
plasticity', Front Neurosci, vol. 9. 
Macas, J, Nern, C, Plate, KH & Momma, S 2006, 'Increased generation of neuronal 
progenitors after ischemic injury in the aged adult human forebrain', J Neurosci, vol. 26, 
pp. 13114-13119. 
MacDonald, ME, Ambrose, CM, Duyao, MP, Myers, RH, Lin, C, Srinidhi, L, . . . Harper, PS 
1993, 'A novel gene containing a trinucleotide repeat that is expanded and unstable on 
Huntington's disease chromosomes', Cell, vol. 72, pp. 971-983. 
Machler, P, Wyss, MT, Elsayed, M, Stobart, J, Gutierrez, R, von Faber-Castell, A, . . . 
Weber, B 2016, 'In Vivo Evidence for a Lactate Gradient from Astrocytes to Neurons', Cell 
Metab, vol. 23, pp. 94-102. 
Maddock, RJ, Buonocore, MH, Copeland, LE & Richards, AL 2009, 'Elevated brain lactate 
responses to neural activation in panic disorder: a dynamic 1H-MRS study', Mol 
Psychiatry, vol. 14, pp. 537-545. 
Mallet, N, Ballion, B, Le Moine, C & Gonon, F 2006, 'Cortical inputs and GABA 
interneurons imbalance projection neurons in the striatum of parkinsonian rats', J 
Neurosci, vol. 26, pp. 3875-3884. 
Malzkorn, B, Wolter, M, Liesenberg, F, Grzendowski, M, Stuhler, K, Meyer, HE & 
Reifenberger, G 2010, 'Identification and functional characterization of microRNAs 
involved in the malignant progression of gliomas', Brain Pathol, vol. 20, pp. 539-550. 
Manczak, M, Anekonda, TS, Henson, E, Park, BS, Quinn, J & Reddy, PH 2006, 
'Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: 
implications for free radical generation and oxidative damage in disease progression', Hum 
Mol Genet, vol. 15, pp. 1437-1449. 
Mangia, S, Tkac, I, Gruetter, R, Van de Moortele, PF, Maraviglia, B & Ugurbil, K 2007, 
'Sustained neuronal activation raises oxidative metabolism to a new steady-state level: 
evidence from 1H NMR spectroscopy in the human visual cortex', J Cereb Blood Flow 
Metab, vol. 27, pp. 1055-1063. 
Manno, I, Macchi, F, Caleo, M & Bozzi, Y 2011, 'Environmental enrichment reduces 
spontaneous seizures in the Q54 transgenic mouse model of temporal lobe epilepsy', 
Epilepsia, vol. 52, pp. e113-117. 
Mar, AC, Horner, AE, Nilsson, SR, Alsio, J, Kent, BA, Kim, CH, . . . Bussey, TJ 2013, 'The 
touchscreen operant platform for assessing executive function in rats and mice', Nat 
Protoc, vol. 8, pp. 1985-2005. 
Markram, H, Lubke, J, Frotscher, M & Sakmann, B 1997, 'Regulation of synaptic efficacy 
by coincidence of postsynaptic APs and EPSPs', Science, vol. 275, pp. 213-215. 
Maroney, PA, Yu, Y, Fisher, J & Nilsen, TW 2006, 'Evidence that microRNAs are 
associated with translating messenger RNAs in human cells', Nat Struct Mol Biol, vol. 13, 
pp. 1102-1107. 
Marti-Fabregas, J, Romaguera-Ros, M, Gomez-Pinedo, U, Martinez-Ramirez, S, Jimenez-
Xarrie, E, Marin, R, . . . Garcia-Verdugo, JM 2010, 'Proliferation in the human ipsilateral 
subventricular zone after ischemic stroke', Neurology, vol. 74, pp. 357-365. 
Martin, LJ, Pan, Y, Price, AC, Sterling, W, Copeland, NG, Jenkins, NA, . . . Lee, MK 2006, 
'Parkinson's disease alpha-synuclein transgenic mice develop neuronal mitochondrial 
degeneration and cell death', J Neurosci, vol. 26, pp. 41-50. 
   155 
Martinez, J, Patkaniowska, A, Urlaub, H, Luhrmann, R & Tuschl, T 2002, 'Single-stranded 
antisense siRNAs guide target RNA cleavage in RNAi', Cell, vol. 110, pp. 563-574. 
Maruff, P, Pantelis, C, Danckert, J, Smith, D & Currie, J 1996, 'Deficits in the endogenous 
redirection of covert visual attention in chronic schizophrenia', Neuropsychologia, vol. 34, 
pp. 1079-1084. 
Matsui, T, Ishikawa, T, Ito, H, Okamoto, M, Inoue, K, Lee, MC, . . . Soya, H 2012, 'Brain 
glycogen supercompensation following exhaustive exercise', J Physiol, vol. 590, pp. 607-
616. 
Matsui, T, Soya, S, Kawanaka, K & Soya, H 2015, 'Brain Glycogen Decreases During 
Intense Exercise Without Hypoglycemia: The Possible Involvement of Serotonin', 
Neurochem Res, vol. 40, pp. 1333-1340. 
Matts, JA, Sytnikova, Y, Chirn, GW, Igloi, GL & Lau, NC 2014, 'Small RNA library 
construction from minute biological samples', Methods Mol Biol, vol. 1093, pp. 123-136. 
McKiernan, RC, Jimenez-Mateos, EM, Bray, I, Engel, T, Brennan, GP, Sano, T, . . . 
Henshall, DC 2012, 'Reduced mature microRNA levels in association with dicer loss in 
human temporal lobe epilepsy with hippocampal sclerosis', PLoS One, vol. 7. 
McLean, CA, Cherny, RA, Fraser, FW, Fuller, SJ, Smith, MJ, Beyreuther, K, . . . Masters, 
CL 1999, 'Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration 
in Alzheimer's disease', Ann Neurol, vol. 46, pp. 860-866. 
McNair, K, Broad, J, Riedel, G, Davies, CH & Cobb, SR 2007, 'Global changes in the 
hippocampal proteome following exposure to an enriched environment', Neuroscience, vol. 
145, pp. 413-422. 
Meister, G, Landthaler, M, Dorsett, Y & Tuschl, T 2004, 'Sequence-specific inhibition of 
microRNA- and siRNA-induced RNA silencing', RNA, vol. 10, pp. 544-550. 
Mercer, TR, Gerhardt, DJ, Dinger, ME, Crawford, J, Trapnell, C, Jeddeloh, JA, . . . Rinn, 
JL 2012, 'Targeted RNA sequencing reveals the deep complexity of the human 
transcriptome', Nat Biotechnol, vol. 30, pp. 99-104. 
Merianda, TT, Lin, AC, Lam, JS, Vuppalanchi, D, Willis, DE, Karin, N, . . . Twiss, JL 2009, 
'A functional equivalent of endoplasmic reticulum and Golgi in axons for secretion of locally 
synthesized proteins', Mol Cell Neurosci, vol. 40, pp. 128-142. 
Mignone, JL, Kukekov, V, Chiang, AS, Steindler, D & Enikolopov, G 2004, 'Neural stem 
and progenitor cells in nestin-GFP transgenic mice', J Comp Neurol, vol. 469, pp. 311-324. 
Miki, N, Kawabe, Y & Kuriyama, K 1977, 'Activation of cerebral guanylate cyclase by nitric 
oxide', Biochem Biophys Res Commun, vol. 75, pp. 851-856. 
Miko, E, Czimmerer, Z, Csanky, E, Boros, G, Buslig, J, Dezso, B & Scholtz, B 2009, 
'Differentially expressed microRNAs in small cell lung cancer', Exp Lung Res, vol. 35, pp. 
646-664. 
Milakovic, T, Quintanilla, RA & Johnson, GV 2006, 'Mutant huntingtin expression induces 
mitochondrial calcium handling defects in clonal striatal cells: functional consequences', J 
Biol Chem, vol. 281, pp. 34785-34795. 
Miles, R, Toth, K, Gulyas, AI, Hajos, N & Freund, TF 1996, 'Differences between somatic 
and dendritic inhibition in the hippocampus', Neuron, vol. 16, pp. 815-823. 
Miller, LM, Wang, Q, Telivala, TP, Smith, RJ, Lanzirotti, A & Miklossy, J 2006, 
'Synchrotron-based infrared and X-ray imaging shows focalized accumulation of Cu and 
   156 
Zn co-localized with beta-amyloid deposits in Alzheimer's disease', J Struct Biol, vol. 155, 
pp. 30-37. 
Minchenko, A, Leshchinsky, I, Opentanova, I, Sang, N, Srinivas, V, Armstead, V & Caro, J 
2002, 'Hypoxia-inducible factor-1-mediated expression of the 6-phosphofructo-2-
kinase/fructose-2,6-bisphosphatase-3 (PFKFB3) gene. Its possible role in the Warburg 
effect', J Biol Chem, vol. 277, pp. 6183-6187. 
Mishra, A, Reynolds, JP, Chen, Y, Gourine, AV, Rusakov, DA & Attwell, D 2016, 
'Astrocytes mediate neurovascular signaling to capillary pericytes but not to arterioles', Nat 
Neurosci, vol. 19, pp. 1619-1627. 
Mizuno, Y, Tokuzawa, Y, Ninomiya, Y, Yagi, K, Yatsuka-Kanesaki, Y, Suda, T, . . . 
Okazaki, Y 2009, 'miR-210 promotes osteoblastic differentiation through inhibition of 
AcvR1b', FEBS Lett, vol. 583, pp. 2263-2268. 
Montgomery, RL, Yu, G, Latimer, PA, Stack, C, Robinson, K, Dalby, CM, . . . van Rooij, E 
2014, 'MicroRNA mimicry blocks pulmonary fibrosis', EMBO Mol Med, vol. 6, pp. 1347-
1356. 
Mortimer, JA 1997, 'Brain reserve and the clinical expression of Alzheimer's disease', 
Geriatrics, vol. 52 Suppl 2, pp. S50-53. 
Mucke, L, Masliah, E, Yu, GQ, Mallory, M, Rockenstein, EM, Tatsuno, G, . . . McConlogue, 
L 2000, 'High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein 
precursor transgenic mice: synaptotoxicity without plaque formation', J Neurosci, vol. 20, 
pp. 4050-4058. 
Mulligan, SJ & MacVicar, BA 2004, 'Calcium transients in astrocyte endfeet cause 
cerebrovascular constrictions', Nature, vol. 431, pp. 195-199. 
Murai, KK, Nguyen, LN, Irie, F, Yamaguchi, Y & Pasquale, EB 2003, 'Control of 
hippocampal dendritic spine morphology through ephrin-A3/EphA4 signaling', Nat 
Neurosci, vol. 6, pp. 153-160. 
Murray, AJ, Sauer, JF, Riedel, G, McClure, C, Ansel, L, Cheyne, L, . . . Wulff, P 2011, 
'Parvalbumin-positive CA1 interneurons are required for spatial working but not for 
reference memory', Nat Neurosci, vol. 14, pp. 297-299. 
Nelson, PT & Wang, WX 2010, 'MiR-107 is reduced in Alzheimer's disease brain 
neocortex: validation study', J Alzheimers Dis, vol. 21, pp. 75-79. 
Niecknig, H, Tug, S, Reyes, BD, Kirsch, M, Fandrey, J & Berchner-Pfannschmidt, U 2012, 
'Role of reactive oxygen species in the regulation of HIF-1 by prolyl hydroxylase 2 under 
mild hypoxia', Free Radic Res, vol. 46, pp. 705-717. 
Nithianantharajah, J & Grant, SG 2013, 'Cognitive components in mice and humans: 
combining genetics and touchscreens for medical translation', Neurobiol Learn Mem, vol. 
105, pp. 13-19. 
Nithianantharajah, J, Komiyama, NH, McKechanie, A, Johnstone, M, Blackwood, DH, St 
Clair, D, . . . Grant, SG 2013, 'Synaptic scaffold evolution generated components of 
vertebrate cognitive complexity', Nat Neurosci, vol. 16, pp. 16-24. 
Niwa, K, Kazama, K, Younkin, L, Younkin, SG, Carlson, GA & Iadecola, C 2002, 
'Cerebrovascular autoregulation is profoundly impaired in mice overexpressing amyloid 
precursor protein', Am J Physiol Heart Circ Physiol, vol. 283, pp. H315-323. 
Norris, EH, Uryu, K, Leight, S, Giasson, BI, Trojanowski, JQ & Lee, VM 2007, 'Pesticide 
exposure exacerbates alpha-synucleinopathy in an A53T transgenic mouse model', Am J 
Pathol, vol. 170, pp. 658-666. 
   157 
Nottrott, S, Simard, MJ & Richter, JD 2006, 'Human let-7a miRNA blocks protein 
production on actively translating polyribosomes', Nat Struct Mol Biol, vol. 13, pp. 1108-
1114. 
Nyathi, Y & Baker, A 2006, 'Plant peroxisomes as a source of signalling molecules', 
Biochim Biophys Acta, vol. 1763, pp. 1478-1495. 
O'Sullivan, NC, McGettigan, PA, Sheridan, GK, Pickering, M, Conboy, L, O'Connor, JJ, . . . 
Murphy, KJ 2007, 'Temporal change in gene expression in the rat dentate gyrus following 
passive avoidance learning', J Neurochem, vol. 101, pp. 1085-1098. 
Oomen, CA, Hvoslef-Eide, M, Heath, CJ, Mar, AC, Horner, AE, Bussey, TJ & Saksida, LM 
2013, 'The touchscreen operant platform for testing working memory and pattern 
separation in rats and mice', Nat Protoc, vol. 8, pp. 2006-2021. 
Orom, UA, Nielsen, FC & Lund, AH 2008, 'MicroRNA-10a binds the 5'UTR of ribosomal 
protein mRNAs and enhances their translation', Mol Cell, vol. 30, pp. 460-471. 
Ota, T, Suzuki, Y, Nishikawa, T, Otsuki, T, Sugiyama, T, Irie, R, . . . Sugano, S 2004, 
'Complete sequencing and characterization of 21,243 full-length human cDNAs', Nat 
Genet, vol. 36, pp. 40-45. 
Ozonoff, S, Pennington, BF & Rogers, SJ 1991, 'Executive function deficits in high-
functioning autistic individuals: relationship to theory of mind', J Child Psychol Psychiatry, 
vol. 32, pp. 1081-1105. 
Pai, B, Siripornmongcolchai, T, Berentsen, B, Pakzad, A, Vieuille, C, Pallesen, S, . . . 
Bramham, CR 2014, 'NMDA receptor-dependent regulation of miRNA expression and 
association with Argonaute during LTP in vivo', Front Cell Neurosci, vol. 7. 
Pak, J & Fire, A 2007, 'Distinct populations of primary and secondary effectors during 
RNAi in C. elegans', Science, vol. 315, pp. 241-244. 
Park, CS, Gong, R, Stuart, J & Tang, SJ 2006, 'Molecular network and chromosomal 
clustering of genes involved in synaptic plasticity in the hippocampus', J Biol Chem, vol. 
281, pp. 30195-30211. 
Park, CS & Tang, SJ 2009, 'Regulation of microRNA expression by induction of 
bidirectional synaptic plasticity', J Mol Neurosci, vol. 38, pp. 50-56. 
Park, CY, Jeker, LT, Carver-Moore, K, Oh, A, Liu, HJ, Cameron, R, . . . McManus, MT 
2012, 'A resource for the conditional ablation of microRNAs in the mouse', Cell Rep, vol. 1, 
pp. 385-391. 
Park, M, Penick, EC, Edwards, JG, Kauer, JA & Ehlers, MD 2004, 'Recycling endosomes 
supply AMPA receptors for LTP', Science, vol. 305, pp. 1972-1975. 
Parker, WD, Jr., Filley, CM & Parks, JK 1990, 'Cytochrome oxidase deficiency in 
Alzheimer's disease', Neurology, vol. 40, pp. 1302-1303. 
Parker, WD, Jr. & Parks, JK 1995, 'Cytochrome c oxidase in Alzheimer's disease brain: 
purification and characterization', Neurology, vol. 45, pp. 482-486. 
Parker, WD, Jr. & Parks, JK 2005, 'Mitochondrial ND5 mutations in idiopathic Parkinson's 
disease', Biochem Biophys Res Commun, vol. 326, pp. 667-669. 
Patel, AB, Lai, JC, Chowdhury, GM, Hyder, F, Rothman, DL, Shulman, RG & Behar, KL 
2014, 'Direct evidence for activity-dependent glucose phosphorylation in neurons with 
implications for the astrocyte-to-neuron lactate shuttle', Proc Natl Acad Sci U S A, vol. 111, 
pp. 5385-5390. 
   158 
Pellerin, L & Magistretti, PJ 1994, 'Glutamate uptake into astrocytes stimulates aerobic 
glycolysis: a mechanism coupling neuronal activity to glucose utilization', Proc Natl Acad 
Sci U S A, vol. 91, pp. 10625-10629. 
Pellerin, L & Magistretti, PJ 1997, 'Glutamate uptake stimulates Na+,K+-ATPase activity in 
astrocytes via activation of a distinct subunit highly sensitive to ouabain', J Neurochem, 
vol. 69, pp. 2132-2137. 
Pepersack, T, Rotsaert, P, Benoit, F, Willems, D, Fuss, M, Bourdoux, P & Duchateau, J 
2001, 'Prevalence of zinc deficiency and its clinical relevance among hospitalised elderly', 
Arch Gerontol Geriatr, vol. 33, pp. 243-253. 
Peppiatt, CM, Howarth, C, Mobbs, P & Attwell, D 2006, 'Bidirectional control of CNS 
capillary diameter by pericytes', Nature, vol. 443, pp. 700-704. 
Perry, SW, Norman, JP, Barbieri, J, Brown, EB & Gelbard, HA 2011, 'Mitochondrial 
membrane potential probes and the proton gradient: a practical usage guide', 
Biotechniques, vol. 50, pp. 98-115. 
Petersen, CP, Bordeleau, ME, Pelletier, J & Sharp, PA 2006, 'Short RNAs repress 
translation after initiation in mammalian cells', Mol Cell, vol. 21, pp. 533-542. 
Pickard, L, Noel, J, Duckworth, JK, Fitzjohn, SM, Henley, JM, Collingridge, GL & Molnar, E 
2001, 'Transient synaptic activation of NMDA receptors leads to the insertion of native 
AMPA receptors at hippocampal neuronal plasma membranes', Neuropharmacology, vol. 
41, pp. 700-713. 
Pinkstaff, JK, Chappell, SA, Mauro, VP, Edelman, GM & Krushel, LA 2001, 'Internal 
initiation of translation of five dendritically localized neuronal mRNAs', Proc Natl Acad Sci 
U S A, vol. 98, pp. 2770-2775. 
Place, RF, Li, LC, Pookot, D, Noonan, EJ & Dahiya, R 2008, 'MicroRNA-373 induces 
expression of genes with complementary promoter sequences', Proc Natl Acad Sci U S A, 
vol. 105, pp. 1608-1613. 
Ploski, JE, Park, KW, Ping, J, Monsey, MS & Schafe, GE 2010, 'Identification of plasticity-
associated genes regulated by Pavlovian fear conditioning in the lateral amygdala', J 
Neurochem, vol. 112, pp. 636-650. 
Plun-Favreau, H, Klupsch, K, Moisoi, N, Gandhi, S, Kjaer, S, Frith, D, . . . Downward, J 
2007, 'The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated 
kinase PINK1', Nat Cell Biol, vol. 9, pp. 1243-1252. 
Pocock, R & Hobert, O 2008, 'Oxygen levels affect axon guidance and neuronal migration 
in Caenorhabditis elegans', Nat Neurosci, vol. 11, pp. 894-900. 
Pocock, R & Hobert, O 2010, 'Hypoxia activates a latent circuit for processing gustatory 
information in C. elegans', Nat Neurosci, vol. 13, pp. 610-614. 
Polidori, MC, Mecocci, P, Browne, SE, Senin, U & Beal, MF 1999, 'Oxidative damage to 
mitochondrial DNA in Huntington's disease parietal cortex', Neurosci Lett, vol. 272, pp. 53-
56. 
Pratico, D, V, MYL, Trojanowski, JQ, Rokach, J & Fitzgerald, GA 1998, 'Increased F2-
isoprostanes in Alzheimer's disease: evidence for enhanced lipid peroxidation in vivo', 
FASEB J, vol. 12, pp. 1777-1783. 
Priyadarshi, A, Khuder, SA, Schaub, EA & Priyadarshi, SS 2001, 'Environmental risk 
factors and Parkinson's disease: a metaanalysis', Environ Res, vol. 86, pp. 122-127. 
   159 
Pulkkinen, K, Malm, T, Turunen, M, Koistinaho, J & Yla-Herttuala, S 2008, 'Hypoxia 
induces microRNA miR-210 in vitro and in vivo ephrin-A3 and neuronal pentraxin 1 are 
potentially regulated by miR-210', FEBS Lett, vol. 582, pp. 2397-2401. 
Rafiki, A, Boulland, JL, Halestrap, AP, Ottersen, OP & Bergersen, L 2003, 'Highly 
differential expression of the monocarboxylate transporters MCT2 and MCT4 in the 
developing rat brain', Neuroscience, vol. 122, pp. 677-688. 
Rajasethupathy, P, Fiumara, F, Sheridan, R, Betel, D, Puthanveettil, SV, Russo, JJ, . . . 
Kandel, E 2009, 'Characterization of small RNAs in Aplysia reveals a role for miR-124 in 
constraining synaptic plasticity through CREB', Neuron, vol. 63, pp. 803-817. 
Ramamoorthy, P & Shi, H 2014, 'Ischemia induces different levels of hypoxia inducible 
factor-1alpha protein expression in interneurons and pyramidal neurons', Acta Neuropathol 
Commun, vol. 2. 
Rampon, C, Jiang, CH, Dong, H, Tang, YP, Lockhart, DJ, Schultz, PG, . . . Hu, Y 2000, 
'Effects of environmental enrichment on gene expression in the brain', Proc Natl Acad Sci 
U S A, vol. 97, pp. 12880-12884. 
Rangaraju, V, Calloway, N & Ryan, TA 2014, 'Activity-driven local ATP synthesis is 
required for synaptic function', Cell, vol. 156, pp. 825-835. 
Raven, EP, Lu, PH, Tishler, TA, Heydari, P & Bartzokis, G 2013, 'Increased iron levels and 
decreased tissue integrity in hippocampus of Alzheimer's disease detected in vivo with 
magnetic resonance imaging', J Alzheimers Dis, vol. 37, pp. 127-136. 
Reichenberg, A, Caspi, A, Harrington, H, Houts, R, Keefe, RS, Murray, RM, . . . Moffitt, TE 
2010, 'Static and dynamic cognitive deficits in childhood preceding adult schizophrenia: a 
30-year study', Am J Psychiatry, vol. 167, pp. 160-169. 
Rhein, V, Song, X, Wiesner, A, Ittner, LM, Baysang, G, Meier, F, . . . Eckert, A 2009, 
'Amyloid-beta and tau synergistically impair the oxidative phosphorylation system in triple 
transgenic Alzheimer's disease mice', Proc Natl Acad Sci U S A, vol. 106, pp. 20057-
20062. 
Rimoldi, S, Terova, G, Ceccuzzi, P, Marelli, S, Antonini, M & Saroglia, M 2012, 'HIF-1alpha 
mRNA levels in Eurasian perch (Perca fluviatilis) exposed to acute and chronic hypoxia', 
Mol Biol Rep, vol. 39, pp. 4009-4015. 
Rivard, A, Berthou-Soulie, L, Principe, N, Kearney, M, Curry, C, Branellec, D, . . . Isner, JM 
2000, 'Age-dependent defect in vascular endothelial growth factor expression is 
associated with reduced hypoxia-inducible factor 1 activity', J Biol Chem, vol. 275, pp. 
29643-29647. 
Robles, Y, Vivas-Mejia, PE, Ortiz-Zuazaga, HG, Felix, J, Ramos, X & Pena de Ortiz, S 
2003, 'Hippocampal gene expression profiling in spatial discrimination learning', Neurobiol 
Learn Mem, vol. 80, pp. 80-95. 
Rodriguez, A, Griffiths-Jones, S, Ashurst, JL & Bradley, A 2004, 'Identification of 
mammalian microRNA host genes and transcription units', Genome Res, vol. 14, pp. 1902-
1910. 
Rogers, RD, Andrews, TC, Grasby, PM, Brooks, DJ & Robbins, TW 2000, 'Contrasting 
cortical and subcortical activations produced by attentional-set shifting and reversal 
learning in humans', J Cogn Neurosci, vol. 12, pp. 142-162. 
Rohrbach, S, Simm, A, Pregla, R, Franke, C & Katschinski, DM 2005, 'Age-dependent 
increase of prolyl-4-hydroxylase domain (PHD) 3 expression in human and mouse heart', 
Biogerontology, vol. 6, pp. 165-171. 
   160 
Rolett, EL, Azzawi, A, Liu, KJ, Yongbi, MN, Swartz, HM & Dunn, JF 2000, 'Critical oxygen 
tension in rat brain: a combined (31)P-NMR and EPR oximetry study', Am J Physiol Regul 
Integr Comp Physiol, vol. 279, pp. R9-R16. 
Row, BW, Liu, R, Xu, W, Kheirandish, L & Gozal, D 2003, 'Intermittent hypoxia is 
associated with oxidative stress and spatial learning deficits in the rat', Am J Respir Crit 
Care Med, vol. 167, pp. 1548-1553. 
Roy, CS & Sherrington, CS 1890, 'On the Regulation of the Blood-supply of the Brain', J 
Physiol, vol. 11, pp. 85-158 117. 
Ryan, MM, Mason-Parker, SE, Tate, WP, Abraham, WC & Williams, JM 2011, 'Rapidly 
induced gene networks following induction of long-term potentiation at perforant path 
synapses in vivo', Hippocampus, vol. 21, pp. 541-553. 
Ryan, MM, Ryan, B, Kyrke-Smith, M, Logan, B, Tate, WP, Abraham, WC & Williams, JM 
2012, 'Temporal profiling of gene networks associated with the late phase of long-term 
potentiation in vivo', PLoS One, vol. 7. 
Ryan, TJ, Kopanitsa, MV, Indersmitten, T, Nithianantharajah, J, Afinowi, NO, Pettit, C, . . . 
Komiyama, NH 2013, 'Evolution of GluN2A/B cytoplasmic domains diversified vertebrate 
synaptic plasticity and behavior', Nat Neurosci, vol. 16, pp. 25-32. 
Rybnikova, E, Vataeva, L, Tyulkova, E, Gluschenko, T, Otellin, V, Pelto-Huikko, M & 
Samoilov, MO 2005, 'Mild hypoxia preconditioning prevents impairment of passive 
avoidance learning and suppression of brain NGFI-A expression induced by severe 
hypoxia', Behav Brain Res, vol. 160, pp. 107-114. 
Ryu, EJ, Harding, HP, Angelastro, JM, Vitolo, OV, Ron, D & Greene, LA 2002, 
'Endoplasmic reticulum stress and the unfolded protein response in cellular models of 
Parkinson's disease', J Neurosci, vol. 22, pp. 10690-10698. 
Saito, K, Ishizuka, A, Siomi, H & Siomi, MC 2005, 'Processing of pre-microRNAs by the 
Dicer-1-Loquacious complex in Drosophila cells', PLoS Biol, vol. 3. 
Santos, RM, Lourenco, CF, Pomerleau, F, Huettl, P, Gerhardt, GA, Laranjinha, J & 
Barbosa, RM 2011, 'Brain nitric oxide inactivation is governed by the vasculature', Antioxid 
Redox Signal, vol. 14, pp. 1011-1021. 
Sarkar, S, Jun, S, Rellick, S, Quintana, DD, Cavendish, JZ & Simpkins, JW 2016, 
'Expression of microRNA-34a in Alzheimer's disease brain targets genes linked to synaptic 
plasticity, energy metabolism, and resting state network activity', Brain Res, vol. 1646, pp. 
139-151. 
Sato, K, Ogoh, S, Hirasawa, A, Oue, A & Sadamoto, T 2011, 'The distribution of blood flow 
in the carotid and vertebral arteries during dynamic exercise in humans', J Physiol, vol. 
589, pp. 2847-2856. 
Satzger, I, Mattern, A, Kuettler, U, Weinspach, D, Voelker, B, Kapp, A & Gutzmer, R 2010, 
'MicroRNA-15b represents an independent prognostic parameter and is correlated with 
tumor cell proliferation and apoptosis in malignant melanoma', Int J Cancer, vol. 126, pp. 
2553-2562. 
Sayin, U, Osting, S, Hagen, J, Rutecki, P & Sutula, T 2003, 'Spontaneous seizures and 
loss of axo-axonic and axo-somatic inhibition induced by repeated brief seizures in kindled 
rats', J Neurosci, vol. 23, pp. 2759-2768. 
Schafer, FQ & Buettner, GR 2001, 'Redox environment of the cell as viewed through the 
redox state of the glutathione disulfide/glutathione couple', Free Radic Biol Med, vol. 30, 
pp. 1191-1212. 
   161 
Schaller, B, Xin, L, O'Brien, K, Magill, AW & Gruetter, R 2014, 'Are glutamate and lactate 
increases ubiquitous to physiological activation? A (1)H functional MR spectroscopy study 
during motor activation in human brain at 7Tesla', Neuroimage, vol. 93 Pt 1, pp. 138-145. 
Schlief, ML, Craig, AM & Gitlin, JD 2005, 'NMDA receptor activation mediates copper 
homeostasis in hippocampal neurons', J Neurosci, vol. 25, pp. 239-246. 
Schmand, B, Smit, JH, Geerlings, MI & Lindeboom, J 1997, 'The effects of intelligence and 
education on the development of dementia. A test of the brain reserve hypothesis', 
Psychol Med, vol. 27, pp. 1337-1344. 
Schmitz, TW, Correia, MM, Ferreira, CS, Prescot, AP & Anderson, MC 2017, 
'Hippocampal GABA enables inhibitory control over unwanted thoughts', Nat Commun, vol. 
8. 
Schouten, M, Fratantoni, SA, Hubens, CJ, Piersma, SR, Pham, TV, Bielefeld, P, . . . 
Fitzsimons, CP 2015, 'MicroRNA-124 and -137 cooperativity controls caspase-3 activity 
through BCL2L13 in hippocampal neural stem cells', Sci Rep, vol. 5. 
Schrag, M, Mueller, C, Oyoyo, U, Smith, MA & Kirsch, WM 2011, 'Iron, zinc and copper in 
the Alzheimer's disease brain: a quantitative meta-analysis. Some insight on the influence 
of citation bias on scientific opinion', Prog Neurobiol, vol. 94, pp. 296-306. 
Schurr, A, Miller, JJ, Payne, RS & Rigor, BM 1999, 'An increase in lactate output by brain 
tissue serves to meet the energy needs of glutamate-activated neurons', J Neurosci, vol. 
19, pp. 34-39. 
Schurr, A, West, CA & Rigor, BM 1988, 'Lactate-supported synaptic function in the rat 
hippocampal slice preparation', Science, vol. 240, pp. 1326-1328. 
Seibenhener, ML & Wooten, MC 2015, 'Use of the Open Field Maze to measure locomotor 
and anxiety-like behavior in mice', J Vis Exp. 
Selbach, M, Schwanhausser, B, Thierfelder, N, Fang, Z, Khanin, R & Rajewsky, N 2008, 
'Widespread changes in protein synthesis induced by microRNAs', Nature, vol. 455, pp. 
58-63. 
Sheth, U & Parker, R 2003, 'Decapping and decay of messenger RNA occur in 
cytoplasmic processing bodies', Science, vol. 300, pp. 805-808. 
Shi, H & Liu, KJ 2006, 'Effects of glucose concentration on redox status in rat primary 
cortical neurons under hypoxia', Neurosci Lett, vol. 410, pp. 57-61. 
Shibata, M, Yamada, S, Kumar, SR, Calero, M, Bading, J, Frangione, B, . . . Zlokovic, BV 
2000, 'Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-
related protein-1 at the blood-brain barrier', J Clin Invest, vol. 106, pp. 1489-1499. 
Shin, C, Nam, JW, Farh, KK, Chiang, HR, Shkumatava, A & Bartel, DP 2010, 'Expanding 
the microRNA targeting code: functional sites with centered pairing', Mol Cell, vol. 38, pp. 
789-802. 
Sholl, DA 1953, 'Dendritic organization in the neurons of the visual and motor cortices of 
the cat', J Anat, vol. 87, pp. 387-406. 
Sienski, G, Donertas, D & Brennecke, J 2012, 'Transcriptional silencing of transposons by 
Piwi and maelstrom and its impact on chromatin state and gene expression', Cell, vol. 151, 
pp. 964-980. 
Silverman, DH, Small, GW, Chang, CY, Lu, CS, Kung De Aburto, MA, Chen, W, . . . 
Phelps, ME 2001, 'Positron emission tomography in evaluation of dementia: Regional 
brain metabolism and long-term outcome', JAMA, vol. 286, pp. 2120-2127. 
   162 
Simon-Sanchez, J, Schulte, C, Bras, JM, Sharma, M, Gibbs, JR, Berg, D, . . . Gasser, T 
2009, 'Genome-wide association study reveals genetic risk underlying Parkinson's 
disease', Nat Genet, vol. 41, pp. 1308-1312. 
Sirri, A, Bianchi, V, Pelizzola, M, Mayhaus, M, Ricciardi-Castagnoli, P, Toniolo, D & 
D'Adamo, P 2010, 'Temporal gene expression profile of the hippocampus following trace 
fear conditioning', Brain Res, vol. 1308, pp. 14-23. 
Smalheiser, NR & Lugli, G 2009, 'microRNA regulation of synaptic plasticity', 
Neuromolecular Med, vol. 11, pp. 133-140. 
Small, GW, Mazziotta, JC, Collins, MT, Baxter, LR, Phelps, ME, Mandelkern, MA, . . . et al. 
1995, 'Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk 
for familial Alzheimer disease', JAMA, vol. 273, pp. 942-947. 
Smith, CD, Carney, JM, Tatsumo, T, Stadtman, ER, Floyd, RA & Markesbery, WR 1992, 
'Protein oxidation in aging brain', Ann N Y Acad Sci, vol. 663, pp. 110-119. 
Smith, MA, Harris, PL, Sayre, LM & Perry, G 1997, 'Iron accumulation in Alzheimer 
disease is a source of redox-generated free radicals', Proc Natl Acad Sci U S A, vol. 94, 
pp. 9866-9868. 
Smith, PJ, Blumenthal, JA, Hoffman, BM, Cooper, H, Strauman, TA, Welsh-Bohmer, K, . . . 
Sherwood, A 2010, 'Aerobic exercise and neurocognitive performance: a meta-analytic 
review of randomized controlled trials', Psychosom Med, vol. 72, pp. 239-252. 
Sohal, VS, Zhang, F, Yizhar, O & Deisseroth, K 2009, 'Parvalbumin neurons and gamma 
rhythms enhance cortical circuit performance', Nature, vol. 459, pp. 698-702. 
Song, X, Deng, JH, Liu, CJ & Bai, Y 2005, 'Specific point mutations may not accumulate 
with aging in the mouse mitochondrial DNA control region', Gene, vol. 350, pp. 193-199. 
Steinert, JR, Kopp-Scheinpflug, C, Baker, C, Challiss, RA, Mistry, R, Haustein, MD, . . . 
Forsythe, ID 2008, 'Nitric oxide is a volume transmitter regulating postsynaptic excitability 
at a glutamatergic synapse', Neuron, vol. 60, pp. 642-656. 
Stern, Y, Alexander, GE, Prohovnik, I, Stricks, L, Link, B, Lennon, MC & Mayeux, R 1995, 
'Relationship between lifetime occupation and parietal flow: implications for a reserve 
against Alzheimer's disease pathology', Neurology, vol. 45, pp. 55-60. 
Stern, Y, Gurland, B, Tatemichi, TK, Tang, MX, Wilder, D & Mayeux, R 1994, 'Influence of 
education and occupation on the incidence of Alzheimer's disease', JAMA, vol. 271, pp. 
1004-1010. 
Steward, O & Fass, B 1983, 'Polyribosomes associated with dendritic spines in the 
denervated dentate gyrus: evidence for local regulation of protein synthesis during 
reinnervation', Prog Brain Res, vol. 58, pp. 131-136. 
Steward, O & Levy, WB 1982, 'Preferential localization of polyribosomes under the base of 
dendritic spines in granule cells of the dentate gyrus', J Neurosci, vol. 2, pp. 284-291. 
Steward, O & Schuman, EM 2003, 'Compartmentalized synthesis and degradation of 
proteins in neurons', Neuron, vol. 40, pp. 347-359. 
Stoodley, CJ 2012, 'The cerebellum and cognition: evidence from functional imaging 
studies', Cerebellum, vol. 11, pp. 352-365. 
Stroka, DM, Burkhardt, T, Desbaillets, I, Wenger, RH, Neil, DA, Bauer, C, . . . Candinas, D 
2001, 'HIF-1 is expressed in normoxic tissue and displays an organ-specific regulation 
under systemic hypoxia', FASEB J, vol. 15, pp. 2445-2453. 
   163 
Suh, SW, Jensen, KB, Jensen, MS, Silva, DS, Kesslak, PJ, Danscher, G & Frederickson, 
CJ 2000, 'Histochemically-reactive zinc in amyloid plaques, angiopathy, and degenerating 
neurons of Alzheimer's diseased brains', Brain Res, vol. 852, pp. 274-278. 
Sun, MK, Xu, H & Alkon, DL 2002, 'Pharmacological protection of synaptic function, spatial 
learning, and memory from transient hypoxia in rats', J Pharmacol Exp Ther, vol. 300, pp. 
408-416. 
Sun, X, He, G, Qing, H, Zhou, W, Dobie, F, Cai, F, . . . Song, W 2006, 'Hypoxia facilitates 
Alzheimer's disease pathogenesis by up-regulating BACE1 gene expression', Proc Natl 
Acad Sci U S A, vol. 103, pp. 18727-18732. 
Suzuki, A, Stern, SA, Bozdagi, O, Huntley, GW, Walker, RH, Magistretti, PJ & Alberini, CM 
2011, 'Astrocyte-neuron lactate transport is required for long-term memory formation', Cell, 
vol. 144, pp. 810-823. 
Tabrizi, SJ, Langbehn, DR, Leavitt, BR, Roos, RA, Durr, A, Craufurd, D, . . . investigators, 
T-H 2009, 'Biological and clinical manifestations of Huntington's disease in the longitudinal 
TRACK-HD study: cross-sectional analysis of baseline data', Lancet Neurol, vol. 8, pp. 
791-801. 
Tabrizi, SJ, Workman, J, Hart, PE, Mangiarini, L, Mahal, A, Bates, G, . . . Schapira, AH 
2000, 'Mitochondrial dysfunction and free radical damage in the Huntington R6/2 
transgenic mouse', Ann Neurol, vol. 47, pp. 80-86. 
Tadi, M, Allaman, I, Lengacher, S, Grenningloh, G & Magistretti, PJ 2015, 'Learning-
Induced Gene Expression in the Hippocampus Reveals a Role of Neuron -Astrocyte 
Metabolic Coupling in Long Term Memory', PLoS One, vol. 10. 
Tai, TC, Wong-Faull, DC, Claycomb, R & Wong, DL 2009, 'Hypoxic stress-induced 
changes in adrenergic function: role of HIF1 alpha', J Neurochem, vol. 109, pp. 513-524. 
Takano, T, Tian, GF, Peng, W, Lou, N, Libionka, W, Han, X & Nedergaard, M 2006, 
'Astrocyte-mediated control of cerebral blood flow', Nat Neurosci, vol. 9, pp. 260-267. 
Talpos, JC, McTighe, SM, Dias, R, Saksida, LM & Bussey, TJ 2010, 'Trial-unique, delayed 
nonmatching-to-location (TUNL): a novel, highly hippocampus-dependent automated 
touchscreen test of location memory and pattern separation', Neurobiol Learn Mem, vol. 
94, pp. 341-352. 
Tam, OH, Aravin, AA, Stein, P, Girard, A, Murchison, EP, Cheloufi, S, . . . Hannon, GJ 
2008, 'Pseudogene-derived small interfering RNAs regulate gene expression in mouse 
oocytes', Nature, vol. 453, pp. 534-538. 
Tan, SM, Kirchner, R, Jin, J, Hofmann, O, McReynolds, L, Hide, W & Lieberman, J 2014, 
'Sequencing of captive target transcripts identifies the network of regulated genes and 
functions of primate-specific miR-522', Cell Rep, vol. 8, pp. 1225-1239. 
Teplyuk, NM, Uhlmann, EJ, Gabriely, G, Volfovsky, N, Wang, Y, Teng, J, . . . Krichevsky, 
AM 2016, 'Therapeutic potential of targeting microRNA-10b in established intracranial 
glioblastoma: first steps toward the clinic', EMBO Mol Med, vol. 8, pp. 268-287. 
Terry, RD, Masliah, E, Salmon, DP, Butters, N, DeTeresa, R, Hill, R, . . . Katzman, R 1991, 
'Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major 
correlate of cognitive impairment', Ann Neurol, vol. 30, pp. 572-580. 
Thai, TH, Calado, DP, Casola, S, Ansel, KM, Xiao, C, Xue, Y, . . . Rajewsky, K 2007, 
'Regulation of the germinal center response by microRNA-155', Science, vol. 316, pp. 604-
608. 
   164 
Thornton, JE, Du, P, Jing, L, Sjekloca, L, Lin, S, Grossi, E, . . . Gregory, RI 2014, 
'Selective microRNA uridylation by Zcchc6 (TUT7) and Zcchc11 (TUT4)', Nucleic Acids 
Res, vol. 42, pp. 11777-11791. 
Tognini, P, Putignano, E, Coatti, A & Pizzorusso, T 2011, 'Experience-dependent 
expression of miR-132 regulates ocular dominance plasticity', Nat Neurosci, vol. 14, pp. 
1237-1239. 
Tomita, S, Ueno, M, Sakamoto, M, Kitahama, Y, Ueki, M, Maekawa, N, . . . Takahama, Y 
2003, 'Defective brain development in mice lacking the Hif-1alpha gene in neural cells', 
Mol Cell Biol, vol. 23, pp. 6739-6749. 
Torre, ER & Steward, O 1996, 'Protein synthesis within dendrites: glycosylation of newly 
synthesized proteins in dendrites of hippocampal neurons in culture', J Neurosci, vol. 16, 
pp. 5967-5978. 
Tougu, V, Karafin, A & Palumaa, P 2008, 'Binding of zinc(II) and copper(II) to the full-
length Alzheimer's amyloid-beta peptide', J Neurochem, vol. 104, pp. 1249-1259. 
Trifunovic, A, Wredenberg, A, Falkenberg, M, Spelbrink, JN, Rovio, AT, Bruder, CE, . . . 
Larsson, NG 2004, 'Premature ageing in mice expressing defective mitochondrial DNA 
polymerase', Nature, vol. 429, pp. 417-423. 
Tronche, F, Kellendonk, C, Kretz, O, Gass, P, Anlag, K, Orban, PC, . . . Schutz, G 1999, 
'Disruption of the glucocorticoid receptor gene in the nervous system results in reduced 
anxiety', Nat Genet, vol. 23, pp. 99-103. 
Ullah, MS, Davies, AJ & Halestrap, AP 2006, 'The plasma membrane lactate transporter 
MCT4, but not MCT1, is up-regulated by hypoxia through a HIF-1alpha-dependent 
mechanism', J Biol Chem, vol. 281, pp. 9030-9037. 
van Dellen, A, Blakemore, C, Deacon, R, York, D & Hannan, AJ 2000, 'Delaying the onset 
of Huntington's in mice', Nature, vol. 404, pp. 721-722. 
van Praag, H, Christie, BR, Sejnowski, TJ & Gage, FH 1999, 'Running enhances 
neurogenesis, learning, and long-term potentiation in mice', Proc Natl Acad Sci U S A, vol. 
96, pp. 13427-13431. 
van Zijl, PC, Hua, J & Lu, H 2012, 'The BOLD post-stimulus undershoot, one of the most 
debated issues in fMRI', Neuroimage, vol. 62, pp. 1092-1102. 
Varkonyi-Gasic, E, Wu, R, Wood, M, Walton, EF & Hellens, RP 2007, 'Protocol: a highly 
sensitive RT-PCR method for detection and quantification of microRNAs', Plant Methods, 
vol. 3. 
Velagapudi, SP, Gallo, SM & Disney, MD 2014, 'Sequence-based design of bioactive 
small molecules that target precursor microRNAs', Nat Chem Biol, vol. 10, pp. 291-297. 
Venter, JC, Adams, MD, Myers, EW, Li, PW, Mural, RJ, Sutton, GG, . . . Zhu, X 2001, 'The 
sequence of the human genome', Science, vol. 291, pp. 1304-1351. 
Ventriglia, M, Bucossi, S, Panetta, V & Squitti, R 2012, 'Copper in Alzheimer's disease: a 
meta-analysis of serum, plasma, and cerebrospinal fluid studies', J Alzheimers Dis, vol. 30, 
pp. 981-984. 
Verdoorn, TA, Burnashev, N, Monyer, H, Seeburg, PH & Sakmann, B 1991, 'Structural 
determinants of ion flow through recombinant glutamate receptor channels', Science, vol. 
252, pp. 1715-1718. 
   165 
Verret, L, Mann, EO, Hang, GB, Barth, AM, Cobos, I, Ho, K, . . . Palop, JJ 2012, 'Inhibitory 
interneuron deficit links altered network activity and cognitive dysfunction in Alzheimer 
model', Cell, vol. 149, pp. 708-721. 
Vetere, G, Barbato, C, Pezzola, S, Frisone, P, Aceti, M, Ciotti, M, . . . Ruberti, F 2014, 
'Selective inhibition of miR-92 in hippocampal neurons alters contextual fear memory', 
Hippocampus, vol. 24, pp. 1458-1465. 
Visvanathan, J, Lee, S, Lee, B, Lee, JW & Lee, SK 2007, 'The microRNA miR-124 
antagonizes the anti-neural REST/SCP1 pathway during embryonic CNS development', 
Genes Dev, vol. 21, pp. 744-749. 
Vlachos, IS, Kostoulas, N, Vergoulis, T, Georgakilas, G, Reczko, M, Maragkakis, M, . . . 
Hatzigeorgiou, AG 2012, 'DIANA miRPath v.2.0: investigating the combinatorial effect of 
microRNAs in pathways', Nucleic Acids Res, vol. 40, pp. W498-504. 
Vogt, K, Mellor, J, Tong, G & Nicoll, R 2000, 'The actions of synaptically released zinc at 
hippocampal mossy fiber synapses', Neuron, vol. 26, pp. 187-196. 
Wagenfuhr, L, Meyer, AK, Braunschweig, L, Marrone, L & Storch, A 2015, 'Brain oxygen 
tension controls the expansion of outer subventricular zone-like basal progenitors in the 
developing mouse brain', Development, vol. 142, pp. 2904-2915. 
Wagenfuhr, L, Meyer, AK, Marrone, L & Storch, A 2016, 'Oxygen Tension Within the 
Neurogenic Niche Regulates Dopaminergic Neurogenesis in the Developing Midbrain', 
Stem Cells Dev, vol. 25, pp. 227-238. 
Wainwright, PE, Levesque, S, Krempulec, L, Bulman-Fleming, B & McCutcheon, D 1993, 
'Effects of environmental enrichment on cortical depth and Morris-maze performance in 
B6D2F2 mice exposed prenatally to ethanol', Neurotoxicol Teratol, vol. 15, pp. 11-20. 
Walsh, DM, Klyubin, I, Fadeeva, JV, Cullen, WK, Anwyl, R, Wolfe, MS, . . . Selkoe, DJ 
2002, 'Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal 
long-term potentiation in vivo', Nature, vol. 416, pp. 535-539. 
Waltz, JA & Gold, JM 2007, 'Probabilistic reversal learning impairments in schizophrenia: 
further evidence of orbitofrontal dysfunction', Schizophr Res, vol. 93, pp. 296-303. 
Wang, S, Aurora, AB, Johnson, BA, Qi, X, McAnally, J, Hill, JA, . . . Olson, EN 2008a, 'The 
endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis', Dev 
Cell, vol. 15, pp. 261-271. 
Wang, WX, Fardo, DW, Jicha, GA & Nelson, PT 2017a, 'A Customized Quantitative PCR 
MicroRNA Panel Provides a Technically Robust Context for Studying Neurodegenerative 
Disease Biomarkers and Indicates a High Correlation Between Cerebrospinal Fluid and 
Choroid Plexus MicroRNA Expression', Mol Neurobiol, vol. 54, pp. 8191-8202. 
Wang, WX, Rajeev, BW, Stromberg, AJ, Ren, N, Tang, G, Huang, Q, . . . Nelson, PT 
2008b, 'The expression of microRNA miR-107 decreases early in Alzheimer's disease and 
may accelerate disease progression through regulation of beta-site amyloid precursor 
protein-cleaving enzyme 1', J Neurosci, vol. 28, pp. 1213-1223. 
Wang, X 2016, 'Improving microRNA target prediction by modeling with unambiguously 
identified microRNA-target pairs from CLIP-ligation studies', Bioinformatics, vol. 32, pp. 
1316-1322. 
Wang, X, Liu, D, Huang, HZ, Wang, ZH, Hou, TY, Yang, X, . . . Zhu, LQ 2017b, 'A Novel 
MicroRNA-124/PTPN1 Signal Pathway Mediates Synaptic and Memory Deficits in 
Alzheimer's Disease', Biol Psychiatry. 
   166 
Wang, X, Moualla, D, Wright, JA & Brown, DR 2010a, 'Copper binding regulates 
intracellular alpha-synuclein localisation, aggregation and toxicity', J Neurochem, vol. 113, 
pp. 704-714. 
Wang, X, Xing, A, Xu, C, Cai, Q, Liu, H & Li, L 2010b, 'Cerebrovascular hypoperfusion 
induces spatial memory impairment, synaptic changes, and amyloid-beta oligomerization 
in rats', J Alzheimers Dis, vol. 21, pp. 813-822. 
Wang, Y, Xu, Z, Jiang, J, Xu, C, Kang, J, Xiao, L, . . . Liu, H 2013, 'Endogenous miRNA 
sponge lincRNA-RoR regulates Oct4, Nanog, and Sox2 in human embryonic stem cell 
self-renewal', Dev Cell, vol. 25, pp. 69-80. 
Wani, S & Cloonan, N 2014, 'Profiling direct mRNA-microRNA interactions using synthetic 
biotinylated microRNA-duplexes', bioRxiv. 
Ward, CP, McCoy, JG, McKenna, JT, Connolly, NP, McCarley, RW & Strecker, RE 2009, 
'Spatial learning and memory deficits following exposure to 24 h of sleep fragmentation or 
intermittent hypoxia in a rat model of obstructive sleep apnea', Brain Res, vol. 1294, pp. 
128-137. 
Weclewicz, K, Svensson, L & Kristensson, K 1998, 'Targeting of endoplasmic reticulum-
associated proteins to axons and dendrites in rotavirus-infected neurons', Brain Res Bull, 
vol. 46, pp. 353-360. 
Welsh, SJ, Bellamy, WT, Briehl, MM & Powis, G 2002, 'The redox protein thioredoxin-1 
(Trx-1) increases hypoxia-inducible factor 1alpha protein expression: Trx-1 overexpression 
results in increased vascular endothelial growth factor production and enhanced tumor 
angiogenesis', Cancer Res, vol. 62, pp. 5089-5095. 
Wibrand, K, Panja, D, Tiron, A, Ofte, ML, Skaftnesmo, KO, Lee, CS, . . . Bramham, CR 
2010, 'Differential regulation of mature and precursor microRNA expression by NMDA and 
metabotropic glutamate receptor activation during LTP in the adult dentate gyrus in vivo', 
Eur J Neurosci, vol. 31, pp. 636-645. 
Widagdo, J, Chai, YJ, Ridder, MC, Chau, YQ, Johnson, RC, Sah, P, . . . Anggono, V 2015, 
'Activity-Dependent Ubiquitination of GluA1 and GluA2 Regulates AMPA Receptor 
Intracellular Sorting and Degradation', Cell Rep. 
Williams, J, Dragunow, M, Lawlor, P, Mason, S, Abraham, WC, Leah, J, . . . Tate, W 1995, 
'Krox20 may play a key role in the stabilization of long-term potentiation', Brain Res Mol 
Brain Res, vol. 28, pp. 87-93. 
Wirths, O, Multhaup, G, Czech, C, Blanchard, V, Moussaoui, S, Tremp, G, . . . Bayer, TA 
2001, 'Intraneuronal Abeta accumulation precedes plaque formation in beta-amyloid 
precursor protein and presenilin-1 double-transgenic mice', Neurosci Lett, vol. 306, pp. 
116-120. 
Wu, Q, Dai, Q, Jiang, L, Wang, Y, Yang, T, Miao, J, . . . Han, Y 2017, 'Downregulation of 
microRNA-448 improves isoflurane-induced learning and memory impairment in rats', Mol 
Med Rep, vol. 16, pp. 1578-1583. 
Xu, M, Kobets, A, Du, JC, Lennington, J, Li, L, Banasr, M, . . . Pittenger, C 2015, 'Targeted 
ablation of cholinergic interneurons in the dorsolateral striatum produces behavioral 
manifestations of Tourette syndrome', Proc Natl Acad Sci U S A, vol. 112, pp. 893-898. 
Xu, W, Cormier, R, Fu, T, Covey, DF, Isenberg, KE, Zorumski, CF & Mennerick, S 2000, 
'Slow death of postnatal hippocampal neurons by GABA(A) receptor overactivation', J 
Neurosci, vol. 20, pp. 3147-3156. 
   167 
Xu, W, San Lucas, A, Wang, Z & Liu, Y 2014, 'Identifying microRNA targets in different 
gene regions', BMC Bioinformatics, vol. 15 Suppl 7. 
Yang, H, Takagi, H, Konishi, Y, Ageta, H, Ikegami, K, Yao, I, . . . Setou, M 2008, 
'Transmembrane and ubiquitin-like domain-containing protein 1 (Tmub1/HOPS) facilitates 
surface expression of GluR2-containing AMPA receptors', PLoS One, vol. 3. 
Yang, N & Kazazian, HH, Jr. 2006, 'L1 retrotransposition is suppressed by endogenously 
encoded small interfering RNAs in human cultured cells', Nat Struct Mol Biol, vol. 13, pp. 
763-771. 
Yang, Y, Qu, A, Liu, J, Wang, R, Liu, Y, Li, G, . . . Wang, C 2015, 'Serum miR-210 
Contributes to Tumor Detection, Stage Prediction and Dynamic Surveillance in Patients 
with Bladder Cancer', PLoS One, vol. 10. 
Yao, J, Irwin, RW, Zhao, L, Nilsen, J, Hamilton, RT & Brinton, RD 2009, 'Mitochondrial 
bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's 
disease', Proc Natl Acad Sci U S A, vol. 106, pp. 14670-14675. 
Yashiro, K & Philpot, BD 2008, 'Regulation of NMDA receptor subunit expression and its 
implications for LTD, LTP, and metaplasticity', Neuropharmacology, vol. 55, pp. 1081-
1094. 
Yi, R, Qin, Y, Macara, IG & Cullen, BR 2003, 'Exportin-5 mediates the nuclear export of 
pre-microRNAs and short hairpin RNAs', Genes Dev, vol. 17, pp. 3011-3016. 
Young, D, Lawlor, PA, Leone, P, Dragunow, M & During, MJ 1999, 'Environmental 
enrichment inhibits spontaneous apoptosis, prevents seizures and is neuroprotective', Nat 
Med, vol. 5, pp. 448-453. 
Zampa, F, Bicker, S & Schratt, G 2018, 'Activity-Dependent Pre-miR-134 Dendritic 
Localization Is Required for Hippocampal Neuron Dendritogenesis', Front Mol Neurosci, 
vol. 11. 
Zeng, L, He, X, Wang, Y, Tang, Y, Zheng, C, Cai, H, . . . Yang, GY 2014, 'MicroRNA-210 
overexpression induces angiogenesis and neurogenesis in the normal adult mouse brain', 
Gene Ther, vol. 21, pp. 37-43. 
Zeng, LL, He, XS, Liu, JR, Zheng, CB, Wang, YT & Yang, GY 2016, 'Lentivirus-Mediated 
Overexpression of MicroRNA-210 Improves Long-Term Outcomes after Focal Cerebral 
Ischemia in Mice', CNS Neurosci Ther, vol. 22, pp. 961-969. 
Zeng, Y, Yi, R & Cullen, BR 2005, 'Recognition and cleavage of primary microRNA 
precursors by the nuclear processing enzyme Drosha', EMBO J, vol. 24, pp. 138-148. 
Zhang, B, Yin, CP, Zhao, Q & Yue, SW 2014, 'Upregulation of HIF-1alpha by Hypoxia 
Protect Neuroblastoma Cells from Apoptosis by Promoting Survivin Expression', Asian Pac 
J Cancer Prev, vol. 15, pp. 8251-8257. 
Zhang, S, Chen, S, Liu, A, Wan, J, Tang, L, Zheng, N & Xiong, Y 2017, 'Inhibition of BDNF 
production by MPP(+) through up-regulation of miR-210-3p contributes to dopaminergic 
neuron damage in MPTP model', Neurosci Lett. 
Zhang, S, Zhang, Z, Sandhu, G, Ma, X, Yang, X, Geiger, JD & Kong, J 2007a, 'Evidence 
of oxidative stress-induced BNIP3 expression in amyloid beta neurotoxicity', Brain Res, 
vol. 1138, pp. 221-230. 
Zhang, W, Gao, S, Zhou, X, Xia, J, Chellappan, P, Zhou, X, . . . Jin, H 2010, 'Multiple 
distinct small RNAs originate from the same microRNA precursors', Genome Biol, vol. 11. 
   168 
Zhang, X, Zhou, K, Wang, R, Cui, J, Lipton, SA, Liao, FF, . . . Zhang, YW 2007b, 'Hypoxia-
inducible factor 1alpha (HIF-1alpha)-mediated hypoxia increases BACE1 expression and 
beta-amyloid generation', J Biol Chem, vol. 282, pp. 10873-10880. 
Zhang, Z, Sun, H, Dai, H, Walsh, RM, Imakura, M, Schelter, J, . . . Grandori, C 2009, 
'MicroRNA miR-210 modulates cellular response to hypoxia through the MYC antagonist 
MNT', Cell Cycle, vol. 8, pp. 2756-2768. 
Zhang, ZJ & Reynolds, GP 2002, 'A selective decrease in the relative density of 
parvalbumin-immunoreactive neurons in the hippocampus in schizophrenia', Schizophr 
Res, vol. 55, pp. 1-10. 
Zhao, A, Li, G, Peoc'h, M, Genin, C & Gigante, M 2013, 'Serum miR-210 as a novel 
biomarker for molecular diagnosis of clear cell renal cell carcinoma', Exp Mol Pathol, vol. 
94, pp. 115-120. 
Zheng, C, Wu, Z, Tian, L, Li, D, Wang, X, He, Y, . . . Zhang, H 2018, 'Long Noncoding 
RNA AK12348 is Involved in the Regulation of Myocardial Ischaemia-Reperfusion Injury by 
Targeting PARP and Caspase-3', Heart Lung Circ, vol. 27, pp. e51-e58. 
Zhou, C, Huang, Y & Przedborski, S 2008, 'Oxidative stress in Parkinson's disease: a 
mechanism of pathogenic and therapeutic significance', Ann N Y Acad Sci, vol. 1147, pp. 
93-104. 
Zhu, FQ, Zeng, L, Tang, N, Tang, YP, Zhou, BP, Li, FF, . . . Peng, SS 2016, 'MicroRNA-
155 Downregulation Promotes Cell Cycle Arrest and Apoptosis in Diffuse Large B-Cell 
Lymphoma', Oncol Res, vol. 24, pp. 415-427. 
Zhu, Y, Li, C, Sun, A, Wang, Y & Zhou, S 2015, 'Quantification of microRNA-210 in the 
cerebrospinal fluid and serum: Implications for Alzheimer's disease', Exp Ther Med, vol. 9, 
pp. 1013-1017. 
Zhu, Y, Wang, D, Wang, F, Li, T, Dong, L, Liu, H, . . . Yu, J 2013, 'A comprehensive 
analysis of GATA-1-regulated miRNAs reveals miR-23a to be a positive modulator of 
erythropoiesis', Nucleic Acids Res, vol. 41, pp. 4129-4143. 
 
 
  
 
 
 
 
 
 
 
 
APPENDICES 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   170 
Appendix I 
Appendix 1.1 
Watts M, Pocock R, Claudianos C, ‘Brain Energy and Oxygen Metabolism: Emerging Role 
in Normal Function and Disease’, Frontiers in Molecular Neuroscience, 2018 is available at 
the following link: 
https://doi.org/10.3389/fnmol.2018.00216 
 
Appendix 1.2 
Watts M, Williams SM, Nithiantharajah J, Claudianos C, ‘Hypoxia-induced microRNA-210 
targets neurodegenerative pathways’, Non-coding RNA, 2018 is available at the following 
link: 
https://doi.org/10.3390/ncrna4020010 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   171 
Appendix II 
 
   172 
 
 
   173 
 
 
 
 
   174 
 
 
 
 
 
 
   175 
Appendix III 
Appendices 3.1 – 3.5 are available for download at the following link: 
https://figshare.com/s/e439730e778e55d584bc 
 
